<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12808450</PMID><DateCompleted><Year>2003</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1078-8956</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>7</Issue><PubDate><Year>2003</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.</ArticleTitle><Pagination><StartPage>907</StartPage><EndPage>913</EndPage><MedlinePgn>907-13</MedlinePgn></Pagination><Abstract><AbstractText>Amyloid-beta peptide (Abeta) interacts with the vasculature to influence Abeta levels in the brain and cerebral blood flow, providing a means of amplifying the Abeta-induced cellular stress underlying neuronal dysfunction and dementia. Systemic Abeta infusion and studies in genetically manipulated mice show that Abeta interaction with receptor for advanced glycation end products (RAGE)-bearing cells in the vessel wall results in transport of Abeta across the blood-brain barrier (BBB) and expression of proinflammatory cytokines and endothelin-1 (ET-1), the latter mediating Abeta-induced vasoconstriction. Inhibition of RAGE-ligand interaction suppresses accumulation of Abeta in brain parenchyma in a mouse transgenic model. These findings suggest that vascular RAGE is a target for inhibiting pathogenic consequences of Abeta-vascular interactions, including development of cerebral amyloidosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deane</LastName><ForeName>Rashid</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Frank P. Smith Laboratories for Neurosurgery, Department of Neurosurgery and Division of Neurovascular Biology, Center for Aging and Developmental Biology, University of Rochester Medical Center, Rochester, New York 14642, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du Yan</LastName><ForeName>Shi</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Submamaryan</LastName><ForeName>Ram Kumar</ForeName><Initials>RK</Initials></Author><Author ValidYN="Y"><LastName>LaRue</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Jovanovic</LastName><ForeName>Suzana</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Hogg</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Welch</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Manness</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chang</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jin</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hong</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Ghiso</LastName><ForeName>Jorge</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Frangione</LastName><ForeName>Blas</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Stern</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Ann Marie</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Don L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>Bernd</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Liliensiek</LastName><ForeName>Birgit</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Nawroth</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Hofman</LastName><ForeName>Florence</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Kindy</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Stern</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Zlokovic</LastName><ForeName>Berislav</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG16223</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS34467</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D065128">Endothelin Receptor Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019332">Endothelin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009842">Oligopeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067759">Receptor for Advanced Glycation End Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044022">Receptor, Endothelin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>141595-53-1</RegistryNumber><NameOfSubstance UI="C087220">BQ 610</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="N">Cerebrovascular Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065128" MajorTopicYN="N">Endothelin Receptor Antagonists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019332" MajorTopicYN="N">Endothelin-1</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009842" MajorTopicYN="N">Oligopeptides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067759" MajorTopicYN="N">Receptor for Advanced Glycation End Products</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044022" MajorTopicYN="N">Receptor, Endothelin A</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011971" MajorTopicYN="N">Receptors, Immunologic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>8</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12808450</ArticleId><ArticleId IdType="doi">10.1038/nm890</ArticleId><ArticleId IdType="pii">nm890</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12824464</PMID><DateCompleted><Year>2003</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>14</Issue><PubDate><Year>2003</Year><Month>Jul</Month><Day>08</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway.</ArticleTitle><Pagination><StartPage>8514</StartPage><EndPage>8519</EndPage><MedlinePgn>8514-9</MedlinePgn></Pagination><Abstract><AbstractText>Innate immunity is an evolutionarily ancient system that provides organisms with immediately available defense mechanisms through recognition of pathogen-associated molecular patterns. We show that in the CNS, specific activation of innate immunity through a Toll-like receptor 4 (TLR4)-dependent pathway leads to neurodegeneration. We identify microglia as the major lipopolysaccharide (LPS)-responsive cell in the CNS. TLR4 activation leads to extensive neuronal death in vitro that depends on the presence of microglia. LPS leads to dramatic neuronal loss in cultures prepared from wild-type mice but does not induce neuronal injury in CNS cultures derived from tlr4 mutant mice. In an in vivo model of neurodegeneration, stimulating the innate immune response with LPS converts a subthreshold hypoxic-ischemic insult from no discernable neuronal injury to severe axonal and neuronal loss. In contrast, animals bearing a loss-of-function mutation in the tlr4 gene are resistant to neuronal injury in the same model. The present study demonstrates a mechanistic link among innate immunity, TLRs, and neurodegeneration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lehnardt</LastName><ForeName>Seija</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massillon</LastName><ForeName>Leon</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Follett</LastName><ForeName>Pamela</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Frances E</ForeName><Initials>FE</Initials></Author><Author ValidYN="Y"><LastName>Ratan</LastName><ForeName>Rajiv</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Rosenberg</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><LastName>Volpe</LastName><ForeName>Joseph J</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Vartanian</LastName><ForeName>Timothy</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 NS038475</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 HD018655</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K02N502028</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01NS38475</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30HD18655</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018950">Lipopolysaccharide Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024201" MajorTopicYN="N">Bystander Effect</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002642" MajorTopicYN="N">Chick Embryo</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018920" MajorTopicYN="N">Coculture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005727" MajorTopicYN="N">Ganglia, Spinal</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020925" MajorTopicYN="N">Hypoxia-Ischemia, Brain</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018950" MajorTopicYN="N">Lipopolysaccharide Receptors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008809" MajorTopicYN="N">Mice, Inbred C3H</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>9</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>12</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12824464</ArticleId><ArticleId IdType="pmc">PMC166260</ArticleId><ArticleId IdType="doi">10.1073/pnas.1432609100</ArticleId><ArticleId IdType="pii">1432609100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kreutzberg, G. W. (1996) Trends Neurosci. 19 312-318.</Citation><ArticleIdList><ArticleId IdType="pubmed">8843599</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S. H. &amp; Brosnan, C. (1993) Glia 7 75-83.</Citation><ArticleIdList><ArticleId IdType="pubmed">8423065</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer, P. L., Itagaki, S., Boyes, B. E. &amp; McGeer, E. G. (1988) Neurology 38 1285-1291.</Citation><ArticleIdList><ArticleId IdType="pubmed">3399080</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapp, B. D., Bo, L., Mork, S. &amp; Chang, A. (1999) J. Neuroimmunol. 98 49-56.</Citation><ArticleIdList><ArticleId IdType="pubmed">10426362</ArticleId></ArticleIdList></Reference><Reference><Citation>Giulian, D., Wendt, E., Vaca, K. &amp; Noonan, C. A. (1993) Proc. Natl. Acad. Sci. USA 90 2769-2773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC46177</ArticleId><ArticleId IdType="pubmed">8464887</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald, D. R., Brunden, K. R. &amp; Landreth, G. E. (1997) J. Neurosci. 17 2284-2294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573513</ArticleId><ArticleId IdType="pubmed">9065490</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M. &amp; Przedborski, S. (1999) Nat. Med. 5 1403-1409.</Citation><ArticleIdList><ArticleId IdType="pubmed">10581083</ArticleId></ArticleIdList></Reference><Reference><Citation>Medzhitov, R. &amp; Janeway, C. A., Jr. (1997) Curr. Opin. Immunol. 9 4-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9039775</ArticleId></ArticleIdList></Reference><Reference><Citation>Medzhitov, R. &amp; Janeway, C., Jr. (2000) Immunol. Rev. 173 89-97.</Citation><ArticleIdList><ArticleId IdType="pubmed">10719670</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K. &amp; Akira, S. (1999) J. Immunol. 162 3749-3752.</Citation><ArticleIdList><ArticleId IdType="pubmed">10201887</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright, S. D. (1999) J. Exp. Med. 189 605-609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192938</ArticleId><ArticleId IdType="pubmed">9989974</ArticleId></ArticleIdList></Reference><Reference><Citation>Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C., Ghosh, S. &amp; Janeway, C. A., Jr. (1998) Mol. Cell 2 253-258.</Citation><ArticleIdList><ArticleId IdType="pubmed">9734363</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K. &amp; Kimoto, M. (1999) J. Exp. Med. 189 1777-1782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193086</ArticleId><ArticleId IdType="pubmed">10359581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix, S., Feinstein, D. &amp; Rivest, S. (1998) Brain Pathol. 8 625-640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8098216</ArticleId><ArticleId IdType="pubmed">9804372</ArticleId></ArticleIdList></Reference><Reference><Citation>Laflamme, N. &amp; Rivest, S. (2001) FASEB J. 15 155-163.</Citation><ArticleIdList><ArticleId IdType="pubmed">11149903</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehnardt, S., Lachance, C., Patrizi, S., Lefebvre, S., Follett, P. L., Jensen, F. E., Rosenberg, P. A., Volpe, J. J. &amp; Vartanian, T. (2002) J. Neurosci. 22 2478-2486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758325</ArticleId><ArticleId IdType="pubmed">11923412</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy, T. H., Schnaar, R. L. &amp; Coyle, J. T. (1990) FASEB J. 4 1624-1633.</Citation><ArticleIdList><ArticleId IdType="pubmed">2180770</ArticleId></ArticleIdList></Reference><Reference><Citation>Vartanian, T., Li, Y., Zhao, M. &amp; Stefansson, K. (1995) Mol. Med. 1 732-743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2230017</ArticleId><ArticleId IdType="pubmed">8612196</ArticleId></ArticleIdList></Reference><Reference><Citation>Eklind, S., Mallard, C., Leverin, A. L., Gilland, E., Blomgren, K., Mattsby-Baltzer, I. &amp; Hagberg, H. (2001) Eur. J. Neurosci. 13 1101-1106.</Citation><ArticleIdList><ArticleId IdType="pubmed">11285007</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, R. C., Hudson, P. M., Wilson, B. C., Liu, B., Abel, H. &amp; Hong, J. S. (2000) Neuroscience 97 757-764.</Citation><ArticleIdList><ArticleId IdType="pubmed">10842021</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeohn, G. H., Kim, W. G. &amp; Hong, J. S. (2000) Brain Res. 880 173-177.</Citation><ArticleIdList><ArticleId IdType="pubmed">11033002</ArticleId></ArticleIdList></Reference><Reference><Citation>Becher, B., Fedorowicz, V. &amp; Antel, J. P. (1996) J. Neurosci. Res. 45 375-381.</Citation><ArticleIdList><ArticleId IdType="pubmed">8872897</ArticleId></ArticleIdList></Reference><Reference><Citation>Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) Science 282 2085-2088.</Citation><ArticleIdList><ArticleId IdType="pubmed">9851930</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi, S. T., Lariviere, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P. &amp; Malo, D. (1999) J. Exp. Med. 189 615-625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192941</ArticleId><ArticleId IdType="pubmed">9989976</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G. &amp; Peterson, P. K. (1992) J. Immunol. 149 2736-2741.</Citation><ArticleIdList><ArticleId IdType="pubmed">1383325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, S. C., Liu, W., Dickson, D. W., Brosnan, C. F. &amp; Berman, J. W. (1993) J. Immunol. 150 2659-2667.</Citation><ArticleIdList><ArticleId IdType="pubmed">8454848</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D. K., Ischiropoulos, H. &amp; Przedborski, S. (2002) J. Neurosci. 22 1763-1771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758858</ArticleId><ArticleId IdType="pubmed">11880505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullrich, O., Diestel, A., Eyupoglu, I. Y. &amp; Nitsch, R. (2001) Nat. Cell Biol. 3 1035-1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">11781564</ArticleId></ArticleIdList></Reference><Reference><Citation>Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Jr., Baron, P., Villalba, M., Ferrari, D. &amp; Rossi, F. (1995) Nature 374 647-650.</Citation><ArticleIdList><ArticleId IdType="pubmed">7715705</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Scarano, F. &amp; Baltuch, G. (1999) Annu. Rev. Neurosci. 22 219-240.</Citation><ArticleIdList><ArticleId IdType="pubmed">10202538</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinner, W. A., Bauer, J., Schmidts, M., Lassmann, H. &amp; Hickey, W. F. (1995) Glia 14 257-266.</Citation><ArticleIdList><ArticleId IdType="pubmed">8530183</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson, A., Hao, C. &amp; Fedoroff, S. (1993) Glia 7 25-33.</Citation><ArticleIdList><ArticleId IdType="pubmed">8423059</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickey, W. F., Vass, K. &amp; Lassmann, H. (1992) J. Neuropathol. Exp. Neurol. 51 246-256.</Citation><ArticleIdList><ArticleId IdType="pubmed">1583531</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon, S., Yin, Y., Nguyen, J., Irwin, N. &amp; Benowitz, L. I. (2000) J. Neurosci. 20 4615-4626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772462</ArticleId><ArticleId IdType="pubmed">10844031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyss-Coray, T., Lin, C., Yan, F., Yu, G. Q., Rohde, M., McConlogue, L., Masliah, E. &amp; Mucke, L. (2001) Nat. Med. 7 612-618.</Citation><ArticleIdList><ArticleId IdType="pubmed">11329064</ArticleId></ArticleIdList></Reference><Reference><Citation>Prewitt, C. M., Niesman, I. R., Kane, C. J. &amp; Houle, J. D. (1997) Exp. Neurol. 148 433-443.</Citation><ArticleIdList><ArticleId IdType="pubmed">9417823</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyle, J. T. &amp; Puttfarcken, P. (1993) Science 262 689-695.</Citation><ArticleIdList><ArticleId IdType="pubmed">7901908</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal, M. F. (1995) Ann. Neurol. 38 357-366.</Citation><ArticleIdList><ArticleId IdType="pubmed">7668820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J. M., Grabb, M. C., Zipfel, G. J. &amp; Choi, D. W. (2000) J. Clin. Invest. 106 723-731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC381398</ArticleId><ArticleId IdType="pubmed">10995780</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal, M. F. (1992) Ann. Neurol. 31 119-130.</Citation><ArticleIdList><ArticleId IdType="pubmed">1349466</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J. M., Zipfel, G. J. &amp; Choi, D. W. (1999) Nature 399 A7-A14.</Citation><ArticleIdList><ArticleId IdType="pubmed">10392575</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12832546</PMID><DateCompleted><Year>2003</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>12</Issue><PubDate><Year>2003</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice.</ArticleTitle><Pagination><StartPage>5219</StartPage><EndPage>5226</EndPage><MedlinePgn>5219-26</MedlinePgn></Pagination><Abstract><AbstractText>A critical question in Alzheimer's disease (AD) research is the cause of memory loss that leads to dementia. The amyloid precursor protein + presenilin-1 (APP+PS1) transgenic mouse is a model for amyloid deposition, and like AD, the mice develop memory deficits as amyloid deposits accumulate. We profiled gene expression in these transgenic mice by microarray and quantitative RT-PCR (qRT-PCR). At the age when these animals developed cognitive dysfunction, they had reduced mRNA expression of several genes essential for long-term potentiation and memory formation (Arc, Zif268, NR2B, GluR1, Homer-1a, Nur77/TR3). These changes appeared to be related to amyloid deposition, because mRNA expression was unchanged in the regions that did not accumulate amyloid. Transgene expression was similar in both amyloid-containing and amyloid-free regions of the brain. Interestingly, these changes occurred without apparent changes in synaptic structure, because a number of presynaptic marker mRNAs (growth-associated protein-43, synapsin, synaptophysin, synaptopodin, synaptotagmin, syntaxin) remained stable. Additionally, a number of genes related to inflammation were elevated in transgenic mice, primarily in the regions containing amyloid. In AD cortical tissue, the same memory-associated genes were downregulated. However, all synaptic and neuronal transcripts were reduced, implying that the loss of neurons and synapses contributed to these changes. We conclude that reduced expression of selected genes associated with memory consolidation are linked to memory loss in both circumstances. This suggests that the memory loss in APP+PS1 transgenic mice may model the early memory dysfunction in AD before the degeneration of synapses and neurons.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dickey</LastName><ForeName>Chad A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Alzheimer's Disease Research Laboratory, Department of Pharmacology, University of South Florida, College of Medicine, Tampa, Florida 33612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loring</LastName><ForeName>Jeanne F</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Marcia N</ForeName><Initials>MN</Initials></Author><Author ValidYN="Y"><LastName>Eastman</LastName><ForeName>P Scott</ForeName><Initials>PS</Initials></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>Dave</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG015490</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG018478</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG 15490</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG 18478</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508853">PSEN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017774" MajorTopicYN="N">Long-Term Potentiation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008568" MajorTopicYN="N">Memory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009473" MajorTopicYN="N">Neuronal Plasticity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>8</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12832546</ArticleId><ArticleId IdType="pmc">PMC6741153</ArticleId><ArticleId IdType="pii">23/12/5219</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-12-05219.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ango F, Pin JP, Tu JC, Xiao B, Worley PF, Bockaert J, Fagni L ( 2000) Dendritic and axonal targeting of type 5 metabotropic glutamate receptor is regulated by homer1 proteins and neuronal excitation. J Neurosci 20: 8710&#x2013;8716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6773061</ArticleId><ArticleId IdType="pubmed">11102477</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope CE, Diamond DM ( 2001) Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 891: 42&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">11164808</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin LA, Arendash GW, Gordon G, Diamond DM, DiCarlo G, Dickey C, Ugen KE, Morgan D ( 2003) Short-term A-beta vaccinations do not improve cognitive performance in cognitively-impaired APP+PS1 mice. Behav Neurosci, in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">12802876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi H, Sze CI ( 2002) N-methyl-d-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. J Neurol Sci 200: 11&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">12127670</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolshakov VY, Golan H, Kandel ER, Siegelbaum SA ( 1997) Recruitment of new sites of synaptic transmission during the cAMP-dependent late phase of LTP at CA3&#x2013;CA1 synapses in the hippocampus. Neuron 19: 635&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pubmed">9331354</ArticleId></ArticleIdList></Reference><Reference><Citation>Brakeman PR, Lanahan AA, O'Brien R, Roche K, Barnes CA, Huganir RL, Worley PF ( 1997) Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386: 284&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">9069287</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, Hsiao KK ( 1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2: 271&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pubmed">10195221</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton DA, Mesches MH, Alvarez E, Bickford PC, Browning MD ( 2002) A hippocampal NR2B deficit can mimic age-related changes in long-term potentiation and spatial learning in the Fischer 344 rat. J Neurosci 22: 3628&#x2013;3637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758397</ArticleId><ArticleId IdType="pubmed">11978838</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis S, Vanhoutte P, Pages C, Caboche J, Laroche S ( 2000) The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo J Neurosci 20: 4563&#x2013;4572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772466</ArticleId><ArticleId IdType="pubmed">10844026</ArticleId></ArticleIdList></Reference><Reference><Citation>Deller T, Merten T, Roth SU, Mundel P, Frotscher M ( 2000) Actin-associated protein synaptopodin in the rat hippocampal formation: localization in the spine neck and close association with the spine apparatus of principal neurons. J Comp Neurol 418: 164&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">10701442</ArticleId></ArticleIdList></Reference><Reference><Citation>Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD ( 2001) &#x3b2;-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal &#x3b1;7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci 21: 4125&#x2013;4133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762764</ArticleId><ArticleId IdType="pubmed">11404397</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzjohn SM, Morton RA, Kuenzi F, Rosahl TW, Shearman M, Lewis H, Smith D, Reynolds DS, Davies CH, Collingridge GL, Seabrook GR ( 2001) Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J Neurosci 21: 4691&#x2013;4698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762352</ArticleId><ArticleId IdType="pubmed">11425896</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsberg SD, Hemby SE, Lee VM, Eberwine JH, Trojanowski JQ ( 2000) Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 48: 77&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">10894219</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon MN, King DL, Diamond DM, Jantzen PT, Boyett KV, Hope CE, Hatcher JM, DiCarlo G, Gottschall WP, Morgan D, Arendash GW ( 2001) Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Neurobiol Aging 22: 377&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">11378242</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon MN, Holcomb LA, Jantzen PT, DiCarlo G, Wilcock D, Boyett KW, Connor K, Melachrino J, O'Callaghan JP, Morgan D ( 2002) Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse. Exp Neurol 173: 183&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">11822882</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF, Barnes CA ( 2000) Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J Neurosci 20: 3993&#x2013;4001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772617</ArticleId><ArticleId IdType="pubmed">10818134</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K ( 1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4: 97&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">9427614</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb LA, Gordon MN, Jantzen P, Hsiao K, Duff K, Morgan D ( 1999) Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet 29: 177&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">10547924</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G ( 1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">8810256</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones MW, Errington ML, French PJ, Fine A, Bliss TV, Garel S, Charnay P, Bozon B, Laroche S, Davis S ( 2001) A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat Neurosci 4: 289&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">11224546</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson J, Lynch G, Games D, Seubert P ( 1999) Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res 840: 23&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">10517949</ArticleId></ArticleIdList></Reference><Reference><Citation>Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R ( 2001) A gene expression profile of Alzheimer's disease. DNA Cell Biol 20: 683&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pubmed">11788046</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Zablow L, Kandel ER, Siegelbaum SA ( 1999) Cyclic AMP induces functional presynaptic boutons in hippocampal CA3&#x2013;CA1 neuronal cultures. Nat Neurosci 2: 24&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">10195176</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel Jr DW, Morris JC ( 2001) Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 56: 127&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">11148253</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuoka Y, Picciano M, Malester B, LaFrancois J, Zehr C, Daeschner JM, Olschowka JA, Fonseca MI, O'Banion MK, Tenner AJ, Lemere CA, Duff K ( 2001) Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am J Pathol 158: 1345&#x2013;1354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1891893</ArticleId><ArticleId IdType="pubmed">11290552</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzucchelli C, Vantaggiato C, Ciamei A, Fasano S, Pakhotin P, Krezel W, Welzl H, Wolfer DP, Pages G, Valverde O, Marowsky A, Porrazzo A, Orban PC, Maldonado R, Ehrengruber MU, Cestari V, Lipp HP, Chapman PF, Pouyssegur J, Brambilla R ( 2002) Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34: 807&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pubmed">12062026</ArticleId></ArticleIdList></Reference><Reference><Citation>Minger SL, Honer WG, Esiri MM, McDonald B, Keene J, Nicoll JA, Carter J, Hope T, Francis PT ( 2001) Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J Neuropathol Exp Neurol 60: 929&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pubmed">11589423</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L ( 1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">2011243</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW ( 2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408: 982&#x2013;985.</Citation><ArticleIdList><ArticleId IdType="pubmed">11140686</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris RG ( 1998) Synaptic plasticity. Down with novelty. Nature 394: 834&#x2013;835.</Citation><ArticleIdList><ArticleId IdType="pubmed">9732865</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaetova-Ladinska EB, Garcia-Siera F, Hurt J, Gertz HJ, Xuereb JH, Hills R, Brayne C, Huppert FA, Paykel ES, McGee M, Jakes R, Honer WG, Harrington CR, Wischik CM ( 2000) Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am J Pathol 157: 623&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1850134</ArticleId><ArticleId IdType="pubmed">10934165</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundel P, Heid HW, Mundel TM, Kruger M, Reiser J, Kriz W ( 1997) Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol 139: 193&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2139823</ArticleId><ArticleId IdType="pubmed">9314539</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute on Aging&#x2013;Reagan Institute ( 1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18: S1&#x2013;S2.</Citation><ArticleIdList><ArticleId IdType="pubmed">9330978</ArticleId></ArticleIdList></Reference><Reference><Citation>Routtenberg A, Cantallops I, Zaffuto S, Serrano P, Namgung U ( 2000) Enhanced learning after genetic overexpression of a brain growth protein. Proc Natl Acad Sci USA 97: 7657&#x2013;7662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16601</ArticleId><ArticleId IdType="pubmed">10861025</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittgen TD, Zakrajsek BA ( 2000) Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RTPCR. J Biochem Biophys Methods 46: 69&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">11086195</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein TD, Johnson JA ( 2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci 22: 7380&#x2013;7388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758007</ArticleId><ArticleId IdType="pubmed">12196559</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ ( 1999) Genetic enhancement of learning and memory in mice. Nature 401: 63&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">10485705</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiraboschi P, Hansen LA, Alford M, Masliah E, Thal LJ, Corey-Bloom J ( 2000) The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease. Neurology 55: 1278&#x2013;1283.</Citation><ArticleIdList><ArticleId IdType="pubmed">11087768</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ ( 2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">11932745</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao B, Tu JC, Petralia RS, Yuan JP, Doan A, Breder CD, Ruggiero A, Lanahan AA, Wenthold RJ, Worley PF ( 1998) Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins. Neuron 21: 707&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pubmed">9808458</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki M, Matsuo R, Fukazawa Y, Ozawa F, Inokuchi K ( 2001) Regulated expression of an actin-associated protein, synaptopodin, during long-term potentiation. J Neurochem 79: 192&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">11595771</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue H, Eastman PS, Wang BB, Minor J, Doctolero MH, Nuttall RL, Stack R, Becker JW, Montgomery JR, Vainer M, Johnston R ( 2001) An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. Nucleic Acids Res 29: E41&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC31325</ArticleId><ArticleId IdType="pubmed">11292855</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12836766</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0146-9592</ISSN><JournalIssue CitedMedium="Print"><Volume>28</Volume><Issue>12</Issue><PubDate><Year>2003</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Optics letters</Title><ISOAbbreviation>Opt Lett</ISOAbbreviation></Journal><ArticleTitle>Two-photon imaging to a depth of 1000 microm in living brains by use of a Ti:Al2O3 regenerative amplifier.</ArticleTitle><Pagination><StartPage>1022</StartPage><EndPage>1024</EndPage><MedlinePgn>1022-4</MedlinePgn></Pagination><Abstract><AbstractText>It is shown that two-photon fluorescence images can be obtained throughout almost the entire gray matter of the mouse neocortex by using optically amplified femtosecond pulses. The achieved imaging depth approaches the theoretical limit set by excitation of out-of-focus fluorescence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Theer</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Max-Planck Institute for Medical Research, Johnstrasse 29, D-69120 Heidelberg, Germany. ptheer@mpimf-heidelberg.mpg.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasan</LastName><ForeName>Mazahir T</ForeName><Initials>MT</Initials></Author><Author ValidYN="Y"><LastName>Denk</LastName><ForeName>Winfried</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Opt Lett</MedlineTA><NlmUniqueID>7708433</NlmUniqueID><ISSNLinking>0146-9592</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003911">Dextrans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007202">Indicators and Reagents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008164">Luminescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C015219">fluorescein isothiocyanate dextran</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-22-9</RegistryNumber><NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>D1JT611TNE</RegistryNumber><NameOfSubstance UI="D014025">Titanium</NameOfSubstance></Chemical><Chemical><RegistryNumber>I223NX31W9</RegistryNumber><NameOfSubstance UI="D016650">Fluorescein-5-isothiocyanate</NameOfSubstance></Chemical><Chemical><RegistryNumber>LMI26O6933</RegistryNumber><NameOfSubstance UI="D000537">Aluminum Oxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000537" MajorTopicYN="N">Aluminum Oxide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001808" MajorTopicYN="N">Blood Vessels</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="N">anatomy &amp; histology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="Y">anatomy &amp; histology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="N">anatomy &amp; histology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="N">Cerebrovascular Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003911" MajorTopicYN="N">Dextrans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016650" MajorTopicYN="N">Fluorescein-5-isothiocyanate</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049452" MajorTopicYN="N">Green Fluorescent Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007202" MajorTopicYN="N">Indicators and Reagents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008164" MajorTopicYN="N">Luminescent Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008856" MajorTopicYN="Y">Microscopy, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010487" MajorTopicYN="N">Periaqueductal Gray</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="N">anatomy &amp; histology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017785" MajorTopicYN="Y">Photons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014025" MajorTopicYN="N">Titanium</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12836766</ArticleId><ArticleId IdType="doi">10.1364/ol.28.001022</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12855764</PMID><DateCompleted><Year>2003</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>16</Issue><PubDate><Year>2003</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease.</ArticleTitle><Pagination><StartPage>9256</StartPage><EndPage>9261</EndPage><MedlinePgn>9256-61</MedlinePgn></Pagination><Abstract><AbstractText>Mutations in DJ-1, a human gene with homologues in organisms from all kingdoms of life, have been shown to be associated with autosomal recessive, early onset Parkinson's disease (PARK7). We report here the three-dimensional structure of the DJ-1 protein, determined at a resolution of 1.1 A by x-ray crystallography. The chain fold of DJ-1 resembles those of a bacterial protein, PfpI, that has been annotated as a cysteine protease, and of a domain of a bacterial catalase whose role in the activity of that enzyme is uncertain. In contrast to PfpI, a hexameric protein whose oligomeric structure is essential for its putative proteolytic activity, DJ-1 is a dimer with completely different intersubunit contacts. The proposed catalytic triad of PfpI is absent from the corresponding region of the structure of DJ-1, and biochemical assays fail to detect any protease activity for purified DJ-1. A highly conserved cysteine residue, which is catalytically essential in homologues of DJ-1, shows an extreme sensitivity to radiation damage and may be subject to other forms of oxidative modification as well. The structure suggests that the loss of function caused by the Parkinson's-associated mutation L166P in DJ-1 is due to destabilization of the dimer interface. Taken together, the crystal structure of human DJ-1 plus other observations suggest the possible involvement of this protein in the cellular oxidative stress response and a general etiology of neurodegenerative diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Chemistry and Rosenstiel Basic Medical Sciences Research Center, Brandeis University, 415 South Street, MS 029, Waltham, MA 02454-9110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Hod</LastName><ForeName>Yaacov</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Ringe</LastName><ForeName>Dagmar</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Petsko</LastName><ForeName>Gregory A</ForeName><Initials>GA</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>PDB</DataBankName><AccessionNumberList><AccessionNumber>1P5F</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>P41 RR007707</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RR07707</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019843">Archaeal Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015513">Oncogene Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.2.-</RegistryNumber><NameOfSubstance UI="C105131">PARK7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.2.-</RegistryNumber><NameOfSubstance UI="D000071617">Protein Deglycase DJ-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="C099365">protease I, Pyrococcus furiosus</NameOfSubstance></Chemical><Chemical><RegistryNumber>K848JZ4886</RegistryNumber><NameOfSubstance UI="D003545">Cysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9111-3. doi: 10.1073/pnas.1633722100.</RefSource><PMID Version="1">12886009</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D019843" MajorTopicYN="Y">Archaeal Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002384" MajorTopicYN="N">Catalysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002850" MajorTopicYN="N">Chromatography, Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003545" MajorTopicYN="N">Cysteine</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019281" MajorTopicYN="N">Dimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005808" MajorTopicYN="N">Genes, Recessive</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015513" MajorTopicYN="N">Oncogene Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071617" MajorTopicYN="N">Protein Deglycase DJ-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>10</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>2</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12855764</ArticleId><ArticleId IdType="pmc">PMC170905</ArticleId><ArticleId IdType="doi">10.1073/pnas.1133288100</ArticleId><ArticleId IdType="pii">1133288100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Olanow, C. W. &amp; Tatton, W. G. (1999) Annu. Rev. Neurosci. 22, 123&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">10202534</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson, J. (1817) An Essay on the Shaking Palsy (Sherwood, Neely, and Jones, London).</Citation></Reference><Reference><Citation>Langston, J. W., Ballard, P., Tetrud, J. W. &amp; Irwin, I. (1983) Science 219, 979&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pubmed">6823561</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershanik, O. S. (2002) in Parkinson's Disease and Movement Disorders, eds. Jankovic, J. J. &amp; Tolosa, E. (Lippincott, Williams &amp; Wilkins, Baltimore), pp. 331&#x2013;357.</Citation></Reference><Reference><Citation>Tretiakoff, C. (1919) Th&#xe8;se de M&#xe9;dicine (University of Paris, Paris).</Citation></Reference><Reference><Citation>Lewy, F. (1912) in Handbuch der Neurologie, eds. Lewandowski, M. &amp; Abelsdorff, G. (Springer, Berlin), Vol. 3, pp. 920&#x2013;933.</Citation></Reference><Reference><Citation>Kotzbauer, P. T., Trojanowski, J. Q. &amp; Lee, V. M. (2001) J. Mol. Neurosci. 17, 225&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">11816795</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrag, A. (2002) in Parkinson's Disease and Movement Disorders, eds. Jankovic, J. J. &amp; Tolosa, E. (Lippincott, Williams &amp; Wilkins, Baltimore), pp. 73&#x2013;89.</Citation></Reference><Reference><Citation>Lang, A. E. &amp; Lozano, A. M. (1998) N. Engl. J. Med. 339, 1044&#x2013;1053.</Citation><ArticleIdList><ArticleId IdType="pubmed">9761807</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson, T. M. &amp; Dawson, V. L. (2003) J. Clin. Invest. 111, 145&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151882</ArticleId><ArticleId IdType="pubmed">12531866</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks, A. A., Petursson, H., Jonsson, T., Stefansson, H., Johannsdottir, H. S., Sainz, J., Frigge, M. L., Kong, A., Gulcher, J. R., Stefansson, K. &amp; Sveinbjornsdottir, S. (2002) Ann. Neurol. 52, 549&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">12402251</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) Science 276, 2045&#x2013;2047.</Citation><ArticleIdList><ArticleId IdType="pubmed">9197268</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R. &amp; Goedert, M. (1997) Nature 388, 839&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">9278044</ArticleId></ArticleIdList></Reference><Reference><Citation>Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) Nature 395, 451&#x2013;452.</Citation><ArticleIdList><ArticleId IdType="pubmed">9774100</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. &amp; Suzuki, T. (2000) Nat. Genet. 25, 302&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">10888878</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) Science 299, 256&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">12446870</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagakubo, D., Taira, T., Kitaura, H., Ikeda, M., Tamai, K., Iguchi-Ariga, S. M. &amp; Ariga, H. (1997) Biochem. Biophys. Res. Commun. 231, 509&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pubmed">9070310</ArticleId></ArticleIdList></Reference><Reference><Citation>Niki, T., Takahashi-Niki, K., Taira, T., Iguchi-Ariga, S. M. &amp; Ariga, H. (2003) Mol. Cancer Res. 1, 247&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">12612053</ArticleId></ArticleIdList></Reference><Reference><Citation>Hod, Y., Pentyala, S. N., Whyard, T. C. &amp; El-Maghrabi, M. R. (1999) J. Cell Biochem. 72, 435&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pubmed">10022524</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch, J. E., Barbee, R. R., Roberts, N. L., Suarez, J. D. &amp; Klinefelter, G. R. (1998) 19, 385&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pubmed">9733139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagenfeld, A., Gromoll, J. &amp; Cooper, T. G. (1998) Biochem. Biophys. Res. Commun. 251, 545&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pubmed">9792810</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto, A., Nakagawa, Y., Takeuchi, A., Okawa, K., Iwamatsu, A. &amp; Takanezawa, Y. (2001) Free Radical Res. 35, 301&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">11697128</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto, A. &amp; Nakagawa, Y. (2001) Free Radical Res. 35, 885&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">11811539</ArticleId></ArticleIdList></Reference><Reference><Citation>Cookson, M. R. (2003) Neuron 37, 7&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12526767</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizote, T., Tsuda, M., Nakazawa, T. &amp; Nakayama, H. (1996) Microbiology 142, 2969&#x2013;2974.</Citation><ArticleIdList><ArticleId IdType="pubmed">8885414</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmani, A. H., May, G. S. &amp; Osmani, S. A. (1999) J. Biol. Chem. 274, 23565&#x2013;23569.</Citation><ArticleIdList><ArticleId IdType="pubmed">10438537</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilski, P., Li, M. Y., Ehrenshaft, M., Daub, M. E. &amp; Chignell, C. F. (2000) Photochem. Photobiol. 71, 129&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">10687384</ArticleId></ArticleIdList></Reference><Reference><Citation>Halio, S. B., Blumentals, I. I., Short, S. A., Merrill, B. M. &amp; Kelly, R. M. (1996) J. Bacteriol. 178, 2605&#x2013;2612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC177986</ArticleId><ArticleId IdType="pubmed">8626329</ArticleId></ArticleIdList></Reference><Reference><Citation>Du, X., Choi, I. G., Kim, R., Wang, W., Jancarik, J., Yokota, H. &amp; Kim, S. H. (2000) Proc. Natl. Acad. Sci. USA 97, 14079&#x2013;14084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18874</ArticleId><ArticleId IdType="pubmed">11114201</ArticleId></ArticleIdList></Reference><Reference><Citation>Raushel, F. M., Thoden, J. B. &amp; Holden, H. M. (1999) Biochemistry 38, 7891&#x2013;7899.</Citation><ArticleIdList><ArticleId IdType="pubmed">10387030</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalkin, H. &amp; Smith, J. L. (1998) Adv. Enzymol. Relat. Areas Mol. Biol. 72, 87&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">9559052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda, H., Ishikawa, J., Hanamoto, A., Shinose, M., Kikuchi, H., Shiba, T., Sakaki, Y., Hattori, M. &amp; Omura, S. (2003) Nat. Biotechnol. 21, 526&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">12692562</ArticleId></ArticleIdList></Reference><Reference><Citation>Quigley, P. M., Korotkov, K., Baneyx, F. &amp; Hol, W. G. (2003) Proc. Natl. Acad. Sci. USA 100, 3137&#x2013;3142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC152259</ArticleId><ArticleId IdType="pubmed">12621151</ArticleId></ArticleIdList></Reference><Reference><Citation>Trotter, E. W., Kao, C. M., Berenfeld, L., Botstein, D., Petsko, G. A. &amp; Gray, J. V. (2002) J. Biol. Chem. 277, 44817&#x2013;44825.</Citation><ArticleIdList><ArticleId IdType="pubmed">12239211</ArticleId></ArticleIdList></Reference><Reference><Citation>Otwinowski, Z. &amp; Minor, W. (1997) Methods Enzymol. 276, 307&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">27754618</ArticleId></ArticleIdList></Reference><Reference><Citation>Terwilliger, T. C. &amp; Berendzen, J. (1999) Acta Crystallogr. D 55, 849&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2746121</ArticleId><ArticleId IdType="pubmed">10089316</ArticleId></ArticleIdList></Reference><Reference><Citation>Terwilliger, T. C., Kim, S. H. &amp; Eisenberg, D. (1987) Acta Crystallogr. A 43, 1&#x2013;5.</Citation></Reference><Reference><Citation>Terwilliger, T. C. (2001) Acta Crystallogr. D 57, 1763&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2745887</ArticleId><ArticleId IdType="pubmed">11717488</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones, T. A., Zou, J. Y., Cowan, S. W. &amp; Kjeldgaard, M. (1991) Acta Crystallogr. A 47, 110&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">2025413</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldrick, G. M. &amp; Schneider, T. R. (1997) Methods Enzymol. 277, 319&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">18488315</ArticleId></ArticleIdList></Reference><Reference><Citation>Laskowski, R. A., Macarthur, M. W., Moss, D. S. &amp; Thornton, J. M. (1993) J. Appl. Crystallogr. 26, 283&#x2013;291.</Citation></Reference><Reference><Citation>Horvath, M. M. &amp; Grishin, N. V. (2001) Proteins 42, 230&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">11119647</ArticleId></ArticleIdList></Reference><Reference><Citation>Loewen, P. (1996) Gene 179, 39&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">8955627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ondrechen, M. J., Clifton, J. G. &amp; Ringe, D. (2001) Proc. Natl. Acad. Sci. USA 98, 12473&#x2013;12478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC60078</ArticleId><ArticleId IdType="pubmed">11606719</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi, K., Taira, T., Niki, T., Seino, C., Iguchi-Ariga, S. M. &amp; Ariga, H. (2001) J. Biol. Chem. 276, 37556&#x2013;37563.</Citation><ArticleIdList><ArticleId IdType="pubmed">11477070</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowther, W. T., Brot, N., Weissbach, H. &amp; Matthews, B. W. (2000) Biochemistry 39, 13307&#x2013;13312.</Citation><ArticleIdList><ArticleId IdType="pubmed">11063566</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissbach, H., Etienne, F., Hoshi, T., Heinemann, S. H., Lowther, W. T., Matthews, B., St. John, G., Nathan, C. &amp; Brot, N. (2002) Arch. Biochem. Biophys. 397, 172&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">11795868</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, D. W., Ahmad, R., Hague, S., Baptista, M. J., Canet-Aviles, R., McLendon, C., Carter, D. M., Zhu, P.-P., Stadler, J., Klinefelter, G. R., et al. (2003) J. Biol. Chem., in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">12851414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman, M. Y. &amp; Goldberg, A. L. (2001) Neuron 29, 15&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">11182078</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenn, T. D., Ringe, D. &amp; Petsko, G. A. (2003) J. Appl. Crystallogr. 36, 944&#x2013;947.</Citation></Reference><Reference><Citation>Tao, X. &amp; Tong, L. (2003) J. Biol. Chem., in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">12761214</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12859672</PMID><DateCompleted><Year>2003</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3042</ISSN><JournalIssue CitedMedium="Print"><Volume>86</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of neurochemistry</Title><ISOAbbreviation>J Neurochem</ISOAbbreviation></Journal><ArticleTitle>Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.</ArticleTitle><Pagination><StartPage>582</StartPage><EndPage>590</EndPage><MedlinePgn>582-90</MedlinePgn></Pagination><Abstract><AbstractText>Neurofibrillary tangles are composed of insoluble aggregates of the microtubule-associated protein tau. In Alzheimer's disease the accumulation of neurofibrillary tangles occurs in the absence of tau mutations. Here we present mice that develop pathology from non-mutant human tau, in the absence of other exogenous factors, including beta-amyloid. The pathology in these mice is Alzheimer-like, with hyperphosphorylated tau accumulating as aggregated paired helical filaments. This pathologic tau accumulates in the cell bodies and dendrites of neurons in a spatiotemporally relevant distribution.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andorfer</LastName><ForeName>Cathy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departments of Neuroscience and Pathology, Albert Einstein College of Medicine, Bronx, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kress</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Espinoza</LastName><ForeName>Marisol</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>de Silva</LastName><ForeName>Rohan</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Tucker</LastName><ForeName>Kerry L</ForeName><Initials>KL</Initials></Author><Author ValidYN="Y"><LastName>Barde</LastName><ForeName>Yves-Alain</ForeName><Initials>YA</Initials></Author><Author ValidYN="Y"><LastName>Duff</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG022102</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH 38623</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS 07098</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurochem</MedlineTA><NlmUniqueID>2985190R</NlmUniqueID><ISSNLinking>0022-3042</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D046911">Macromolecular Substances</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017398" MajorTopicYN="N">Alternative Splicing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001923" MajorTopicYN="N">Brain Chemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003712" MajorTopicYN="N">Dendrites</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046911" MajorTopicYN="N">Macromolecular Substances</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016874" MajorTopicYN="N">Neurofibrillary Tangles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>9</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12859672</ArticleId><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01879.x</ArticleId><ArticleId IdType="pii">1879</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12860573</PMID><DateCompleted><Year>2003</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-9926</ISSN><JournalIssue CitedMedium="Print"><Volume>163</Volume><Issue>13</Issue><PubDate><Year>2003</Year><Month>Jul</Month><Day>14</Day></PubDate></JournalIssue><Title>Archives of internal medicine</Title><ISOAbbreviation>Arch Intern Med</ISOAbbreviation></Journal><ArticleTitle>An 18-year follow-up of overweight and risk of Alzheimer disease.</ArticleTitle><Pagination><StartPage>1524</StartPage><EndPage>1528</EndPage><MedlinePgn>1524-8</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Overweight and obesity are epidemic in Western societies and constitute a major public health problem because of adverse effects on vascular health. Vascular factors may play a role in the development of a rapidly growing disease of late life, Alzheimer disease (AD). Using body mass index (BMI, calculated as weight in kilograms divided by the square of height in meters), we examined whether overweight is a risk factor for dementia and AD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The relationship between BMI and dementia risk was investigated in a representative cohort of 392 nondemented Swedish adults who were followed up from age 70 to 88 years, with the use of neuropsychiatric, anthropometric, and other measurements. Multivariate Cox proportional hazards regression analyses included BMI, blood pressure, cardiovascular disease, cigarette smoking, socioeconomic status, and treatment for hypertension.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During the 18-year follow-up (4184.8 risk-years), 93 participants were diagnosed as having dementia. Women who developed dementia between ages 79 and 88 years were overweight, with a higher average BMI at age 70 years (27.7 vs 25.7; P =.007), 75 years (27.9 vs 25.0; P&lt;.001), and 79 years (26.9 vs 25.1; P =.02) compared with nondemented women. A higher degree of overweight was observed in women who developed AD at 70 years (29.3; P =.009), 75 years (29.6; P&lt;.001), and 79 years (28.2; P =.003) compared with nondemented women. For every 1.0 increase in BMI at age 70 years, AD risk increased by 36%. These associations were not found in men.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Overweight is epidemic in Western societies. Our data suggest that overweight at high ages is a risk factor for dementia, particularly AD, in women. This may have profound implications for dementia prevention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gustafson</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Food Sciences, Utah State University, Logan, USA. deb.gustafson@neuro.gu.se</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothenberg</LastName><ForeName>Elisabet</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Blennow</LastName><ForeName>Kaj</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Steen</LastName><ForeName>Bertil</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Skoog</LastName><ForeName>Ingmar</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Intern Med</MedlineTA><NlmUniqueID>0372440</NlmUniqueID><ISSNLinking>0003-9926</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Arch Intern Med. 2004 Jan 12;164(1):109-10; author reply 110. doi: 10.1001/archinte.164.1.109-b.</RefSource><PMID Version="1">14718338</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>8</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12860573</ArticleId><ArticleId IdType="doi">10.1001/archinte.163.13.1524</ArticleId><ArticleId IdType="pii">163/13/1524</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12869766</PMID><DateCompleted><Year>2003</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>301</Volume><Issue>5631</Issue><PubDate><Year>2003</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.</ArticleTitle><Pagination><StartPage>386</StartPage><EndPage>389</EndPage><MedlinePgn>386-9</MedlinePgn></Pagination><Abstract><AbstractText>In a prospective-longitudinal study of a representative birth cohort, we tested why stressful experiences lead to depression in some people but not in others. A functional polymorphism in the promoter region of the serotonin transporter (5-HT T) gene was found to moderate the influence of stressful life events on depression. Individuals with one or two copies of the short allele of the 5-HT T promoter polymorphism exhibited more depressive symptoms, diagnosable depression, and suicidality in relation to stressful life events than individuals homozygous for the long allele. This epidemiological study thus provides evidence of a gene-by-environment interaction, in which an individual's response to environmental insults is moderated by his or her genetic makeup.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caspi</LastName><ForeName>Avshalom</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Research Council Social, Genetic, and Developmental Psychiatry Research Centre, Institute of Psychiatry, King's College London, PO80 De Crespigny Park, London, SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugden</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Moffitt</LastName><ForeName>Terrie E</ForeName><Initials>TE</Initials></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Craig</LastName><ForeName>Ian W</ForeName><Initials>IW</Initials></Author><Author ValidYN="Y"><LastName>Harrington</LastName><ForeName>HonaLee</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>McClay</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Mill</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Judy</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Braithwaite</LastName><ForeName>Antony</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Poulton</LastName><ForeName>Richie</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MH45070</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH49414</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026901">Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C493230">SLC6A4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050486">Serotonin Plasma Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.4.3.4</RegistryNumber><NameOfSubstance UI="D008995">Monoamine Oxidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Science. 2003 Jul 18;301(5631):291-3. doi: 10.1126/science.301.5631.291a.</RefSource><PMID Version="1">12869733</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="Y">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002649" MajorTopicYN="N">Child Abuse</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026901" MajorTopicYN="Y">Membrane Transport Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008995" MajorTopicYN="N">Monoamine Oxidase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="Y">Nerve Tissue Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050486" MajorTopicYN="N">Serotonin Plasma Membrane Transport Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013406" MajorTopicYN="N">Suicide, Attempted</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>8</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12869766</ArticleId><ArticleId IdType="doi">10.1126/science.1083968</ArticleId><ArticleId IdType="pii">301/5631/386</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12872001</PMID><DateCompleted><Year>2003</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>17</Issue><PubDate><Year>2003</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.</ArticleTitle><Pagination><StartPage>9980</StartPage><EndPage>9985</EndPage><MedlinePgn>9980-5</MedlinePgn></Pagination><Abstract><AbstractText>Frontotemporal dementia with parkinsonism chromosome 17 type (FTDP-17) is caused by mutations in MAPT, the gene encoding tau. FTDP-17 begins with executive function deficits and other abnormal behaviors, which progress to dementia. Neurodegenerative changes include accumulation of aggregated tau as neuronal and glial fibrillary tangles. Aggregated tau is seen in numerous other neurodegenerative diseases, including Alzheimer's disease (AD). We expressed normal and FTDP-17 mutant human tau (mutations P301L and V337M) in Caenorhabditis elegans to model tauopathy disorders. Tau pan-neuronal expression caused progressive uncoordinated locomotion (Unc), characteristic of nervous system defects in worms. Subsequently, insoluble tau accumulates and both soluble and insoluble tau is phosphorylated at many of the sites hyperphosphorylated in FTDP-17, AD, and other tauopathies. Substantial neurodegeneration, seen as bulges and gaps in nerve cords followed by loss of neurons, occurs after insoluble tau begins to accumulate. Axons show vacuoles, membranous infoldings, and whorls with associated amorphous tau accumulations and abnormal tau-positive aggregates. FTDP-17 mutation lines had a more severe Unc phenotype, accumulated more insoluble tau at a younger age, were more resistant to cholinergic inhibitors, and had more severe axonal degeneration when compared with lines expressing normal tau. The Unc phenotype is caused by a presynaptic defect. Postsynaptic transmission is intact. This transgenic model will enable mechanistic dissection of tau-induced neurodegeneration and identification of genes and compounds that inhibit pathological tau formation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kraemer</LastName><ForeName>Brian C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108-1597, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Bin</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Leverenz</LastName><ForeName>James B</ForeName><Initials>JB</Initials></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>James H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Trojanowski</LastName><ForeName>John Q</ForeName><Initials>JQ</Initials></Author><Author ValidYN="Y"><LastName>Schellenberg</LastName><ForeName>Gerard D</ForeName><Initials>GD</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM048700</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG 17583</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM 48700</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C054369">MAPT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9653-5. doi: 10.1073/pnas.1834191100.</RefSource><PMID Version="1">12913116</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017173" MajorTopicYN="N">Caenorhabditis elegans</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016253" MajorTopicYN="N">Microscopy, Immunoelectron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024801" MajorTopicYN="N">Tauopathies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>10</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12872001</ArticleId><ArticleId IdType="pmc">PMC187908</ArticleId><ArticleId IdType="doi">10.1073/pnas.1533448100</ArticleId><ArticleId IdType="pii">1533448100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) Nature 393, 702&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pubmed">9641683</ArticleId></ArticleIdList></Reference><Reference><Citation>Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M. &amp; Schellenberg, C. D. (1998) Ann. Neurol. 43, 815&#x2013;825.</Citation><ArticleIdList><ArticleId IdType="pubmed">9629852</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A. &amp; Ghetti, B. (1998) Proc. Natl. Acad. Sci. USA 95, 7737&#x2013;7741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22742</ArticleId><ArticleId IdType="pubmed">9636220</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B. I., Geschwind, D. H., Bird, T. D., McKeel, D. Goate, A., et al. (1998) Science 282, 1914&#x2013;1917.</Citation><ArticleIdList><ArticleId IdType="pubmed">9836646</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert, M., Jakes, R. &amp; Crowther, R. A. (1999) FEBS Lett. 450, 306&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">10359094</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacharaju, P., Lewis, J., Easson, C., Yen, S., Hackett, J., Hutton, M. &amp; Yen, S. H. (1999) FEBS Lett. 447, 195&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">10214944</ArticleId></ArticleIdList></Reference><Reference><Citation>Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A. &amp; Hof, P. R. (2000) Brain Res. Rev. 33, 95&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">10967355</ArticleId></ArticleIdList></Reference><Reference><Citation>K. Iwasaki, K., Staunton, J., Saifee, O., Nonet, M. &amp; Thomas, J. H. (1997) Neuron 18, 613&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pubmed">9136770</ArticleId></ArticleIdList></Reference><Reference><Citation>Taub, J., Lau, J. F., Ma, C., Hahn, J. H., Hoque, R., Rothblatt, J. &amp; Chalfie, M. (1999) Nature 399, 162&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">10335847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M. K., Trojanowski, J. Q. &amp; Lee, V. M. Y. (1999) Neuron 24, 751&#x2013;762.</Citation><ArticleIdList><ArticleId IdType="pubmed">10595524</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlowe, E. &amp; Lane, D. (1999) in Using Antibodies: A Laboratory Manual (Cold Spring Harbor Lab. Press, Plainview, NY), pp. 153&#x2013;219 and 269&#x2013;309.</Citation></Reference><Reference><Citation>Ishihara, T., Zhang, B., Higuchi, M., Yoshiyama, Y., Trojanowski, J. Q. &amp; Lee, V. M. Y. (2001) Am. J. Pathol. 158, 555&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1850303</ArticleId><ArticleId IdType="pubmed">11159192</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, C. M. &amp; Swash, M. (1978) Ann. Neurol. 3, 471&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">209723</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, V. M. Y., Balin, B. J., Otvos, L. &amp; Trojanowski, J. Q. (1991) Science 251, 675&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pubmed">1899488</ArticleId></ArticleIdList></Reference><Reference><Citation>Barghorn, S., Zheng-Fischhofer, Q., Ackmann, M., Biernat, J., von Bergen, M., Mandelkow, E.-M. &amp; Mandelkow, E. (2000) Biochemistry 39, 11714&#x2013;11721.</Citation><ArticleIdList><ArticleId IdType="pubmed">10995239</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamblin, T. C., King, M. E., Kuret, J., Berry, R. W. &amp; Binder, L. I. (2000) Biochemistry 39, 14203&#x2013;14210.</Citation><ArticleIdList><ArticleId IdType="pubmed">11087369</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis, J. A., Wu, C. H., Levine, J. H. &amp; Berg, H. (1980) Neuroscience 5, 967&#x2013;989.</Citation><ArticleIdList><ArticleId IdType="pubmed">7402460</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas, J. H. (1990) Genetics 124, 855&#x2013;872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1203977</ArticleId><ArticleId IdType="pubmed">2323555</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntire, S. L., Garriga, G., White, J., Jacobson, D. &amp; Horvitz, H. R. (1992) Neuron 8, 307&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">1739461</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonet, M. L., Grundahl, K., Meyer, B. J. &amp; Rand, J. B. (1993) Cell 73, 1291&#x2013;1305.</Citation><ArticleIdList><ArticleId IdType="pubmed">8391930</ArticleId></ArticleIdList></Reference><Reference><Citation>Avery, L., Bargmann, C. I. &amp; Horvitz, H. R. (1993) Genetics 134, 455&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1205489</ArticleId><ArticleId IdType="pubmed">8325482</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen, M., Alfonso, A., Johnson, C. D. &amp; Rand, J. B. (1995) Genetics 140, 527&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1206632</ArticleId><ArticleId IdType="pubmed">7498734</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, Y., Jorgensen, E., Hartwieg, E. &amp; Horvitz, H. R. (1999) J. Neurosci. 19, 539&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782196</ArticleId><ArticleId IdType="pubmed">9880574</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall, D. H., Gu, G., Garcia-Anoveros, J., Gong, L., Chalfie, M. &amp; Driscoll, M. (1997) J. Neurosci. 17, 1033&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573168</ArticleId><ArticleId IdType="pubmed">8994058</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M. &amp; Feany, M. B. (2001) Science 293, 711&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pubmed">11408621</ArticleId></ArticleIdList></Reference><Reference><Citation>Spittaels, K., Van den Haute, C., Van Dorpe, J., Bruynseels, K., Vandezande, K., Laenen, I., Geerts, H., Mercken, M., Sciot, R., Van Lommel, A., et al. (1999) Am. J. Pathol. 155, 2153&#x2013;2165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866931</ArticleId><ArticleId IdType="pubmed">10595944</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., et al. (2000) Nat. Genet. 25, 402&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">10932182</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini, M. G., Goedert, M., Crowther, R. A., Murrell, J. R., Farlow, M. R. &amp; Ghetti, B. (1997) Proc. Natl. Acad. Sci. USA 94, 4113&#x2013;4118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC20577</ArticleId><ArticleId IdType="pubmed">9108114</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Souza, I., Poorkaj, P., Hong, M., Nochlin, D., Lee, V. M. Y., Bird, T. D. &amp; Schellenberg, G. D. (1999) Proc. Natl. Acad. Sci. USA 96, 5598&#x2013;5603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC21906</ArticleId><ArticleId IdType="pubmed">10318930</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson, G. R., Wiedau-Pazos, M., Sang, T. K., Wagle, N., Brown, C. A., Massachi, S. &amp; Geschwind, D. H. (2002) Neuron 34, 509&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">12062036</ArticleId></ArticleIdList></Reference><Reference><Citation>Spittaels, K., Van den Haute, C., Van Dorpe, J., Geerts, H., Mercken, M., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T., et al. (2000) J. Biol. Chem. 275, 41340&#x2013;41349.</Citation><ArticleIdList><ArticleId IdType="pubmed">11007782</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownlees, J., Irving, N. G., Brion, J. P., Gibb, B. J. M., Wagner, U., Woodgett, J. &amp; Miller, C. C. J. (1997) NeuroReport 8, 3251&#x2013;3255.</Citation><ArticleIdList><ArticleId IdType="pubmed">9351652</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas, J. L., Hernandez, F., Gomezramos, P., Moran, M. A., Hen, R. &amp; Avila, J. (2001) EMBO J. 20, 27&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC140191</ArticleId><ArticleId IdType="pubmed">11226152</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamer, K., Vogel, R., Thies, E., Mandelkow, E. &amp; Mandelkow, E. M. (2002) J. Cell Biol. 156, 1051&#x2013;1063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2173473</ArticleId><ArticleId IdType="pubmed">11901170</ArticleId></ArticleIdList></Reference><Reference><Citation>Higuchi, M., Ishihara, T., Zhang, B., Hong, M., Andreadis, A., Trojanowski, J. Q. &amp; Lee, V. M. Y. (2002) Neuron 35, 433&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">12165467</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels, S. A., Ailion, M., Thomas, J. H. &amp; Sengupta, P. (2000) Genetics 156, 123&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1461244</ArticleId><ArticleId IdType="pubmed">10978280</ArticleId></ArticleIdList></Reference><Reference><Citation>Crittenden, S. L. &amp; Kimble, J. (1999) Methods Mol. Biol. 122, 141&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pubmed">10231789</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12873380</PMID><DateCompleted><Year>2003</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Jul</Month><Day>17</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration.</ArticleTitle><Pagination><StartPage>217</StartPage><EndPage>225</EndPage><MedlinePgn>217-25</MedlinePgn></Pagination><Abstract><AbstractText>Local axon degeneration is a common pathological feature of many neurodegenerative diseases and peripheral neuropathies. While it is believed to operate with an apoptosis-independent molecular program, the underlying molecular mechanisms are largely unknown. In this study, we used the degeneration of transected axons, termed "Wallerian degeneration," as a model to examine the possible involvement of the ubiquitin proteasome system (UPS). Inhibiting UPS activity by both pharmacological and genetic means profoundly delays axon degeneration both in vitro and in vivo. In addition, we found that the fragmentation of microtubules is the earliest detectable change in axons undergoing Wallerian degeneration, which among other degenerative events, can be delayed by proteasome inhibitors. Interestingly, similar to transected axons, degeneration of axons from nerve growth factor (NGF)-deprived sympathetic neurons could also be suppressed by proteasome inhibitors. Our findings suggest a possibility that inhibiting UPS activity may serve to retard axon degeneration in pathological conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhai</LastName><ForeName>Qiwei</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Division of Neuroscience, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jing</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qing</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Watts</LastName><ForeName>Ryan</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Hoopfer</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Mitchison</LastName><ForeName>Timothy</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Liqun</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01-NS41044</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001562">Benzimidazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002614">Chelating Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015853">Cysteine Proteinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007976">Leupeptins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009097">Multienzyme Complexes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014404">Tubulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C098463">dolaisoleucine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C447680">hoechst 32258</NameOfSubstance></Chemical><Chemical><RegistryNumber>526U7A2651</RegistryNumber><NameOfSubstance UI="D004533">Egtazic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9061-61-4</RegistryNumber><NameOfSubstance UI="D020932">Nerve Growth Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D002154">Calpain</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.99.-</RegistryNumber><NameOfSubstance UI="C059237">ubiquitin-Nalpha-protein hydrolase</NameOfSubstance></Chemical><Chemical><RegistryNumber>RF1P63GW3K</RegistryNumber><NameOfSubstance UI="C072553">benzyloxycarbonylleucyl-leucyl-leucine aldehyde</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001562" MajorTopicYN="N">Benzimidazoles</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002154" MajorTopicYN="N">Calpain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002614" MajorTopicYN="N">Chelating Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015853" MajorTopicYN="N">Cysteine Proteinase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003599" MajorTopicYN="N">Cytoskeleton</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004533" MajorTopicYN="N">Egtazic Acid</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005728" MajorTopicYN="N">Ganglia, Sympathetic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007976" MajorTopicYN="N">Leupeptins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008870" MajorTopicYN="N">Microtubules</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009097" MajorTopicYN="N">Multienzyme Complexes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020932" MajorTopicYN="N">Nerve Growth Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009900" MajorTopicYN="N">Optic Nerve</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020221" MajorTopicYN="N">Optic Nerve Injuries</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014404" MajorTopicYN="N">Tubulin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014855" MajorTopicYN="N">Wallerian Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>8</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12873380</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00429-x</ArticleId><ArticleId IdType="pii">S089662730300429X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12873381</PMID><DateCompleted><Year>2003</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Jul</Month><Day>17</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1.</ArticleTitle><Pagination><StartPage>227</StartPage><EndPage>239</EndPage><MedlinePgn>227-39</MedlinePgn></Pagination><Abstract><AbstractText>Huntington's disease (HD) is caused by polyglutamine expansion (exp) in huntingtin (Htt). The type 1 inositol (1,4,5)-triphosphate receptor (InsP3R1) is an intracellular calcium (Ca2+) release channel that plays an important role in neuronal function. In a yeast two-hybrid screen with the InsP3R1 carboxy terminus, we isolated Htt-associated protein-1A (HAP1A). We show that an InsP3R1-HAP1A-Htt ternary complex is formed in vitro and in vivo. In planar lipid bilayer reconstitution experiments, InsP3R1 activation by InsP3 is sensitized by Httexp, but not by normal Htt. Transfection of full-length Httexp or caspase-resistant Httexp, but not normal Htt, into medium spiny striatal neurons faciliates Ca2+ release in response to threshold concentrations of the selective mGluR1/5 agonist 3,5-DHPG. Our findings identify a novel molecular link between Htt and InsP3R1-mediated neuronal Ca2+ signaling and provide an explanation for the derangement of cytosolic Ca2+ signaling in HD patients and mouse models.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Tie-Shan</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Physiology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Huiping</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Edmond Y W</ForeName><Initials>EY</Initials></Author><Author ValidYN="Y"><LastName>Maximov</LastName><ForeName>Anton</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhengnan</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Wellington</LastName><ForeName>Cheryl L</ForeName><Initials>CL</Initials></Author><Author ValidYN="Y"><LastName>Hayden</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Bezprozvanny</LastName><ForeName>Ilya</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS038082</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS38082</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015220">Calcium Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C096896">HAP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086055">HTT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C490758">Hap1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071058">Huntingtin Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C506926">ITPR1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053496">Inositol 1,4,5-Trisphosphate Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008051">Lipid Bilayers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008164">Luminescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-22-9</RegistryNumber><NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>534-82-7</RegistryNumber><NameOfSubstance UI="D008734">Methoxyhydroxyphenylglycol</NameOfSubstance></Chemical><Chemical><RegistryNumber>85166-31-0</RegistryNumber><NameOfSubstance UI="D015544">Inositol 1,4,5-Trisphosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical><Chemical><RegistryNumber>TSN3DL106G</RegistryNumber><NameOfSubstance UI="D016257">Fura-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>UEH9K539KJ</RegistryNumber><NameOfSubstance UI="C010117">3,4-dihydroxyphenylglycol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neuron. 2003 Jul 17;39(2):195-7. doi: 10.1016/s0896-6273(03)00425-2.</RefSource><PMID Version="1">12873376</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015220" MajorTopicYN="N">Calcium Channels</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020013" MajorTopicYN="N">Calcium Signaling</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016257" MajorTopicYN="N">Fura-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049452" MajorTopicYN="N">Green Fluorescent Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071058" MajorTopicYN="N">Huntingtin Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015544" MajorTopicYN="N">Inositol 1,4,5-Trisphosphate</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053496" MajorTopicYN="N">Inositol 1,4,5-Trisphosphate Receptors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008051" MajorTopicYN="N">Lipid Bilayers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008164" MajorTopicYN="N">Luminescent Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008734" MajorTopicYN="N">Methoxyhydroxyphenylglycol</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018408" MajorTopicYN="N">Patch-Clamp Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020798" MajorTopicYN="N">Two-Hybrid System Techniques</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>8</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2011</Year><Month>11</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12873381</ArticleId><ArticleId IdType="mid">NIHMS334104</ArticleId><ArticleId IdType="pmc">PMC3220623</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00366-0</ArticleId><ArticleId IdType="pii">S0896627303003660</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berridge MJ. Neuronal calcium signaling. Neuron. 1998;21:13&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">9697848</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertaux F, Sharp AH, Ross CA, Lehrach H, Bates GP, Wanker E. HAP1-huntingtin interactions do not contribute to the molecular pathology in Huntington&#x2019;s disease transgenic mice. FEBS Lett. 1998;426:229&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">9599014</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezprozvanny I, Watras J, Ehrlich BE. Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature. 1991;351:751&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pubmed">1648178</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabresi P, Centonze D, Pisani A, Bernardi G. Metabotropic glutamate receptors and cell-type-specific vulnerability the striatum: implication for ischemia and Huntington&#x2019;s disease. Exp. Neurol. 1999;158:97&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">10448421</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan EY, Nasir J, Gutekunst CA, Coleman S, Maclean A, Maas A, Metzler M, Gertsenstein M, Ross CA, Nagy A, Hayden MR. Targeted disruption of Huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behavior. Hum. Mol. Genet. 2002;11:945&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pubmed">11971876</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Luo T, Wellington C, Metzler M, McCutcheon K, Hayden MR, Raymond LA. Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J. Neurochem. 1999;72:1890&#x2013;1898.</Citation><ArticleIdList><ArticleId IdType="pubmed">10217265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesselet MF, Mercugliano M, Soghomonian JJ, Salin P, Qin Y, Gonzales C. Regulation of glutamic acid decarboxylase gene expression in efferent neurons of the basal ganglia. Prog. Brain Res. 1993;99:143&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">8108545</ArticleId></ArticleIdList></Reference><Reference><Citation>Colomer V, Engelender S, Sharp AH, Duan K, Cooper JK, Lanahan A, Lyford G, Worley P, Ross CA. Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain. Hum. Mol. Genet. 1997;6:1519&#x2013;1525.</Citation><ArticleIdList><ArticleId IdType="pubmed">9285789</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper JK, Schilling G, Peters MF, Herring WJ, Sharp AH, Kaminsky Z, Masone J, Khan FA, Delanoy M, Borchelt DR, et al. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 1998;7:783&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">9536081</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross AJ, Crow TJ, Johnson JA, Dawson JM, Peters TJ. Loss of endoplasmic reticulum-associated enzymes affected brain regions in Huntington&#x2019;s disease and Alzheimer-type dementia. J. Neurol. Sci. 1985;71:137&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">2935594</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelender S, Sharp AH, Colomer V, Tokito MK, Flanagan A, Worley P, Holzbaur EL, Ross CA. Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum. Mol. Genet. 1997;6:2205&#x2013;2212.</Citation><ArticleIdList><ArticleId IdType="pubmed">9361024</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuichi T, Kohda K, Miyawaki A, Mikoshiba K. Intra-cellular channels. Curr. Opin. Neurobiol. 1994;4:294&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">7522674</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerfen CR. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 1992;15:133&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">1374971</ArticleId></ArticleIdList></Reference><Reference><Citation>Goffredo D, Rigamonti D, Tartari M, De Micheli A, Verderio C, Matteoli M, Zuccato C, Cattaneo E. Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons. J. Biol. Chem. 2002;277:39594&#x2013;39598.</Citation><ArticleIdList><ArticleId IdType="pubmed">12200414</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusella JF, MacDonald ME. Huntingtin: a single bait hooks many species. Curr. Opin. Neurobiol. 1998;8:425&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">9687360</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutekunst CA, Li SH, Yi H, Ferrante RJ, Li XJ, Hersch SM. The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human. J. Neurosci. 1998;18:7674&#x2013;7686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793025</ArticleId><ArticleId IdType="pubmed">9742138</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackam AS, Singaraja R, Wellington CL, Metzler M, McCutcheon K, Zhang T, Kalchman M, Hayden MR. The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 1998;141:1097&#x2013;1105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2137174</ArticleId><ArticleId IdType="pubmed">9606203</ArticleId></ArticleIdList></Reference><Reference><Citation>HDCRG (The Huntington&#x2019;s Disease Collaborative Research Group) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington&#x2019;s disease chromosomes. Cell. 1993;72:971&#x2013;983.</Citation><ArticleIdList><ArticleId IdType="pubmed">8458085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J, et al. A YAC mouse model for Huntington&#x2019;s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron. 1999;23:181&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">10402204</ArticleId></ArticleIdList></Reference><Reference><Citation>Juin P, Pelletier M, Oliver L, Tremblais K, Gregoire M, Meflah K, Vallette FM. Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J. Biol. Chem. 1998;273:17559&#x2013;17564.</Citation><ArticleIdList><ArticleId IdType="pubmed">9651349</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalchman MA, Koide HB, McCutcheon K, Graham RK, Nichol K, Nishiyama K, Kazemi-Esfarjani P, Lynn FC, Wellington C, Metzler M, et al. HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat. Genet. 1997;16:44&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">9140394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaznacheyeva E, Lupu VD, Bezprozvanny I. Single-channel properties of inositol (1,4,5)-trisphosphate receptor heterologously expressed in HEK-293 cells. J. Gen. Physiol. 1998;111:847&#x2013;856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2217157</ArticleId><ArticleId IdType="pubmed">9607940</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerner JA, Standaert DG, Penney JB, Jr, Young AB, Landwehrmeyer GB. Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus. Brain Res. Mol. Brain Res. 1997;48:259&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">9332723</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YJ, Yi Y, Sapp E, Wang Y, Cuiffo B, Kegel KB, Qin ZH, Aronin N, DiFiglia M. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington&#x2019;s disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc. Natl. Acad. Sci. USA. 2001;98:12784&#x2013;12789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC60131</ArticleId><ArticleId IdType="pubmed">11675509</ArticleId></ArticleIdList></Reference><Reference><Citation>Korkotian E, Schwarz A, Pelled D, Schwarzmann G, Segal M, Futerman AH. Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J. Biol. Chem. 1999;274:21673&#x2013;21678.</Citation><ArticleIdList><ArticleId IdType="pubmed">10419477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuppenbender KD, Albers DS, Iadarola MJ, Landwehrmeyer GB, Standaert DG. Localization of alternatively spliced NMDAR1 glutamate receptor isoforms in rat striatal neurons. J. Comp. Neurol. 1999;415:204&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">10545160</ArticleId></ArticleIdList></Reference><Reference><Citation>Landwehrmeyer GB, Standaert DG, Testa CM, Penney JB, Jr, Young AB. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 1995;15:5297&#x2013;5307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6577881</ArticleId><ArticleId IdType="pubmed">7623152</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XJ, Li SH, Sharp AH, Nucifora FC, Jr, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA. A huntingtin-associated protein enriched in brain with implications for pathology. Nature. 1995;378:398&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">7477378</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SH, Gutekunst CA, Hersch SM, Li XJ. Interaction of huntingtin-associated protein with dynactin P150Glued. J. Neurosci. 1998a;18:1261&#x2013;1269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792727</ArticleId><ArticleId IdType="pubmed">9454836</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SH, Hosseini SH, Gutekunst CA, Hersch SM, Ferrante RJ, Li XJ. A human HAP1 homologue. Cloning, expression, and interaction with huntingtin. J. Biol. Chem. 1998b;273:19220&#x2013;19227.</Citation><ArticleIdList><ArticleId IdType="pubmed">9668110</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Chin LS, Levey AI, Li L. Huntingtin-associated protein 1 interacts with hepatocyte growth factor-regulated tyrosine kinase substrate and functions in endosomal trafficking. J. Biol. Chem. 2002;277:28212&#x2013;28221.</Citation><ArticleIdList><ArticleId IdType="pubmed">12021262</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Wang JQ. Upregulation of preprodynorphin and preproenkephalin mRNA expression by selective activation of group I metabotropic glutamate receptors in characterized primary cultures of rat striatal neurons. Brain Res. Mol. Brain Res. 2001;86:125&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">11165379</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Wang JQ. Glutamate cascade to cAMP response element-binding protein phosphorylation in cultured striatal neurons through calcium-coupled group I metabotropic glutamate receptors. Mol. Pharmacol. 2002;62:473&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pubmed">12181423</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto M, Nakagawa T, Inoue T, Nagata E, Tanaka K, Takano H, Minowa O, Kuno J, Sakakibara S, Yamada M, et al. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature. 1996;379:168&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">8538767</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson MP. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 2000;1:120&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">11253364</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson MP, Chan SL. Dysregulation of cellular calcium homeostasis in Alzheimer&#x2019;s disease: bad genes and bad habits. J. Mol. Neurosci. 2001;17:205&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">11816794</ArticleId></ArticleIdList></Reference><Reference><Citation>Maximov A, Bezprozvanny I. Synaptic targeting of N-type calcium channels in hippocampal neurons. J. Neurosci. 2002;22:6939&#x2013;6952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3307533</ArticleId><ArticleId IdType="pubmed">12177192</ArticleId></ArticleIdList></Reference><Reference><Citation>Maximov A, Tang T-S, Bezprozvanny I. Association of the type 1 inositol (1,4,5)-trisphosphate receptor with 4.1N protein in neurons. Mol. Cell. Neurosci. 2003;22:271&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">12676536</ArticleId></ArticleIdList></Reference><Reference><Citation>Menalled LB, Chesselet MF. Mouse models of Huntington&#x2019;s disease. Trends Pharmacol. Sci. 2002;23:32&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">11804649</ArticleId></ArticleIdList></Reference><Reference><Citation>Mignery GA, Newton CL, Archer BT, Sudhof TC. Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 1990;265:12679&#x2013;12685.</Citation><ArticleIdList><ArticleId IdType="pubmed">2165071</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasir J, Goldberg YP, Hayden MR. Huntington disease: new insights into the relationship between CAG expansion and disease. Hum. Mol. Genet. 1996;5:1431&#x2013;1435.</Citation><ArticleIdList><ArticleId IdType="pubmed">8875248</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasir J, Duan K, Nichol K, Engelender S, Ashworth R, Colomer V, Thomas S, Disteche CM, Hayden MR, Ross CA. Gene structure and map location of the murine homolog of the Huntington-associated protein, Hap1. Mamm. Genome. 1998;9:565&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">9657855</ArticleId></ArticleIdList></Reference><Reference><Citation>Page KJ, Potter L, Aronni S, Everitt BJ, Dunnett SB. The expression of Huntingtin-associated protein (HAP1) mRNA in developing, adult and ageing rat CNS: implications for Huntington&#x2019;s disease neuropathology. Eur. J. Neurosci. 1998;10:1835&#x2013;1845.</Citation><ArticleIdList><ArticleId IdType="pubmed">9751154</ArticleId></ArticleIdList></Reference><Reference><Citation>Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT. Early mitochondrial calcium defects in Huntington&#x2019;s disease are a direct effect of polyglutamines. Nat. Neurosci. 2002;5:731&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">12089530</ArticleId></ArticleIdList></Reference><Reference><Citation>Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 1995;34:1&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">7623957</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisani A, Gubellini P, Bonsi P, Conquet F, Picconi B, Centonze D, Bernardi G, Calabresi P. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience. 2001;106:579&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pubmed">11591458</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinsztein DC. Lessons from animal models of Huntington&#x2019;s disease. Trends Genet. 2002;18:202&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">11932021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd Edition. New York: Cold Spring Harbor Laboratory Press; 1989.</Citation></Reference><Reference><Citation>Schoepp DD, Jane DE, Monn JA. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology. 1999;38:1431&#x2013;1476.</Citation><ArticleIdList><ArticleId IdType="pubmed">10530808</ArticleId></ArticleIdList></Reference><Reference><Citation>Singaraja RR, Hadano S, Metzler M, Givan S, Wellington CL, Warby S, Yanai A, Gutekunst CA, Leavitt BR, Yi H, et al. HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis. Hum. Mol. Genet. 2002;11:2815&#x2013;2828.</Citation><ArticleIdList><ArticleId IdType="pubmed">12393793</ArticleId></ArticleIdList></Reference><Reference><Citation>Skeberdis VA, Lan J, Opitz T, Zheng X, Bennett MV, Zukin RS. mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology. 2001;40:856&#x2013;865.</Citation><ArticleIdList><ArticleId IdType="pubmed">11378156</ArticleId></ArticleIdList></Reference><Reference><Citation>Street VA, Bosma MM, Demas VP, Regan MR, Lin DD, Robinson LC, Agnew WS, Tempel BL. The type 1 inositol 1,4,5-trisphosphate receptor gene is altered in the opisthotonos mouse. J. Neurosci. 1997;17:635&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573232</ArticleId><ArticleId IdType="pubmed">8987786</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Savanenin A, Reddy PH, Liu YF. Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95. J. Biol. Chem. 2001;276:24713&#x2013;24718.</Citation><ArticleIdList><ArticleId IdType="pubmed">11319238</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallaksen-Greene SJ, Kaatz KW, Romano C, Albin RL. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Res. 1998;780:210&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">9507137</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang TS, Tu H, Wang Z, Bezprozvanny I. Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase a and protein phosphatase 1alpha. J. Neurosci. 2003;23:403&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6741879</ArticleId><ArticleId IdType="pubmed">12533600</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobin AJ, Signer ER. Huntington&#x2019;s disease: the challenge for cell biologists. Trends Cell Biol. 2000;10:531&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pubmed">11121745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu H, Miyakawa T, Wang Z, Glouchankova L, Iino M, Bezprozvanny I. Functional characterization of the type 1 inositol 1,4,5-trisphosphate receptor coupling domain SII(+/&#x2212;) splice variants and the opisthotonos mutant form. Biophys. J. 2002;82:1995&#x2013;2004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1301995</ArticleId><ArticleId IdType="pubmed">11916857</ArticleId></ArticleIdList></Reference><Reference><Citation>Vonsattel JP, DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 1998;57:369&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">9596408</ArticleId></ArticleIdList></Reference><Reference><Citation>Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP., Jr Neuropathological classification of Huntington&#x2019;s disease. J. Neuropathol. Exp. Neurol. 1985;44:559&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">2932539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellington CL, Singaraja R, Ellerby L, Savill J, Roy S, Leavitt B, Cattaneo E, Hackam A, Sharp A, Thornberry N, et al. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem. 2000;275:19831&#x2013;19838.</Citation><ArticleIdList><ArticleId IdType="pubmed">10770929</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellington CL, Ellerby LM, Gutekunst CA, Rogers D, Warby S, Graham RK, Loubser O, van Raamsdonk J, Singaraja R, Yang YZ, et al. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington&#x2019;s disease. J. Neurosci. 2002;22:7862&#x2013;7872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758089</ArticleId><ArticleId IdType="pubmed">12223539</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeron MM, Chen N, Moshaver A, Lee AT, Wellington CL, Hayden MR, Raymond LA. Mutant huntingtin enhances excitotoxic cell death. Mol. Cell. Neurosci. 2001;17:41&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">11161468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, Raymond LA. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington&#x2019;s disease. Neuron. 2002;33:849&#x2013;860.</Citation><ArticleIdList><ArticleId IdType="pubmed">11906693</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12873849</PMID><DateCompleted><Year>2003</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-9942</ISSN><JournalIssue CitedMedium="Print"><Volume>60</Volume><Issue>7</Issue><PubDate><Year>2003</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Archives of neurology</Title><ISOAbbreviation>Arch Neurol</ISOAbbreviation></Journal><ArticleTitle>Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease.</ArticleTitle><Pagination><StartPage>940</StartPage><EndPage>946</EndPage><MedlinePgn>940-6</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Dietary n-3 polyunsaturated fatty acids improve brain functioning in animal studies, but there is limited study of whether this type of fat protects against Alzheimer disease.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine whether fish consumption and intake of different types of n-3 fatty acids protect against Alzheimer disease.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective study conducted from 1993 through 2000, of a stratified random sample from a geographically defined community. Participants were followed up for an average of 3.9 years for the development of Alzheimer disease.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">A total of 815 residents, aged 65 to 94 years, who were initially unaffected by Alzheimer disease and completed a dietary questionnaire on average 2.3 years before clinical evaluation of incident disease.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Incident Alzheimer disease diagnosed in a structured neurologic examination by means of standardized criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 131 sample participants developed Alzheimer disease. Participants who consumed fish once per week or more had 60% less risk of Alzheimer disease compared with those who rarely or never ate fish (relative risk, 0.4; 95% confidence interval, 0.2-0.9) in a model adjusted for age and other risk factors. Total intake of n-3 polyunsaturated fatty acids was associated with reduced risk of Alzheimer disease, as was intake of docosahexaenoic acid (22:6n-3). Eicosapentaenoic acid (20:5n-3) was not associated with Alzheimer disease. The associations remained unchanged with additional adjustment for intakes of other dietary fats and of vitamin E and for cardiovascular conditions.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Dietary intake of n-3 fatty acids and weekly consumption of fish may reduce the risk of incident Alzheimer disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Martha Clare</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Rush Institute for Healthy Aging, Department of Internal Medicine, Rush Alzheimer's Disease Center, Rush-Presbyterian-St Luke's Medical Center, Chicago, IL 60612, USA. Marth_C_Morris@rush.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Denis A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Bienias</LastName><ForeName>Julia L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Tangney</LastName><ForeName>Christine C</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Robert S</ForeName><Initials>RS</Initials></Author><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Neelum</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG10161</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG11101</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG13170</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Neurol</MedlineTA><NlmUniqueID>0372436</NlmUniqueID><ISSNLinking>0003-9942</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015525">Fatty Acids, Omega-3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005231">Fatty Acids, Unsaturated</NameOfSubstance></Chemical><Chemical><RegistryNumber>25167-62-8</RegistryNumber><NameOfSubstance UI="D004281">Docosahexaenoic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>AAN7QOV9EA</RegistryNumber><NameOfSubstance UI="D015118">Eicosapentaenoic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Arch Neurol. 2003 Jul;60(7):923-4. doi: 10.1001/archneur.60.7.923.</RefSource><PMID Version="1">12873846</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="Y">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004281" MajorTopicYN="N">Docosahexaenoic Acids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015118" MajorTopicYN="N">Eicosapentaenoic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015525" MajorTopicYN="N">Fatty Acids, Omega-3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005231" MajorTopicYN="N">Fatty Acids, Unsaturated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015596" MajorTopicYN="N">Nutrition Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017747" MajorTopicYN="Y">Seafood</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>8</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12873849</ArticleId><ArticleId IdType="doi">10.1001/archneur.60.7.940</ArticleId><ArticleId IdType="pii">60/7/940</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12881722</PMID><DateCompleted><Year>2003</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1061-4036</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nature genetics</Title><ISOAbbreviation>Nat Genet</ISOAbbreviation></Journal><ArticleTitle>Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.</ArticleTitle><Pagination><StartPage>76</StartPage><EndPage>83</EndPage><MedlinePgn>76-83</MedlinePgn></Pagination><Abstract><AbstractText>Huntingtin protein is mutated in Huntington disease. We previously reported that wild-type but not mutant huntingtin stimulates transcription of the gene encoding brain-derived neurotrophic factor (BDNF; ref. 2). Here we show that the neuron restrictive silencer element (NRSE) is the target of wild-type huntingtin activity on BDNF promoter II. Wild-type huntingtin inhibits the silencing activity of NRSE, increasing transcription of BDNF. We show that this effect occurs through cytoplasmic sequestering of repressor element-1 transcription factor/neuron restrictive silencer factor (REST/NRSF), the transcription factor that binds to NRSE. In contrast, aberrant accumulation of REST/NRSF in the nucleus is present in Huntington disease. We show that wild-type huntingtin coimmunoprecipitates with REST/NRSF and that less immunoprecipitated material is found in brain tissue with Huntington disease. We also report that wild-type huntingtin acts as a positive transcriptional regulator for other NRSE-containing genes involved in the maintenance of the neuronal phenotype. Consistently, loss of expression of NRSE-controlled neuronal genes is shown in cells, mice and human brain with Huntington disease. We conclude that wild-type huntingtin acts in the cytoplasm of neurons to regulate the availability of REST/NRSF to its nuclear NRSE-binding site and that this control is lost in the pathology of Huntington disease. These data identify a new mechanism by which mutation of huntingtin causes loss of transcription of neuronal genes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zuccato</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases, University of Milano, Via Balzaretti 9, 20133 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tartari</LastName><ForeName>Marzia</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Crotti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Goffredo</LastName><ForeName>Donato</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Valenza</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Conti</LastName><ForeName>Luciano</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Cataudella</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Leavitt</LastName><ForeName>Blair R</ForeName><Initials>BR</Initials></Author><Author ValidYN="Y"><LastName>Hayden</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Timmusk</LastName><ForeName>T&#xf5;nis</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Rigamonti</LastName><ForeName>Dorotea</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Cattaneo</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>E.0840</GrantID><Acronym>TI_</Acronym><Agency>Telethon</Agency><Country>Italy</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Genet</MedlineTA><NlmUniqueID>9216904</NlmUniqueID><ISSNLinking>1061-4036</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086055">HTT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C506812">Htt protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C499524">Htt protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071058">Huntingtin Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C092779">RE1-silencing transcription factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012097">Repressor Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Genet. 2003 Sep;35(1):13-4. doi: 10.1038/ng0903-13.</RefSource><PMID Version="1">12947403</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="N">Brain-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071058" MajorTopicYN="N">Huntingtin Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012097" MajorTopicYN="N">Repressor Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037941" MajorTopicYN="N">Silencer Elements, Transcriptional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>9</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12881722</ArticleId><ArticleId IdType="doi">10.1038/ng1219</ArticleId><ArticleId IdType="pii">ng1219</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1288359</PMID><DateCompleted><Year>1993</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0077-8923</ISSN><JournalIssue CitedMedium="Print"><Volume>674</Volume><PubDate><Year>1992</Year><Month>Dec</Month><Day>31</Day></PubDate></JournalIssue><Title>Annals of the New York Academy of Sciences</Title><ISOAbbreviation>Ann N Y Acad Sci</ISOAbbreviation></Journal><ArticleTitle>Normal processing of the Alzheimer's disease amyloid beta protein precursor generates potentially amyloidogenic carboxyl-terminal derivatives.</ArticleTitle><Pagination><StartPage>138</StartPage><EndPage>148</EndPage><MedlinePgn>138-48</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Estus</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Neuropathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golde</LastName><ForeName>T E</ForeName><Initials>TE</Initials></Author><Author ValidYN="Y"><LastName>Younkin</LastName><ForeName>S G</ForeName><Initials>SG</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann N Y Acad Sci</MedlineTA><NlmUniqueID>7506858</NlmUniqueID><ISSNLinking>0077-8923</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="Y">Protein Processing, Post-Translational</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>44</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>12</Month><Day>31</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>12</Month><Day>31</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1288359</ArticleId><ArticleId IdType="doi">10.1111/j.1749-6632.1992.tb27483.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12888622</PMID><DateCompleted><Year>2003</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>17</Issue><PubDate><Year>2003</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.</ArticleTitle><Pagination><StartPage>10032</StartPage><EndPage>10037</EndPage><MedlinePgn>10032-7</MedlinePgn></Pagination><Abstract><AbstractText>The principal pathological features of Alzheimer's disease (AD) are extracellular amyloid plaques and intracellular neurofibrillary tangles, the latter composed of the microtubule-binding protein tau assembled into paired helical and straight filaments. Recent studies suggest that these pathological entities may be functionally linked, although the mechanisms by which amyloid deposition promotes pathological tau filament assembly are poorly understood. Here, we report that tau is proteolyzed by multiple caspases at a highly conserved aspartate residue (Asp421) in its C terminus in vitro and in neurons treated with amyloid-beta (Abeta) (1-42) peptide. Tau is rapidly cleaved at Asp421 in Abeta-treated neurons (within 2 h), and its proteolysis appears to precede the nuclear events of apoptosis. We also demonstrate that caspase cleavage of tau generates a truncated protein that lacks its C-terminal 20 amino acids and assembles more rapidly and more extensively into tau filaments in vitro than wild-type tau. Using a monoclonal antibody that specifically recognizes tau truncated at Asp421, we show that tau is proteolytically cleaved at this site in the fibrillar pathologies of AD brain. Taken together, our results suggest a novel mechanism linking amyloid deposition and neurofibrillary tangles in AD: Abeta peptides promote pathological tau filament assembly in neurons by triggering caspase cleavage of tau and generating a proteolytic product with enhanced polymerization kinetics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gamblin</LastName><ForeName>T Chris</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, 303 East Chicago Avenue, Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Feng</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Zambrano</LastName><ForeName>Angara</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Abraha</LastName><ForeName>Aida</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Lagalwar</LastName><ForeName>Sarita</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Guillozet</LastName><ForeName>Angela L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Meiling</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Yifan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Garcia-Sierra</LastName><ForeName>Francisco</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>LaPointe</LastName><ForeName>Nichole</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Berry</LastName><ForeName>Robert W</ForeName><Initials>RW</Initials></Author><Author ValidYN="Y"><LastName>Binder</LastName><ForeName>Lester I</ForeName><Initials>LI</Initials></Author><Author ValidYN="Y"><LastName>Cryns</LastName><ForeName>Vincent L</ForeName><Initials>VL</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG009466</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS031957</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG 09466</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS 31957</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018076">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>30KYC7MIAI</RegistryNumber><NameOfSubstance UI="D001224">Aspartic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D020169">Caspases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001224" MajorTopicYN="N">Aspartic Acid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020169" MajorTopicYN="N">Caspases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016874" MajorTopicYN="N">Neurofibrillary Tangles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017384" MajorTopicYN="N">Sequence Deletion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>7</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>10</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>7</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12888622</ArticleId><ArticleId IdType="pmc">PMC187753</ArticleId><ArticleId IdType="doi">10.1073/pnas.1630428100</ArticleId><ArticleId IdType="pii">1630428100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yuan, J. &amp; Yankner, B. A. (2000) Nature 407, 802&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pubmed">11048732</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojanowski, J. Q., Schmidt, M. L., Shin, R. W., Bramblett, G. T., Rao, D. &amp; Lee, V. M. (1993) Brain Pathol. 3, 45&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">8269083</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy, J. &amp; Selkoe, D. J. (2002) Science 297, 353&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) Nature 393, 702&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pubmed">9641683</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A. &amp; Ghetti, B. (1998) Proc. Natl. Acad. Sci. USA 95, 7737&#x2013;7741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22742</ArticleId><ArticleId IdType="pubmed">9636220</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark, L. N., Poorkaj, P., Wszolek, Z., Geschwind, D. H., Nasreddine, Z. S., Miller, B., Li, D., Payami, H., Awert, F., Markopoulou, K., et al. (1998) Proc. Natl. Acad. Sci. USA 95, 13103&#x2013;13107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23724</ArticleId><ArticleId IdType="pubmed">9789048</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotz, J., Chen, F., van Dorpe, J. &amp; Nitsch, R. M. (2001) Science 293, 1491&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pubmed">11520988</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis, J., Dickson, D. W., Lin, W. L., Chisholm, L., Corral, A., Jones, G., Yen, S. H., Sahara, N., Skipper, L., Yager, D., et al. (2001) Science 293, 1487&#x2013;1491.</Citation><ArticleIdList><ArticleId IdType="pubmed">11520987</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M. &amp; Binder, L. I. (1986) Proc. Natl. Acad. Sci. USA 83, 4913&#x2013;4917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC323854</ArticleId><ArticleId IdType="pubmed">3088567</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak, M., Kabat, J. &amp; Wischik, C. M. (1993) EMBO J. 12, 365&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC413214</ArticleId><ArticleId IdType="pubmed">7679073</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso, A. C., Zaidi, T., Grundke-Iqbal, I. &amp; Iqbal, K. (1994) Proc. Natl. Acad. Sci. USA 91, 5562&#x2013;5566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC44036</ArticleId><ArticleId IdType="pubmed">8202528</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraha, A., Ghoshal, N., Gamblin, T. C., Cryns, V., Berry, R. W., Kuret, J. &amp; Binder, L. I. (2000) J. Cell Sci. 113, 3737&#x2013;3745.</Citation><ArticleIdList><ArticleId IdType="pubmed">11034902</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso, A., Zaidi, T., Novak, M., Grundke-Iqbal, I. &amp; Iqbal, K. (2001) Proc. Natl. Acad. Sci. USA 98, 6923&#x2013;6928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC34454</ArticleId><ArticleId IdType="pubmed">11381127</ArticleId></ArticleIdList></Reference><Reference><Citation>Gervais, F. G., Xu, D., Robertson, G. S., Vaillancourt, J. P., Zhu, Y., Huang, J., LeBlanc, A., Smith, D., Rigby, M., Shearman, M. S., et al. (1999) Cell 97, 395&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">10319819</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A. &amp; Yuan, J. (2000) Nature 403, 98&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">10638761</ArticleId></ArticleIdList></Reference><Reference><Citation>Troy, C. M., Rabacchi, S. A., Friedman, W. J., Frappier, T. F., Brown, K. &amp; Shelanski, M. L. (2000) J. Neurosci. 20, 1386&#x2013;1392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772358</ArticleId><ArticleId IdType="pubmed">10662829</ArticleId></ArticleIdList></Reference><Reference><Citation>Canu, N., Dus, L., Barbato, C., Ciotti, M. T., Brancolini, C., Rinaldi, A. M., Novak, M., Cattaneo, A., Bradbury, A. &amp; Calissano, P. (1998) J. Neurosci. 18, 7061&#x2013;7074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793249</ArticleId><ArticleId IdType="pubmed">9736630</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasulo, L., Ugolini, G., Visintin, M., Bradbury, A., Brancolini, C., Verzillo, V., Novak, M. &amp; Cattaneo, A. (2000) J. Neurochem. 75, 624&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">10899937</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung, C. W., Song, Y. H., Kim, I. K., Yoon, W. J., Ryu, B. R., Jo, D. G., Woo, H. N., Kwon, Y. K., Kim, H. H., Gwag, B. J., et al. (2001) Neurobiol. Dis. 8, 162&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">11162250</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryns, V. L., Byun, Y., Rana, A., Mellor, H., Lustig, K. D., Ghanem, L., Parker, P. J., Kirschner, M. W. &amp; Yuan, J. (1997) J. Biol. Chem. 272, 29449&#x2013;29453.</Citation><ArticleIdList><ArticleId IdType="pubmed">9368003</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryns, V. L., Bergeron, L., Zhu, H., Li, H. &amp; Yuan, J. (1996) J. Biol. Chem. 271, 31277&#x2013;31282.</Citation><ArticleIdList><ArticleId IdType="pubmed">8940132</ArticleId></ArticleIdList></Reference><Reference><Citation>Binder, L. I., Frankfurter, A. &amp; Rebhun, L. I. (1985) J. Cell Biol. 101, 1371&#x2013;1378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2113928</ArticleId><ArticleId IdType="pubmed">3930508</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmel, G., Mager, E. M., Binder, L. I. &amp; Kuret, J. (1996) J. Biol. Chem. 271, 32789&#x2013;32795.</Citation><ArticleIdList><ArticleId IdType="pubmed">8955115</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez, A., Toro, R., C&#xe1;ceres, A. &amp; Maccioni, R. B. (1999) FEBS Lett. 459, 421&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pubmed">10526177</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez, A., Mu&#xf1;oz, J. P. &amp; Maccioni, R. B. (2001) Exp. Cell Res. 64, 266&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">11262183</ArticleId></ArticleIdList></Reference><Reference><Citation>LoPresti, P., Szuchet, S., Papasozomenos, S. C., Zinkowski, R. P. &amp; Binder, L. I. (1995) Proc. Natl. Acad. Sci. USA 92, 10369&#x2013;10373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC40798</ArticleId><ArticleId IdType="pubmed">7479786</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurston, V. C., Pena, P., Pestell, R. &amp; Binder, L. I. (1997) Cell Motil. Cytoskeleton 38, 100&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">9295144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoshal, N., Garcia-Sierra, F., Fu, Y., Beckett, L. A., Mufson, E. J., Kuret, J., Berry, R. W. &amp; Binder, L. I. (2001) J. Neurochem. 77, 1372&#x2013;1385.</Citation><ArticleIdList><ArticleId IdType="pubmed">11389188</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamradt, M. C., Chen F., Sam S. &amp; Cryns, V. L. (2002) J. Biol. Chem. 277, 38731&#x2013;38736.</Citation><ArticleIdList><ArticleId IdType="pubmed">12140279</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamblin, T. C., King, M. E., Dawson, H., Vitek, M. P., Kuret, J., Berry, R. W. &amp; Binder, L. I. (2000) Biochemistry 39, 6136&#x2013;6144.</Citation><ArticleIdList><ArticleId IdType="pubmed">10821687</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G. &amp; Earnshaw, W. C. (1994) Nature 371, 346&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">8090205</ArticleId></ArticleIdList></Reference><Reference><Citation>Slee, E. A., Adrain, C. &amp; Martin, S. J. (2001) J. Biol. Chem. 276, 7320&#x2013;7326.</Citation><ArticleIdList><ArticleId IdType="pubmed">11058599</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena, R., Edwards, P. C., Perez-Olvera, O. &amp; Wischik, C. M. (1995) Acta Neuropathol. 89, 50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">7709731</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammerman, M., Yen, S. H. &amp; Shafit-Zagardo, B. (1989) J. Neurosci. Res. 24, 487&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pubmed">2481044</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P. &amp; Ferreira, A. (2002) Proc. Natl. Acad. Sci. USA 99, 6364&#x2013;6369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122954</ArticleId><ArticleId IdType="pubmed">11959919</ArticleId></ArticleIdList></Reference><Reference><Citation>Goode, B. L. &amp; Feinstein, S. C. (1994) J. Cell Biol. 124, 769&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2119949</ArticleId><ArticleId IdType="pubmed">8120098</ArticleId></ArticleIdList></Reference><Reference><Citation>Goode, B. L., Chau, M., Denis, P. E. &amp; Feinstein, S. C. (2000) J. Biol. Chem. 275, 38182&#x2013;38189.</Citation><ArticleIdList><ArticleId IdType="pubmed">10984497</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackmann, M., Wiech, H. &amp; Mandelkow, E. (2000) J. Biol. Chem. 275, 30335&#x2013;30343.</Citation><ArticleIdList><ArticleId IdType="pubmed">10869348</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P. &amp; Tsai, L. H. (1999) Nature 402, 615&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pubmed">10604467</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington, C. R., Mukaetova-Ladinska, E. B., Hills, R., Edwards, P. C., Montejo de Garcini, E., Novak, M. &amp; Wischik, C. M. (1991) Proc. Natl. Acad. Sci. USA 88, 5842&#x2013;5846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC51974</ArticleId><ArticleId IdType="pubmed">1905817</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12890786</PMID><DateCompleted><Year>2003</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>17</Issue><PubDate><Year>2003</Year><Month>Jul</Month><Day>30</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3.</ArticleTitle><Pagination><StartPage>6914</StartPage><EndPage>6927</EndPage><MedlinePgn>6914-27</MedlinePgn></Pagination><Abstract><AbstractText>Apoptotic pathways and DNA synthesis are activated in neurons in the brains of individuals with Alzheimer disease (AD). However, the signaling mechanisms that mediate these events have not been defined. We show that expression of familial AD (FAD) mutants of the amyloid precursor protein (APP) in primary neurons in culture causes apoptosis and DNA synthesis. Both the apoptosis and the DNA synthesis are mediated by the p21 activated kinase PAK3, a serine-threonine kinase that interacts with APP. A dominant-negative kinase mutant of PAK3 inhibits the neuronal apoptosis and DNA synthesis; this effect is abolished by deletion of the PAK3 APP-binding domain or by coexpression of a peptide representing this binding domain. The involvement of PAK3 specifically in FAD APP-mediated apoptosis rather than in general apoptotic pathways is suggested by the facts that a dominant-positive mutant of PAK3 does not alone cause neuronal apoptosis and that the dominant-negative mutant of PAK3 does not inhibit chemically induced apoptosis. Pertussis toxin, which inactivates the heterotrimeric G-proteins Go and Gi, inhibits the apoptosis and DNA synthesis caused by FAD APP mutants; the apoptosis and DNA synthesis are rescued by coexpression of a pertussis toxin-insensitive Go. FAD APP-mediated DNA synthesis precedes FAD APP-mediated apoptosis in neurons, and inhibition of neuronal entry into the cell cycle inhibits the apoptosis. These data suggest that a normal signaling pathway mediated by the interaction of APP, PAK3, and Go is constitutively activated in neurons by FAD mutations in APP and that this activation causes cell cycle entry and consequent apoptosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McPhie</LastName><ForeName>Donna L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, Massachusetts 02478, USA. mcphie@helix.mgh.harvard.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coopersmith</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Hines-Peralta</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yuzhi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Ivins</LastName><ForeName>Kathryn J</ForeName><Initials>KJ</Initials></Author><Author ValidYN="Y"><LastName>Manly</LastName><ForeName>Susan P</ForeName><Initials>SP</Initials></Author><Author ValidYN="Y"><LastName>Kozlowski</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Neve</LastName><ForeName>Kim A</ForeName><Initials>KA</Initials></Author><Author ValidYN="Y"><LastName>Neve</LastName><ForeName>Rachael L</ForeName><Initials>RL</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG012954</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG12954</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C515913">Pak3 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D054462">p21-Activated Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C088986">rab11 protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020691">rab GTP-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020696">rab5 GTP-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>G34N38R2N1</RegistryNumber><NameOfSubstance UI="D001973">Bromodeoxyuridine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001973" MajorTopicYN="N">Bromodeoxyuridine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005799" MajorTopicYN="N">Genes, Dominant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020287" MajorTopicYN="N">In Situ Nick-End Labeling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009420" MajorTopicYN="N">Nervous System</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017384" MajorTopicYN="N">Sequence Deletion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054462" MajorTopicYN="N">p21-Activated Kinases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020691" MajorTopicYN="N">rab GTP-Binding Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020696" MajorTopicYN="N">rab5 GTP-Binding Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>9</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>1</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12890786</ArticleId><ArticleId IdType="pmc">PMC6740729</ArticleId><ArticleId IdType="pii">23/17/6914</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-17-06914.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arendt T ( 2002) Dysregulation of neuronal differentiation and cell cycle control in Alzheimer's disease. J Neural Transm Suppl 62: 77-85.</Citation><ArticleIdList><ArticleId IdType="pubmed">12456053</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt T, Rodel L, Gartner U, Holzer M ( 1996) Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. NeuroReport 7: 3047-3049.</Citation><ArticleIdList><ArticleId IdType="pubmed">9116237</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagrodia S, Taylor SJ, Creasy CL, Chernoff J, Cerione RA ( 1995) Identification of a mouse p21cdc42/rac activated kinase. J Biol Chem 270: 22731-22737.</Citation><ArticleIdList><ArticleId IdType="pubmed">7559398</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouillet E, Trembleau A, Galanaud D, Volovitch M, Bouillot C, Valenza C, Prochiantz A, Allinquant B ( 1999) The amyloid precursor protein interacts with Go heterotrimeric protein within a cell compartment specialized in signal transduction. J Neurosci 19: 1717-1727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782156</ArticleId><ArticleId IdType="pubmed">10024358</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbelo PD, Brechsel D, Hall A ( 1995) A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases. J Biol Chem 270: 29071-29074.</Citation><ArticleIdList><ArticleId IdType="pubmed">7493928</ArticleId></ArticleIdList></Reference><Reference><Citation>Bursztajn S, DeSouza R, McPhie DL, Berman SA, Shioi J, Robakis NK, Neve RL ( 1998) Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis. J Neurosci 18: 9790-9799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793279</ArticleId><ArticleId IdType="pubmed">9822738</ArticleId></ArticleIdList></Reference><Reference><Citation>Busser J, Geldmacher DS, Herrup K ( 1998) Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 18: 2801-2807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792587</ArticleId><ArticleId IdType="pubmed">9525997</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxbaum J, Thinakaran G, Koliatsos V, O'Callahan J, Slunt HH, Price DL, Sisodia SS ( 1990) Processing of Alzheimer &#x3b2;/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci USA 87: 6003-6006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC54458</ArticleId><ArticleId IdType="pubmed">2116015</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X, S&#xfc;dhof TC ( 2001) A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293: 115-120.</Citation><ArticleIdList><ArticleId IdType="pubmed">11441186</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, McPhie DL, Hirschberg J, Neve RL ( 2000) The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons. J Biol Chem 275: 8929-8935.</Citation><ArticleIdList><ArticleId IdType="pubmed">10722740</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow N, Korenberg JR, Chen XN, Neve RL ( 1996) APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein. J Biol Chem 271: 11339-11346.</Citation><ArticleIdList><ArticleId IdType="pubmed">8626687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow N, Cox C, Callahan LM, Weimer JM, Guo L, Coleman PD ( 1998) Expression profiles of multiple genes in single neurons of Alzheimer's disease. Proc Natl Acad Sci USA 95: 9620-9625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC21388</ArticleId><ArticleId IdType="pubmed">9689130</ArticleId></ArticleIdList></Reference><Reference><Citation>Copani A, Uberti D, Sortino MA, Bruno V, Nicoletti F, Merno M ( 2001) Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci 24: 25-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">11163884</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotman CW ( 1998) Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease. Neurobiol Aging 19: S29-S32.</Citation><ArticleIdList><ArticleId IdType="pubmed">9562464</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotman CW, Anderson AJ ( 1995) A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 10: 19-45.</Citation><ArticleIdList><ArticleId IdType="pubmed">7598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Farinelli SE, Greene LA ( 1996) Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after the removal of trophic support. J Neurosci 16: 1150-1162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578784</ArticleId><ArticleId IdType="pubmed">8558244</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambarella U, Yamatsuji T, Okamoto T, Matsui T, Ikezu T, Murayama Y, Levine MA, Katz A, Gautam N, Nishimoto I ( 1997) G-protein &#x3b2;&#x3b3; complex-mediated apoptosis by familial Alzheimer's disease mutant of APP. EMBO J 16: 4897-4907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1170125</ArticleId><ArticleId IdType="pubmed">9305632</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, Bondada V, Rangnekar VM, Mattson MP ( 1998) Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nature 4: 957-962.</Citation><ArticleIdList><ArticleId IdType="pubmed">9701251</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffer ZM, Chernoff J ( 2002) p21-activated kinases: three more join the Pak. Int J Biochem Biol 34: 713-717.</Citation><ArticleIdList><ArticleId IdType="pubmed">11950587</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobi R, Chen CJ, Tuazon PT, Traugh JA ( 1996) Molecular cloning and sequencing of the cytostatic G-protein-activated protein kinase PAK I. J Biol Chem 271: 6206-6211.</Citation><ArticleIdList><ArticleId IdType="pubmed">8626411</ArticleId></ArticleIdList></Reference><Reference><Citation>Joneson T, McDonough M, Bar-Sagi D, Van Aelst L ( 1998) Kinase suppressor of Ras inhibits the activation of extracellular ligand-regulated (ERK) mitogen-activated protein (MAP) kinase by growth factors, activated Ras, and Ras effectors. J Biol Chem 273: 7743-7749.</Citation><ArticleIdList><ArticleId IdType="pubmed">9516483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita A, Whelan CM, Berezovska O, Hyman BT ( 2002) The &#x3b3;-secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J Biol Chem 277: 28530-28536.</Citation><ArticleIdList><ArticleId IdType="pubmed">12032152</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondratick CM, Vandre DD ( 1996) Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes. J Neurochem 67: 2405-2416.</Citation><ArticleIdList><ArticleId IdType="pubmed">8931473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlowski MR, Spanoyannis AF, Manly SP, Fidel SA, Neve RL ( 1992) The neurotoxic carboxy terminal fragment of the Alzheimer amyloid precursor binds specifically to a neuronal cell surface molecule: pH dependence of the neurotoxicity and the binding. J Neurosci 12: 1679-1687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6575880</ArticleId><ArticleId IdType="pubmed">1578262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang J, Nishimoto I, Okamoto T, Regazzi R, Kiraly C, Weller U, Wollheim CB ( 1995) Direct control of exocytosis by receptor-mediated activation of the heterotrimeric GTPases Gi and G(o) or by the expression of their active G alpha subunits. EMBO J 14: 3635-3644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC394438</ArticleId><ArticleId IdType="pubmed">7641683</ArticleId></ArticleIdList></Reference><Reference><Citation>Leberer E, Dignard D, Harcus D, Thomas DY, Whiteway M ( 1992) The protein kinase homologue Ste20p is required to link the yeast pheromone response G-protein &#x3b2;&#x3b3; subunits to downstream signalling components. EMBO J 11: 4815-4824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC556957</ArticleId><ArticleId IdType="pubmed">1464311</ArticleId></ArticleIdList></Reference><Reference><Citation>Leeuw T, Wu C, Schrag JD, Whiteway M, Thomas DY, Leberer E ( 1998) Interaction of a G-protein &#x3b2;-subunit with a conserved sequence in Ste20/PAK family protein kinases. Nature 391: 191-196.</Citation><ArticleIdList><ArticleId IdType="pubmed">9428767</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WK, Williams R, Hall F, Dickson D, Yen SH ( 1995) Detection of a cdc2-related kinase associated with Alzheimer paired helical filaments. Am J Pathol 146: 228-238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1870752</ArticleId><ArticleId IdType="pubmed">7856730</ArticleId></ArticleIdList></Reference><Reference><Citation>Manser E, Chong C, Zhao ZS, Leung T, Michael G, Hall C, Lim L ( 1995) Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family. J Biol Chem 270: 25070-25078.</Citation><ArticleIdList><ArticleId IdType="pubmed">7559638</ArticleId></ArticleIdList></Reference><Reference><Citation>Manser E, Huang HY, Loo TH, Chen XQ, Dong JM, Leung T, Lim L ( 1997) Expression of constitutively active &#x3b1;-PAK reveals effects of the kinase on actin and focal complexes. Mol Cell Biol 17: 1129-1143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC231838</ArticleId><ArticleId IdType="pubmed">9032240</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GA, Bollag G, McCormick FA, Abo A ( 1995) A novel serine kinase activated by rac/Cdc42Hs-dependent autophosphorylation is related to PAK65 and Ste20. EMBO J 14: 1970-1978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC398296</ArticleId><ArticleId IdType="pubmed">7744004</ArticleId></ArticleIdList></Reference><Reference><Citation>McPhie DL, Lee RKK, Eckman CB, Olstein DH, Durham SP, Yager D, Younkin SG, Wurtman RJ, Neve RL ( 1997) Neuronal expression of &#x3b2;-amyloid precursor protein Alzheimer mutations causes intracellular accumulation of a C-terminal fragment containing both the amyloid &#x3b2; and cytoplasmic domains. J Biol Chem 272: 24743-24746.</Citation><ArticleIdList><ArticleId IdType="pubmed">9312066</ArticleId></ArticleIdList></Reference><Reference><Citation>McPhie DL, Golde T, Eckman CB, Yager D, Younkin SG, Neve RL ( 2001) The &#x3b2;-secretase cleavage product of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations. Mol Brain Res 97: 103-113.</Citation><ArticleIdList><ArticleId IdType="pubmed">11744168</ArticleId></ArticleIdList></Reference><Reference><Citation>McShea A, Harris PL, Webster KR, Wahl AF, Smith MA ( 1997) Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol 150: 1933-1939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1858317</ArticleId><ArticleId IdType="pubmed">9176387</ArticleId></ArticleIdList></Reference><Reference><Citation>Neve RL, Perrone-Bizzozero NI, Finklestein S, Zwiers H, Bird E, Kurnit DM, Benowitz LI ( 1987) The neuronal growth-associated protein GAP-43 (B-50, F1): Neuronal specificity, developmental regulation and regional expression of the human and rat cDNAs. Mol Brain Res 2: 177-183.</Citation><ArticleIdList><ArticleId IdType="pubmed">3620911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto I, Okamoto T, Matsuura Y, Okamoto T, Murayama Y, Ogata E ( 1993) Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). Nature 362: 75-79.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446172</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura I, Uetsuki T, Dani SU, Ohsawa Y, Saito I, Okamura H, Uchiyama Y, Yoshikawa K ( 1998) Degeneration in vivo of rat hippocampal neurons by wild-type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer. J Neurosci 18: 2387-2398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793123</ArticleId><ArticleId IdType="pubmed">9502800</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto T, Takeda S, Murayama Y, Ogata E, Nishimoto I ( 1995) Ligand-dependent G-protein coupling function of amyloid transmembrane precursor. J Biol Chem 270: 4205-4208.</Citation><ArticleIdList><ArticleId IdType="pubmed">7876177</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai L-H ( 1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402: 615-622.</Citation><ArticleIdList><ArticleId IdType="pubmed">10604467</ArticleId></ArticleIdList></Reference><Reference><Citation>Raina AK, Hochman A, Ickes H, Zhu X, Ogawa O, Cash AD, Shimohama S, Perry G, Smith MA ( 2003) Apoptotic promoters and inhibitors in Alzheimer's disease: who wins out? Prog Neuropsychopharmacol Biol Psychiatry 27: 251-254.</Citation><ArticleIdList><ArticleId IdType="pubmed">12657364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramer SW, Davis RW ( 1993) A dominant truncation allele identifies a gene, STE20, that encodes a putative protein kinase necessary for mating in Saccharomyces cerevisiae Proc Natl Acad Sci USA 90: 452-456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC45681</ArticleId><ArticleId IdType="pubmed">8421676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren M, Xu G, Zeng, De Lemos-Chiarandini C, Adesnik M, Sabatini DD ( 1998) Hydrolysis of GTP on rab11 is required for the direct delivery of transferrin from the pericentriolar recycling compartment to the cell surface but not from sorting endosomes. Proc Natl Acad Sci USA 95: 6187-6192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27621</ArticleId><ArticleId IdType="pubmed">9600939</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohn TT, Ivins KJ, Bahr BA, Cotman CW, Cribbs DH ( 2000) A monoclonal antibody to amyloid precursor protein induces neuronal apoptosis. J Neurochem 75: 2331-2342.</Citation><ArticleIdList><ArticleId IdType="pubmed">10820193</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth KA ( 2001) Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol 60: 829-838.</Citation><ArticleIdList><ArticleId IdType="pubmed">11556539</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo T, Faraonio R, Minopoli G, De Candia P, De Renzis S, Zambrano N ( 1998) Fe65 and the protein network centered around the cytosolic domain of the Alzheimer's &#x3b2;-amyloid precursor protein. FEBS Lett 434: 1-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9738440</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheinfeld MH, Roncarati R, Vito P, Lopez PA, Abdallah M, D'Adamio L ( 2002) Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer's &#x3b2;-amyloid precursor protein (APP). J Biol Chem 277: 3767-3775.</Citation><ArticleIdList><ArticleId IdType="pubmed">11724784</ArticleId></ArticleIdList></Reference><Reference><Citation>Seemann J, Weber K, Gerke V ( 1997) Annexin I targets S100C to early endosomes. FEBS Lett 413: 185-190.</Citation><ArticleIdList><ArticleId IdType="pubmed">9287141</ArticleId></ArticleIdList></Reference><Reference><Citation>Sells MA, Knaus UG, Bagrodia S, Ambrose DM, Bokoch GM, Chernoff J ( 1997) Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr Biol 7: 202-210.</Citation><ArticleIdList><ArticleId IdType="pubmed">9395435</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TW, Lippa CF ( 1995) Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J Neuropathol Exp Neurol 54: 297-303.</Citation><ArticleIdList><ArticleId IdType="pubmed">7745428</ArticleId></ArticleIdList></Reference><Reference><Citation>Su JH, Anderson AJ, Cummings BJ, Cotman CW ( 1994) Immunohistochemical evidence for DNA fragmentation in neurons in the AD brain. NeuroReport 5: 2529-2533.</Citation><ArticleIdList><ArticleId IdType="pubmed">7696596</ArticleId></ArticleIdList></Reference><Reference><Citation>Taussig R, Sanchez S, Rifo M, Gilman AG ( 1992) Inhibition of the &#x3c9;-conotoxin-sensitive calcium current by distinct G-proteins. Neuron 8: 799-809.</Citation><ArticleIdList><ArticleId IdType="pubmed">1348951</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo M, Manser E, Lim L ( 1995) Identification and molecular cloning of a p21cdc42/rac1-activated serine/threonine kinase that is rapidly activated by thrombin in platelets. J Biol Chem 270: 26690-26697.</Citation><ArticleIdList><ArticleId IdType="pubmed">7592896</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich O, Reinsch S, Urbe S, Zerial M, Parton RG ( 1996) Rab 11 regulates recycling through the pericentriolar recycling endosomes. J Cell Biol 135: 913-924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2133374</ArticleId><ArticleId IdType="pubmed">8922376</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent I, Rosado M, Davies P ( 1996) Mitotic mechanisms in Alzheimer's disease? J Cell Biol 132: 413-425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120731</ArticleId><ArticleId IdType="pubmed">8636218</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent I, Jicha G, Rosado M, Dickson D ( 1997) Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 17: 3588-3598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573674</ArticleId><ArticleId IdType="pubmed">9133382</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent I, Zheng JH, Dickson DW, Kress Y, Davies P ( 1998) Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol Aging 19: 287-296.</Citation><ArticleIdList><ArticleId IdType="pubmed">9733160</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamatsuji T, Okamoto T, Takeda S, Fukumoto H, Iwatsubo T, Suzuki N, Asami-Odaka A, Ireland S, Kinane TB, Nishimoto I ( 1996) G-protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science 272: 1349-1352.</Citation><ArticleIdList><ArticleId IdType="pubmed">8650548</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Geldmacher DS, Herrup K ( 2001) DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci 21: 2661-2668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762514</ArticleId><ArticleId IdType="pubmed">11306619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z-S, Manser E, Chen X-Q, Chong C, Leung T, Lim L ( 1998) A conserved negative regulatory region in &#x3b1;PAK: inhibition of PAK kinases reveals their morphological roles downstream of cdc42 and rac1. Mol Cell Biol 18: 2153-2163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC121452</ArticleId><ArticleId IdType="pubmed">9528787</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12891359</PMID><DateCompleted><Year>2003</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>424</Volume><Issue>6948</Issue><PubDate><Year>2003</Year><Month>Jul</Month><Day>31</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration.</ArticleTitle><Pagination><StartPage>556</StartPage><EndPage>561</EndPage><MedlinePgn>556-61</MedlinePgn></Pagination><Abstract><AbstractText>The neuropathological hallmarks of Alzheimer's disease and other tauopathies include senile plaques and/or neurofibrillary tangles. Although mouse models have been created by overexpressing specific proteins including beta-amyloid precursor protein, presenilin and tau, no model has been generated by gene knockout. Phosphorylation of tau and other proteins on serine or threonine residues preceding proline seems to precede tangle formation and neurodegeneration in Alzheimer's disease. Notably, these phospho(Ser/Thr)-Pro motifs exist in two distinct conformations, whose conversion in some proteins is catalysed by the Pin1 prolyl isomerase. Pin1 activity can directly restore the conformation and function of phosphorylated tau or it can do so indirectly by promoting its dephosphorylation, which suggests that Pin1 is involved in neurodegeneration; however, genetic evidence is lacking. Here we show that Pin1 expression is inversely correlated with predicted neuronal vulnerability and actual neurofibrillary degeneration in Alzheimer's disease. Pin1 knockout in mice causes progressive age-dependent neuropathy characterized by motor and behavioural deficits, tau hyperphosphorylation, tau filament formation and neuronal degeneration. Thus, Pin1 is pivotal in protecting against age-dependent neurodegeneration, providing insight into the pathogenesis and treatment of Alzheimer's disease and other tauopathies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liou</LastName><ForeName>Yih-Cherng</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Cancer Biology Program, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Anyang</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ryo</LastName><ForeName>Akihide</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xiao Zhen</ForeName><Initials>XZ</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zhao-Xue</ForeName><Initials>ZX</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Han-Kuei</ForeName><Initials>HK</Initials></Author><Author ValidYN="Y"><LastName>Uchida</LastName><ForeName>Takafumi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Bronson</LastName><ForeName>Roderick</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Bing</LastName><ForeName>Guoying</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaojiang</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Hunter</LastName><ForeName>Tony</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Kun Ping</ForeName><Initials>KP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072340">NIMA-Interacting Peptidylprolyl Isomerase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>1114-81-4</RegistryNumber><NameOfSubstance UI="D010769">Phosphothreonine</NameOfSubstance></Chemical><Chemical><RegistryNumber>17885-08-4</RegistryNumber><NameOfSubstance UI="D010768">Phosphoserine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.2.1.8</RegistryNumber><NameOfSubstance UI="C000606846">PIN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.2.1.8</RegistryNumber><NameOfSubstance UI="D019696">Peptidylprolyl Isomerase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.2.1.8</RegistryNumber><NameOfSubstance UI="C000606850">Pin1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020816" MajorTopicYN="N">Amino Acid Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017353" MajorTopicYN="N">Gene Deletion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072340" MajorTopicYN="N">NIMA-Interacting Peptidylprolyl Isomerase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016874" MajorTopicYN="N">Neurofibrillary Tangles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019696" MajorTopicYN="N">Peptidylprolyl Isomerase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010768" MajorTopicYN="N">Phosphoserine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010769" MajorTopicYN="N">Phosphothreonine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024801" MajorTopicYN="N">Tauopathies</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>8</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12891359</ArticleId><ArticleId IdType="doi">10.1038/nature01832</ArticleId><ArticleId IdType="pii">nature01832</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12891676</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2010</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0364-5134</ISSN><JournalIssue CitedMedium="Print"><Volume>54</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Annals of neurology</Title><ISOAbbreviation>Ann Neurol</ISOAbbreviation></Journal><ArticleTitle>Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs.</ArticleTitle><Pagination><StartPage>235</StartPage><EndPage>238</EndPage><MedlinePgn>235-8</MedlinePgn></Pagination><Abstract><AbstractText>The hypothesis that blockade of muscarinic receptors is associated with increased Alzheimer-type pathology was investigated in Parkinson's disease. Amyloid plaque densities were more than 2.5-fold higher in cases treated with antimuscarinic medication in the long term compared with untreated or short-term treated cases (p = 0.005 and 0.00005, respectively). Neurofibrillary tangle densities were also highest in chronic compared with untreated or acute-treated groups (p = 0.02 and 0.05, respectively). The findings, if replicated, have potential implications for the use of anticholinergic medication in elderly Parkinson's disease patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Elaine K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>MRC Building, Wolfson Research Centre, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom. e.k.perry@ncl.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kilford</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Lees</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Neurol</MedlineTA><NlmUniqueID>7707449</NlmUniqueID><ISSNLinking>0364-5134</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000929">Antidepressive Agents, Tricyclic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018727">Muscarinic Antagonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Neurol. 2003 Aug;54(2):144-6. doi: 10.1002/ana.10667.</RefSource><PMID Version="1">12891665</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Surv Ophthalmol. 2005 May-Jun;50(3):290-1. doi: 10.1016/j.survophthal.2005.02.003.</RefSource><PMID Version="1">15850818</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000929" MajorTopicYN="N">Antidepressive Agents, Tricyclic</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001344" MajorTopicYN="N">Autopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018727" MajorTopicYN="N">Muscarinic Antagonists</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016874" MajorTopicYN="N">Neurofibrillary Tangles</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12891676</ArticleId><ArticleId IdType="doi">10.1002/ana.10639</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12897211</PMID><DateCompleted><Year>2003</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0021-9738</ISSN><JournalIssue CitedMedium="Print"><Volume>112</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The Journal of clinical investigation</Title><ISOAbbreviation>J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo.</ArticleTitle><Pagination><StartPage>440</StartPage><EndPage>449</EndPage><MedlinePgn>440-9</MedlinePgn></Pagination><Abstract><AbstractText>Epidemiologic studies demonstrate that long-term use of NSAIDs is associated with a reduced risk for the development of Alzheimer disease (AD). In this study, 20 commonly used NSAIDs, dapsone, and enantiomers of flurbiprofen were analyzed for their ability to lower the level of the 42-amino-acid form of amyloid beta protein (Abeta42) in a human H4 cell line. Thirteen of the NSAIDs and the enantiomers of flurbiprofen were then tested in acute dosing studies in amyloid beta protein precursor (APP) transgenic mice, and plasma and brain levels of Abeta and the drug were evaluated. These studies show that (a). eight FDA-approved NSAIDs lower Abeta42 in vivo, (b). the ability of an NSAID to lower Abeta42 levels in cell culture is highly predicative of its in vivo activity, (c). in vivo Abeta42 lowering in mice occurs at drug levels achievable in humans, and (d). there is a significant correlation between Abeta42 lowering and levels of ibuprofen. Importantly, flurbiprofen and its enantiomers selectively lower Abeta42 levels in broken cell gamma-secretase assays, indicating that these compounds directly target the gamma-secretase complex that generates Abeta from APP. Of the compounds tested, meclofenamic acid, racemic flurbiprofen, and the purified R and S enantiomers of flurbiprofen lowered Abeta42 levels to the greatest extent. Because R-flurbiprofen reduces Abeta42 levels by targeting gamma-secretase and has reduced side effects related to inhibition of cyclooxygenase (COX), it is an excellent candidate for clinical testing as an Abeta42 lowering agent.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eriksen</LastName><ForeName>Jason L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Graduate School, Mayo Clinic Jacksonville, Jacksonville, Florida 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sagi</LastName><ForeName>Sarah A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Tawnya E</ForeName><Initials>TE</Initials></Author><Author ValidYN="Y"><LastName>Weggen</LastName><ForeName>Sascha</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Pritam</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>McLendon</LastName><ForeName>D C</ForeName><Initials>DC</Initials></Author><Author ValidYN="Y"><LastName>Ozols</LastName><ForeName>Victor V</ForeName><Initials>VV</Initials></Author><Author ValidYN="Y"><LastName>Jessing</LastName><ForeName>Kevin W</ForeName><Initials>KW</Initials></Author><Author ValidYN="Y"><LastName>Zavitz</LastName><ForeName>Kenton H</ForeName><Initials>KH</Initials></Author><Author ValidYN="Y"><LastName>Koo</LastName><ForeName>Edward H</ForeName><Initials>EH</Initials></Author><Author ValidYN="Y"><LastName>Golde</LastName><ForeName>Todd E</ForeName><Initials>TE</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG020206</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS039072</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG20206</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG00216</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Invest</MedlineTA><NlmUniqueID>7802877</NlmUniqueID><ISSNLinking>0021-9738</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011480">Protease Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C075222">amyloid beta-protein (1-42)</NameOfSubstance></Chemical><Chemical><RegistryNumber>48I5LU4ZWD</RegistryNumber><NameOfSubstance UI="D008469">Meclofenamic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>5GRO578KLP</RegistryNumber><NameOfSubstance UI="D005480">Flurbiprofen</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Clin Invest. 2003 Aug;112(3):321-3. doi: 10.1172/JCI19420.</RefSource><PMID Version="1">12897198</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005480" MajorTopicYN="N">Flurbiprofen</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008469" MajorTopicYN="N">Meclofenamic Acid</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011480" MajorTopicYN="N">Protease Inhibitors</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013237" MajorTopicYN="N">Stereoisomerism</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>9</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12897211</ArticleId><ArticleId IdType="pmc">PMC166298</ArticleId><ArticleId IdType="doi">10.1172/JCI18162</ArticleId><ArticleId IdType="pii">112/3/440</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Selkoe DJ. Alzheimer&#x2019;s disease: genes, proteins, and therapy. Physiol. Rev. 2001;81:741&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pubmed">11274343</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy JA, Higgins GA. Alzheimer&#x2019;s disease: the amyloid cascade hypothesis. Science. 1992;256:184&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">1566067</ArticleId></ArticleIdList></Reference><Reference><Citation>Golde TE, Eckman CB, Younkin SG. Biochemical detection of A&#x3b2; isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer&#x2019;s disease. . Biochim. Biophys. Acta. 2000; 1502:172&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">10899442</ArticleId></ArticleIdList></Reference><Reference><Citation>Younkin SG. The role of A beta 42 in Alzheimer&#x2019;s disease. J. Physiol. (Paris). 1998;92:289&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">9789825</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheuner D, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer&#x2019;s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer&#x2019;s disease. Nat. Med. 1996;2:864&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">8705854</ArticleId></ArticleIdList></Reference><Reference><Citation>Duff K, et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature. 1996;383:710&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">8878479</ArticleId></ArticleIdList></Reference><Reference><Citation>Games D, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F &#x3b2;-amyloid precursor protein. Nature. 1995;373:523&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">7845465</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama H, et al. Inflammation and Alzheimer&#x2019;s disease. Neurobiol. Aging. 2000;21:383&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3887148</ArticleId><ArticleId IdType="pubmed">10858586</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyss-Coray T, et al. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer&#x2019;s mice. Proc. Natl. Acad. Sci. U. S. A. 2002;99:10837&#x2013;10842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125059</ArticleId><ArticleId IdType="pubmed">12119423</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen PS. Inflammation and Alzheimer&#x2019;s disease: mechanisms and therapeutic strategies. Gerontology. 1997;43:143&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">8996836</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer&#x2019;s disease: a review of 17 epidemiologic studies. Neurology. 1996;47:425&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pubmed">8757015</ArticleId></ArticleIdList></Reference><Reference><Citation>in t&#x2019;Veld BA, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer&#x2019;s disease. N. Engl. J. Med. 2001;345:1515&#x2013;1521.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794217</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart WF, Kawas C, Corrada M, Metter EJ. Risk of Alzheimer&#x2019;s disease and duration of NSAID use. Neurology. 1997;48:626&#x2013;632.</Citation><ArticleIdList><ArticleId IdType="pubmed">9065537</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi PP, et al. Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology. 2002;59:880&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pubmed">12297571</ArticleId></ArticleIdList></Reference><Reference><Citation>Weggen S, et al. A subset of NSAIDs lower amyloidogenic A&#x3b2;42 independently of cyclooxygenase activity. Nature. 2001;414:212&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11700559</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisslinger G, Lotsch J, Menzel S, Kobal G, Brune K. Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. Br. J. Clin. Pharmacol. 1994;37:392&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1364742</ArticleId><ArticleId IdType="pubmed">8018462</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechter WJ, et al. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. Cancer Res. 2000;60:2203&#x2013;2208.</Citation><ArticleIdList><ArticleId IdType="pubmed">10786685</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechter WJ, et al. Treatment and survival study in the C57BL/6J-APC(Min)/+(Min) mouse with R-flurbiprofen. Life Sci. 2000;66:745&#x2013;753.</Citation><ArticleIdList><ArticleId IdType="pubmed">10680582</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy MP, et al. Presenilin 1 regulates pharmacologically distinct gamma-secretase activities. Implications for the role of presenilin in gamma-secretase cleavage. J. Biol. Chem. 2000;275:26277&#x2013;26284.</Citation><ArticleIdList><ArticleId IdType="pubmed">10816583</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Sweeney D, Gandy SE, Sisodia SS. The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. J. Biol. Chem. 1996;271:31894&#x2013;31902.</Citation><ArticleIdList><ArticleId IdType="pubmed">8943233</ArticleId></ArticleIdList></Reference><Reference><Citation>McLendon C, et al. Cell-free assays for &#x3b3;-secretase activity. FASEB J. 2000;14:2383&#x2013;2386.</Citation><ArticleIdList><ArticleId IdType="pubmed">11024004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahrle S, et al. Cholesterol-dependent &#x3b3;-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis. 2002;9:11&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">11848681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao K, et al. Correlative memory deficits, A&#x3b2; elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">8810256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawarabayashi T, et al. Age-dependent changes in brain, CSF, and plasma amyloid protein in the Tg2576 transgenic mouse model of Alzheimer&#x2019;s disease. J. Neurosci. 2001;21:372&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763819</ArticleId><ArticleId IdType="pubmed">11160418</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N, et al. An increased percentage of long amyloid &#x3b2; protein is secreted by familial amyloid &#x3b2; protein precursor (&#x3b2;APP717) mutants. Science. 1994;264:1336&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pubmed">8191290</ArticleId></ArticleIdList></Reference><Reference><Citation>Takasugi N, et al. The role of presenilin cofactors in the &#x3b3;-secretase complex. Nature. 2003;422:438&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">12660785</ArticleId></ArticleIdList></Reference><Reference><Citation>Edbauer D, et al. Reconstitution of gamma-secretase activity. Nat. Cell Biol. 2003;7:7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12679784</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe MS, et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 1999;398:513&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pubmed">10206644</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim GP, et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer&#x2019;s disease. J. Neurosci. 2000;20:5709&#x2013;5714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772529</ArticleId><ArticleId IdType="pubmed">10908610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritschel, W.A., and Kerns, G.L. 1999. Handbook of basic pharmacokinetics... including clinical applications. J.I. Graubart, editor. American Pharmaceutical Association. Washington, DC, USA. 563 pp.</Citation></Reference><Reference><Citation>Wechter WJ, Bigornia AE, Murray ED, Jr, Jee WS. Chiral pharmacokinetics of Rac-flurbiprofen and pharmacodynamics of anabolic bone response in the normal rat. Chirality. 1994;6:457&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pubmed">7946972</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Halim MS, Sjoquist B, Anggard E. Inhibition of prostaglandin synthesis in rat brain. Acta Pharmacol. Toxicol. (Copenh.). 1978;43:266&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">716943</ArticleId></ArticleIdList></Reference><Reference><Citation>Golde TE. Alzheimer disease therapy: can the amyloid cascade be halted? J. Clin. Invest. 2003;111:11&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151845</ArticleId><ArticleId IdType="pubmed">12511580</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 2000;57:1439&#x2013;1443.</Citation><ArticleIdList><ArticleId IdType="pubmed">11030795</ArticleId></ArticleIdList></Reference><Reference><Citation>Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet. 2000;356:1627&#x2013;1631.</Citation><ArticleIdList><ArticleId IdType="pubmed">11089820</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharf S, Mander A, Ugoni A, Vajda F, Christophidis N. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer&#x2019;s disease. Neurology. 1999;53:197&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">10408559</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J, et al. Clinical trial of indomethacin in Alzheimer&#x2019;s disease. Neurology. 1993;43:1609&#x2013;1611.</Citation><ArticleIdList><ArticleId IdType="pubmed">8351023</ArticleId></ArticleIdList></Reference><Reference><Citation>Marnett LJ, Kalgutkar AS. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends Pharmacol. Sci. 1999;20:465&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pubmed">10542447</ArticleId></ArticleIdList></Reference><Reference><Citation>Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE. Inflammatory mechanisms in Alzheimer&#x2019;s disease: inhibition of &#x3b2;-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR&#x3b3; agonists. J. Neurosci. 2000;20:558&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772401</ArticleId><ArticleId IdType="pubmed">10632585</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, et al. Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase. J. Neuroimmunol. 1999;100:156&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">10695726</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer&#x2019;s disease. Science. 2002;295:2264&#x2013;2267.</Citation><ArticleIdList><ArticleId IdType="pubmed">11910111</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos RB, et al. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. U. S. A. 2001;98:8850&#x2013;8855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC37524</ArticleId><ArticleId IdType="pubmed">11438712</ArticleId></ArticleIdList></Reference><Reference><Citation>Morihara T, Chu T, Ubeda O, Beech W, Cole GM. Selective inhibition of A&#x3b2;42 production by NSAID R-enantiomers. J. Neurochem. 2002;83:1009&#x2013;1012.</Citation><ArticleIdList><ArticleId IdType="pubmed">12421374</ArticleId></ArticleIdList></Reference><Reference><Citation>Jantzen PT, et al. Microglial activation and &#x3b2;-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J. Neurosci. 2002;22:2246&#x2013;2254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758281</ArticleId><ArticleId IdType="pubmed">11896164</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegeder I, et al. Inhibition of NF-&#x3ba;B and AP-1 activation by R- and S-flurbiprofen. FASEB J. 2001;15:2&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">11099482</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray ED, Jr, et al. Phase I single-dose pharmacokinetics and lack of enantiomer bioinversion of E-7869 (R-flurbiprofen) Clin. Pharmacol. Ther. 2000;67:103.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12904458</PMID><DateCompleted><Year>2003</Year><Month>09</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>18</Issue><PubDate><Year>2003</Year><Month>Aug</Month><Day>06</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals.</ArticleTitle><Pagination><StartPage>6972</StartPage><EndPage>6981</EndPage><MedlinePgn>6972-81</MedlinePgn></Pagination><Abstract><AbstractText>Neurofibrillary pathology [paired helical filaments (PHFs)] formed by the microtubule-associated protein tau in a hyperphosphorylated form is a major hallmark of Alzheimer's disease and related disorders. The process of tau phosphorylation, thought to be of critical importance for PHF formation, and its potential link to neurodegeneration, however, is not understood very well, mostly because of the lack of a physiological in vivo model of PHF-like tau phosphorylation. Here we describe the formation of highly phosphorylated tau, containing a number of PHF-like epitopes in torpor during hibernation. PHF-like phosphorylation of tau was not associated with fibril formation and was fully reversible after arousal. Distribution of PHF-like tau followed a consistent pattern, being most intense in the entorhinal cortex, hippocampus, and isocortical areas. Within the hippocampus, a particularly high labeling was seen in CA3 pyramidal cells. Somewhat lesser reactivity was present in CA1 neurons while dentate gyrus granule cells were not reactive. Formation of PHF-like tau in CA3 neurons was paralleled by the regression of synaptic contacts of the mossy fiber system terminating on CA3 apical dendrites. Mossy fiber afferentation was re-established during arousal, concomitantly with the decrease of PHF-like tau in CA3 neurons. These findings implicate an essential link between neuronal plasticity and PHF-like phosphorylation of tau. The repeated formation and degradation of PHF-like tau might, thus, represent a physiological mechanism not necessarily associated with pathological effects. Hibernation will, therefore, be a valuable model to study the regulation of PHF-like tau-phosphorylation and its cell biological sequelae under physiological in vivo conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arendt</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neuroanatomy, Paul Flechsig Institute of Brain Research, University of Leipzig, D-04109 Leipzig, Germany. aret@medizin.uni-leipzig.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stieler</LastName><ForeName>Jens</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Strijkstra</LastName><ForeName>Arjen M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Hut</LastName><ForeName>Roelof A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>R&#xfc;diger</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Van der Zee</LastName><ForeName>Eddy A</ForeName><Initials>EA</Initials></Author><Author ValidYN="Y"><LastName>Harkany</LastName><ForeName>Tibor</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Holzer</LastName><ForeName>Max</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>H&#xe4;rtig</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000222" MajorTopicYN="N">Adaptation, Physiological</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001143" MajorTopicYN="N">Arousal</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001831" MajorTopicYN="N">Body Temperature</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006605" MajorTopicYN="N">Hibernation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019599" MajorTopicYN="N">Mossy Fibers, Hippocampal</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009473" MajorTopicYN="N">Neuronal Plasticity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010507" MajorTopicYN="N">Periodicity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012589" MajorTopicYN="N">Sciuridae</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>9</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>9</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>9</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>2</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12904458</ArticleId><ArticleId IdType="pmc">PMC6740664</ArticleId><ArticleId IdType="pii">23/18/6972</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-18-06972.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alexander L ( 1934) The neurofibrils in systemic disease and in supravital experiments, with remarks on pseudo-atrophy of the brain. Arch Neurol Psychiatry 32: 933-962.</Citation></Reference><Reference><Citation>Arendt T, Br&#xfc;ckner MK, Gertz HJ, Marcova L ( 1998a) Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurones that retain their capacity of plastic remodelling in the adult brain. Neuroscience 83: 991-1002.</Citation><ArticleIdList><ArticleId IdType="pubmed">9502241</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt T, Holzer M, Fruth R, Br&#xfc;ckner MK, G&#xe4;rtner U ( 1998b) Phosphorylation of tau, A&#x3b2;-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol Aging 19: 3-13.</Citation><ArticleIdList><ArticleId IdType="pubmed">9562497</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong SC, Ganote CE ( 1992) Effects of protein phosphatase inhibitors okadaic acid and calyculin A on metabolically inhibited and ischaemic isolated myocytes. J Mol Cell Cardiol 24: 869-884.</Citation><ArticleIdList><ArticleId IdType="pubmed">1331472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashford JW, Jarvik L ( 1985) Alzheimer's disease: does neuron plasticity pre-dispose to axonal neurofibrillary degeneration? N Engl J Med 313: 388-389.</Citation><ArticleIdList><ArticleId IdType="pubmed">4010760</ArticleId></ArticleIdList></Reference><Reference><Citation>Balli R ( 1906) Lesioni del reticolo neurofibrillare endocellulare in mammiferi adulti totalmente o parzialmente privati dell'apparecchio tiroparatiroideo e loro rapporto colla temperatura. Riv sper di freniat 32: 803-812.</Citation></Reference><Reference><Citation>Braak H, Braak E ( 1991) Neuropathological staging of Alzheimer related changes. Acta Neuropathol 82: 239-259.</Citation><ArticleIdList><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Matsushita M, Nairn AC, Damuni Z, Cai D, Frerichs KU, Hallenbeck JM ( 2001) Mechanisms for increased levels of phosphorylation of elongation factor-2 during hibernation in ground squirrels. Biochemistry 40: 11565-11570.</Citation><ArticleIdList><ArticleId IdType="pubmed">11560506</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotman CW, Anderson KJ ( 1988) Synaptic plasticity and functional stabilization in the hippocampal formation: possible role in Alzheimer's disease. Adv Neurol 47: 313-335.</Citation><ArticleIdList><ArticleId IdType="pubmed">3278521</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremer H, Chazal G, Goridis C, Represa A ( 1997) NCAM is essential for axonal growth and fasciculation in the hippocampus. Mol Cell Neurosci 8: 323-335.</Citation><ArticleIdList><ArticleId IdType="pubmed">9073395</ArticleId></ArticleIdList></Reference><Reference><Citation>Daan S, Barnes BM, Strijkstra AM ( 1991) Warming up for sleep? Ground squirrels sleep during arousals from hibernation. Neurosci Lett 128: 265-268.</Citation><ArticleIdList><ArticleId IdType="pubmed">1945046</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaggio A ( 1906) Effetti dell'azione combinata del digiuno e del freddo sui centri nervosi di mammiferi adulti. Riv sper di freniat 32: 373-393.</Citation></Reference><Reference><Citation>Drewes G, Lichtenberg-Kraag B, Doring F, Mandelkow EM, Biernat J, Goris J, Doree M, Mandelkow E ( 1992) Mitogen activated protein (Map) kinase transforms tau-protein into an Alzheimer-like state. EMBO J 11: 2131-2138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC556680</ArticleId><ArticleId IdType="pubmed">1376245</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbec P, Cremer H ( 2001) Revisiting the function of PSA-NCAM in the nervous system. Mol Neurobiol 24: 53-64.</Citation><ArticleIdList><ArticleId IdType="pubmed">11831554</ArticleId></ArticleIdList></Reference><Reference><Citation>Esclaire F, Terro F, Yardin C, Hugon J ( 1998) Neuronal apoptosis is associated with a decrease in tau mRNA expression. NeuroReport 9: 1173-1177.</Citation><ArticleIdList><ArticleId IdType="pubmed">9601689</ArticleId></ArticleIdList></Reference><Reference><Citation>Flood DG, Coleman PD ( 1990) Hippocampal plasticity in normal aging and decreased plasticity in Alzheimer's disease. Prog Brain Res 83: 435-443.</Citation><ArticleIdList><ArticleId IdType="pubmed">2203107</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox GB, O'Connell AW, Murphy KJ, Regan CM ( 1995) Memory consolidation induces a transient and time-dependent increase in the frequency of neural cell adhesion molecule polysialylated cells in the adult rat hippocampus. J Neurochem 65: 2796-2799.</Citation><ArticleIdList><ArticleId IdType="pubmed">7595580</ArticleId></ArticleIdList></Reference><Reference><Citation>French A ( 1985) Allometries of the durations of torpid and euthermic intervals during mammalian hibernation: a test of theory of metabolic control of the timing of changes in body temperature. J Comp Physiol [B] 156: 13-19.</Citation><ArticleIdList><ArticleId IdType="pubmed">3836228</ArticleId></ArticleIdList></Reference><Reference><Citation>Frerichs KU, Hallenbeck JM ( 1998) Hibernation in ground squirrels induces state and species-specific tolerance to hypoxia and aglycemia: an in vitro study in hippocampal slices. J Cereb Blood Flow Metab 18: 168-175.</Citation><ArticleIdList><ArticleId IdType="pubmed">9469159</ArticleId></ArticleIdList></Reference><Reference><Citation>Frerichs KU, Smith CB, Brenner M, DeGracia DJ, Krause GS, Marrone L, Dever TE, Hallenbeck JM ( 1998) Suppression of protein synthesis in brain during hibernation involves inhibition of protein initiation and elongation. Proc Natl Acad Sci USA 95: 14511-14516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC24404</ArticleId><ArticleId IdType="pubmed">9826731</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabriel A, Klussmann FW, Igelmund P ( 1998) Rapid temperature changes induce adenosine-mediated depression of synaptic transmission in hippocampal slices from rats (non-hibernators.). Neuroscience 86: 67-77.</Citation><ArticleIdList><ArticleId IdType="pubmed">9692744</ArticleId></ArticleIdList></Reference><Reference><Citation>Geddes JW, Cotman CW ( 1991) Plasticity in Alzheimer's disease: too much or not enough? Neurobiol Aging 12: 330-333.</Citation><ArticleIdList><ArticleId IdType="pubmed">1961362</ArticleId></ArticleIdList></Reference><Reference><Citation>Geiser F ( 1988) Reduction of metabolism during hibernation and daily torpor in mammals and birds: temperature effect or physiological inhibition? J Comp Physiol [B] 158: 25-37.</Citation><ArticleIdList><ArticleId IdType="pubmed">3385059</ArticleId></ArticleIdList></Reference><Reference><Citation>Geiser F, Kenagy GJ ( 1988) Torpor duration in relation to temperature and metabolisms in hibernating ground squirrels. Physiol Zool 61: 442-449.</Citation></Reference><Reference><Citation>Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA ( 1989a) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3: 519-526.</Citation><ArticleIdList><ArticleId IdType="pubmed">2484340</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA ( 1989b) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 8: 393-399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC400819</ArticleId><ArticleId IdType="pubmed">2498079</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Cohen ES, Jakes R, Cohen P ( 1992a) P42 Map kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase-2A1: implications for Alzheimer's disease. FEBS Lett 312: 95-99.</Citation><ArticleIdList><ArticleId IdType="pubmed">1330687</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Spillantini MG, Cairns NJ, Crowther RA ( 1992b) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8: 159-168.</Citation><ArticleIdList><ArticleId IdType="pubmed">1530909</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Jakes R, Crowther RA, Six J, Lubke U, Vandermeeren M, Cras P, Trojanowski JQ, Lee VM ( 1993) The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 90: 5066-5070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC46655</ArticleId><ArticleId IdType="pubmed">8506352</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong CX, Grundke-Iqbal I, Iqbal K ( 1994) Dephosphorylation of Alzheimer's disease abnormally phosphorylated-tau by protein phosphatase-2A. Neuroscience 61: 765-772.</Citation><ArticleIdList><ArticleId IdType="pubmed">7838376</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;rtig W, Br&#xfc;ckner G, Holzer M, Brauer K, Bigl V ( 1995) Digoxigenylated primary antibodies for sensitive dual-peroxidase labelling of neural markers. Histochem Cell Biol 104: 467-472.</Citation><ArticleIdList><ArticleId IdType="pubmed">8777733</ArticleId></ArticleIdList></Reference><Reference><Citation>Heldmaier G, Ruf T ( 1992) Body temperature and metabolic rate during natural hypothermia in endotherms. J Comp Physiol [B] 162: 696-706.</Citation><ArticleIdList><ArticleId IdType="pubmed">1494028</ArticleId></ArticleIdList></Reference><Reference><Citation>Hut RA, de Wilde MC, Strijkstra AM, Van der Zee EA, Daan S ( 2001) Neuronal changes in the hippocampus and SCN of hibernating ground squirrels. Soc Neurosci Abstr 27: 535.11.</Citation></Reference><Reference><Citation>Hut RA, Barnes BM, Daan S ( 2002a) Body temperature patterns before, during, and after semi-natural hibernation in the European ground squirrel. J Comp Physiol [B] 172: 47-58.</Citation><ArticleIdList><ArticleId IdType="pubmed">11824403</ArticleId></ArticleIdList></Reference><Reference><Citation>Hut RA, Van der Zee EA, Jansen K, Gerkema MP, Daan S ( 2002b) Gradual reappearance of post-hibernation circadian rhythmicity correlates with numbers of vasopressin-containing neurons in the suprachiasmatic nuclei of European ground squirrels. J Comp Physiol [B] 172: 59-70.</Citation><ArticleIdList><ArticleId IdType="pubmed">11828985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara Y ( 2001) PHF and PHF-like fibrils: cause or consequence? Neurobiol Aging 22: 123-126.</Citation><ArticleIdList><ArticleId IdType="pubmed">11164285</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MM ( 2000) Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol 53: 733-737.</Citation><ArticleIdList><ArticleId IdType="pubmed">11155096</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavanau JL ( 1997) Memory, sleep and the evolution of mechanisms of synaptic efficacy maintenance. Neuroscience 79: 7-44.</Citation><ArticleIdList><ArticleId IdType="pubmed">9178863</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenagy GJ, Sharbaugh SM, Nagy KA ( 1989) Annual cycle of energy and time expenditure in a Golden mantled ground squirrel population. Oecologia 78: 269-282.</Citation><ArticleIdList><ArticleId IdType="pubmed">28312369</ArticleId></ArticleIdList></Reference><Reference><Citation>Krilowicz BL, Glotzbach SF, Heller HC ( 1988) Neuronal activity during sleep and complete bouts of hibernation. Am J Physiol 255: R1008-R1019.</Citation><ArticleIdList><ArticleId IdType="pubmed">3202216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesort M, Blanchard C, Yardin C, Esclaire F, Hugon J ( 1997) Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivation. Mol Brain Res 45: 127-132.</Citation><ArticleIdList><ArticleId IdType="pubmed">9105678</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewy FH ( 1923) Die Lehre von Tonus und der Bewegung. In: Monographien aus dem Gesamtgebiet der Neurologie und Psychiatrie (Alzheimer A, Lewandowski, M, eds), p 34. Berlin: Springer.</Citation></Reference><Reference><Citation>MacDonald JA, Storey B ( 1998) cAMP-dependent protein kinase from brown adipose tissue: temperature effects on kinetic properties and enzyme role in hibernating ground squirrels. J Comp Physiol [B] 168: 513-525.</Citation><ArticleIdList><ArticleId IdType="pubmed">9810716</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald JA, Storey B ( 1999) Regulation of ground squirrel Na+ K+-ATPase activity by reversible phosphorylation during hibernation. Biochem Biophys Res Commun 254: 424-429.</Citation><ArticleIdList><ArticleId IdType="pubmed">9918854</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee G, Andrews JF ( 1992) The costs and savings of hibernation in the golden hamster. J Physiol (Lond) 446: 451.</Citation></Reference><Reference><Citation>Malinsky J ( 1983) Quantitative analysis of morphological changes in the spinal cord of the hibernating bat. Folia Morphologica 31: 40-45.</Citation><ArticleIdList><ArticleId IdType="pubmed">6852701</ArticleId></ArticleIdList></Reference><Reference><Citation>Malinsky J, Malinska J ( 1975) Changes of the motoneurons and synapses of the spinal cord of the hedgehog during hibernation. Proceedings of the Xth International Congress of Anatomists, Tokyo, Japan.</Citation></Reference><Reference><Citation>Malinsky J, Malinska J ( 1988) Ultrastructural changes of synapses in supraoptic nucleus of Hedgehog during Hibernation. Acta Universitatis Palackianae Olomucensis 12: 117-125.</Citation><ArticleIdList><ArticleId IdType="pubmed">2977884</ArticleId></ArticleIdList></Reference><Reference><Citation>Malinsky J, Polach A ( 1985) Changes of synaptic apparatus in the brain cortex of the hedgehog during hibernation (a quantitative Golgi and electron microscopic study). Acta Universitatis Palackianae Olomucensis 108: 109-115.</Citation><ArticleIdList><ArticleId IdType="pubmed">2411110</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrani H, Storey KB ( 1997) Protein kinase C from bat brain: the enzyme from a hibernating mammal. Neurochem Int 31: 139-150.</Citation><ArticleIdList><ArticleId IdType="pubmed">9185174</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesulam MM ( 1999) Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 24: 521-529.</Citation><ArticleIdList><ArticleId IdType="pubmed">10595506</ArticleId></ArticleIdList></Reference><Reference><Citation>Millesi E, Prossinger H, Dittami JP, Fieder M ( 2001) Hibernation effects on memory in European ground squirrels (Spermophilus citellus). J Biol Rhythm 16: 264-271.</Citation><ArticleIdList><ArticleId IdType="pubmed">11407786</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills JC, Lee VMY, Pittman RN ( 1998) Activation of a PP2A-like phosphatase and dephosphorylation of &#x3c4; protein characterize onset of the execution phase of apoptosis. J Cell Sci 111: 625-636.</Citation><ArticleIdList><ArticleId IdType="pubmed">9454736</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller D, Wang C, Skibo G, Toni N, Cremer H, Calaora V, Rougon G, Kiss JZ ( 1996) PSA-NCAM is required for activity-induced synaptic plasticity. Neuron 17: 413-422.</Citation><ArticleIdList><ArticleId IdType="pubmed">8816705</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy JK, O'Connell W, Regan CM ( 1996) Repetitive and transient increases in hippocampal neural cell adhesion molecule polysialylation state following multitrial spatial training. J Neurochem 67: 1268-1274.</Citation><ArticleIdList><ArticleId IdType="pubmed">8752135</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy Z, Esiri MM ( 1997) Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol Aging 18: 565-571.</Citation><ArticleIdList><ArticleId IdType="pubmed">9461054</ArticleId></ArticleIdList></Reference><Reference><Citation>Oklejewicz M, Daan S, Strijkstra AM ( 2001) Temporal organisation of hibernation in wild-type and tau mutant Syrian hamsters. J Comp Physiol [B] 171: 431:439.</Citation><ArticleIdList><ArticleId IdType="pubmed">11497131</ArticleId></ArticleIdList></Reference><Reference><Citation>Planel E, Yasutake K, Fujitas SC, Ishiguro K ( 2001) Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3&#x3b2; and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J Biol Chem 276: 34298-34306.</Citation><ArticleIdList><ArticleId IdType="pubmed">11441005</ArticleId></ArticleIdList></Reference><Reference><Citation>Popov VI, Bocharova LS ( 1992) Hibernation-induced structural changes in synaptic contracts between mossy fibres and hippocampal neurons. Neuroscience 48: 53-62.</Citation><ArticleIdList><ArticleId IdType="pubmed">1584425</ArticleId></ArticleIdList></Reference><Reference><Citation>Popov VL, Bocharova LS, Bragin AG ( 1992) Repeated changes of dendritic morphology in the hippocampus of ground squirrels in the course of hibernation. Neuroscience 48: 45-51.</Citation><ArticleIdList><ArticleId IdType="pubmed">1584424</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xf3;n y Cajal S ( 1904) Variacones morfol&#xf3;gicas, normales y pathol&#xf3;gicas del reticulo neurofibrillar Trabajos del laborat de investig biol. de la Univ de Madrid 3: 9-15.</Citation></Reference><Reference><Citation>Ram&#xf3;n y Cajal S ( 1928) Degeneration and regeneration of the nervous system. London: Oxford UP.</Citation></Reference><Reference><Citation>Rasdolsky J ( 1926) Histologische Ver&#xe4;nderungen in dem zentralen und peripherischen Nervensystem der Tiere mit exstirpierten Schildund Nebenschilddr&#xfc;sen. Z Neurol Psychiat 106: 96-113.</Citation></Reference><Reference><Citation>R&#xf6;sner H, Rebhan M, Vacu G, Vanmechelen E ( 1994) Expression of a paired helical filament tau epitope in embryonic chicken central nervous system. NeuroReport 5: 1164-1166.</Citation><ArticleIdList><ArticleId IdType="pubmed">7521684</ArticleId></ArticleIdList></Reference><Reference><Citation>Seki T, Arai Y ( 1993) Distribution and possible roles of the highly polysialylated neural cell adhesion molecule (NCAM-H) in the developing and adult central nervous system. Neurosci Res 17: 265-290.</Citation><ArticleIdList><ArticleId IdType="pubmed">8264989</ArticleId></ArticleIdList></Reference><Reference><Citation>Seki T, Arai Y ( 1999) Different polysialic acid-neural cell adhesion molecule expression patterns in distinct types of mossy fiber boutons in the adult hippocampus. J Comp Neurol 410: 115-125.</Citation><ArticleIdList><ArticleId IdType="pubmed">10397399</ArticleId></ArticleIdList></Reference><Reference><Citation>Shchipakina T, Zharikova A, Arkhipov V ( 1995) Protein phosphorylation of synaptic membranes isolated from the brain of ground squirrels during hibernation. NeuroReport 7: 278-280.</Citation><ArticleIdList><ArticleId IdType="pubmed">8742469</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern K, Elliott KAC ( 1949) Experimental observation on the so-called senile changes of intracellular neurofibrils. Am J Psychiat 106: 190-194.</Citation><ArticleIdList><ArticleId IdType="pubmed">18147404</ArticleId></ArticleIdList></Reference><Reference><Citation>Strijkstra AM, Daan S ( 1997) Sleep during arousal episodes as a function of prior torpor duration in hibernating European ground squirrels. J Sleep Res 6: 36-43.</Citation><ArticleIdList><ArticleId IdType="pubmed">9125697</ArticleId></ArticleIdList></Reference><Reference><Citation>Strijkstra AM, Daan S ( 1998) Dissimilarity of slow-wave activity enhancement by torpor and sleep deprivation in a hibernator. Am J Physiol 275: R1110-R1117.</Citation><ArticleIdList><ArticleId IdType="pubmed">9756541</ArticleId></ArticleIdList></Reference><Reference><Citation>Strijkstra AM, Deboer T, Daan S ( 1999) Dynamics of cortical EEG power decrease rate during entry into natural hypothermia in European ground squirrels. In: Sleep-Wake Research in The Netherlands, Vol 10 (Van Bemmel AL, Beersma DGM, Folgering H, Hofman WF, Ruigt GSF, eds), pp 157-162. Utrecht, The Netherlands: Drukkerij Elinkwijk B.V.</Citation></Reference><Reference><Citation>Strijkstra AM, Hut RA, Stieler J, Van der Zee EA ( 2003) Hippocampal synaptophysin immunoreactivity is reduced during natural hypothermia in ground squirrels. Neurosci Lett 344: 29-32.</Citation><ArticleIdList><ArticleId IdType="pubmed">12781914</ArticleId></ArticleIdList></Reference><Reference><Citation>Storey KB ( 1987) Regulation of liver metabolism by enzyme phosphorylation during mammalian hibernation. J Biol Chem 262: 1670-1673.</Citation><ArticleIdList><ArticleId IdType="pubmed">2948958</ArticleId></ArticleIdList></Reference><Reference><Citation>Storey KB ( 1997) Metabolic regulation in mammalian hibernation: Enzyme and protein adaptations. Comp Biochem Physiol [A] 118: 1115-1124.</Citation><ArticleIdList><ArticleId IdType="pubmed">9505421</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaab DF ( 1991) Brain aging and Alzheimer's disease, &#x201c;wear and tear&#x201d; versus &#x201c;use it or lose it&#x201d;. Neurobiol Aging 12: 317-324.</Citation><ArticleIdList><ArticleId IdType="pubmed">1755879</ArticleId></ArticleIdList></Reference><Reference><Citation>Tello F ( 1904) Las neurofibrillas en los vertebrados inferiores. Trab lab invest biol Univ Madrid 3: 113-151.</Citation></Reference><Reference><Citation>Thompson JD, Higgins DG, Gibson TJ ( 1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308517</ArticleId><ArticleId IdType="pubmed">7984417</ArticleId></ArticleIdList></Reference><Reference><Citation>Walaas SI, Greengard P ( 1991) Protein phosphorylation and neuronal function. Pharmacol Rev 43: 299-349.</Citation><ArticleIdList><ArticleId IdType="pubmed">1956954</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker JM, Glotzbach SF, Berger RJ, Heller HC ( 1977) Sleep and hibernation in ground squirrels: Electrophysiological observations. Am J Physiol 233: 213-221.</Citation><ArticleIdList><ArticleId IdType="pubmed">200149</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LCH ( 1978) Energetic and field aspects of mammalian torpor: the Richardson's ground squirrel. In: Strategies in cold: natural torpidity and thermogenesis. pp 109-145. New York: Academic.</Citation></Reference><Reference><Citation>Wang LCH ( 1989) Ecological, physiological and biochemical aspects of torpor in mammals and birds. In: Advances in comparative and environmental physiology, Vol 4, (Wang LCH, ed), pp 361-401. Heidelberg: Springer.</Citation></Reference><Reference><Citation>Weinbrenner C, Baines CP, Liu GS, Armstrong SC, Ganote CE, Walsh AH, Honkanen RE, Cohen MV, Downey JM ( 1998) Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia. Circulation 98: 899-905.</Citation><ArticleIdList><ArticleId IdType="pubmed">9738645</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagisawa M, Planel E, Ishiguro K, Fujita SC ( 1999) Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease. FEBS Lett 461: 329-333.</Citation><ArticleIdList><ArticleId IdType="pubmed">10567721</ArticleId></ArticleIdList></Reference><Reference><Citation>Yardin C, Terro F, Esclaire F, Rigaud M, Hugon J ( 1998) Brefeldin A-induced apoptosis is expressed in rat neurons with dephosphorylated tau protein. Neurosci Lett 250: 1-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">9696051</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12906797</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0960-9822</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>15</Issue><PubDate><Year>2003</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>Current biology : CB</Title><ISOAbbreviation>Curr Biol</ISOAbbreviation></Journal><ArticleTitle>Learning and memory deficits in Notch mutant mice.</ArticleTitle><Pagination><StartPage>1348</StartPage><EndPage>1354</EndPage><MedlinePgn>1348-54</MedlinePgn></Pagination><Abstract><AbstractText>Notch is a critical component of evolutionarily conserved signaling mechanisms that regulate development and may contribute to plasticity-related processes, including changes in neurite structure and maintenance of neural stem cells. Deficits in the Notch pathway are responsible for Alagille and Cadasil syndromes, which are associated with mental retardation and dementia. Additionally, in postmitotic neurons, Notch proteins interact with presenilins and with beta-amyloid precursor protein and could therefore have a role in the memory deficits associated with familial and sporadic Alzheimer's disease. To test if alterations in Notch signaling can lead to learning and memory deficits, we studied mice with mutations in this pathway. Here, we show that null heterozygous mutations in Notch1 result in deficits in spatial learning and memory without affecting other forms of learning, motor control, or exploratory activity. We also show that null heterozygous mutations in the downstream cofactor RBP-J result in similarly specific spatial learning and memory deficits. These data indicate that a constitutive decrease in Notch signaling can result in specific learning and memory deficits and suggest that abnormalities in Notch-dependent transcription may contribute to the cognitive deficits associated with Alzheimer's disease and Alagille and Cadasil syndromes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Rui M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>University of California, Los Angeles, Department of Neurobiology, and Brain Research Institute, 695 Young Drive South, Room 2554, Box 951761, Los Angeles, CA 90095-1761, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honjo</LastName><ForeName>Tasuku</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Alcino J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Biol</MedlineTA><NlmUniqueID>9107782</NlmUniqueID><ISSNLinking>0960-9822</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051819">Immunoglobulin J Recombination Signal Sequence-Binding Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497762">Notch1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497571">Rbpj protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051881">Receptor, Notch1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051819" MajorTopicYN="N">Immunoglobulin J Recombination Signal Sequence-Binding Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018782" MajorTopicYN="N">Maze Learning</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008568" MajorTopicYN="N">Memory</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008817" MajorTopicYN="N">Mice, Mutant Strains</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051881" MajorTopicYN="N">Receptor, Notch1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011956" MajorTopicYN="N">Receptors, Cell Surface</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013037" MajorTopicYN="N">Spatial Behavior</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="Y">Transcription Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>9</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>9</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12906797</ArticleId><ArticleId IdType="doi">10.1016/s0960-9822(03)00492-5</ArticleId><ArticleId IdType="pii">S0960-9822(03)00492-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12913006</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-9258</ISSN><JournalIssue CitedMedium="Print"><Volume>278</Volume><Issue>43</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>24</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor.</ArticleTitle><Pagination><StartPage>42161</StartPage><EndPage>42169</EndPage><MedlinePgn>42161-9</MedlinePgn></Pagination><Abstract><AbstractText>The generation of biologically active proteins by regulated intramembrane proteolysis is a highly conserved mechanism in cell signaling. Presenilin-dependent gamma-secretase activity is responsible for the intramembrane proteolysis of selected type I membrane proteins, including beta-amyloid precursor protein (APP) and Notch. A small fraction of intracellular domains derived from both APP and Notch translocates to and appears to function in the nucleus, suggesting a generic role for gamma-secretase cleavage in nuclear signaling. Here we show that the p75 neurotrophin receptor (p75NTR) undergoes presenilin-dependent intramembrane proteolysis to yield the soluble p75-intracellular domain. The p75NTR is a multifunctional type I membrane protein that promotes neurotrophin-induced neuronal survival and differentiation by forming a heteromeric co-receptor complex with the Trk receptors. Mass spectrometric analysis revealed that gamma-secretase-mediated cleavage of p75NTR occurs at a position located in the middle of the transmembrane (TM) domain, which is reminiscent of the amyloid beta-peptide 40 (Abeta40) cleavage of APP and is topologically distinct from the major TM cleavage site of Notch 1. Size exclusion chromatography and co-immunoprecipitation analyses revealed that TrkA forms a molecular complex together with either full-length p75 or membrane-tethered C-terminal fragments. The p75-ICD was not recruited into the TrkA-containing high molecular weight complex, indicating that gamma-secretase-mediated removal of the p75 TM domain may perturb the interaction with TrkA. Independent of the possible nuclear function, our studies suggest that gamma-secretase-mediated p75NTR proteolysis plays a role in the formation/disassembly of the p75-TrkA receptor complex by regulating the availability of the p75 TM domain that is required for this interaction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Kwang-Mook</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Pathology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Center for Neurobiology and Behavior, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Serena</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Landman</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Petrova</LastName><ForeName>Kseniya</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Renee</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Peter K</ForeName><Initials>PK</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Dae Sup</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Sung Ho</ForeName><Initials>SH</Initials></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Moses V</ForeName><Initials>MV</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae-Wan</ForeName><Initials>TW</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CA 056490</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS 43467</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508853">PSEN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508861">PSEN2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053766">Presenilin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020800">Receptor, Nerve Growth Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017475">Receptors, Nerve Growth Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D020917">Receptor, trkA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011233" MajorTopicYN="N">Precipitin Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053766" MajorTopicYN="N">Presenilin-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020800" MajorTopicYN="N">Receptor, Nerve Growth Factor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020917" MajorTopicYN="N">Receptor, trkA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017475" MajorTopicYN="N">Receptors, Nerve Growth Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12913006</ArticleId><ArticleId IdType="doi">10.1074/jbc.M306028200</ArticleId><ArticleId IdType="pii">S0021-9258(20)82753-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12917687</PMID><DateCompleted><Year>2003</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>424</Volume><Issue>6950</Issue><PubDate><Year>2003</Year><Month>Aug</Month><Day>14</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme.</ArticleTitle><Pagination><StartPage>783</StartPage><EndPage>788</EndPage><MedlinePgn>783-8</MedlinePgn></Pagination><Abstract><AbstractText>Amyloid diseases are characterized by an aberrant assembly of a specific protein or protein fragment into fibrils and plaques that are deposited in various organs and tissues, often with serious pathological consequences. Non-neuropathic systemic amyloidosis is associated with single point mutations in the gene coding for human lysozyme. Here we report that a single-domain fragment of a camelid antibody raised against wild-type human lysozyme inhibits the in vitro aggregation of its amyloidogenic variant, D67H. Our structural studies reveal that the epitope includes neither the site of mutation nor most residues in the region of the protein structure that is destabilized by the mutation. Instead, the binding of the antibody fragment achieves its effect by restoring the structural cooperativity characteristic of the wild-type protein. This appears to occur at least in part through the transmission of long-range conformational effects to the interface between the two structural domains of the protein. Thus, reducing the ability of an amyloidogenic protein to form partly unfolded species can be an effective method of preventing its aggregation, suggesting approaches to the rational design of therapeutic agents directed against protein deposition diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dumoulin</LastName><ForeName>Mireille</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Last</LastName><ForeName>Alexander M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Desmyter</LastName><ForeName>Aline</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Decanniere</LastName><ForeName>Klaas</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Canet</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Larsson</LastName><ForeName>G&#xf6;ran</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Spencer</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Archer</LastName><ForeName>David B</ForeName><Initials>DB</Initials></Author><Author ValidYN="Y"><LastName>Sasse</LastName><ForeName>Jurgen</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Muyldermans</LastName><ForeName>Serge</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wyns</LastName><ForeName>Lode</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Redfield</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Matagne</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Carol V</ForeName><Initials>CV</Initials></Author><Author ValidYN="Y"><LastName>Dobson</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007140">Immunoglobulin Fab Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.1.17</RegistryNumber><NameOfSubstance UI="D009113">Muramidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000686" MajorTopicYN="N">Amyloidosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002161" MajorTopicYN="N">Camelids, New World</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002942" MajorTopicYN="N">Circular Dichroism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007140" MajorTopicYN="N">Immunoglobulin Fab Fragments</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009113" MajorTopicYN="N">Muramidase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011489" MajorTopicYN="N">Protein Denaturation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014961" MajorTopicYN="N">X-Ray Diffraction</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>8</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12917687</ArticleId><ArticleId IdType="doi">10.1038/nature01870</ArticleId><ArticleId IdType="pii">nature01870</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12917692</PMID><DateCompleted><Year>2003</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2010</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>424</Volume><Issue>6950</Issue><PubDate><Year>2003</Year><Month>Aug</Month><Day>14</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Rationalization of the effects of mutations on peptide and protein aggregation rates.</ArticleTitle><Pagination><StartPage>805</StartPage><EndPage>808</EndPage><MedlinePgn>805-8</MedlinePgn></Pagination><Abstract><AbstractText>In order for any biological system to function effectively, it is essential to avoid the inherent tendency of proteins to aggregate and form potentially harmful deposits. In each of the various pathological conditions associated with protein deposition, such as Alzheimer's and Parkinson's diseases, a specific peptide or protein that is normally soluble is deposited as insoluble aggregates generally referred to as amyloid. It is clear that the aggregation process is generally initiated from partially or completely unfolded forms of the peptides and proteins associated with each disease. Here we show that the intrinsic effects of specific mutations on the rates of aggregation of unfolded polypeptide chains can be correlated to a remarkable extent with changes in simple physicochemical properties such as hydrophobicity, secondary structure propensity and charge. This approach allows the pathogenic effects of mutations associated with known familial forms of protein deposition diseases to be rationalized, and more generally enables prediction of the effects of mutations on the aggregation propensity of any polypeptide chain.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chiti</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefani</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Taddei</LastName><ForeName>Niccol&#xf2;</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Ramponi</LastName><ForeName>Giampietro</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Dobson</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000686" MajorTopicYN="N">Amyloidosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057927" MajorTopicYN="N">Hydrophobic and Hydrophilic Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017354" MajorTopicYN="N">Point Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011489" MajorTopicYN="N">Protein Denaturation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017433" MajorTopicYN="N">Protein Structure, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055672" MajorTopicYN="N">Static Electricity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013816" MajorTopicYN="N">Thermodynamics</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>8</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12917692</ArticleId><ArticleId IdType="doi">10.1038/nature01891</ArticleId><ArticleId IdType="pii">nature01891</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12920299</PMID><DateCompleted><Year>2003</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>301</Volume><Issue>5635</Issue><PubDate><Year>2003</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>SCNM1, a putative RNA splicing factor that modifies disease severity in mice.</ArticleTitle><Pagination><StartPage>967</StartPage><EndPage>969</EndPage><MedlinePgn>967-9</MedlinePgn></Pagination><Abstract><AbstractText>The severity of many inherited disorders is influenced by genetic background. We describe a modifier interaction in C57BL/6Jmice that converts a chronic movement disorder into a lethal neurological disease. The primary mutation (medJ) changes a splice donor site of the sodium channel gene Scn8a (Nav1.6). The modifier mutation is characteristic of strain C57BL/6Jand introduces a nonsense codon into sodium channel modifier 1 (SCNM1), a zinc finger protein and a putative splice factor. An internally deleted SCNM1 protein is also predicted as a result of exon skipping associated with disruption of a consensus exonic splicing enhancer. The effect of the modifier mutation is to reduce the abundance of correctly spliced sodium channel transcripts below the threshold for survival. Our finding that genetic variation in a putative RNA splicing factor influences disease susceptibility in mice raises the possibility that a similar mechanism modifies the severity of human inherited disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buchner</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, University of Michigan School of Medicine, Ann Arbor, MI 48109-0618, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trudeau</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Meisler</LastName><ForeName>Miriam H</ForeName><Initials>MH</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GM24872</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 DC00011</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM07544</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HG00040</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018389">Codon, Nonsense</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018388">Codon, Terminator</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062557">NAV1.6 Voltage-Gated Sodium Channel</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072260">RNA Splicing Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C100681">SCN8A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C486783">SCNM1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C491046">Scn8a protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C476996">Scnm1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015222">Sodium Channels</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Science. 2003 Aug 15;301(5635):927-8. doi: 10.1126/science.1088948.</RefSource><PMID Version="1">12920288</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002874" MajorTopicYN="N">Chromosome Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018389" MajorTopicYN="N">Codon, Nonsense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018388" MajorTopicYN="N">Codon, Terminator</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008818" MajorTopicYN="N">Mice, Neurologic Mutants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009069" MajorTopicYN="N">Movement Disorders</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062557" MajorTopicYN="N">NAV1.6 Voltage-Gated Sodium Channel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="Y">Nerve Tissue Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012326" MajorTopicYN="Y">RNA Splicing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072260" MajorTopicYN="N">RNA Splicing Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015222" MajorTopicYN="N">Sodium Channels</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016335" MajorTopicYN="N">Zinc Fingers</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>9</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12920299</ArticleId><ArticleId IdType="doi">10.1126/science.1086187</ArticleId><ArticleId IdType="pii">301/5635/967</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12925731</PMID><DateCompleted><Year>2003</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>18</Issue><PubDate><Year>2003</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.</ArticleTitle><Pagination><StartPage>10417</StartPage><EndPage>10422</EndPage><MedlinePgn>10417-22</MedlinePgn></Pagination><Abstract><AbstractText>A molecular basis for memory failure in Alzheimer's disease (AD) has been recently hypothesized, in which a significant role is attributed to small, soluble oligomers of amyloid beta-peptide (A beta). A beta oligomeric ligands (also known as ADDLs) are known to be potent inhibitors of hippocampal long-term potentiation, which is a paradigm for synaptic plasticity, and have been linked to synapse loss and reversible memory failure in transgenic mouse AD models. If such oligomers were to build up in human brain, their neurological impact could provide the missing link that accounts for the poor correlation between AD dementia and amyloid plaques. This article, using antibodies raised against synthetic A beta oligomers, verifies the predicted accumulation of soluble oligomers in AD frontal cortex. Oligomers in AD reach levels up to 70-fold over control brains. Brain-derived and synthetic oligomers show structural equivalence with respect to mass, isoelectric point, and recognition by conformation-sensitive antibodies. Both oligomers, moreover, exhibit the same striking patterns of attachment to cultured hippocampal neurons, binding on dendrite surfaces in small clusters with ligand-like specificity. Binding assays using solubilized membranes show oligomers to be high-affinity ligands for a small number of nonabundant proteins. Current results confirm the prediction that soluble oligomeric A beta ligands are intrinsic to AD pathology, and validate their use in new approaches to therapeutic AD drugs and vaccines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Yuesong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurobiology and Physiology, Northwestern University, Evanston, IL 60208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Lei</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Viola</LastName><ForeName>Kirsten L</ForeName><Initials>KL</Initials></Author><Author ValidYN="Y"><LastName>Lacor</LastName><ForeName>Pascale N</ForeName><Initials>PN</Initials></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Mary P</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Finch</LastName><ForeName>Caleb E</ForeName><Initials>CE</Initials></Author><Author ValidYN="Y"><LastName>Krafft</LastName><ForeName>Grant A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>William L</ForeName><Initials>WL</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG018877</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01-AG15501</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01-AG18877</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009842">Oligopeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014020">Tissue Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C098994">amyloid beta-protein (1-43)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001923" MajorTopicYN="Y">Brain Chemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015151" MajorTopicYN="N">Immunoblotting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017774" MajorTopicYN="N">Long-Term Potentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009842" MajorTopicYN="N">Oligopeptides</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014020" MajorTopicYN="N">Tissue Extracts</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>10</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>3</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12925731</ArticleId><ArticleId IdType="pmc">PMC193576</ArticleId><ArticleId IdType="doi">10.1073/pnas.1834302100</ArticleId><ArticleId IdType="pii">1834302100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardy, J. &amp; Selkoe, D. J. (2002) Science 297, 353-356.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkitadze, M. D., Bitan, G. &amp; Teplow, D. B. (2002) J. Neurosci. Res. 69, 567-577.</Citation><ArticleIdList><ArticleId IdType="pubmed">12210822</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, W. L. (2000) in Molecular Mechanisms of Neurodegenerative Diseases, ed. Chesselet, M.-F. (Humana, Totowa, NJ), pp. 1-49.</Citation></Reference><Reference><Citation>Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K. &amp; Muller-Hill, B. (1987) Nature 325, 733-736.</Citation><ArticleIdList><ArticleId IdType="pubmed">2881207</ArticleId></ArticleIdList></Reference><Reference><Citation>Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N. &amp; James, L. (1991) Nature 349, 704-706.</Citation><ArticleIdList><ArticleId IdType="pubmed">1671712</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertekin-Taner, N., Graff-Radford, N., Younkin, L. H., Eckman, C., Baker, M., Adamson, J., Ronald, J., Blangero, J., Hutton, M. &amp; Younkin, S. G. (2000) Science 290, 2303-2304.</Citation><ArticleIdList><ArticleId IdType="pubmed">11125143</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper, J. D. &amp; Lansbury, P. T., Jr. (1997) Annu. Rev. Biochem. 66, 385-407.</Citation><ArticleIdList><ArticleId IdType="pubmed">9242912</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenner, G. G. &amp; Wong, C. W. (1984) Biochem. Biophys. Res. Commun. 122, 1131-1135.</Citation><ArticleIdList><ArticleId IdType="pubmed">6236805</ArticleId></ArticleIdList></Reference><Reference><Citation>Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L. &amp; Beyreuther, K. (1985) Proc. Natl. Acad. Sci. USA 82, 4245-4249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC397973</ArticleId><ArticleId IdType="pubmed">3159021</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrett, J. T., Berger, E. P. &amp; Lansbury, P. T., Jr. (1993) Biochemistry 32, 4693-4697.</Citation><ArticleIdList><ArticleId IdType="pubmed">8490014</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzo, A. &amp; Yankner, B. A. (1994) Proc. Natl. Acad. Sci. USA 91, 12243-12247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC45413</ArticleId><ArticleId IdType="pubmed">7991613</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G. &amp; Cotman, C. W. (1993) J. Neurosci. 13, 1676-1687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6576726</ArticleId><ArticleId IdType="pubmed">8463843</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy, J. A. &amp; Higgins, G. A. (1992) Science 256, 184-185.</Citation><ArticleIdList><ArticleId IdType="pubmed">1566067</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry, R. D. (1999) in Alzheimer Disease, eds. Terry, R. D., Katzman, R., Bick, K. L. &amp; Sisodia, S. S. (Lippincott, Williams &amp; Wilkins, Philadelphia), pp. 187-206.</Citation></Reference><Reference><Citation>Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K. &amp; McConlogue, L. (2000) J. Neurosci. 20, 4050-4058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772621</ArticleId><ArticleId IdType="pubmed">10818140</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, W. L., Krafft, G. A. &amp; Finch, C. E. (2001) Trends Neurosci. 24, 219-224.</Citation><ArticleIdList><ArticleId IdType="pubmed">11250006</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, W. L. (2002) Neurobiol. Aging 23, 231-235.</Citation><ArticleIdList><ArticleId IdType="pubmed">11804707</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) Proc. Natl. Acad. Sci. USA 95, 6448-6453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27787</ArticleId><ArticleId IdType="pubmed">9600986</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J. &amp; Selkoe, D. J. (2002) Nature 416, 535-539.</Citation><ArticleIdList><ArticleId IdType="pubmed">11932745</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, H. W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., et al. (2002) Brain Res. 924, 133-140.</Citation><ArticleIdList><ArticleId IdType="pubmed">11750898</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) Nature 408, 982-985.</Citation><ArticleIdList><ArticleId IdType="pubmed">11140686</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodart, J. C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) Nat. Neurosci. 5, 452-457.</Citation><ArticleIdList><ArticleId IdType="pubmed">11941374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotilinek, L. A., Bacskai, B., Westerman, M., Kawarabayashi, T., Younkin, L., Hyman, B. T., Younkin, S. &amp; Ashe, K. H. (2002) J. Neurosci. 22, 6331-6335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758140</ArticleId><ArticleId IdType="pubmed">12151510</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe, D. J. (2002) Science 298, 789-791.</Citation><ArticleIdList><ArticleId IdType="pubmed">12399581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert, M. P., Viola, K. L., Chromy, B. A., Chang, L., Morgan, T. E., Yu, J., Venton, D. L., Krafft, G. A., Finch, C. E. &amp; Klein, W. L. (2001) J. Neurochem. 79, 595-605.</Citation><ArticleIdList><ArticleId IdType="pubmed">11701763</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, W. L. (2002) Neurochem. Int. 41, 345-352.</Citation><ArticleIdList><ArticleId IdType="pubmed">12176077</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewer, G. J., Torricelli, J. R., Evege, E. K. &amp; Price, P. J. (1993) J. Neurosci. Res. 35, 567-576.</Citation><ArticleIdList><ArticleId IdType="pubmed">8377226</ArticleId></ArticleIdList></Reference><Reference><Citation>Samdani, A. F., Newcamp, C., Resink, A., Facchinetti, F., Hoffman, B. E., Dawson, V. L. &amp; Dawson, T. M. (1997) J. Neurosci. 17, 4633-4641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573350</ArticleId><ArticleId IdType="pubmed">9169524</ArticleId></ArticleIdList></Reference><Reference><Citation>Friso, G. &amp; Wikstrom, L. (1999) Electrophoresis 20, 917-927.</Citation><ArticleIdList><ArticleId IdType="pubmed">10344267</ArticleId></ArticleIdList></Reference><Reference><Citation>Denda, S., Reichardt, L. F. &amp; Muller, U. (1998) Mol. Biol. Cell 9, 1425-1435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC25364</ArticleId><ArticleId IdType="pubmed">9614184</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, C., Lambert, M. P., Bunch, C., Barber, K., Wade, W. S., Krafft, G. A. &amp; Klein, W. L. (1994) J. Biol. Chem. 269, 25247-25250.</Citation><ArticleIdList><ArticleId IdType="pubmed">7929215</ArticleId></ArticleIdList></Reference><Reference><Citation>Potempska, A., Mack, K., Mehta, P., Kim, K. S. &amp; Miller, D. L. (1999) Amyloid 6, 14-21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10211407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, H., Bhatia, R. &amp; Lal, R. (2001) FASEB J. 15, 2433-2444.</Citation><ArticleIdList><ArticleId IdType="pubmed">11689468</ArticleId></ArticleIdList></Reference><Reference><Citation>Kourie, J. I., Culverson, A. L., Farrelly, P. V., Henry, C. L. &amp; Laohachai, K. N. (2002) Cell Biochem. Biophys. 36, 191-207.</Citation><ArticleIdList><ArticleId IdType="pubmed">12139405</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe, M. A., Mendis, D. B. &amp; Fallon, J. R. (2000) J. Cell Biol. 148, 801-810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169361</ArticleId><ArticleId IdType="pubmed">10684260</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons, K. &amp; Toomre, D. (2000) Nat. Rev. Mol. Cell Biol. 1, 31-39.</Citation><ArticleIdList><ArticleId IdType="pubmed">11413487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehehalt, R., Keller, P., Haass, C., Thiele, C. &amp; Simons, K. (2003) J. Cell Biol. 160, 113-123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2172747</ArticleId><ArticleId IdType="pubmed">12515826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakio, A., Nishimoto, S., Yanagisawa, K., Kozutsumi, Y. &amp; Matsuzaki, K. (2002) Biochemistry 41, 7385-7390.</Citation><ArticleIdList><ArticleId IdType="pubmed">12044171</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruses, J. L., Chauvet, N. &amp; Rutishauser, U. (2001) J. Neurosci. 21, 504-512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763807</ArticleId><ArticleId IdType="pubmed">11160430</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M. &amp; Stefani, M. (2002) Nature 416, 507-511.</Citation><ArticleIdList><ArticleId IdType="pubmed">11932737</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, L., Gong, Y., Bakhos, L., Yu, J., Venton, D. L. &amp; Klein, W. L. (2003) J. Mol. Neurosci., in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">14501013</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B. &amp; Selkoe, D. J. (1999) J. Neurosci. 19, 8876-8884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782787</ArticleId><ArticleId IdType="pubmed">10516307</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitschke, M., Prior, R., Haupt, M. &amp; Riesner, D. (1998) Nat. Med. 4, 832-834.</Citation><ArticleIdList><ArticleId IdType="pubmed">9662376</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong, L., Thornton, P. L., Balazs, R. &amp; Cotman, C. W. (2001) J. Biol. Chem. 276, 17301-17306.</Citation><ArticleIdList><ArticleId IdType="pubmed">11278679</ArticleId></ArticleIdList></Reference><Reference><Citation>Takasu, M. A., Dalva, M. B., Zigmond, R. E. &amp; Greenberg, M. E. (2002) Science 295, 491-495.</Citation><ArticleIdList><ArticleId IdType="pubmed">11799243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying, S. W., Futter, M., Rosenblum, K., Webber, M. J., Hunt, S. P., Bliss, T. V. &amp; Bramham, C. R. (2002) J. Neurosci. 22, 1532-1540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758896</ArticleId><ArticleId IdType="pubmed">11880483</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant, S. G. &amp; Silva, A. J. (1994) Trends Neurosci. 17, 71-75.</Citation><ArticleIdList><ArticleId IdType="pubmed">7512771</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirazi, S. K. &amp; Wood, J. G. (1993) NeuroReport 4, 435-437.</Citation><ArticleIdList><ArticleId IdType="pubmed">8388744</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng, M. (2001) Proc. Natl. Acad. Sci. USA 98, 7058-7061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC34622</ArticleId><ArticleId IdType="pubmed">11416187</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosshans, D. R., Clayton, D. A., Coultrap, S. J. &amp; Browning, M. D. (2002) Nat. Neurosci. 5, 27-33.</Citation><ArticleIdList><ArticleId IdType="pubmed">11740502</ArticleId></ArticleIdList></Reference><Reference><Citation>Birmingham, K. &amp; Frantz, S. (2002) Nat. Med. 8, 199-200.</Citation><ArticleIdList><ArticleId IdType="pubmed">11875473</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. B. &amp; Cohen, F. E. (2002) J. Biol. Chem. 277, 21140-21148.</Citation><ArticleIdList><ArticleId IdType="pubmed">11912192</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12930788</PMID><DateCompleted><Year>2003</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>20</Issue><PubDate><Year>2003</Year><Month>Aug</Month><Day>20</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.</ArticleTitle><Pagination><StartPage>7504</StartPage><EndPage>7509</EndPage><MedlinePgn>7504-9</MedlinePgn></Pagination><Abstract><AbstractText>Alzheimer's disease (AD) is characterized by a microglial-mediated inflammatory response elicited by extensive amyloid deposition in the brain. Nonsteroidal anti-inflammatory drug (NSAID) treatment reduces AD risk, slows disease progression, and reduces microglial activation; however, the basis of these effects is unknown. We report that treatment of 11-month-old Tg2576 mice overexpressing human amyloid precursor protein (APP) with the NSAID ibuprofen for 16 weeks resulted in the dramatic and selective reduction of SDS-soluble beta-amyloid (Abeta)42, whereas it had smaller effects on SDS-soluble Abeta40 levels. Ibuprofen treatment resulted in 60% reduction of amyloid plaque load in the cortex of these animals. In vitro studies using APP-expressing 293 cells showed that ibuprofen directly affected APP processing, specifically reducing the production of Abeta42. Ibuprofen treatment resulted in a significant reduction in microglial activation in the Tg2576 mice, as measured by CD45 and CD11b expression. NSAIDs activate the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARgamma); however, a potent agonist of this receptor, pioglitazone, only modestly reduced SDS-soluble Abeta levels and did not affect amyloid plaque burden or microglia activation, indicating that PPARgamma activation is not involved in the Abeta lowering effect of NSAIDs. These data show that chronic NSAID treatment can reduce brain Abeta levels, amyloid plaque burden, and microglial activation in an animal model of Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Qiao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Amgen Inc., Thousand Oaks, California 91320, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jianhua</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hantao</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Babu-Khan</LastName><ForeName>Safura</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Vassar</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Biere</LastName><ForeName>Anja Leona</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Citron</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Landreth</LastName><ForeName>Gary</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013844">Thiazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D045162">Thiazolidinediones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C078592">amyloid beta-protein (1-40)</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C075222">amyloid beta-protein (1-42)</NameOfSubstance></Chemical><Chemical><RegistryNumber>WK2XYI10QM</RegistryNumber><NameOfSubstance UI="D007052">Ibuprofen</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4OV71U42S</RegistryNumber><NameOfSubstance UI="D000077205">Pioglitazone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007052" MajorTopicYN="N">Ibuprofen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077205" MajorTopicYN="N">Pioglitazone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013844" MajorTopicYN="N">Thiazoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045162" MajorTopicYN="Y">Thiazolidinediones</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>9</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>2</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12930788</ArticleId><ArticleId IdType="pmc">PMC6740758</ArticleId><ArticleId IdType="pii">23/20/7504</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-20-07504.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aisen PS ( 2002) Anti-inflammatory agents in Alzheimer's disease. Curr Neurol Neurosci Rep 2: 405-409.</Citation><ArticleIdList><ArticleId IdType="pubmed">12169220</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, et al. ( 2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21: 383-421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3887148</ArticleId><ArticleId IdType="pubmed">10858586</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, Rosenfeld MG ( 2002) Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110: 55-67.</Citation><ArticleIdList><ArticleId IdType="pubmed">12150997</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzing WC, Wujek JR, Ward EK, Shaffer D, Ashe KH, Younkin SG, Brunden KR ( 1999) Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol Aging 20: 581-589.</Citation><ArticleIdList><ArticleId IdType="pubmed">10674423</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger J, Moller DE ( 2002) The mechanisms of action of PPARs. Annu Rev Med 53: 409-435.</Citation><ArticleIdList><ArticleId IdType="pubmed">11818483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornemann KD, Wiederhold KH, Pauli C, Ermini F, Stalder M, Schnell L, Sommer B, Jucker M, Staufenbiel M ( 2001) Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol 158: 63-73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1850262</ArticleId><ArticleId IdType="pubmed">11141480</ArticleId></ArticleIdList></Reference><Reference><Citation>Citron M ( 2002) Alzheimer's disease: treatments in discovery and development. Nat Neurosci [Suppl] 5: 1055-1057.</Citation><ArticleIdList><ArticleId IdType="pubmed">12403985</ArticleId></ArticleIdList></Reference><Reference><Citation>Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE ( 2000) Inflammatory mechanisms in Alzheimer's disease: inhibition of &#x3b2;-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR&#x3b3; agonists. J Neurosci 20: 558-567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772401</ArticleId><ArticleId IdType="pubmed">10632585</ArticleId></ArticleIdList></Reference><Reference><Citation>Delerive P, Fruchart JC, Staels B ( 2001) Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169: 453-459.</Citation><ArticleIdList><ArticleId IdType="pubmed">11375115</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin KBJ and Paxinos G ( 1996) Mouse brain in stereotaxic coordinates. New York: Morgan Kaufmann.</Citation></Reference><Reference><Citation>Frautschy SA, Yang F, Irrizarry M, Hyman B, Saido TC, Hsiao K, Cole GM ( 1998) Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol 152: 307-317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1858113</ArticleId><ArticleId IdType="pubmed">9422548</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Klockgether T, Feinstein DL ( 2000) Peroxisome proliferator-activated receptor-&#x3b3; ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo J Neurosci 20: 6862-6867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772804</ArticleId><ArticleId IdType="pubmed">10995830</ArticleId></ArticleIdList></Reference><Reference><Citation>in t' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM, Stricker BH ( 2001) Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345: 1515-1521.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794217</ArticleId></ArticleIdList></Reference><Reference><Citation>Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN ( 2002) Microglial activation and &#x3b2;-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-transgenic mice. J Neurosci 22: 2246-2254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758281</ArticleId><ArticleId IdType="pubmed">11896164</ArticleId></ArticleIdList></Reference><Reference><Citation>Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D ( 2000) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408: 979-982.</Citation><ArticleIdList><ArticleId IdType="pubmed">11140685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalaria RN ( 1999) Microglia and Alzheimer's disease. Curr Opin Hematol 6: 15-24.</Citation><ArticleIdList><ArticleId IdType="pubmed">9915549</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyota Y, Kondo T, Maeshiba Y, Hashimoto A, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S ( 1997) Studies on the metabolism of the new antidiabetic agent pioglitazone. Identification of metabolites in rats and dogs. Arzneimittelforschung 47: 22-28.</Citation><ArticleIdList><ArticleId IdType="pubmed">9037439</ArticleId></ArticleIdList></Reference><Reference><Citation>Landreth GE, Heneka MT ( 2001) Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease. Neurobiol Aging 22: 937-944.</Citation><ArticleIdList><ArticleId IdType="pubmed">11755002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA ( 1997) Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272: 3406-3410.</Citation><ArticleIdList><ArticleId IdType="pubmed">9013583</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM ( 2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20: 5709-5714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772529</ArticleId><ArticleId IdType="pubmed">10908610</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim GP, Yang F, Chu T, Gahtan E, Ubeda O, Beech W, Overmier JB, Hsiao-Ashec K, Frautschy SA, Cole GM ( 2001) Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice. Neurobiol Aging 22: 983-991.</Citation><ArticleIdList><ArticleId IdType="pubmed">11755007</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Munoz DG ( 1998) Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 50: 986-990.</Citation><ArticleIdList><ArticleId IdType="pubmed">9566383</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Mallory M, Hansen L, Alford M, Albright T, Terry R, Shapiro P, Sundsmo M, Saitoh T ( 1991) Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease. Acta Neuropathol (Berl) 83: 12-20.</Citation><ArticleIdList><ArticleId IdType="pubmed">1838850</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer PL, Schulzer M, McGeer EG ( 1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47: 425-432.</Citation><ArticleIdList><ArticleId IdType="pubmed">8757015</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehlhorn G, Hollborn M, Schliebs R ( 2000) Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int J Dev Neurosci 18: 423-431.</Citation><ArticleIdList><ArticleId IdType="pubmed">10817926</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinetti GM ( 2001) Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia. Arch Gerontol Geriatr 33: 13-28.</Citation><ArticleIdList><ArticleId IdType="pubmed">11461718</ArticleId></ArticleIdList></Reference><Reference><Citation>Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J ( 1995) Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45: 51-55.</Citation><ArticleIdList><ArticleId IdType="pubmed">7824134</ArticleId></ArticleIdList></Reference><Reference><Citation>Sainati S, Ingram D, Talwalker G, Geis G ( 2000) Results of a double-blind, randomized, placebo-controlled study of celecoxib in the treatment of Alzheimer's disease. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy, Stockholm, April.</Citation></Reference><Reference><Citation>Stalder M, Phinney A, Probst A, Sommer B, Staufenbiel M, Jucker M ( 1999) Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am J Pathol 154: 1673-1684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866618</ArticleId><ArticleId IdType="pubmed">10362792</ArticleId></ArticleIdList></Reference><Reference><Citation>Stalder M, Deller T, Staufenbiel M, Jucker M ( 2001) 3D-reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid. Neurobiol Aging 22: 427-434.</Citation><ArticleIdList><ArticleId IdType="pubmed">11378249</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart WF, Kawas C, Corrada M, Metter EJ ( 1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48: 626-632.</Citation><ArticleIdList><ArticleId IdType="pubmed">9065537</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B ( 1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94: 13287-13292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC24301</ArticleId><ArticleId IdType="pubmed">9371838</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegeder I, Pfeilschifter P, Geisslinger G ( 2001) Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 15: 2057-2072.</Citation><ArticleIdList><ArticleId IdType="pubmed">11641233</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, et al. ( 1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741.</Citation><ArticleIdList><ArticleId IdType="pubmed">10531052</ArticleId></ArticleIdList></Reference><Reference><Citation>Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH ( 2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414: 212-216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11700559</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcock DM, Gordon MN, Ugen KE, Gottschall PE, DiCarlo G, Dickey C, Boyett KW, Jantzen PT, Connor KE, Melachrino J, Hardy J, Morgan D ( 2001) Number of Abeta inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels. DNA Cell Biol 20: 731-736.</Citation><ArticleIdList><ArticleId IdType="pubmed">11788051</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Q, Radeke MJ, Matheson CR, Talvenheimo J, Welcher AA, Feinstein SC ( 1997) Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J Comp Neurol 378: 135-157.</Citation><ArticleIdList><ArticleId IdType="pubmed">9120052</ArticleId></ArticleIdList></Reference><Reference><Citation>Yermakova A, O'Banion MK ( 2000) Cyclooxygenases in the central nervous system: implications for treatment of neurological disorders. Curr Pharmacol Res 6: 1755-1776.</Citation><ArticleIdList><ArticleId IdType="pubmed">11203433</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12944419</PMID><DateCompleted><Year>2004</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2008</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0964-6906</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>20</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>A reporter for amyloid precursor protein gamma-secretase activity in Drosophila.</ArticleTitle><Pagination><StartPage>2669</StartPage><EndPage>2678</EndPage><MedlinePgn>2669-78</MedlinePgn></Pagination><Abstract><AbstractText>A key event in the pathogenesis of Alzheimer's disease (AD) is the deposition of senile plaques consisting largely of a peptide known as beta-amyloid (Abeta) that is derived from the amyloid precursor protein (APP). A proteolytic activity called gamma-secretase cleaves APP in the transmembrane domain and is required for Abeta generation. Aberrant gamma-secretase cleavage of APP underlies the majority of early onset, familial AD. gamma-Secretase resides in a large multi-protein complex, of which Presenilin, Nicastrin, APH-1 and PEN-2 are four essential components. Thus, identifying components and pathways by which the gamma-secretase activity is regulated is crucial to understanding the mechanisms underlying AD pathogenesis, and may provide new diagnostic tools and therapeutic targets. Here we describe the generation of Drosophila that act as living reporters of gamma-secretase activity in the fly eye. In these reporter flies the size of the eye correlates with the level of endogenous gamma-secretase activity, and is very sensitive to the levels of three genes required for APP gamma-secretase activity, presenilin, nicastrin and aph-1. Thus, these flies provide a sensitized system with which to identify other components of the gamma-secretase complex and regulators of its activity. We have used these flies to carry out a screen for mutations that suppress gamma-secretase activity and have identified a small chromosomal region that contains a gene or genes whose products may promote gamma-secretase activity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Research Institute, The David Geffen School of Medicine, University of California, Los Angeles 90095, USA. mingfly@ucla.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Jolene</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Zipursky</LastName><ForeName>S Larry</ForeName><Initials>SL</Initials></Author><Author ValidYN="Y"><LastName>Hay</LastName><ForeName>Bruce A</ForeName><Initials>BA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KO8 NS 42580</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017930" MajorTopicYN="Y">Genes, Reporter</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008855" MajorTopicYN="N">Microscopy, Electron, Scanning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="N">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017956" MajorTopicYN="N">Photoreceptor Cells, Invertebrate</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019076" MajorTopicYN="N">Transgenes</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>7</Month><Day>21</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12944419</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddg292</ArticleId><ArticleId IdType="pii">ddg292</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12970516</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4628</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>10</Issue><PubDate><Year>2003</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Stroke</Title><ISOAbbreviation>Stroke</ISOAbbreviation></Journal><ArticleTitle>Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.</ArticleTitle><Pagination><StartPage>2323</StartPage><EndPage>2330</EndPage><MedlinePgn>2323-30</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Clinical observations suggest that patients with vascular dementia (VaD) may benefit from treatment with cholinesterase inhibitors. This study evaluated the efficacy and safety of donepezil for relieving symptoms of dementia in VaD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients (n=603; mean age, 73.9 years; 55.2% men) with probable (70.5%) or possible (29.5%) VaD, according to criteria of the National Institute of Neurological Disorders and Stroke (NINDS) and the Association Internationale pour la Recherche et l'Enseignement en Neurosciences (AIREN), were randomized to 24 weeks of treatment with donepezil 5 mg/d (n=198), donepezil 10 mg/d (5 mg/d for first 28 days; n=206), or placebo (n=199). Analyses were based on the intent-to-treat population.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At week 24, both donepezil groups showed significant improvement in cognition versus placebo on the Alzheimer's Disease Assessment Scale-cognitive subscale (mean change from baseline score effect size: donepezil 5 mg/d, -1.90; P=0.001; donepezil 10 mg/d, -2.33; P&lt;0.001). Significant improvements in patients' global function were seen versus placebo at week 24 (observed cases), on the Clinician's Interview-Based Impression of Change-Plus version only for patients on donepezil 5 mg/d (P=0.014), and on the Sum of the Boxes of the Clinical Dementia Rating only for patients on 10 mg/d (P=0.007). Donepezil-treated patients showed significant benefits in activities of daily living over placebo on the Alzheimer's Disease Functional Assessment and Change Scale (mean change from baseline score effect size at week 24: donepezil 5 mg/d, -1.31, P=0.02; donepezil 10 mg/d, -1.31, P=0.02). Donepezil was well tolerated. Withdrawal rates due to adverse events were relatively low (placebo, 11.1%; donepezil 5 mg/d, 11.1%; donepezil 10 mg/d, 21.8%; P=0.005 versus placebo).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These data demonstrate that donepezil is an effective and well-tolerated treatment for VaD and show it may have an important place in the management of this condition.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Toronto, Department of Medicine (Division of Neurology), Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rom&#xe1;n</LastName><ForeName>Gustavo C</ForeName><Initials>GC</Initials></Author><Author ValidYN="Y"><LastName>Geldmacher</LastName><ForeName>David S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Salloway</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Hecker</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Alistair</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Perdomo</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Dinesh</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Pratt</LastName><ForeName>Raymond</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><CollectiveName>Donepezil 307 Vascular Dementia Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stroke</MedlineTA><NlmUniqueID>0235266</NlmUniqueID><ISSNLinking>0039-2499</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002800">Cholinesterase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007189">Indans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018697">Nootropic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010880">Piperidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>8SSC91326P</RegistryNumber><NameOfSubstance UI="D000077265">Donepezil</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Stroke. 2003 Oct;34(10):2331-2. doi: 10.1161/01.STR.0000094580.14898.7C.</RefSource><PMID Version="1">14500926</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002319" MajorTopicYN="N">Cardiovascular System</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002800" MajorTopicYN="N">Cholinesterase Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015140" MajorTopicYN="N">Dementia, Vascular</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003967" MajorTopicYN="N">Diarrhea</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077265" MajorTopicYN="N">Donepezil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007189" MajorTopicYN="N">Indans</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038622" MajorTopicYN="N">Internationality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009325" MajorTopicYN="N">Nausea</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018697" MajorTopicYN="N">Nootropic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010880" MajorTopicYN="N">Piperidines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>9</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>11</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>9</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12970516</ArticleId><ArticleId IdType="doi">10.1161/01.STR.0000091396.95360.E1</ArticleId><ArticleId IdType="pii">01.STR.0000091396.95360.E1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1303289</PMID><DateCompleted><Year>1993</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2011</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1061-4036</ISSN><JournalIssue CitedMedium="Print"><Volume>2</Volume><Issue>4</Issue><PubDate><Year>1992</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Nature genetics</Title><ISOAbbreviation>Nat Genet</ISOAbbreviation></Journal><ArticleTitle>Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14.</ArticleTitle><Pagination><StartPage>330</StartPage><EndPage>334</EndPage><MedlinePgn>330-4</MedlinePgn></Pagination><Abstract><AbstractText>Familial Alzheimer's disease (FAD) has been shown to be genetically heterogeneous, with a very small proportion of early onset pedigrees being associated with mutations in the amyloid precursor protein (APP) gene on chromosome 21, and some late onset pedigrees showing associations with markers on chromosome 19. We now provide evidence for a major early onset FAD locus on the long arm of chromosome 14 near the markers D14S43 and D14S53 (multipoint lod score z = 23.4) and suggest that the inheritance of FAD may be more complex than had initially been suspected.</AbstractText></Abstract><AuthorList CompleteYN="N"><Author ValidYN="Y"><LastName>St George-Hyslop</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dept. of Medicine, University of Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haines</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Rogaev</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Mortilla</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Vaula</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Pericak-Vance</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Foncin</LastName><ForeName>J F</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Montesi</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bruni</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Sorbi</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Rainero</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Pinessi</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Pollen</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Polinsky</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Nee</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Macciardi</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Rogaeva</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Alexandrova</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Lukiw</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Schlumpf</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Tanzi</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Tsuda</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Farrer</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Cantu</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Duara</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Amaducci</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Bergamini</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Gusella</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Roses</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Crapper McLachlan</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Genet</MedlineTA><NlmUniqueID>9216904</NlmUniqueID><ISSNLinking>1061-4036</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><GeneSymbolList><GeneSymbol>APP</GeneSymbol><GeneSymbol>FAD</GeneSymbol></GeneSymbolList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002874" MajorTopicYN="N">Chromosome Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002883" MajorTopicYN="Y">Chromosomes, Human, Pair 14</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008126" MajorTopicYN="N">Lod Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1303289</ArticleId><ArticleId IdType="doi">10.1038/ng1292-330</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1346802</PMID><DateCompleted><Year>1992</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0270-6474</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>1992</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.</ArticleTitle><Pagination><StartPage>376</StartPage><EndPage>389</EndPage><MedlinePgn>376-89</MedlinePgn></Pagination><Abstract><AbstractText>In Alzheimer's disease (AD), abnormal accumulations of beta-amyloid are present in the brain and degenerating neurons exhibit cytoskeletal aberrations (neurofibrillary tangles). Roles for beta-amyloid in the neuronal degeneration of AD have been suggested based on recent data obtained in rodent studies demonstrating neurotoxic actions of beta-amyloid. However, the cellular mechanism of action of beta-amyloid is unknown, and there is no direct information concerning the biological activity of beta-amyloid in human neurons. We now report on experiments in human cerebral cortical cell cultures that tested the hypothesis that beta-amyloid can destabilize neuronal calcium regulation and render neurons more vulnerable to environmental stimuli that elevate intracellular calcium levels. Synthetic beta-amyloid peptides (beta APs) corresponding to amino acids 1-38 or 25-35 of the beta-amyloid protein enhanced glutamate neurotoxicity in cortical cultures, while a peptide with a scrambled sequence was without effect. beta APs alone had no effect on neuronal survival during a 4 d exposure period. beta APs enhanced both kainate and NMDA neurotoxicity, indicating that the effect was not specific for a particular subtype of glutamate receptor. The effects of beta APs on excitatory amino acid (EAA)-induced neuronal degeneration were concentration dependent and required prolonged (days) exposures. The beta APs also rendered neurons more vulnerable to calcium ionophore neurotoxicity, indicating that beta APs compromised the ability of the neurons to reduce intracellular calcium levels to normal limits. Direct measurements of intracellular calcium levels demonstrated that beta APs elevated rest levels of calcium and enhanced calcium responses to EAAs and calcium ionophore. The neurotoxicity caused by EAAs and potentiated by beta APs was dependent upon calcium influx since it did not occur in calcium-deficient culture medium. Finally, the beta APs made neurons more vulnerable to neurofibrillary tangle-like antigenic changes induced by EAAs or calcium ionophore (i.e., increased staining with tau and ubiquitin antibodies). Taken together, these data suggest that beta-amyloid destabilizes neuronal calcium homeostasis and thereby renders neurons more vulnerable to environmental insults.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mattson</LastName><ForeName>M P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Sanders-Brown Research Center on Aging, University of Kentucky, Lexington 40536-0230.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Bryant</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Lieberburg</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Rydel</LastName><ForeName>R E</ForeName><Initials>RE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005971">Glutamates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007202">Indicators and Reagents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>37H9VM9WZL</RegistryNumber><NameOfSubstance UI="D000001">Calcimycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>3KX376GY7L</RegistryNumber><NameOfSubstance UI="D018698">Glutamic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000001" MajorTopicYN="N">Calcimycin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005333" MajorTopicYN="N">Fetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005971" MajorTopicYN="N">Glutamates</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018698" MajorTopicYN="N">Glutamic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007202" MajorTopicYN="N">Indicators and Reagents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1992</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1346802</ArticleId><ArticleId IdType="pmc">PMC6575616</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.12-02-00376.1992</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">13678586</PMID><DateCompleted><Year>2003</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0092-8674</ISSN><JournalIssue CitedMedium="Print"><Volume>114</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Sep</Month><Day>05</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations.</ArticleTitle><Pagination><StartPage>635</StartPage><EndPage>645</EndPage><MedlinePgn>635-45</MedlinePgn></Pagination><Abstract><AbstractText>Presenilin1 (PS1), a protein implicated in Alzheimer's disease (AD), forms complexes with N-cadherin, a transmembrane protein with important neuronal and synaptic functions. Here, we show that a PS1-dependent gamma-secretase protease activity promotes an epsilon-like cleavage of N-cadherin to produce its intracellular domain peptide, N-Cad/CTF2. NMDA receptor agonists stimulate N-Cad/CTF2 production suggesting that this receptor regulates the epsilon-cleavage of N-cadherin. N-Cad/CTF2 binds the transcription factor CBP and promotes its proteasomal degradation, inhibiting CRE-dependent transactivation. Thus, the PS1-dependent epsilon-cleavage product N-Cad/CTF2 functions as a potent repressor of CBP/CREB-mediated transcription. Importantly, PS1 mutations associated with familial AD (FAD) and a gamma-secretase dominant-negative mutation inhibit N-Cad/CTF2 production and upregulate CREB-mediated transcription indicating that FAD mutations cause a gain of transcriptional function by inhibiting production of transcriptional repressor N-Cad/CTF2. These data raise the possibility that FAD mutation-induced transcriptional abnormalities maybe causally related to the dementia associated with FAD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marambaud</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Fishberg Research Center for Neurobiology, Mount Sinai School of Medicine, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Paul H</ForeName><Initials>PH</Initials></Author><Author ValidYN="Y"><LastName>Dutt</LastName><ForeName>Anindita</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Shioi</LastName><ForeName>Junichi</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Takashima</LastName><ForeName>Akihiko</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Siman</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Robakis</LastName><ForeName>Nikolaos K</ForeName><Initials>NK</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG-05138</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG-08200</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG-17926</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005138-190025</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG008200-18</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG017926-05</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015820">Cadherins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009097">Multienzyme Complexes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508853">PSEN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014404">Tubulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C020723">citrate-binding transport protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2003 Sep 5;114(5):533-5. doi: 10.1016/s0092-8674(03)00686-x.</RefSource><PMID Version="1">13678577</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015820" MajorTopicYN="N">Cadherins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005799" MajorTopicYN="N">Genes, Dominant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015151" MajorTopicYN="N">Immunoblotting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008856" MajorTopicYN="N">Microscopy, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009097" MajorTopicYN="N">Multienzyme Complexes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011233" MajorTopicYN="N">Precipitin Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013347" MajorTopicYN="N">Subcellular Fractions</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="Y">Transcription, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015533" MajorTopicYN="N">Transcriptional Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014404" MajorTopicYN="N">Tubulin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>9</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>10</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>9</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">13678586</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2003.08.008</ArticleId><ArticleId IdType="pii">S0092867403006512</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1383826</PMID><DateCompleted><Year>1992</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-0836</ISSN><JournalIssue CitedMedium="Print"><Volume>359</Volume><Issue>6393</Issue><PubDate><Year>1992</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Amyloid beta-peptide is produced by cultured cells during normal metabolism.</ArticleTitle><Pagination><StartPage>322</StartPage><EndPage>325</EndPage><MedlinePgn>322-5</MedlinePgn></Pagination><Abstract><AbstractText>Alzheimer's disease is characterized by the extracellular deposition in the brain and its blood vessels of insoluble aggregates of the amyloid beta-peptide (A beta), a fragment, of about 40 amino acids in length, of the integral membrane protein beta-amyloid precursor protein (beta-APP). The mechanism of extracellular accumulation of A beta in brain is unknown and no simple in vitro or in vivo model systems that produce extracellular A beta have been described. We report here the unexpected identification of the 4K (M(r) 4,000) A beta and a truncated form of A beta (approximately 3K) in media from cultures of primary cells and untransfected and beta-APP-transfected cell lines grown under normal conditions. These peptides were immunoprecipitated readily from culture medium by A beta-specific antibodies and their identities confirmed by sequencing. The concept that pathological processes are responsible for the production of A beta must not be reassessed in light of the observation that A beta is produced in soluble form in vitro and in vivo during normal cellular metabolism. Further, these findings provide the basis for using simple cell culture systems to identify drugs that block the formation or release of A beta, the primary protein constituent of the senile plaques of Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="N"><Author ValidYN="Y"><LastName>Haass</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology and Program in Neuroscience, Harvard Medical School, Boston, Massachusetts 02155.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlossmacher</LastName><ForeName>M G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>A Y</ForeName><Initials>AY</Initials></Author><Author ValidYN="Y"><LastName>Vigo-Pelfrey</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Mellon</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ostaszewski</LastName><ForeName>B L</ForeName><Initials>BL</Initials></Author><Author ValidYN="Y"><LastName>Lieberburg</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Koo</LastName><ForeName>E H</ForeName><Initials>EH</Initials></Author><Author ValidYN="Y"><LastName>Schenk</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Teplow</LastName><ForeName>D B</ForeName><Initials>DB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000906">Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>AE28F7PNPL</RegistryNumber><NameOfSubstance UI="D008715">Methionine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nature. 1992 Sep 24;359(6393):268-9. doi: 10.1038/359268a0.</RefSource><PMID Version="1">1406927</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008715" MajorTopicYN="N">Methionine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>9</Month><Day>24</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>9</Month><Day>24</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1383826</ArticleId><ArticleId IdType="doi">10.1038/359322a0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1406936</PMID><DateCompleted><Year>1992</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-0836</ISSN><JournalIssue CitedMedium="Print"><Volume>359</Volume><Issue>6393</Issue><PubDate><Year>1992</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.</ArticleTitle><Pagination><StartPage>325</StartPage><EndPage>327</EndPage><MedlinePgn>325-7</MedlinePgn></Pagination><Abstract><AbstractText>Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of Alzheimer's disease. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein, no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid, plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography, we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for Alzheimer's disease and therapeutic strategies aimed at reducing the cerebral deposition of A beta.</AbstractText></Abstract><AuthorList CompleteYN="N"><Author ValidYN="Y"><LastName>Seubert</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Athena Neurosciences Inc., South San Francisco, California 94080.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vigo-Pelfrey</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Esch</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Dovey</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Sinha</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Schlossmacher</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Whaley</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Swindlehurst</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nature. 1992 Sep 24;359(6393):268-9. doi: 10.1038/359268a0.</RefSource><PMID Version="1">1406927</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011863" MajorTopicYN="N">Radioimmunoassay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>9</Month><Day>24</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>9</Month><Day>24</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1406936</ArticleId><ArticleId IdType="doi">10.1038/359325a0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1411576</PMID><DateCompleted><Year>1992</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0036-8075</ISSN><JournalIssue CitedMedium="Print"><Volume>258</Volume><Issue>5082</Issue><PubDate><Year>1992</Year><Month>Oct</Month><Day>23</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.</ArticleTitle><Pagination><StartPage>668</StartPage><EndPage>671</EndPage><MedlinePgn>668-71</MedlinePgn></Pagination><Abstract><AbstractText>Linkage analysis was used to search the genome for chromosomal regions harboring familial Alzheimer's disease genes. Markers on chromosome 14 gave highly significant positive lod scores in early-onset non-Volga German kindreds; a Zmax of 9.15 (theta = 0.01) was obtained with the marker D14S43 at 14q24.3. One early-onset family yielded a lod score of 4.89 (theta = 0.0). When no assumptions were made about age-dependent penetrance, significant results were still obtained (Zmax = 5.94, theta = 0.0), despite the loss of power to detect linkage under these conditions. Results for the Volga German families were either negative or nonsignificant for markers in this region. Thus, evidence indicates a familial Alzheimer's disease locus on chromosome 14.</AbstractText></Abstract><AuthorList CompleteYN="N"><Author ValidYN="Y"><LastName>Schellenberg</LastName><ForeName>G D</ForeName><Initials>GD</Initials></Author><Author ValidYN="Y"><LastName>Bird</LastName><ForeName>T D</ForeName><Initials>TD</Initials></Author><Author ValidYN="Y"><LastName>Wijsman</LastName><ForeName>E M</ForeName><Initials>EM</Initials></Author><Author ValidYN="Y"><LastName>Orr</LastName><ForeName>H T</ForeName><Initials>HT</Initials></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Nemens</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Bonnycastle</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>J L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Alonso</LastName><ForeName>M E</ForeName><Initials>ME</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG08017</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HG00248</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01MH43240</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015345">Oligonucleotide Probes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><GeneSymbolList><GeneSymbol>PI</GeneSymbol></GeneSymbolList><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002883" MajorTopicYN="Y">Chromosomes, Human, Pair 14</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008040" MajorTopicYN="N">Genetic Linkage</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015345" MajorTopicYN="N">Oligonucleotide Probes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1411576</ArticleId><ArticleId IdType="doi">10.1126/science.1411576</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">14188276</PMID><DateCompleted><Year>1996</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0006-8950</ISSN><JournalIssue CitedMedium="Print"><Volume>87</Volume><PubDate><Year>1964</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY.</ArticleTitle><Pagination><StartPage>307</StartPage><EndPage>320</EndPage><MedlinePgn>307-20</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>KIDD</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>OM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="Y">Amyloid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="Y">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="Y">Cell Nucleus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="Y">Cerebral Cortex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="Y">Cytoplasm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004583" MajorTopicYN="Y">Electrons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008853" MajorTopicYN="Y">Microscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008854" MajorTopicYN="Y">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="Y">Psychotic Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="Y">Radiography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NLM"><Keyword MajorTopicYN="Y">AMYLOID</Keyword><Keyword MajorTopicYN="Y">BIOPSY</Keyword><Keyword MajorTopicYN="Y">CELL NUCLEUS</Keyword><Keyword MajorTopicYN="Y">CEREBRAL CORTEX</Keyword><Keyword MajorTopicYN="Y">CYTOPLASM</Keyword><Keyword MajorTopicYN="Y">DEMENTIA, PRESENILE</Keyword><Keyword MajorTopicYN="Y">MICROSCOPY, ELECTRON</Keyword><Keyword MajorTopicYN="Y">PSYCHOSES, PRESENILE</Keyword><Keyword MajorTopicYN="Y">VENTRICULOGRAPHY</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1964</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1964</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1964</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14188276</ArticleId><ArticleId IdType="doi">10.1093/brain/87.2.307</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1438289</PMID><DateCompleted><Year>1992</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>89</Volume><Issue>22</Issue><PubDate><Year>1992</Year><Month>Nov</Month><Day>15</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain.</ArticleTitle><Pagination><StartPage>10857</StartPage><EndPage>10861</EndPage><MedlinePgn>10857-61</MedlinePgn></Pagination><Abstract><AbstractText>The deposition of amyloid in senile plaques and along the walls of the cerebral vasculature is a characteristic feature of Alzheimer disease. The peptide comprising the carboxyl-terminal 100 amino acids of the beta-amyloid precursor protein (beta APP) has been shown to aggregate into amyloid-like fibrils in vitro and to be neurotoxic, suggesting that this fragment may play a role in the etiology of Alzheimer disease. To address this question, we expressed this carboxyl-terminal 100-amino acid peptide of beta APP in transgenic mice under the control of the brain dystrophin promoter. We used an antibody to the principal component of amyloid, beta/A4, to demonstrate cell-body and neuropil accumulation of beta/A4 immunoreactivity in the brains of 4- and 6-month-old transgenic mice. Only light cytoplasmic staining with this antibody was visible in control mice. In addition, immunocytochemical analysis of the brains with an antibody to the carboxyl terminus of beta APP revealed abnormal aggregation of this epitope of beta APP within vesicular structures in the cytoplasm and in abnormal-appearing neurites in the CA2/3 region of the hippocampus in transgenic mice, similar to its aggregation in the cells of Alzheimer disease brains. Thioflavin S histochemistry suggested accumulations of amyloid in the cerebrovasculature of transgenic mice with the highest expression of the beta APP-C100 transgene. These observations suggest that expression of abnormal carboxyl-terminal subfragments of beta APP in vivo may cause amyloidogenesis and specific neuropathology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kammesheidt</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychobiology, University of California, Irvine 92717.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyce</LastName><ForeName>F M</ForeName><Initials>FM</Initials></Author><Author ValidYN="Y"><LastName>Spanoyannis</LastName><ForeName>A F</ForeName><Initials>AF</Initials></Author><Author ValidYN="Y"><LastName>Cummings</LastName><ForeName>B J</ForeName><Initials>BJ</Initials></Author><Author ValidYN="Y"><LastName>Orteg&#xf3;n</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Cotman</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Vaught</LastName><ForeName>J L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Neve</LastName><ForeName>R L</ForeName><Initials>RL</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HD18658</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N01-HD-0-2911</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS28406</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016189">Dystrophin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003433" MajorTopicYN="N">Crosses, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016189" MajorTopicYN="N">Dystrophin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011712" MajorTopicYN="N">Pyramidal Tracts</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015183" MajorTopicYN="N">Restriction Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013347" MajorTopicYN="N">Subcellular Fractions</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>11</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>11</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1993</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1438289</ArticleId><ArticleId IdType="pmc">PMC50441</ArticleId><ArticleId IdType="doi">10.1073/pnas.89.22.10857</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neuroscience. 1992 Jun;48(4):763-77</Citation><ArticleIdList><ArticleId IdType="pubmed">1378573</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Neurol. 1989 Dec;106(3):237-50</Citation><ArticleIdList><ArticleId IdType="pubmed">2591522</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1992 Mar 13;255(5050):1443-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1542796</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3448-52</Citation><ArticleIdList><ArticleId IdType="pubmed">1565637</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 1992 May;12(5):1679-87</Citation><ArticleIdList><ArticleId IdType="pubmed">1578262</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1989 Apr 7;57(1):115-26</Citation><ArticleIdList><ArticleId IdType="pubmed">2649245</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 1988 Apr;7(4):949-57</Citation><ArticleIdList><ArticleId IdType="pubmed">2900137</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1988 Oct;85(19):7341-5</Citation><ArticleIdList><ArticleId IdType="pubmed">3140239</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3159021</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 1984 May 16;120(3):885-90</Citation><ArticleIdList><ArticleId IdType="pubmed">6375662</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1990 May;87(10):3861-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1692625</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 1990 Jul;9(7):2079-84</Citation><ArticleIdList><ArticleId IdType="pubmed">1694126</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 1991 Feb;138(2):373-84</Citation><ArticleIdList><ArticleId IdType="pubmed">1704190</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1992 Feb 7;255(5045):728-30</Citation><ArticleIdList><ArticleId IdType="pubmed">1738847</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1991 Jul 12;253(5016):179-82</Citation><ArticleIdList><ArticleId IdType="pubmed">1853202</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1991 Jul 18;352(6332):239-41</Citation><ArticleIdList><ArticleId IdType="pubmed">1906990</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 1991 Jul 8;128(1):126-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1922940</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1990 Oct 11;347(6293):566-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1977086</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1276-80</Citation><ArticleIdList><ArticleId IdType="pubmed">1996328</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1989 Jul 28;245(4916):417-20</Citation><ArticleIdList><ArticleId IdType="pubmed">2474201</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1992 Mar 5;267(7):4376-85</Citation><ArticleIdList><ArticleId IdType="pubmed">1531651</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1439760</PMID><DateCompleted><Year>1992</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0036-8075</ISSN><JournalIssue CitedMedium="Print"><Volume>258</Volume><Issue>5079</Issue><PubDate><Year>1992</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Production of the Alzheimer amyloid beta protein by normal proteolytic processing.</ArticleTitle><Pagination><StartPage>126</StartPage><EndPage>129</EndPage><MedlinePgn>126-9</MedlinePgn></Pagination><Abstract><AbstractText>The 4-kilodalton (39 to 43 amino acids) amyloid beta protein (beta AP), which is deposited as amyloid in the brains of patients with Alzheimer's diseases, is derived from a large protein, the amyloid beta protein precursor (beta APP). Human mononuclear leukemic (K562) cells expressing a beta AP-bearing, carboxyl-terminal beta APP derivative released significant amounts of a soluble 4-kilodalton beta APP derivative essentially identical to the beta AP deposited in Alzheimer's disease. Human neuroblastoma (M17) cells transfected with constructs expressing full-length beta APP and M17 cells expressing only endogenous beta APP also released soluble 4-kilodalton beta AP, and a similar, if not identical, fragment was readily detected in cerebrospinal fluid from individuals with Alzheimer's disease and normal individuals. Thus cells normally produce and release soluble 4-kilodalton beta AP that is essentially identical to the 4-kilodalton beta AP deposited as insoluble amyloid fibrils in Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="N"><Author ValidYN="Y"><LastName>Shoji</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Gunma University, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golde</LastName><ForeName>T E</ForeName><Initials>TE</Initials></Author><Author ValidYN="Y"><LastName>Ghiso</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>T T</ForeName><Initials>TT</Initials></Author><Author ValidYN="Y"><LastName>Estus</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Shaffer</LastName><ForeName>L M</ForeName><Initials>LM</Initials></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>X D</ForeName><Initials>XD</Initials></Author><Author ValidYN="Y"><LastName>McKay</LastName><ForeName>D M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Tintner</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Frangione</LastName><ForeName>B</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG05891</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG06656</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AR02594</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015151" MajorTopicYN="N">Immunoblotting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007951" MajorTopicYN="N">Leukemia, Myeloid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009447" MajorTopicYN="N">Neuroblastoma</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>10</Month><Day>2</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>10</Month><Day>2</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1439760</ArticleId><ArticleId IdType="doi">10.1126/science.1439760</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14502203</PMID><DateCompleted><Year>2004</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1087-0156</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>10</Issue><PubDate><Year>2003</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nature biotechnology</Title><ISOAbbreviation>Nat Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice.</ArticleTitle><Pagination><StartPage>1200</StartPage><EndPage>1207</EndPage><MedlinePgn>1200-7</MedlinePgn></Pagination><Abstract><AbstractText>Existing protocols for the neural differentiation of mouse embryonic stem (ES) cells require extended in vitro culture, yield variable differentiation results or are limited to the generation of selected neural subtypes. Here we provide a set of coculture conditions that allows rapid and efficient derivation of most central nervous system phenotypes. The fate of both fertilization- and nuclear transfer-derived ES (ntES) cells was directed selectively into neural stem cells, astrocytes, oligodendrocytes or neurons. Specific differentiation into gamma-aminobutyric acid (GABA), dopamine, serotonin or motor neurons was achieved by defining conditions to induce forebrain, midbrain, hindbrain and spinal cord identity. Neuronal function of ES cell-derived dopaminergic neurons was shown in vitro by electron microscopy, measurement of neurotransmitter release and intracellular recording. Furthermore, transplantation of ES and ntES cell-derived dopaminergic neurons corrected the phenotype of a mouse model of Parkinson disease, demonstrating an in vivo application of therapeutic cloning in neural disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barberi</LastName><ForeName>Tiziano</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Stem Cell and Tumor Biology, Division of Neurosurgery and Developmental Biology Program, Weill Medical College of Cornell University, New York, New York 10021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klivenyi</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Calingasan</LastName><ForeName>Noel Y</ForeName><Initials>NY</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hyojin</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Kawamata</LastName><ForeName>Hibiki</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Loonam</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Perrier</LastName><ForeName>Anselme L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Bruses</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Rubio</LastName><ForeName>Maria E</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>Topf</LastName><ForeName>Norbert</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Tabar</LastName><ForeName>Viviane</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Neil L</ForeName><Initials>NL</Initials></Author><Author ValidYN="Y"><LastName>Beal</LastName><ForeName>M Flint</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Malcolm A S</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Studer</LastName><ForeName>Lorenz</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1R21NS44231-01</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Biotechnol</MedlineTA><NlmUniqueID>9604648</NlmUniqueID><ISSNLinking>1087-0156</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018920" MajorTopicYN="N">Coculture Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005306" MajorTopicYN="N">Fertilization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053652" MajorTopicYN="Y">Nuclear Transfer Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020734" MajorTopicYN="N">Parkinsonian Disorders</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033581" MajorTopicYN="N">Stem Cell Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>4</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14502203</ArticleId><ArticleId IdType="doi">10.1038/nbt870</ArticleId><ArticleId IdType="pii">nbt870</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14519670</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2012</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-6860</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>13</Issue><PubDate><Year>2003</Year><Month>Oct</Month></PubDate></JournalIssue><Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title><ISOAbbreviation>FASEB J</ISOAbbreviation></Journal><ArticleTitle>Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.</ArticleTitle><Pagination><StartPage>1945</StartPage><EndPage>1947</EndPage><MedlinePgn>1945-7</MedlinePgn></Pagination><Abstract><AbstractText>Parkinson's disease (PD) and other related disorders are characterized by the accumulation of fibrillar aggregates of alpha-synuclein protein (alpha-syn) inside brain cells. It is likely that the formation of alpha-syn aggregates plays a seminal role in the pathogenesis of at least some of these diseases, because two different mutations in the gene encoding alpha-syn have been found in inherited forms of PD. alpha-Syn is mainly expressed by neuronal cells and is generally considered to exist as a cytoplasmic protein. Here, we report the unexpected identification of alpha-syn in conditioned culture media from untransfected and alpha-syn-transfected human neuroblastoma cells, as well as in human cerebrospinal fluid and blood plasma. The method used was immunocapture by using anti-alpha-syn antibodies coupled to magnetic beads, followed by detection on Western blots. In all cases, alpha-syn was identified as a single 15 kDa band, which co-migrated with a recombinant form of the protein and reacted with five different antibodies to alpha-syn. Our findings suggest that cells normally secrete alpha-syn into their surrounding media, both in vitro and in vivo. The detection of extracellular alpha-syn and/or its modified forms in body fluids, particularly in human plasma, offers new opportunities for the development of diagnostic tests for PD and related diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El-Agnaf</LastName><ForeName>Omar M A</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Lancaster University, Lancaster LA1 4YQ, UK. o.el-agnaf@lancaster.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salem</LastName><ForeName>Sultan A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Paleologou</LastName><ForeName>Katerina E</ForeName><Initials>KE</Initials></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Leanne J</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><LastName>Fullwood</LastName><ForeName>Nigel J</ForeName><Initials>NJ</Initials></Author><Author ValidYN="Y"><LastName>Gibson</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Curran</LastName><ForeName>Martin D</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Court</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Mann</LastName><ForeName>David M A</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>Shu-ichi</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Cookson</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Allsop</LastName><ForeName>David</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>FASEB J</MedlineTA><NlmUniqueID>8804484</NlmUniqueID><ISSNLinking>0892-6638</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497604">SNCA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051843">Synucleins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005110" MajorTopicYN="N">Extracellular Space</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051843" MajorTopicYN="N">Synucleins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>11</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14519670</ArticleId><ArticleId IdType="doi">10.1096/fj.03-0098fje</ArticleId><ArticleId IdType="pii">03-0098fje</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14523085</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>26</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.</ArticleTitle><Pagination><StartPage>8844</StartPage><EndPage>8853</EndPage><MedlinePgn>8844-53</MedlinePgn></Pagination><Abstract><AbstractText>Soluble amyloid-beta (Abeta) peptide converts to structures with high beta-sheet content in Alzheimer's disease (AD). Soluble Abeta is released by neurons into the brain interstitial fluid (ISF), in which it can convert into toxic aggregates. Because assessment of ISF Abeta levels may provide unique insights into Abeta metabolism and AD, an in vivo microdialysis technique was developed to measure it. Our Abeta microdialysis technique was validated ex vivo with human CSF and then in vivo in awake, freely moving mice. Using human amyloid precursor protein (APP) transgenic mice, we found that, before the onset of AD-like pathology, ISF Abeta in hippocampus and cortex correlated with levels of APP in those tissues. After the onset of Abeta deposition, significant changes in the ISF Abeta40/Abeta42 ratio developed without changes in Abeta1-x. These changes differed from changes seen in tissue lysates from the same animals. By rapidly inhibiting Abeta production, we found that ISF Abeta half-life was short ( approximately 2 hr) in young mice but was twofold longer in mice with Abeta deposits. This increase in half-life, without an increase in steady-state levels, suggests that inhibition of Abeta synthesis reveals a portion of the insoluble Abeta pool that is in dynamic equilibrium with ISF Abeta. This now measurable in vivo pool is a likely target for new diagnostic and therapeutic strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cirrito</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>May</LastName><ForeName>Patrick C</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>O'Dell</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Jennie W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Parsadanian</LastName><ForeName>Maia</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Cramer</LastName><ForeName>Jeffrey W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Audia</LastName><ForeName>James E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Nissen</LastName><ForeName>Jeffrey S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Bales</LastName><ForeName>Kelly R</ForeName><Initials>KR</Initials></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Steven M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>DeMattos</LastName><ForeName>Ronald B</ForeName><Initials>RB</Initials></Author><Author ValidYN="Y"><LastName>Holtzman</LastName><ForeName>David M</ForeName><Initials>DM</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG020222</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG13956</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR000036</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG011355</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR00036</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG013956</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG20222</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AG013956</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG11355</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002555" MajorTopicYN="N">Cerebrospinal Fluid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005110" MajorTopicYN="N">Extracellular Space</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017551" MajorTopicYN="N">Microdialysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>11</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14523085</ArticleId><ArticleId IdType="pmc">PMC6740389</ArticleId><ArticleId IdType="pii">23/26/8844</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-26-08844.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM ( 1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet 17: 263-264.</Citation><ArticleIdList><ArticleId IdType="pubmed">9354781</ArticleId></ArticleIdList></Reference><Reference><Citation>Benveniste H ( 1989) Brain microdialysis. J Neurochem 52: 1667-1679.</Citation><ArticleIdList><ArticleId IdType="pubmed">2656913</ArticleId></ArticleIdList></Reference><Reference><Citation>Benveniste H, Huttemeier PC ( 1990) Microdialysis&#x2014;theory and application. Prog Neurobiol 35: 195-215.</Citation><ArticleIdList><ArticleId IdType="pubmed">2236577</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI ( 2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30: 665-676.</Citation><ArticleIdList><ArticleId IdType="pubmed">11430801</ArticleId></ArticleIdList></Reference><Reference><Citation>Cserr HF, Harling-Berg CJ, Knopf PM ( 1992) Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol 2: 269-276.</Citation><ArticleIdList><ArticleId IdType="pubmed">1341962</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM ( 2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 98: 8850-8855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC37524</ArticleId><ArticleId IdType="pubmed">11438712</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM ( 2002a) Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295: 2264-2267.</Citation><ArticleIdList><ArticleId IdType="pubmed">11910111</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos RB, Bales KR, Parsadanian M, O'Dell MA, Foss EM, Paul SM, Holtzman DM ( 2002b) Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease. J Neurochem 81: 229-236.</Citation><ArticleIdList><ArticleId IdType="pubmed">12064470</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos RB, O'Dell MA, Parsadanian M, Taylor JW, Harmony JA, Bales KR, Paul SM, Aronow BJ, Holtzman DM ( 2002c) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 99: 10843-10848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125060</ArticleId><ArticleId IdType="pubmed">12145324</ArticleId></ArticleIdList></Reference><Reference><Citation>Dovey HF, John V, Anderson JP, Chen LZ, de Saint Andrieu P, Fang LY, Freedman SB, Folmer B, Goldbach E, Holsztynska EJ, Hu KL, Johnson-Wood KL, Kennedy SL, Kholodenko D, Knops JE, Latimer LH, Lee M, Liao Z, Lieberburg IM, Motter RN, et al. ( 2001) Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem 76: 173-181.</Citation><ArticleIdList><ArticleId IdType="pubmed">11145990</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Ni B, Glinn M, Dodel RC, Bales KR, Zhang Z, Hyslop PA, Paul SM ( 1997) alpha2-Macroglobulin as a beta-amyloid peptide-binding plasma protein. J Neurochem 69: 299-305.</Citation><ArticleIdList><ArticleId IdType="pubmed">9202323</ArticleId></ArticleIdList></Reference><Reference><Citation>Dykstra KH, Hsiao JK, Morrison PF, Bungay PM, Mefford IN, Scully MM, Dedrick RL ( 1992) Quantitative examination of tissue concentration profiles associated with microdialysis. J Neurochem 58: 931-940.</Citation><ArticleIdList><ArticleId IdType="pubmed">1738000</ArticleId></ArticleIdList></Reference><Reference><Citation>Esler WP, Stimson ER, Jennings JM, Vinters HV, Ghilardi JR, Lee JP, Mantyh PW, Maggio JE ( 2000) Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 39: 6288-6295.</Citation><ArticleIdList><ArticleId IdType="pubmed">10828941</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG, Holtzman DM ( 2000) Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann Neurol 48: 201-210.</Citation><ArticleIdList><ArticleId IdType="pubmed">10939571</ArticleId></ArticleIdList></Reference><Reference><Citation>Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S ( 2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100: 4162-4167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC153065</ArticleId><ArticleId IdType="pubmed">12634421</ArticleId></ArticleIdList></Reference><Reference><Citation>Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, et al. ( 1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373: 523-527.</Citation><ArticleIdList><ArticleId IdType="pubmed">7845465</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghiso J, Matsubara E, Koudinov A, Choi-Miura NH, Tomita M, Wisniewski T, Frangione B ( 1993) The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40, 40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J 293: 27-30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1134315</ArticleId><ArticleId IdType="pubmed">8328966</ArticleId></ArticleIdList></Reference><Reference><Citation>Golde TE, Eckman CB, Younkin SG ( 2000) Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochim Biophys Acta 1502: 172-187.</Citation><ArticleIdList><ArticleId IdType="pubmed">10899442</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ ( 1999) Protofibrillar intermediates of amyloid &#x3b2;-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19: 8876-8884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782787</ArticleId><ArticleId IdType="pubmed">10516307</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman DM ( 2001) Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. J Mol Neurosci 17: 147-155.</Citation><ArticleIdList><ArticleId IdType="pubmed">11816788</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM ( 2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 97: 2892-2897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16026</ArticleId><ArticleId IdType="pubmed">10694577</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-Aizawa Y, Saido TC ( 2000) Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6: 143-150.</Citation><ArticleIdList><ArticleId IdType="pubmed">10655101</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson I, Sandberg M, Hamberger A ( 1985) Mass transfer in brain dialysis devices&#x2014;a new method for the estimation of extracellular amino acids concentration. J Neurosci Methods 15: 263-268.</Citation><ArticleIdList><ArticleId IdType="pubmed">4094481</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson-Wood K, Lee M, Motter R, Hu K, Gordon G, Barbour R, Khan K, Gordon M, Tan H, Games D, Lieberburg I, Schenk D, Seubert P, McConlogue L ( 1997) Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA 94: 1550-1555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC19829</ArticleId><ArticleId IdType="pubmed">9037091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R ( 2003) APP processing and synaptic function. Neuron 37: 925-937.</Citation><ArticleIdList><ArticleId IdType="pubmed">12670422</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG ( 2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489.</Citation><ArticleIdList><ArticleId IdType="pubmed">12702875</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyh PW ( 1992) Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 89: 5462-5466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC49312</ArticleId><ArticleId IdType="pubmed">1608956</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsubara E, Frangione B, Ghiso J ( 1995) Characterization of apolipoprotein J-Alzheimer's A beta interaction. J Biol Chem 270: 7563-7567.</Citation><ArticleIdList><ArticleId IdType="pubmed">7706304</ArticleId></ArticleIdList></Reference><Reference><Citation>Menacherry S, Hubert W, Justice Jr JB ( 1992) In vivo calibration of microdialysis probes for exogenous compounds. Anal Chem 64: 577-583.</Citation><ArticleIdList><ArticleId IdType="pubmed">1580357</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer-Luehmann M, Stalder M, Herzig MC, Kaeser SA, Kohler E, Pfeifer M, Boncristiano S, Mathews PM, Mercken M, Abramowski D, Staufenbiel M, Jucker M ( 2003) Extracellular amyloid formation and associated pathology in neural grafts. Nat Neurosci 6: 370-377.</Citation><ArticleIdList><ArticleId IdType="pubmed">12598899</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan ME, Singhal D, Anderson BD ( 1996) Quantitative assessment of blood-brain barrier damage during microdialysis. J Pharmacol Exp Ther 277: 1167-1176.</Citation><ArticleIdList><ArticleId IdType="pubmed">8627529</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, Price AL ( 2001) Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 17: 101-118.</Citation><ArticleIdList><ArticleId IdType="pubmed">11816784</ArticleId></ArticleIdList></Reference><Reference><Citation>Price DL, Sisodia SS, Borchelt DR ( 1998) Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282: 1079-1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">9804539</ArticleId></ArticleIdList></Reference><Reference><Citation>Pype S, Moechars D, Dillen L, Mercken M ( 2003) Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein. J Neurochem 84: 602-609.</Citation><ArticleIdList><ArticleId IdType="pubmed">12558980</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ ( 2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741-766.</Citation><ArticleIdList><ArticleId IdType="pubmed">11274343</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV ( 2000) Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106: 1489-1499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC387254</ArticleId><ArticleId IdType="pubmed">11120756</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN ( 1994) Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45: 373-379.</Citation><ArticleIdList><ArticleId IdType="pubmed">8145724</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisodia SS ( 1999) Alzheimer's disease: perspectives for the new millennium. J Clin Invest 104: 1169-1170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC409829</ArticleId><ArticleId IdType="pubmed">10545514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisodia SS, Koo EH, Hoffman PN, Perry G, Price DL ( 1993) Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J Neurosci 13: 3136-3142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6576678</ArticleId><ArticleId IdType="pubmed">8331390</ArticleId></ArticleIdList></Reference><Reference><Citation>St. George-Hyslop PH ( 2000) Genetic factors in the genesis of Alzheimer's disease. Ann NY Acad Sci 924: 1-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11193785</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanzi RE, Kovacs DM, Kim TW, Moir RD, Guenette SY, Wasco W ( 1996) The gene defects responsible for familial Alzheimer's disease. Neurobiol Dis 3: 159-168.</Citation><ArticleIdList><ArticleId IdType="pubmed">8980016</ArticleId></ArticleIdList></Reference><Reference><Citation>Teplow DB ( 1998) Structural and kinetic features of amyloid beta-protein fibrillogenesis. Amyloid 5: 121-142.</Citation><ArticleIdList><ArticleId IdType="pubmed">9686307</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Selkoe DJ, Teplow DB ( 1999) Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 274: 25945-25952.</Citation><ArticleIdList><ArticleId IdType="pubmed">10464339</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ ( 2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539.</Citation><ArticleIdList><ArticleId IdType="pubmed">11932745</ArticleId></ArticleIdList></Reference><Reference><Citation>Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH ( 2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414: 212-216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11700559</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiltfang J, Esselmann H, Bibl M, Smirnov A, Otto M, Paul S, Schmidt B, Klafki HW, Maler M, Dyrks T, Bienert M, Beyermann M, Ruther E, Kornhuber J ( 2002) Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J Neurochem 81: 481-496.</Citation><ArticleIdList><ArticleId IdType="pubmed">12065657</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisniewski T, Ghiso J, Frangione B ( 1997) Biology of A beta amyloid in Alzheimer's disease. Neurobiol Dis 4: 313-328.</Citation><ArticleIdList><ArticleId IdType="pubmed">9440120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JT, Tung JS, Thorsett ED, Pleiss MA, Nissen JS, Neitz J, Latimer LH, John V, Freedman S, Britton TC, Audia JE, Reel JK, Mabry TE, Dressman BA, Cwi CL, Droste JJ, Henry SS, McDaniel SL, Scott WL, Stucky RD, Porter WJ ( 1998) Preparation of cycloalkyl, lactam, lactone and related compounds for inhibiting b-amyloid peptide release and/or its synthesis. PCT Int Appl WO 9828268 A 2: 889.</Citation></Reference><Reference><Citation>Yang DS, Smith JD, Zhou Z, Gandy SE, Martins RN ( 1997) Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J Neurochem 68: 721-725.</Citation><ArticleIdList><ArticleId IdType="pubmed">9003062</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ET, Richards HK, Kida S, Weller RO ( 1992) Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain. Acta Neuropathol (Berl) 83: 233-239.</Citation><ArticleIdList><ArticleId IdType="pubmed">1373020</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14523244</PMID><DateCompleted><Year>2003</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>21</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Gleevec inhibits beta-amyloid production but not Notch cleavage.</ArticleTitle><Pagination><StartPage>12444</StartPage><EndPage>12449</EndPage><MedlinePgn>12444-9</MedlinePgn></Pagination><Abstract><AbstractText>Amyloid-beta (Abeta) peptides, consisting mainly of 40 and 42 aa (Abeta40 and Abeta42, respectively), are metabolites of the amyloid precursor protein and are believed to be major pathological determinants of Alzheimer's disease. The proteolytic cleavages that form the Abeta N and C termini are catalyzed by beta-secretase and gamma-secretase, respectively. Here we demonstrate that gamma-secretase generation of Abeta in an N2a cell-free system is ATP dependent. In addition, the Abl kinase inhibitor imatinib mesylate (Gleevec, or STI571), which targets the ATP-binding site of Abl and several other tyrosine kinases, potently reduces Abeta production in the N2a cell-free system and in intact N2a cells. Both STI571 and a related compound, inhibitor 2, also reduce Abeta production in rat primary neuronal cultures and in vivo in guinea pig brain. STI571 does not inhibit the gamma-secretase-catalyzed S3 cleavage of Notch-1. Furthermore, production of Abeta and its inhibition by STI571 were demonstrated to occur to similar extents in both Abl-/- and WT mouse fibroblasts, indicating that the effect of STI571 on Abeta production does not involve Abl kinase. The efficacy of STI571 in reducing Abeta without affecting Notch-1 cleavage may prove useful as a basis for developing novel therapies for Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Netzer</LastName><ForeName>William J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Fisher Center for Research on Alzheimer's Disease, Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10021, USA..</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dou</LastName><ForeName>Fei</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Dongming</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Veach</LastName><ForeName>Darren</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Jean</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yueming</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Bornmann</LastName><ForeName>William G</ForeName><Initials>WG</Initials></Author><Author ValidYN="Y"><LastName>Clarkson</LastName><ForeName>Bayard</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Huaxi</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Greengard</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG 09464</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG009464</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 CA064593</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA 64593</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001549">Benzamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497762">Notch1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497763">Notch1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010879">Piperazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051881">Receptor, Notch1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>8A1O1M485B</RegistryNumber><NameOfSubstance UI="D000068877">Imatinib Mesylate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="D016315">Proto-Oncogene Proteins c-abl</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001549" MajorTopicYN="N">Benzamides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016313" MajorTopicYN="N">Genes, abl</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068877" MajorTopicYN="N">Imatinib Mesylate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011505" MajorTopicYN="N">Protein-Tyrosine Kinases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016315" MajorTopicYN="N">Proto-Oncogene Proteins c-abl</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051881" MajorTopicYN="N">Receptor, Notch1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011956" MajorTopicYN="Y">Receptors, Cell Surface</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="Y">Transcription Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>4</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14523244</ArticleId><ArticleId IdType="pmc">PMC218777</ArticleId><ArticleId IdType="doi">10.1073/pnas.1534745100</ArticleId><ArticleId IdType="pii">1534745100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rojas-Fernandez, C. H., Chen, M. &amp; Fernandez, H. L. (2002) Pharmacotherapy 22, 1547-1563.</Citation><ArticleIdList><ArticleId IdType="pubmed">12495166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy, J. &amp; Selkoe, D. J. (2002) Science 297, 353-356.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Citron, M. (2002) Neurobiol. Aging 23, 1017-1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">12470797</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts, S. B. (2002) Adv. Drug Delivery Rev. 54, 1579-1588.</Citation><ArticleIdList><ArticleId IdType="pubmed">12453675</ArticleId></ArticleIdList></Reference><Reference><Citation>Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) Nature 414, 212-216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11700559</ArticleId></ArticleIdList></Reference><Reference><Citation>Phiel, C. J., Wilson, C. A., Lee, V. M. &amp; Klein, P. S. (2003) Nature 423, 435-439.</Citation><ArticleIdList><ArticleId IdType="pubmed">12761548</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, X., Sato, S., Murayama, O., Murayama, M., Park, J. M., Yamaguchi, H. &amp; Takashima, A. (2002) Neurosci. Lett. 321, 61-64.</Citation><ArticleIdList><ArticleId IdType="pubmed">11872257</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenfield, J. P., Tsai, J., Gouras, G. K., Hai, B., Thinakaran, G., Checler, F., Sisodia, S. S., Greengard, P. &amp; Xu, H. (1999) Proc. Natl. Acad. Sci. USA 96, 742-747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC15207</ArticleId><ArticleId IdType="pubmed">9892704</ArticleId></ArticleIdList></Reference><Reference><Citation>Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R. &amp; Talpaz, M. (2001) N. Engl. J. Med. 344, 1038-1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">11287973</ArticleId></ArticleIdList></Reference><Reference><Citation>Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S. &amp; Sawyers, C. L. (2001) N. Engl. J. Med. 344, 1031-1037.</Citation><ArticleIdList><ArticleId IdType="pubmed">11287972</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisniewski, D., Lambek, C. L., Liu, C., Strife, A., Veach, D. R., Nagar, B., Young, M. A., Schindler, T., Bornmann, W. G., Bertino, J. R., et al. (2002) Cancer Res. 62, 4244-4255.</Citation><ArticleIdList><ArticleId IdType="pubmed">12154026</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagar, B., Bornmann, W. G., Pellicena, P., Schindler, T., Veach, D. R., Miller, W. T., Clarkson, B. &amp; Kuriyan, J. (2002) Cancer Res. 62, 4236-4243.</Citation><ArticleIdList><ArticleId IdType="pubmed">12154025</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagar, B., Hantschel, O., Young, M. A., Scheffzek, K., Veach, D., Bornmann, W., Clarkson, B., Superti-Furga, G. &amp; Kuriyan, J. (2003) Cell 112, 859-871.</Citation><ArticleIdList><ArticleId IdType="pubmed">12654251</ArticleId></ArticleIdList></Reference><Reference><Citation>Strife, A., Wisniewski, D., Liu, C., Lambek, C. L., Darzynkiewicz, Z., Silver, R. T. &amp; Clarkson, B. (2003) Mol. Cancer Res. 1, 176-185.</Citation><ArticleIdList><ArticleId IdType="pubmed">12556557</ArticleId></ArticleIdList></Reference><Reference><Citation>Hantschel, O., Nagar, B., Guettler, S., Kretzschmar, J., Dorey, K., Kuriyan, J. &amp; Superti-Furga, G. (2003) Cell 112, 845-857.</Citation><ArticleIdList><ArticleId IdType="pubmed">12654250</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, H., Gouras, G. K., Greenfield, J. P., Vincent, B., Naslund, J., Mazzarelli, L., Fried, G., Jovanovic, J. N., Seeger, M., Relkin, N. R., et al. (1998) Nat. Med. 4, 447-451.</Citation><ArticleIdList><ArticleId IdType="pubmed">9546791</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, H. &amp; Shields, D. (1993) J. Cell Biol. 122, 1169-1184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2119863</ArticleId><ArticleId IdType="pubmed">8104189</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobin, R. B. &amp; Slater, E. C. (1965) Biochim. Biophys. Acta. 105, 214-220.</Citation><ArticleIdList><ArticleId IdType="pubmed">4221367</ArticleId></ArticleIdList></Reference><Reference><Citation>Austen, B. M., Frears, E. R. &amp; Davies, H. (2000) J. Pept. Sci. 6, 459-469.</Citation><ArticleIdList><ArticleId IdType="pubmed">11016883</ArticleId></ArticleIdList></Reference><Reference><Citation>Frears, E. R., Stephens, D. J., Walters, C. E., Davies, H. &amp; Austen, B. M. (1999) NeuroReport 10, 1699-1705.</Citation><ArticleIdList><ArticleId IdType="pubmed">10501560</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopan, R., Schroeter, E. H., Weintraub, H. &amp; Nye, J. S. (1996) Proc. Natl. Acad. Sci. USA 93, 1683-1688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC40002</ArticleId><ArticleId IdType="pubmed">8643690</ArticleId></ArticleIdList></Reference><Reference><Citation>Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I. &amp; Selkoe, D. J. (1992) Nature 360, 672-674.</Citation><ArticleIdList><ArticleId IdType="pubmed">1465129</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C. M., Kim, G., Seekins, S., Yager, D., et al. (1996) Neuron 17, 1005-1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">8938131</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebert, D. N. &amp; Carruthers, A. (1986) J. Biol. Chem. 261, 10093-10099.</Citation><ArticleIdList><ArticleId IdType="pubmed">3733703</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, F., Yang, D. S., Petanceska, S., Yang, A., Tandon, A., Yu, G., Rozmahel, R., Ghiso, J., Nishimura, M., Zhang, D. M., et al. (2000) J. Biol. Chem. 275, 36794-36802.</Citation><ArticleIdList><ArticleId IdType="pubmed">10962005</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia, W., Zhang, J., Ostaszewski, B. L., Kimberly, W. T., Seubert, P., Koo, E. H., Shen, J. &amp; Selkoe, D. J. (1998) Biochemistry 37, 16465-16471.</Citation><ArticleIdList><ArticleId IdType="pubmed">9843412</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocca, A., Lamaze, C., Subtil, A. &amp; Dautry-Varsat, A. (2001) Mol. Biol. Cell. 12, 1293-1301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC34584</ArticleId><ArticleId IdType="pubmed">11359922</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y. M., Lai, M. T., Xu, M., Huang, Q., DiMuzio-Mower, J., Sardana, M. K., Shi, X. P., Yin, K. C., Shafer, J. A. &amp; Gardell, S. J. (2000) Proc. Natl. Acad. Sci. USA 97, 6138-6143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18571</ArticleId><ArticleId IdType="pubmed">10801983</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasserman, T. H. &amp; Twentyman, P. (1988) Int. J. Radiat. Oncol. Biol. Phys. 15, 699-702.</Citation><ArticleIdList><ArticleId IdType="pubmed">3417490</ArticleId></ArticleIdList></Reference><Reference><Citation>Geling, A., Steiner, H., Willem, M., Bally-Cuif, L. &amp; Haass, C. (2002) EMBO Rep. 3, 688-694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1084181</ArticleId><ArticleId IdType="pubmed">12101103</ArticleId></ArticleIdList></Reference><Reference><Citation>Shearman, M. S., Beher, D., Clarke, E. E., Lewis, H. D., Harrison, T., Hunt, P., Nadin, A., Smith, A. L., Stevenson, G. &amp; Castro, J. L. (2000) Biochemistry 39, 8698-8704.</Citation><ArticleIdList><ArticleId IdType="pubmed">10913280</ArticleId></ArticleIdList></Reference><Reference><Citation>Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J. &amp; Lydon, N. B. (1996) Nat. Med. 2, 561-566.</Citation><ArticleIdList><ArticleId IdType="pubmed">8616716</ArticleId></ArticleIdList></Reference><Reference><Citation>Whang, Y. E., Tran, C., Henderson, C., Syljuasen, R. G., Rozengurt, N., McBride, W. H. &amp; Sawyers, C. L. (2000) Proc. Natl. Acad. Sci. USA 97, 5486-5491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC25855</ArticleId><ArticleId IdType="pubmed">10805805</ArticleId></ArticleIdList></Reference><Reference><Citation>Moasser, M. M., Srethapakdi, M., Sachar, K. S., Kraker, A. J. &amp; Rosen, N. (1999) Cancer Res. 59, 6145-6152.</Citation><ArticleIdList><ArticleId IdType="pubmed">10626805</ArticleId></ArticleIdList></Reference><Reference><Citation>Calingasan, N. Y., Park, L. C., Gandy, S. E. &amp; Gibson, G. E. (1998) Dev. Neurosci. (Basel) 20, 454-461.</Citation><ArticleIdList><ArticleId IdType="pubmed">9778584</ArticleId></ArticleIdList></Reference><Reference><Citation>Takayama, N., Sato, N., O'Brien, S. G., Ikeda, Y. &amp; Okamoto, S. (2002) Br. J. Haematol. 119, 106-108.</Citation><ArticleIdList><ArticleId IdType="pubmed">12358909</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold, B. G. (1997) Neuroscience 76, 1153-1158.</Citation><ArticleIdList><ArticleId IdType="pubmed">9027875</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, H., Saura, C. A., Choi, S. Y., Sun, L. D., Yang, X., Handler, M., Kawarabayashi, T., Younkin, L., Fedeles, B., Wilson, M. A., et al. (2001) Neuron 31, 713-726.</Citation><ArticleIdList><ArticleId IdType="pubmed">11567612</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha, S. &amp; Lieberburg, I. (1999) Proc. Natl. Acad. Sci. USA 96, 11049-11053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC34239</ArticleId><ArticleId IdType="pubmed">10500121</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeuchi, T. &amp; Sisodia, S. S. (2002) Neuromolecular Med. 1, 43-54.</Citation><ArticleIdList><ArticleId IdType="pubmed">12025815</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, C., Kim, S. H., Ikeuchi, T., Xu, H., Gasparini, L., Wang, R. &amp; Sisodia, S. S. (2001) J. Biol. Chem. 276, 43756-43760.</Citation><ArticleIdList><ArticleId IdType="pubmed">11583985</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeter, E. H., Kisslinger, J. A. &amp; Kopan, R. (1998) Nature 393, 382-386.</Citation><ArticleIdList><ArticleId IdType="pubmed">9620803</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianni, D., Zambrano, N., Bimonte, M., Minopoli, G., Mercken, L., Talamo, F., Scaloni, A. &amp; Russo, T. (2003) J. Biol. Chem. 278, 9290-9297.</Citation><ArticleIdList><ArticleId IdType="pubmed">12645527</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14526083</PMID><DateCompleted><Year>2003</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><Issue>5642</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.</ArticleTitle><Pagination><StartPage>113</StartPage><EndPage>117</EndPage><MedlinePgn>113-7</MedlinePgn></Pagination><Abstract><AbstractText>The most common inherited [correct] form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease affecting adult motor neurons, is caused by dominant mutations in the ubiquitously expressed Cu-Zn superoxide dismutase (SOD1). In chimeric mice that are mixtures of normal and SOD1 mutant-expressing cells, toxicity to motor neurons is shown to require damage from mutant SOD1 acting within nonneuronal cells. Normal motor neurons in SOD1 mutant chimeras develop aspects of ALS pathology. Most important, nonneuronal cells that do not express mutant SOD1 delay degeneration and significantly extend survival of mutant-expressing motor neurons.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clement</LastName><ForeName>A M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Ludwig Institute for Cancer Research, University of California, 9500 Gilman Drive, La Jolla, CA 92093-0670, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>M D</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>E A</ForeName><Initials>EA</Initials></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Boill&#xe9;e</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Rule</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>McMahon</LastName><ForeName>A P</ForeName><Initials>AP</Initials></Author><Author ValidYN="Y"><LastName>Doucette</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Siwek</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Ferrante</LastName><ForeName>R J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>R H</ForeName><Initials>RH</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>Julien</LastName><ForeName>J-P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>L S B</ForeName><Initials>LS</Initials></Author><Author ValidYN="Y"><LastName>Cleveland</LastName><ForeName>D W</ForeName><Initials>DW</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NS 31248</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG 13846</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 NS027036</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS 37912</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS 27036</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HD 30249</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG 12992</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016900">Neurofilament Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C044882">neurofilament protein L</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Science. 2003 Oct 24;302(5645):568</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002678" MajorTopicYN="N">Chimera</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016900" MajorTopicYN="N">Neurofilament Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>10</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14526083</ArticleId><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pii">302/5642/113</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14527431</PMID><DateCompleted><Year>2003</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila.</ArticleTitle><Pagination><StartPage>25</StartPage><EndPage>40</EndPage><MedlinePgn>25-40</MedlinePgn></Pagination><Abstract><AbstractText>We tested whether proteins implicated in Huntington's and other polyglutamine (polyQ) expansion diseases can cause axonal transport defects. Reduction of Drosophila huntingtin and expression of proteins containing pathogenic polyQ repeats disrupt axonal transport. Pathogenic polyQ proteins accumulate in axonal and nuclear inclusions, titrate soluble motor proteins, and cause neuronal apoptosis and organismal death. Expression of a cytoplasmic polyQ repeat protein causes adult retinal degeneration, axonal blockages in larval neurons, and larval lethality, but not neuronal apoptosis or nuclear inclusions. A nuclear polyQ repeat protein induces neuronal apoptosis and larval lethality but no axonal blockages. We suggest that pathogenic polyQ proteins cause neuronal dysfunction and organismal death by two non-mutually exclusive mechanisms. One mechanism requires nuclear accumulation and induces apoptosis; the other interferes with axonal transport. Thus, disruption of axonal transport by pathogenic polyQ proteins could contribute to early neuropathology in Huntington's and other polyQ expansion diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gunawardena</LastName><ForeName>Shermali</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Her</LastName><ForeName>Lu-Shiun</ForeName><Initials>LS</Initials></Author><Author ValidYN="Y"><LastName>Brusch</LastName><ForeName>Richard G</ForeName><Initials>RG</Initials></Author><Author ValidYN="Y"><LastName>Laymon</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Niesman</LastName><ForeName>Ingrid R</ForeName><Initials>IR</Initials></Author><Author ValidYN="Y"><LastName>Gordesky-Gold</LastName><ForeName>Beth</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Sintasath</LastName><ForeName>Louis</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Bonini</LastName><ForeName>Nancy M</ForeName><Initials>NM</Initials></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Lawrence S B</ForeName><Initials>LS</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GM35252</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086055">HTT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071058">Huntingtin Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neuron. 2003 Sep 25;40(1):1-2. doi: 10.1016/s0896-6273(03)00600-7.</RefSource><PMID Version="1">14527425</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001370" MajorTopicYN="N">Axonal Transport</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071058" MajorTopicYN="N">Huntingtin Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>10</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14527431</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00594-4</ArticleId><ArticleId IdType="pii">S0896627303005944</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14527432</PMID><DateCompleted><Year>2003</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport.</ArticleTitle><Pagination><StartPage>41</StartPage><EndPage>52</EndPage><MedlinePgn>41-52</MedlinePgn></Pagination><Abstract><AbstractText>Huntington's and Kennedy's disease are autosomal dominant neurodegenerative diseases caused by pathogenic expansion of polyglutamine tracts. Expansion of glutamine repeats must in some way confer a gain of pathological function that disrupts an essential cellular process and leads to loss of affected neurons. Association of huntingtin with vesicular structures raised the possibility that axonal transport might be altered. Here we show that polypeptides containing expanded polyglutamine tracts, but not normal N-terminal huntingtin or androgen receptor, directly inhibit both fast axonal transport in isolated axoplasm and elongation of neuritic processes in intact cells. Effects were greater with truncated polypeptides and occurred without detectable morphological aggregates.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Szebenyi</LastName><ForeName>Gy&#xf6;rgyi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morfini</LastName><ForeName>Gerardo A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Babcock</LastName><ForeName>Alyssa</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Gould</LastName><ForeName>Milena</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Selkoe</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Stenoien</LastName><ForeName>David L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Maureen</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Faber</LastName><ForeName>Pieter W</ForeName><Initials>PW</Initials></Author><Author ValidYN="Y"><LastName>MacDonald</LastName><ForeName>Marcy E</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>McPhaul</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Brady</LastName><ForeName>Scott T</ForeName><Initials>ST</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DK03892</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS16367</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS23320</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS23868</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS32765</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS41170</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS43408</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086055">HTT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071058">Huntingtin Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neuron. 2003 Sep 25;40(1):1-2. doi: 10.1016/s0896-6273(03)00600-7.</RefSource><PMID Version="1">14527425</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001370" MajorTopicYN="N">Axonal Transport</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048429" MajorTopicYN="N">Cell Size</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049832" MajorTopicYN="N">Decapodiformes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071058" MajorTopicYN="N">Huntingtin Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009433" MajorTopicYN="N">Neural Inhibition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>10</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14527432</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00569-5</ArticleId><ArticleId IdType="pii">S0896627303005695</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14530399</PMID><DateCompleted><Year>2003</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>21</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1.</ArticleTitle><Pagination><StartPage>12438</StartPage><EndPage>12443</EndPage><MedlinePgn>12438-43</MedlinePgn></Pagination><Abstract><AbstractText>Mutations in the parkin gene are linked to autosomal-recessive juvenile parkinsonism (AR-JP). Parkin functions as a ubiquitin protein ligase in the degradation of several proteins, including the neuron-specific septin CDCrel-1. AR-JP-associated parkin mutations inhibit ubiquitination and degradation of CDCrel-1 and other parkin target proteins. Here we show that recombinant adeno-associated virus-mediated CDCrel-1 gene transfer to the substantia nigra of rats results in a rapid onset (6-10 days) of nigral and striatal CDCrel-1 expression that is followed by a progressive loss of nigral dopaminergic neurons and a decline of the striatal dopamine levels. In contrast, neurons of the globus pallidus are spared from CDCrel-1 toxicity. Furthermore, CDCrel-1 inhibits the release of dopamine from stably-transfected PC12 cells, and pharmacological inhibition of tyrosine hydroxylase and dopamine synthesis in rats prevents CDCrel-1-induced nigral neurodegeneration. These results show that CDCrel-1 overexpression exerts dopamine-dependent neurotoxicity and suggest that inhibition of dopamine secretion by CDCrel-1 may contribute to the development of AR-JP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Zhizhong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology, University of Zurich, 8057 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferger</LastName><ForeName>Boris</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Paterna</LastName><ForeName>Jean-Charles</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Vogel</LastName><ForeName>Denise</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Furler</LastName><ForeName>Sven</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Osinde</LastName><ForeName>Maribel</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Feldon</LastName><ForeName>Joram</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>B&#xfc;eler</LastName><ForeName>Hansruedi</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>658-48-0</RegistryNumber><NameOfSubstance UI="D019805">alpha-Methyltyrosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.16.2</RegistryNumber><NameOfSubstance UI="D014446">Tyrosine 3-Monooxygenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C111567">parkin protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C109366">SEPTIN5 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C491613">Septin5 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D058112">Septins</NameOfSubstance></Chemical><Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber><NameOfSubstance UI="D004298">Dopamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="Y">Cell Cycle Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003342" MajorTopicYN="N">Corpus Striatum</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000229" MajorTopicYN="N">Dependovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018014" MajorTopicYN="N">Gene Transfer Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016716" MajorTopicYN="N">PC12 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020734" MajorTopicYN="N">Parkinsonian Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058112" MajorTopicYN="N">Septins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013378" MajorTopicYN="N">Substantia Nigra</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014446" MajorTopicYN="N">Tyrosine 3-Monooxygenase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019805" MajorTopicYN="N">alpha-Methyltyrosine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>8</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>8</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>4</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14530399</ArticleId><ArticleId IdType="pmc">PMC218776</ArticleId><ArticleId IdType="doi">10.1073/pnas.2132992100</ArticleId><ArticleId IdType="pii">2132992100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jenner, P. &amp; Olanow, C. W. (1998) Ann. Neurol. 44, S72-S84.</Citation><ArticleIdList><ArticleId IdType="pubmed">9749577</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussbaum, R. L. &amp; Ellis, C. E. (2003) N. Engl. J. Med. 348, 1356-1364.</Citation><ArticleIdList><ArticleId IdType="pubmed">12672864</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson, T. M. &amp; Dawson, V. L. (2003) J. Clin. Invest. 111, 145-151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151882</ArticleId><ArticleId IdType="pubmed">12531866</ArticleId></ArticleIdList></Reference><Reference><Citation>Cookson, M. R. (2003) Neuron 37, 7-10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12526767</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. T., Schols, L. &amp; Riess, O. (1998) Nat. Genet. 18, 106-108.</Citation><ArticleIdList><ArticleId IdType="pubmed">9462735</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) Science 276, 2045-2047.</Citation><ArticleIdList><ArticleId IdType="pubmed">9197268</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas, N., Lucking, C. B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R., et al. (1999) Hum. Mol. Genet. 8, 567-574.</Citation><ArticleIdList><ArticleId IdType="pubmed">10072423</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. &amp; Shimizu, N. (1998) Nature 392, 605-608.</Citation><ArticleIdList><ArticleId IdType="pubmed">9560156</ArticleId></ArticleIdList></Reference><Reference><Citation>Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) Nature 395, 451-452.</Citation><ArticleIdList><ArticleId IdType="pubmed">9774100</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) Science 299, 256-259.</Citation><ArticleIdList><ArticleId IdType="pubmed">12446870</ArticleId></ArticleIdList></Reference><Reference><Citation>Le, W. D., Xu, P., Jankovic, J., Jiang, H., Appel, S. H., Smith, R. G. &amp; Vassilatis, D. K. (2003) Nat. Genet. 33, 85-89.</Citation><ArticleIdList><ArticleId IdType="pubmed">12496759</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. &amp; Suzuki, T. (2000) Nat. Genet. 25, 302-305.</Citation><ArticleIdList><ArticleId IdType="pubmed">10888878</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y., Gao, J., Chung, K. K., Huang, H., Dawson, V. L. &amp; Dawson, T. M. (2000) Proc. Natl. Acad. Sci. USA 97, 13354-13359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27228</ArticleId><ArticleId IdType="pubmed">11078524</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita, A., Noda, M. &amp; Kinoshita, M. (2000) J. Comp. Neurol. 428, 223-239.</Citation><ArticleIdList><ArticleId IdType="pubmed">11064363</ArticleId></ArticleIdList></Reference><Reference><Citation>Caltagarone, J., Rhodes, J., Honer, W. G. &amp; Bowser, R. (1998) NeuroReport 9, 2907-2912.</Citation><ArticleIdList><ArticleId IdType="pubmed">9760144</ArticleId></ArticleIdList></Reference><Reference><Citation>Honer, W. G., Hu, L. &amp; Davies, P. (1993) Brain Res. 609, 9-20.</Citation><ArticleIdList><ArticleId IdType="pubmed">7685234</ArticleId></ArticleIdList></Reference><Reference><Citation>Beites, C. L., Xie, H., Bowser, R. &amp; Trimble, W. S. (1999) Nat. Neurosci. 2, 434-439.</Citation><ArticleIdList><ArticleId IdType="pubmed">10321247</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. &amp; Takahashi, R. (2001) Cell 105, 891-902.</Citation><ArticleIdList><ArticleId IdType="pubmed">11439185</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S. &amp; Selkoe, D. J. (2001) Science 293, 263-269.</Citation><ArticleIdList><ArticleId IdType="pubmed">11431533</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung, K. K., Zhang, Y., Lim, K. L., Tanaka, Y., Huang, H., Gao, J., Ross, C. A., Dawson, V. L. &amp; Dawson, T. M. (2001) Nat. Med. 7, 1144-1150.</Citation><ArticleIdList><ArticleId IdType="pubmed">11590439</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren, Y., Zhao, J. &amp; Feng, J. (2003) J. Neurosci. 23, 3316-3324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1876717</ArticleId><ArticleId IdType="pubmed">12716939</ArticleId></ArticleIdList></Reference><Reference><Citation>Feany, M. B. &amp; Pallanck, L. J. (2003) Neuron 38, 13-16.</Citation><ArticleIdList><ArticleId IdType="pubmed">12691660</ArticleId></ArticleIdList></Reference><Reference><Citation>Furler, S., Paterna, J. C., Weibel, M. &amp; Bueler, H. (2001) Gene Ther. 8, 864-873.</Citation><ArticleIdList><ArticleId IdType="pubmed">11423934</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterna, J. C., Moccetti, T., Mura, A., Feldon, J. &amp; Bueler, H. (2000) Gene Ther. 7, 1304-1311.</Citation><ArticleIdList><ArticleId IdType="pubmed">10918501</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimm, D., Kern, A., Rittner, K. &amp; Kleinschmidt, J. A. (1998) Hum. Gene Ther. 9, 2745-2760.</Citation><ArticleIdList><ArticleId IdType="pubmed">9874273</ArticleId></ArticleIdList></Reference><Reference><Citation>Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J. &amp; Muzyczka, N. (1999) Gene Ther. 6, 973-985.</Citation><ArticleIdList><ArticleId IdType="pubmed">10455399</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, Z., Ferger, B., Feldon, J. &amp; Bueler, H. (2002) J. Neurobiol. 53, 1-10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12360578</ArticleId></ArticleIdList></Reference><Reference><Citation>Pothos, E. N., Larsen, K. E., Krantz, D. E., Liu, Y., Haycock, J. W., Setlik, W., Gershon, M. D., Edwards, R. H. &amp; Sulzer, D. (2000) J. Neurosci. 20, 7297-7306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772799</ArticleId><ArticleId IdType="pubmed">11007887</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanis, L., Larsen, K. E., Rideout, H. J., Sulzer, D. &amp; Greene, L. A. (2001) J. Neurosci. 21, 9549-9560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763041</ArticleId><ArticleId IdType="pubmed">11739566</ArticleId></ArticleIdList></Reference><Reference><Citation>Giasson, B. I. &amp; Lee, V. M. (2001) Neuron 31, 885-888.</Citation><ArticleIdList><ArticleId IdType="pubmed">11580890</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer, E. S., Sanderson, M. J. &amp; Wasterlain, C. G. (1995) J. Cell Sci. 108, 2619-2628.</Citation><ArticleIdList><ArticleId IdType="pubmed">7593303</ArticleId></ArticleIdList></Reference><Reference><Citation>Junn, E. &amp; Mouradian, M. M. (2001) J. Neurochem. 78, 374-383.</Citation><ArticleIdList><ArticleId IdType="pubmed">11461973</ArticleId></ArticleIdList></Reference><Reference><Citation>McNaught, K. S., Belizaire, R., Isacson, O., Jenner, P. &amp; Olanow, C. W. (2003) Exp. Neurol. 179, 38-46.</Citation><ArticleIdList><ArticleId IdType="pubmed">12504866</ArticleId></ArticleIdList></Reference><Reference><Citation>McNaught, K. S. &amp; Olanow, C. W. (2003) Ann. Neurol. 53, S73-S86.</Citation><ArticleIdList><ArticleId IdType="pubmed">12666100</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung, K. K., Dawson, V. L. &amp; Dawson, T. M. (2001) Trends Neurosci. 24, S7-S14.</Citation><ArticleIdList><ArticleId IdType="pubmed">11881748</ArticleId></ArticleIdList></Reference><Reference><Citation>Longtine, M. S., DeMarini, D. J., Valencik, M. L., Al-Awar, O. S., Fares, H., De Virgilio, C. &amp; Pringle, J. R. (1996) Curr. Opin. Cell Biol. 8, 106-119.</Citation><ArticleIdList><ArticleId IdType="pubmed">8791410</ArticleId></ArticleIdList></Reference><Reference><Citation>Field, C. M. &amp; Kellogg, D. (1999) Trends Cell Biol. 9, 387-394.</Citation><ArticleIdList><ArticleId IdType="pubmed">10481176</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimble, W. S. (1999) J. Membr. Biol. 169, 75-81.</Citation><ArticleIdList><ArticleId IdType="pubmed">10341029</ArticleId></ArticleIdList></Reference><Reference><Citation>Kartmann, B. &amp; Roth, D. (2001) J. Cell Sci. 114, 839-844.</Citation><ArticleIdList><ArticleId IdType="pubmed">11181167</ArticleId></ArticleIdList></Reference><Reference><Citation>Beites, C. L., Peng, X. R. &amp; Trimble, W. S. (2001) Methods Enzymol. 329, 499-510.</Citation><ArticleIdList><ArticleId IdType="pubmed">11210570</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu, S. C., Hazuka, C. D., Roth, R., Foletti, D. L., Heuser, J. &amp; Scheller, R. H. (1998) Neuron 20, 1111-1122.</Citation><ArticleIdList><ArticleId IdType="pubmed">9655500</ArticleId></ArticleIdList></Reference><Reference><Citation>Joberty, G., Perlungher, R. R., Sheffield, P. J., Kinoshita, M., Noda, M., Haystead, T. &amp; Macara, I. G. (2001) Nat. Cell Biol. 3, 861-866.</Citation><ArticleIdList><ArticleId IdType="pubmed">11584266</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, W., Efanov, A., Yang, S. N., Fried, G., Kolare, S., Brown, H., Zaitsev, S., Berggren, P. O. &amp; Meister, B. (2000) J. Biol. Chem. 275, 41521-41527.</Citation><ArticleIdList><ArticleId IdType="pubmed">11024017</ArticleId></ArticleIdList></Reference><Reference><Citation>Dent, J., Kato, K., Peng, X. R., Martinez, C., Cattaneo, M., Poujol, C., Nurden, P., Nurden, A., Trimble, W. S. &amp; Ware, J. (2002) Proc. Natl. Acad. Sci. USA 99, 3064-3069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122473</ArticleId><ArticleId IdType="pubmed">11880646</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, J., Kao, S. Y., Lee, F. J., Song, W., Jin, L. W. &amp; Yankner, B. A. (2002) Nat. Med. 8, 600-606.</Citation><ArticleIdList><ArticleId IdType="pubmed">12042811</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway, K. A., Rochet, J. C., Bieganski, R. M. &amp; Lansbury, P. T., Jr. (2001) Science 294, 1346-1349.</Citation><ArticleIdList><ArticleId IdType="pubmed">11701929</ArticleId></ArticleIdList></Reference><Reference><Citation>Volles, M. J., Lee, S. J., Rochet, J. C., Shtilerman, M. D., Ding, T. T., Kessler, J. C. &amp; Lansbury, P. T., Jr. (2001) Biochemistry 40, 7812-7819.</Citation><ArticleIdList><ArticleId IdType="pubmed">11425308</ArticleId></ArticleIdList></Reference><Reference><Citation>Volles, M. J. &amp; Lansbury, P. T., Jr. (2002) Biochemistry 41, 4595-4602.</Citation><ArticleIdList><ArticleId IdType="pubmed">11926821</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotharius, J. &amp; Brundin, P. (2002) Nat. Rev. Neurosci. 3, 932-942.</Citation><ArticleIdList><ArticleId IdType="pubmed">12461550</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J. &amp; Bjorklund, A. (2002) J. Neurosci. 22, 2780-2791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758323</ArticleId><ArticleId IdType="pubmed">11923443</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahle, P. J., Neumann, M., Ozmen, L., Muller, V., Odoy, S., Okamoto, N., Jacobsen, H., Iwatsubo, T., Trojanowski, J. Q., Takahashi, H., et al. (2001) Am. J. Pathol. 159, 2215-2225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1850592</ArticleId><ArticleId IdType="pubmed">11733371</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A. &amp; Mucke, L. (2000) Science 287, 1265-1269.</Citation><ArticleIdList><ArticleId IdType="pubmed">10678833</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuoka, Y., Vila, M., Lincoln, S., McCormack, A., Picciano, M., LaFrancois, J., Yu, X., Dickson, D., Langston, W. J., McGowan, E., et al. (2001) Neurobiol. Dis. 8, 535-539.</Citation><ArticleIdList><ArticleId IdType="pubmed">11442360</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Putten, H., Wiederhold, K. H., Probst, A., Barbieri, S., Mistl, C., Danner, S., Kauffmann, S., Hofele, K., Spooren, W. P., Ruegg, M. A., et al. (2000) J. Neurosci. 20, 6021-6029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772584</ArticleId><ArticleId IdType="pubmed">10934251</ArticleId></ArticleIdList></Reference><Reference><Citation>Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q. &amp; Lee, V. M. (2002) Neuron 34, 521-533.</Citation><ArticleIdList><ArticleId IdType="pubmed">12062037</ArticleId></ArticleIdList></Reference><Reference><Citation>Dracopoli, N. C., Haines, J. L., Korf, B. R., Moir, D. T., Morton, C. C., Seidman, C. E., Seidman, J. G. &amp; Smith, D. R., eds. (1997) Current Protocols in Human Genetics (Wiley, New York), pp. 12.1.1-12.1.20.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14535955</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3042</ISSN><JournalIssue CitedMedium="Print"><Volume>87</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of neurochemistry</Title><ISOAbbreviation>J Neurochem</ISOAbbreviation></Journal><ArticleTitle>Caspase cleavage of the amyloid precursor protein modulates amyloid beta-protein toxicity.</ArticleTitle><Pagination><StartPage>733</StartPage><EndPage>741</EndPage><MedlinePgn>733-41</MedlinePgn></Pagination><Abstract><AbstractText>The amyloid beta-protein precursor (APP) is proteolytically cleaved to generate the amyloid beta-protein (Abeta), the principal constituent of senile plaques found in Alzheimer's disease (AD). In addition, Abeta in its oligomeric and fibrillar forms have been hypothesized to induce neuronal toxicity. We and others have previously shown that APP can be cleaved by caspases at the C-terminus to generate a potentially cytotoxic peptide termed C31. Furthermore, this cleavage event and caspase activation were increased in the brains of AD, but not control, cases. In this study, we show that in cultured cells, Abeta induces caspase cleavage of APP in the C-terminus and that the subsequent generation of C31 contributes to the apoptotic cell death associated with Abeta. Interestingly, both Abeta toxicity and C31 pathway are dependent on the presence of APP. Both APP-dependent Abeta toxicity and C31-induced apoptotic cell death involve apical or initiator caspases-8 and -9. Our results suggest that Abeta-mediated toxicity initiates a cascade of events that includes caspase activation and APP cleavage. These findings link C31 generation and its potential cell death activity to Abeta cytotoxicity, the leading mechanism proposed for neuronal death in AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Daniel C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California, San Diego, La Jolla 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soriano</LastName><ForeName>Salvador</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Bredesen</LastName><ForeName>Dale E</ForeName><Initials>DE</Initials></Author><Author ValidYN="Y"><LastName>Koo</LastName><ForeName>Edward H</ForeName><Initials>EH</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG05131</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM07198</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS28121</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurochem</MedlineTA><NlmUniqueID>2985190R</NlmUniqueID><ISSNLinking>0022-3042</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C075222">amyloid beta-protein (1-42)</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D020169">Caspases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020169" MajorTopicYN="N">Caspases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020134" MajorTopicYN="N">Catalytic Domain</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009447" MajorTopicYN="N">Neuroblastoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14535955</ArticleId><ArticleId IdType="doi">10.1046/j.1471-4159.2003.02059.x</ArticleId><ArticleId IdType="pii">2059</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1455056</PMID><DateCompleted><Year>1993</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0923-2494</ISSN><JournalIssue CitedMedium="Print"><Volume>143</Volume><Issue>6</Issue><PubDate><Year>1992</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Research in immunology</Title><ISOAbbreviation>Res Immunol</ISOAbbreviation></Journal><ArticleTitle>The role of perivascular and microglial cells in fibrillogenesis of beta-amyloid and PrP protein in Alzheimer's disease and scrapie.</ArticleTitle><Pagination><StartPage>642</StartPage><EndPage>645</EndPage><MedlinePgn>642-5</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wisniewski</LastName><ForeName>H M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wegiel</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AGO-4220</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Res Immunol</MedlineTA><NlmUniqueID>8907467</NlmUniqueID><ISSNLinking>0923-2494</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002415" MajorTopicYN="N">Cats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004730" MajorTopicYN="N">Endothelium, Vascular</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009454" MajorTopicYN="N">Neurofibrils</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012608" MajorTopicYN="N">Scrapie</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>34</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1455056</ArticleId><ArticleId IdType="doi">10.1016/0923-2494(92)80049-q</ArticleId><ArticleId IdType="pii">0923-2494(92)80049-Q</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14562104</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>06</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>425</Volume><Issue>6959</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>RNA molecules stimulate prion protein conversion.</ArticleTitle><Pagination><StartPage>717</StartPage><EndPage>720</EndPage><MedlinePgn>717-20</MedlinePgn></Pagination><Abstract><AbstractText>Much evidence supports the hypothesis that the infectious agents of prion diseases are devoid of nucleic acid, and instead are composed of a specific infectious protein. This protein, PrP(Sc), seems to be generated by template-induced conformational change of a normally expressed glycoprotein, PrP(C) (ref. 2). Although numerous studies have established the conversion of PrP(C) to PrP(Sc) as the central pathogenic event of prion disease, it is unknown whether cellular factors other than PrP(C) might be required to stimulate efficient PrP(Sc) production. We investigated the biochemical amplification of protease-resistant PrP(Sc)-like protein (PrPres) using a modified version of the protein-misfolding cyclic amplification method. Here we report that stoichiometric transformation of PrP(C) to PrPres in vitro requires specific RNA molecules. Notably, whereas mammalian RNA preparations stimulate in vitro amplification of PrPres, RNA preparations from invertebrate species do not. Our findings suggest that host-encoded stimulatory RNA molecules may have a role in the pathogenesis of prion disease. They also provide a practical approach to improve the sensitivity of diagnostic techniques based on PrPres amplification.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deleault</LastName><ForeName>Nathan R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, 7200 Vail Building, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucassen</LastName><ForeName>Ralf W</ForeName><Initials>RW</Initials></Author><Author ValidYN="Y"><LastName>Supattapone</LastName><ForeName>Surachai</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011328">Prions</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D004720">Endonucleases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nature. 2003 Oct 16;425(6959):673-4. doi: 10.1038/425673a.</RefSource><PMID Version="1">14562085</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017173" MajorTopicYN="N">Caenorhabditis elegans</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004720" MajorTopicYN="N">Endonucleases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008647" MajorTopicYN="N">Mesocricetus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017096" MajorTopicYN="N">Prion Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011328" MajorTopicYN="N">Prions</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="Y">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012608" MajorTopicYN="N">Scrapie</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>11</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14562104</ArticleId><ArticleId IdType="doi">10.1038/nature01979</ArticleId><ArticleId IdType="pii">nature01979</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14566063</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>22</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>28</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>A presenilin dimer at the core of the gamma-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis.</ArticleTitle><Pagination><StartPage>13075</StartPage><EndPage>13080</EndPage><MedlinePgn>13075-80</MedlinePgn></Pagination><Abstract><AbstractText>Notch receptors and the amyloid precursor protein are type I membrane proteins that are proteolytically cleaved within their transmembrane domains by a presenilin (PS)-dependent gamma-secretase activity. In both proteins, two peptide bonds are hydrolyzed: one near the inner leaflet and the other in the middle of the transmembrane domain. Under saturating conditions the substrates compete with each other for proteolysis, but not for binding to PS. At least some Alzheimer's disease-causing PS mutations reside in proteins possessing low catalytic activity. We demonstrate (i) that differentially tagged PS molecules coimmunoprecipitate, and (ii) that PS N-terminal fragment dimers exist by using a photoaffinity probe based on a transition state analog gamma-secretase inhibitor. We propose that gamma-secretase contains a PS dimer in its catalytic core, that binding of substrate is at a site separate from the active site, and that substrate is cleaved at the interface of two PS molecules.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schroeter</LastName><ForeName>Eric H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilagan</LastName><ForeName>Ma Xenia G</ForeName><Initials>MX</Initials></Author><Author ValidYN="Y"><LastName>Brunkan</LastName><ForeName>Anne L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Hecimovic</LastName><ForeName>Silva</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yue-ming</ForeName><Initials>YM</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Min</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Huw D</ForeName><Initials>HD</Initials></Author><Author ValidYN="Y"><LastName>Saxena</LastName><ForeName>Meera T</ForeName><Initials>MT</Initials></Author><Author ValidYN="Y"><LastName>De Strooper</LastName><ForeName>Bart</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Coonrod</LastName><ForeName>Archie</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Tomita</LastName><ForeName>Taisuke</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Iwatsubo</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Chad L</ForeName><Initials>CL</Initials></Author><Author ValidYN="Y"><LastName>Goate</LastName><ForeName>Alison</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Wolfe</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Shearman</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kopan</LastName><ForeName>Raphael</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NS 41355</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM 55479</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM055479</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG017050</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG 17050</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS041355</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497761">NOTCH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497762">Notch1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508853">PSEN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508861">PSEN2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053766">Presenilin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051881">Receptor, Notch1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019281" MajorTopicYN="N">Dimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053766" MajorTopicYN="N">Presenilin-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051881" MajorTopicYN="N">Receptor, Notch1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011956" MajorTopicYN="N">Receptors, Cell Surface</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="Y">Transcription Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>21</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>21</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14566063</ArticleId><ArticleId IdType="pmc">PMC240747</ArticleId><ArticleId IdType="doi">10.1073/pnas.1735338100</ArticleId><ArticleId IdType="pii">1735338100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Selkoe, D. &amp; Kopan, R. (2003) Annu. Rev. Neurosci. 26 565-597.</Citation><ArticleIdList><ArticleId IdType="pubmed">12730322</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass, C. &amp; Steiner, H. (2002) Trends Cell Biol. 12 556-562.</Citation><ArticleIdList><ArticleId IdType="pubmed">12495843</ArticleId></ArticleIdList></Reference><Reference><Citation>Annaert, W. &amp; De Strooper, B. (2002) Annu. Rev. Cell Dev. Biol. 18 25-51.</Citation><ArticleIdList><ArticleId IdType="pubmed">12142279</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper, B. &amp; Annaert, W. (2000) J. Cell Sci. 113 1857-1870.</Citation><ArticleIdList><ArticleId IdType="pubmed">10806097</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassar, R. (2002) Adv. Drug Deliv. Rev. 54 1589-1602.</Citation><ArticleIdList><ArticleId IdType="pubmed">12453676</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy, M. P., Hickman, L. J., Eckman, C. B., Uljon, S. N., Wang, R. &amp; Golde, T. E. (1999) J. Biol. Chem. 274 11914-11923.</Citation><ArticleIdList><ArticleId IdType="pubmed">10207012</ArticleId></ArticleIdList></Reference><Reference><Citation>Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. W., Murphy, M. P., Butler, T., et al. (2001) Nature 414 212-216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11700559</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao, X. &amp; Sudhof, T. C. (2001) Science 293 115-120.</Citation><ArticleIdList><ArticleId IdType="pubmed">11441186</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimberly, W. T., Zheng, J. B., Guenette, S. Y. &amp; Selkoe, D. J. (2001) J. Biol. Chem. 276 40288-40292.</Citation><ArticleIdList><ArticleId IdType="pubmed">11544248</ArticleId></ArticleIdList></Reference><Reference><Citation>Cupers, P., Orlans, I., Craessaerts, K., Annaert, W. &amp; De Strooper, B. (2001) J. Neurochem. 78 1168-1178.</Citation><ArticleIdList><ArticleId IdType="pubmed">11553691</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, Y. H. &amp; Pimplikar, S. W. (2001) Proc. Natl. Acad. Sci. USA 98 14979-14984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC64969</ArticleId><ArticleId IdType="pubmed">11742091</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumm, J. S. &amp; Kopan, R. (2000) Dev. Biol. 228 151-165.</Citation><ArticleIdList><ArticleId IdType="pubmed">11112321</ArticleId></ArticleIdList></Reference><Reference><Citation>Struhl, G. &amp; Adachi, A. (1998) Cell 93 649-660.</Citation><ArticleIdList><ArticleId IdType="pubmed">9604939</ArticleId></ArticleIdList></Reference><Reference><Citation>Huppert, S., Le, A., Schroeter, E. H., Mumm, S. J., Saxena, M. T., Milner, A. L. &amp; Kopan, R. (2000) Nature 405 966-970.</Citation><ArticleIdList><ArticleId IdType="pubmed">10879540</ArticleId></ArticleIdList></Reference><Reference><Citation>Okochi, M., Steiner, H., Fukumori, A., Tanii, H., Tomita, T., Tanaka, T., Iwatsubo, T., Kudo, T., Takeda, M. &amp; Haass, C. (2002) EMBO J. 21 5408-5416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC129073</ArticleId><ArticleId IdType="pubmed">12374741</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama, K., Tomita, T., Shinozaki, K., Kume, H., Asada, H., Saido, T. C., Ishiura, S., Iwatsubo, T. &amp; Obata, K. (1996) Biochem. Biophys. Res. Commun. 227 730-735.</Citation><ArticleIdList><ArticleId IdType="pubmed">8886002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichtenthaler, S. F., Ida, N., Multhaup, G., Masters, C. L. &amp; Beyreuther, K. (1997) Biochemistry 36 15396-15403.</Citation><ArticleIdList><ArticleId IdType="pubmed">9398269</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichtenthaler, S. F., Wang, R., Grimm, H., Uljon, S. N., Masters, C. L. &amp; Beyreuther, K. (1999) Proc. Natl. Acad. Sci. USA 96 3053-3058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC15893</ArticleId><ArticleId IdType="pubmed">10077635</ArticleId></ArticleIdList></Reference><Reference><Citation>Tischer, E. &amp; Cordell, B. (1996) J. Biol. Chem. 271 21914-21919.</Citation><ArticleIdList><ArticleId IdType="pubmed">8702994</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy, M. P., Uljon, S. N., Fraser, P. E., Fauq, A., Lookingbill, H. A., Findlay, K. A., Smith, T. E., Lewis, P. A., McLendon, D. C., Wang, R., et al. (2000) J. Biol. Chem. 275 26277-26284.</Citation><ArticleIdList><ArticleId IdType="pubmed">10816583</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeter, E. H., Kisslinger, J. A. &amp; Kopan, R. (1998) Nature 393 382-386.</Citation><ArticleIdList><ArticleId IdType="pubmed">9620803</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena, M. T., Schroeter, E. H., Mumm, J. S. &amp; Kopan, R. (2001) J. Biol. Chem. 276 40268-40273.</Citation><ArticleIdList><ArticleId IdType="pubmed">11518718</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, Y., Misonou, H., Sato, T., Dohmae, N., Takio, K. &amp; Ihara, Y. (2001) J. Biol. Chem. 276 35235-35238.</Citation><ArticleIdList><ArticleId IdType="pubmed">11483588</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastre, M., Steiner, H., Fuchs, K., Capell, A., Multhaup, G., Condron, M. M., Teplow, D. B. &amp; Haass, C. (2001) EMBO Rep. 2 835-841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1084035</ArticleId><ArticleId IdType="pubmed">11520861</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, W. H., Nadeau, P., Yuan, M. L., Yang, X. D., Shen, J. &amp; Yankner, B. A. (1999) Proc. Natl. Acad. Sci. USA 96 6959-6963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22024</ArticleId><ArticleId IdType="pubmed">10359821</ArticleId></ArticleIdList></Reference><Reference><Citation>Moehlmann, T., Winkler, E., Xia, X. F., Edbauer, D., Murrelll, J., Capell, A., Kaether, C., Zheng, H., Ghetti, B., Haass, C., et al. (2002) Proc. Natl. Acad. Sci. USA 99 8025-8030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC123014</ArticleId><ArticleId IdType="pubmed">12048239</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, F., Gu, Y., Hasegawa, H., Ruan, X., Arawaka, S., Fraser, P., Westaway, D., Mount, H. &amp; St. George-Hyslop, P. (2002) J. Biol. Chem. 277 36521-36526.</Citation><ArticleIdList><ArticleId IdType="pubmed">12119298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy, J. &amp; Crook, R. (2001) Neurosci. Lett. 306 203-205.</Citation><ArticleIdList><ArticleId IdType="pubmed">11406330</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, F., Yu, G., Arawaka, S., Nishimura, M., Kawarai, T., Yu, H., Tandon, A., Supala, A., Song, Y. Q., Rogaeva, E., et al. (2001) Nat. Cell Biol. 3 751-754.</Citation><ArticleIdList><ArticleId IdType="pubmed">11483961</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi, Y., Karlstrom, H., Lundkvist, J., Mizutani, T., Otaka, A., Vestling, M., Bernstein, A., Donoviel, D., Lendahl, U. &amp; Honjo, T. (2002) Proc. Natl. Acad. Sci. USA 99 4014-4019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122640</ArticleId><ArticleId IdType="pubmed">11891288</ArticleId></ArticleIdList></Reference><Reference><Citation>Petit, A., St. George-Hyslop, P., Fraser, P. &amp; Checler, F. (2002) Biochem. Biophys. Res. Commun. 290 1408-1410.</Citation><ArticleIdList><ArticleId IdType="pubmed">11820778</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson, C. A., Doms, R. W., Zheng, H. &amp; Lee, V. M. (2002) Nat. Neurosci. 5 849-855.</Citation><ArticleIdList><ArticleId IdType="pubmed">12145638</ArticleId></ArticleIdList></Reference><Reference><Citation>Herreman, A., Hartmann, D., Annaert, W., Saftig, P., Craessaerts, K., Serneels, L., Umans, L., Schrijvers, V., Checler, F., Vanderstichele, H., et al. (1999) Proc. Natl. Acad. Sci. USA 96 11872-11877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18379</ArticleId><ArticleId IdType="pubmed">10518543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopan, R., Schroeter, E. H., Weintraub, H. &amp; Nye, J. S. (1996) Proc. Natl. Acad. Sci. USA 93 1683-1687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC40002</ArticleId><ArticleId IdType="pubmed">8643690</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumm, J. S., Schroeter, E. H., Saxena, M. T., Griesemer, A., Tian, X., Pan, D. J., Ray, W. J. &amp; Kopan, R. (2000) Mol. Cell 5 197-206.</Citation><ArticleIdList><ArticleId IdType="pubmed">10882062</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray, W. J., Yao, M., Nowotny, P., Mumm, J., Zhang, W. J., Wu, J. Y., Kopan, R. &amp; Goate, A. M. (1999) Proc. Natl. Acad. Sci. USA 96 3263-3268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC15930</ArticleId><ArticleId IdType="pubmed">10077672</ArticleId></ArticleIdList></Reference><Reference><Citation>Podlisny, M. B., Citron, M., Amarante, P., Sherrington, R., Xia, W., Zhang, J., Diehl, T., Levesque, G., Fraser, P., Haass, C., et al. (1997) Neurobiol. Dis. 3 325-337.</Citation><ArticleIdList><ArticleId IdType="pubmed">9173929</ArticleId></ArticleIdList></Reference><Reference><Citation>Malin, S. A., Guo, W. X., Jafari, G., Goate, A. M. &amp; Nerbonne, J. M. (1998) Neurobiol. Dis. 4 398-409.</Citation><ArticleIdList><ArticleId IdType="pubmed">9666479</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimberly, W. T., Esler, W. P., Ye, W., Ostaszewski, B. L., Gao, J., Diehl, T., Selkoe, D. J. &amp; Wolfe, M. S. (2003) Biochemistry 42 137-144.</Citation><ArticleIdList><ArticleId IdType="pubmed">12515548</ArticleId></ArticleIdList></Reference><Reference><Citation>Berezovska, O., Jack, C., Deng, A., Gastineau, N., Rebeck, G. W. &amp; Hyman, B. T. (2001) J. Biol. Chem. 276 30018-30023.</Citation><ArticleIdList><ArticleId IdType="pubmed">11408475</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray, W. J., Yao, M., Mumm, J., Schroeter, E. H., Saftig, P., Wolfe, M., Selkoe, D. J., Kopan, R. &amp; Goate, A. M. (1999) J. Biol. Chem. 274 36801-36807.</Citation><ArticleIdList><ArticleId IdType="pubmed">10593990</ArticleId></ArticleIdList></Reference><Reference><Citation>Annaert, W. G., Esselens, C., Baert, V., Boeve, C., Snellings, G., Cupers, P., Craessaerts, K. &amp; De Strooper, B. (2001) Neuron 32 579-589.</Citation><ArticleIdList><ArticleId IdType="pubmed">11719200</ArticleId></ArticleIdList></Reference><Reference><Citation>Esler, W. P., Kimberly, W. T., Ostaszewski, B. L., Ye, W., Diehl, T. S., Selkoe, D. J. &amp; Wolfe, M. S. (2002) Proc. Natl. Acad. Sci. USA 99 2720-2725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122414</ArticleId><ArticleId IdType="pubmed">11867728</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. S., Schroeter, E. H., Schrijvers, V., Wolfe, M. S., Ray, W. J., et al. (1999) Nature 398 518-522.</Citation><ArticleIdList><ArticleId IdType="pubmed">10206645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe, M. S., Citron, M., Diehl, T. S., Xia, W., Donkor, I. O. &amp; Selkoe, D. J. (1998) J. Med. Chem. 41 6-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9438016</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe, M. S., Xia, W., Moore, C. L., Leatherwood, D. D., Ostaszewski, B., Rahmati, T., Donkor, I. O. &amp; Selkoe, D. J. (1999) Biochemistry 38 4720-4727.</Citation><ArticleIdList><ArticleId IdType="pubmed">10200159</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, L., Song, L., Terracina, G., Liu, Y., Pramanik, B. &amp; Parker, E. (2001) Biochemistry 40 5049-5055.</Citation><ArticleIdList><ArticleId IdType="pubmed">11305921</ArticleId></ArticleIdList></Reference><Reference><Citation>Foote, J. &amp; Schachman, H. K. (1985) J. Mol. Biol. 186 175-184.</Citation><ArticleIdList><ArticleId IdType="pubmed">3908690</ArticleId></ArticleIdList></Reference><Reference><Citation>LaVoie, M. J., Fraering, P. C., Ostaszewski, B. L., Ye, W., Kimberly, W. T., Wolfe, M. S. &amp; Selkoe, D. J. (2003) J. Biol. Chem. 278 37213-37222.</Citation><ArticleIdList><ArticleId IdType="pubmed">12857757</ArticleId></ArticleIdList></Reference><Reference><Citation>Edbauer, D., Winkler, E., Regula, J. T., Pesold, B., Steiner, H. &amp; Haass, C. (2003) Nat. Cell Biol. 5 486-488.</Citation><ArticleIdList><ArticleId IdType="pubmed">12679784</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo, W. J., Wang, H., Li, H., Kim, B. S., Shah, S., Lee, H. J., Thinakaran, G., Kim, T. W., Yu, G. &amp; Xu, H. (2003) J. Biol. Chem. 278 7850-7854.</Citation><ArticleIdList><ArticleId IdType="pubmed">12522139</ArticleId></ArticleIdList></Reference><Reference><Citation>Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y., Thinakaran, G. &amp; Iwatsubo, T. (2003) Nature 422 438-441.</Citation><ArticleIdList><ArticleId IdType="pubmed">12660785</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimberly, W. T., LaVoie, M. J., Ostaszewski, B. L., Ye, W., Wolfe, M. S. &amp; Selkoe, D. J. (2003) Proc. Natl. Acad. Sci. USA 100 6382-6387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC164455</ArticleId><ArticleId IdType="pubmed">12740439</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmery, M. R., Tjernberg, L. O., Pursglove, S. E., Bergman, A., Winblad, B. &amp; Naslund, J. (2003) J. Biol. Chem. 278 24277-24284.</Citation><ArticleIdList><ArticleId IdType="pubmed">12697771</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M. &amp; Haass, C. (2002) J. Biol. Chem. 277 39062-39065.</Citation><ArticleIdList><ArticleId IdType="pubmed">12198112</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y. M., Lai, M. T., Xu, M., Huang, Q., DiMuzio-Mower, J., Sardana, M. K., Shi, X. P., Yin, K. C., Shafer, J. A. &amp; Gardell, S. J. (2000) Proc. Natl. Acad. Sci. USA 97 6138-6143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18571</ArticleId><ArticleId IdType="pubmed">10801983</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervantes, S., Gonzalez-Duarte, R. &amp; Marfany, G. (2001) FEBS Lett. 505 81-86.</Citation><ArticleIdList><ArticleId IdType="pubmed">11557046</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebert, S. S., Godin, C., Tomiyama, T., Mori, H. &amp; Levesque, G. (2003) Biochem. Biophys. Res. Commun. 301 119-126.</Citation><ArticleIdList><ArticleId IdType="pubmed">12535650</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopan, R. &amp; Goate, A. (2002) Neuron 33 321-324.</Citation><ArticleIdList><ArticleId IdType="pubmed">11832221</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis, R., McGrath, G., Zhang, J., Ruddy, D. A., Sym, M., Apfeld, J., Nicoll, M., Maxwell, M., Hai, B., Ellis, M. C., et al. (2002) Dev Cell 3 85-97.</Citation><ArticleIdList><ArticleId IdType="pubmed">12110170</ArticleId></ArticleIdList></Reference><Reference><Citation>Thinakaran, G., Borchelt, D. R., Lee, M. K., Slunt, H. H., Spitzer, L., Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger, M., et al. (1996) Neuron 17 181-190.</Citation><ArticleIdList><ArticleId IdType="pubmed">8755489</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner, H., Romig, H., Grim, M. G., Philipp, U., Pesold, B., Citron, M., Baumeister, R. &amp; Haass, C. (1999) J. Biol. Chem. 274 7615-7618.</Citation><ArticleIdList><ArticleId IdType="pubmed">10075646</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y. M., Xu, M., Lai, M. T., Huang, Q., Castro, J. L., DiMuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J. G., et al. (2000) Nature 405 689-694.</Citation><ArticleIdList><ArticleId IdType="pubmed">10864326</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok, J. B., Halliday, G. M., Brooks, W. S., Dolios, G., Laudon, H., Murayama, O., Hallupp, M., Badenhop, R. F., Vickers, J., Wang, R., et al. (2003) J. Biol. Chem. 278 6748-6754.</Citation><ArticleIdList><ArticleId IdType="pubmed">12493737</ArticleId></ArticleIdList></Reference><Reference><Citation>Saura, C. A., Tomita, T., Davenport, F., Harris, C. L., Iwatsubo, T. &amp; Thinakaran, G. (1999) J. Biol. Chem. 274 13818-13823.</Citation><ArticleIdList><ArticleId IdType="pubmed">10318786</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitan, D., Lee, J., Song, L. X., Manning, R., Wong, G., Parker, E. &amp; Zhang, L. L. (2001) Proc. Natl. Acad. Sci. USA 98 12186-12190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC59789</ArticleId><ArticleId IdType="pubmed">11593035</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper, B. (2003) Neuron 38 9-12.</Citation><ArticleIdList><ArticleId IdType="pubmed">12691659</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14569018</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>22</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>28</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Expression of T cell receptor beta locus in central nervous system neurons.</ArticleTitle><Pagination><StartPage>13048</StartPage><EndPage>13053</EndPage><MedlinePgn>13048-53</MedlinePgn></Pagination><Abstract><AbstractText>MHC class I proteins are cell-surface ligands that bind to T cell receptors and other immunoreceptors and act to regulate the activation state of immune cells. Recent work has shown that MHC class I genes and CD3zeta, an obligate component of T cell receptors, are expressed in neurons, are regulated by neuronal activity, and function in neuronal development and plasticity. A search for additional neuronally expressed T cell receptor components has revealed that the T cell antigen receptor beta (TCRbeta) locus is expressed in neurons of the murine central nervous system and that this expression is dynamically regulated over development. In neonates, expression is most abundant in various thalamic nuclei. At later ages and in adults, thalamic expression fades and cortical expression is robust, particularly in layer 6. In T cells, protein-encoding transcripts are produced only after recombination of the TCRbeta genomic locus, which joins variable, diversity, and joining regions, a process that creates much of the diversity of the immune system. We detect no genomic recombination in neurons. Rather, transcripts begin in regions upstream of several joining regions, and are spliced to constant region segments. One of the transcripts encodes a hypothetical 207-aa, 23-kDa protein, which includes the TCRbeta J2.7 region, and the entire C region. These observations suggest that TCRbeta may function in neurons.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Syken</LastName><ForeName>Josh</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shatz</LastName><ForeName>Carla J</ForeName><Initials>CJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F32 NS041890</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5F32 NS 41890-02</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017931">DNA Primers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015395">Histocompatibility Antigens Class I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016693">Receptors, Antigen, T-Cell, alpha-beta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015152" MajorTopicYN="N">Blotting, Northern</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002874" MajorTopicYN="N">Chromosome Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017931" MajorTopicYN="N">DNA Primers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019674" MajorTopicYN="N">Genes, T-Cell Receptor beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015395" MajorTopicYN="N">Histocompatibility Antigens Class I</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016693" MajorTopicYN="N">Receptors, Antigen, T-Cell, alpha-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013154" MajorTopicYN="N">Spleen</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013788" MajorTopicYN="N">Thalamus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14569018</ArticleId><ArticleId IdType="pmc">PMC240742</ArticleId><ArticleId IdType="doi">10.1073/pnas.1735415100</ArticleId><ArticleId IdType="pii">1735415100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ploegh, H. L., Orr, H. T. &amp; Strominger, J. L. (1981) Cell 24 287-299.</Citation><ArticleIdList><ArticleId IdType="pubmed">7016338</ArticleId></ArticleIdList></Reference><Reference><Citation>Rammensee, H. G., Falk, K. &amp; Rotzschke, O. (1993) Curr. Opin. Immunol. 5 35-44.</Citation><ArticleIdList><ArticleId IdType="pubmed">7680871</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampson, L. A. (1987) Trends Neurosci. 10 211-216.</Citation></Reference><Reference><Citation>Wong, G. H., Bartlett, P. F., Clark-Lewis, I., Battye, F. &amp; Schrader, J. W. (1984) Nature 310 688-691.</Citation><ArticleIdList><ArticleId IdType="pubmed">6433204</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, G. H., Bartlett, P. F., Clark-Lewis, I., McKimm-Breschkin, J. L. &amp; Schrader, J. W. (1985) J. Neuroimmunol. 7 255-278.</Citation><ArticleIdList><ArticleId IdType="pubmed">3919057</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann, H., Cavalie, A., Jenne, D. E. &amp; Wekerle, H. (1995) Science 269 549-552.</Citation><ArticleIdList><ArticleId IdType="pubmed">7624779</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann, H., Schmidt, H., Cavalie, A., Jenne, D. &amp; Wekerle, H. (1997) J. Exp. Med. 185 305-316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2196130</ArticleId><ArticleId IdType="pubmed">9016879</ArticleId></ArticleIdList></Reference><Reference><Citation>Corriveau, R. A., Huh, G. S. &amp; Shatz, C. J. (1998) Neuron 21 505-520.</Citation><ArticleIdList><ArticleId IdType="pubmed">9768838</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh, G. S., Boulanger, L. M., Du, H., Riquelme, P. A., Brotz, T. M. &amp; Shatz, C. J. (2000) Science 290 2155-2159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2175035</ArticleId><ArticleId IdType="pubmed">11118151</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorfman, J. R., Zerrahn, J., Coles, M. C. &amp; Raulet, D. H. (1997) J. Immunol. 159 5219-5225.</Citation><ArticleIdList><ArticleId IdType="pubmed">9548460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii, T., Hirota, J. &amp; Mombaerts, P. (2003) Curr. Biol. 13 394-400.</Citation><ArticleIdList><ArticleId IdType="pubmed">12620187</ArticleId></ArticleIdList></Reference><Reference><Citation>Loconto, J., Papes, F., Chang, E., Stowers, L., Jones, E. P., Takada, T., Kumanovics, A., Fischer Lindahl, K. &amp; Dulac, C. (2003) Cell 112 607-618.</Citation><ArticleIdList><ArticleId IdType="pubmed">12628182</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe, L. R. &amp; Weiss, A. (1995) Trends Biochem. Sci. 20 59-64.</Citation><ArticleIdList><ArticleId IdType="pubmed">7701563</ArticleId></ArticleIdList></Reference><Reference><Citation>Barten, R., Torkar, M., Haude, A., Trowsdale, J. &amp; Wilson, M. J. (2001) Trends Immunol. 22 52-57.</Citation><ArticleIdList><ArticleId IdType="pubmed">11286693</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanier, L. L. (1998) Annu. Rev. Immunol. 16 359-393.</Citation><ArticleIdList><ArticleId IdType="pubmed">9597134</ArticleId></ArticleIdList></Reference><Reference><Citation>Trowsdale, J. (2001) Immunity 15 363-374.</Citation><ArticleIdList><ArticleId IdType="pubmed">11567627</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons, D. M., Arriza, J. L. &amp; Swanson, L. W. (1989) J. Histotechnol. 12 169-181.</Citation></Reference><Reference><Citation>Schatz, D. G., Oettinger, M. A. &amp; Schlissel, M. S. (1992) Annu. Rev. Immunol. 10 359-383.</Citation><ArticleIdList><ArticleId IdType="pubmed">1590991</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonegawa, S. (1983) Nature 302 575-581.</Citation><ArticleIdList><ArticleId IdType="pubmed">6300689</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassing, C. H., Swat, W. &amp; Alt, F. W. (2002) Cell 109 Suppl., S45-S55.</Citation><ArticleIdList><ArticleId IdType="pubmed">11983152</ArticleId></ArticleIdList></Reference><Reference><Citation>Selemon, L. D. &amp; Goldman-Rakic, P. S. (1985) J. Neurosci. 5 776-794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6565017</ArticleId><ArticleId IdType="pubmed">2983048</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu, G., Kronenberg, M., Strauss, E., Haars, R., Mak, T. W. &amp; Hood, L. (1984) Nature 13 344-350.</Citation><ArticleIdList><ArticleId IdType="pubmed">6090932</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark, S. P., Yoshikai, Y., Taylor, S., Sui, G., Hood, L. &amp; Mak, T. W. (1984) Nature 311 387-389.</Citation><ArticleIdList><ArticleId IdType="pubmed">6434993</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurwitz, J. L., Samaridis, J. &amp; Pelkonen, J. (1988) Cell 52 821-829.</Citation><ArticleIdList><ArticleId IdType="pubmed">3349521</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasunobu, Y., Anatoniou, D., Clark, S. P., Yanagi, Y., Sangster, R., Van den Elsen, P., Terhorst, C. &amp; Mak, T. W. (1984) Nature 312 521-524.</Citation><ArticleIdList><ArticleId IdType="pubmed">6334237</ArticleId></ArticleIdList></Reference><Reference><Citation>Martoglio, B. &amp; Dobberstein, B. (1998) Trends Cell Biol. 8 410-415.</Citation><ArticleIdList><ArticleId IdType="pubmed">9789330</ArticleId></ArticleIdList></Reference><Reference><Citation>Minami, Y., Weissman, A. M., Samelson, L. E. &amp; Klausner, R. D. (1987) Proc. Natl. Acad. Sci. USA 84 2688-2692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC304723</ArticleId><ArticleId IdType="pubmed">3495001</ArticleId></ArticleIdList></Reference><Reference><Citation>Sussman, J. J., Bonifacino, J. S., Lippincott-Schwartz, J., Weissman, A. M., Saito, T., Klausner, R. D. &amp; Ashwell, J. D. (1988) Cell 52 85-95.</Citation><ArticleIdList><ArticleId IdType="pubmed">3278811</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino, J. S., Suzuki, C. K., Lippincott-Schwartz, J., Weissman, A. M. &amp; Klausner, R. D. (1989) J. Cell Biol. 109 73-83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2115459</ArticleId><ArticleId IdType="pubmed">2663883</ArticleId></ArticleIdList></Reference><Reference><Citation>Eddy, S. R. (2001) Nat. Rev. Genet. 2 919-929.</Citation><ArticleIdList><ArticleId IdType="pubmed">11733745</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockdorff, N. (2002) Trends Genet. 18 352-358.</Citation><ArticleIdList><ArticleId IdType="pubmed">12127775</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikes, M. L., Gomez, R. J., Song, J. &amp; Oltz, E. M. (1998) J. Immunol. 161 1399-1405.</Citation><ArticleIdList><ArticleId IdType="pubmed">9686603</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehurst, C. E., Chattopadhyay, S. &amp; Chen, J. (1999) Immunity 10 313-322.</Citation><ArticleIdList><ArticleId IdType="pubmed">10204487</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty, R. T., Xia, D., Nguyen, S. P., Hathaway, T. R. &amp; Willerford, D. M. (1999) Blood 93 3017-3025.</Citation><ArticleIdList><ArticleId IdType="pubmed">10216098</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardoll, D. M., Fowlkes, B. J., Lechler, R. I., Germain, R. N. &amp; Schwartz, R. H. (1987) J. Exp. Med. 165 1624-1638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2188376</ArticleId><ArticleId IdType="pubmed">2884272</ArticleId></ArticleIdList></Reference><Reference><Citation>Abeliovich, A., Gerber, D., Tanaka, O., Katsuki, M., Graybiel, A. M. &amp; Tonegawa, S. (1992) Science 257 404-410.</Citation><ArticleIdList><ArticleId IdType="pubmed">1631561</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuoka, M., Nagawa, F., Okazaki, K., Kingsbury, L., Yoshida, K., Muller, U., Larue, D. T., Winer, J. A. &amp; Sakano, H. (1991) Science 254 81-86.</Citation><ArticleIdList><ArticleId IdType="pubmed">1925563</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun, J. J., Schatz, D. G., Oettinger, M. A., Jaenisch, R. &amp; Baltimore, D. (1991) Cell 64 189-200.</Citation><ArticleIdList><ArticleId IdType="pubmed">1986864</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon, J. P., Haire, R. N. &amp; Litman, G. W. (2002) Nat. Immunol. 3 1200-1207.</Citation><ArticleIdList><ArticleId IdType="pubmed">12415263</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal, A., Eastman, Q. M. &amp; Schatz, D. G. (1998) Nature 394 744-751.</Citation><ArticleIdList><ArticleId IdType="pubmed">9723614</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14570706</PMID><DateCompleted><Year>2004</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0964-6906</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>24</Issue><PubDate><Year>2003</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.</ArticleTitle><Pagination><StartPage>3259</StartPage><EndPage>3267</EndPage><MedlinePgn>3259-67</MedlinePgn></Pagination><Abstract><AbstractText>We previously reported genetic linkage of loci controlling age-at-onset in Alzheimer disease (AD) and Parkinson's disease (PD) to a 15 cM region on chromosome 10q. Given the large number of genes in this initial starting region, we applied the process of 'genomic convergence' to prioritize and reduce the number of candidate genes for further analysis. As our second convergence factor we performed gene expression studies on hippocampus obtained from AD patients and controls. Analysis revealed that four of the genes [stearoyl-CoA desaturase; NADH-ubiquinone oxidoreductase 1 beta subcomplex 8; protease, serine 11; and glutathione S-transferase, omega-1 (GSTO1)] were significantly different in their expression between AD and controls and mapped to the 10q age-at-onset linkage region, the first convergence factor. Using 2814 samples from our AD dataset (1773 AD patients) and 1362 samples from our PD dataset (635 PD patients), allelic association studies for age-at-onset effects in AD and PD revealed no association for three of the candidates, but a significant association was found for GSTO1 (P=0.007) and a second transcribed member of the GST omega class, GSTO2 (P=0.005), located next to GSTO1. The functions of GSTO1 and GSTO2 are not well understood, but recent data suggest that GSTO1 maybe involved in the post-translational modification of the inflammatory cytokine interleukin-1beta. This is provocative given reports of the possible role of inflammation in these two neurodegenerative disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yi-Ju</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Center for Human Genetics, Institute for Genome Science and Policy, Duke University Medical Center, Box 3445, Durham, NC 27710, USA. yiju.li@duke.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Sofia A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Puting</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Eden R</ForeName><Initials>ER</Initials></Author><Author ValidYN="Y"><LastName>Stenger</LastName><ForeName>Judith E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Scherzer</LastName><ForeName>Clemens R</ForeName><Initials>CR</Initials></Author><Author ValidYN="Y"><LastName>Hauser</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>William K</ForeName><Initials>WK</Initials></Author><Author ValidYN="Y"><LastName>Small</LastName><ForeName>Gary W</ForeName><Initials>GW</Initials></Author><Author ValidYN="Y"><LastName>Nance</LastName><ForeName>Martha A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Watts</LastName><ForeName>Ray L</ForeName><Initials>RL</Initials></Author><Author ValidYN="Y"><LastName>Hubble</LastName><ForeName>Jean P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Koller</LastName><ForeName>William C</ForeName><Initials>WC</Initials></Author><Author ValidYN="Y"><LastName>Pahwa</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Stern</LastName><ForeName>Mathew B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Hiner</LastName><ForeName>Bradley C</ForeName><Initials>BC</Initials></Author><Author ValidYN="Y"><LastName>Jankovic</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Goetz</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials></Author><Author ValidYN="Y"><LastName>Mastaglia</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Middleton</LastName><ForeName>Lefkos T</ForeName><Initials>LT</Initials></Author><Author ValidYN="Y"><LastName>Roses</LastName><ForeName>Allen D</ForeName><Initials>AD</Initials></Author><Author ValidYN="Y"><LastName>Saunders</LastName><ForeName>Ann M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Schmechel</LastName><ForeName>Donald E</ForeName><Initials>DE</Initials></Author><Author ValidYN="Y"><LastName>Gullans</LastName><ForeName>Steven R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Haines</LastName><ForeName>Jonathan L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Gilbert</LastName><ForeName>John R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Vance</LastName><ForeName>Jeffery M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Pericak-Vance</LastName><ForeName>Margaret A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Hulette</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Welsh-Bohmer</LastName><ForeName>Kathleen A</ForeName><Initials>KA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RR00865</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG13308</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH59528</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 AG021886</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH52453</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG05128</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS26630</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS39764</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG10123</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS31153</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG11268</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS031153</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG19085</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.5.1.18</RegistryNumber><NameOfSubstance UI="C490476">GSTO1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.5.1.18</RegistryNumber><NameOfSubstance UI="D005982">Glutathione Transferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Hum Mol Genet. 2004 Mar 1;13(5):573</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="Y">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002874" MajorTopicYN="N">Chromosome Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002879" MajorTopicYN="N">Chromosomes, Human, Pair 10</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005982" MajorTopicYN="N">Glutathione Transferase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015810" MajorTopicYN="N">Linkage Disequilibrium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008126" MajorTopicYN="N">Lod Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>9</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14570706</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddg357</ArticleId><ArticleId IdType="pii">ddg357</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14574408</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>425</Volume><Issue>6960</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>23</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Imaging coexisting fluid domains in biomembrane models coupling curvature and line tension.</ArticleTitle><Pagination><StartPage>821</StartPage><EndPage>824</EndPage><MedlinePgn>821-4</MedlinePgn></Pagination><Abstract><AbstractText>Lipid bilayer membranes--ubiquitous in biological systems and closely associated with cell function--exhibit rich shape-transition behaviour, including bud formation and vesicle fission. Membranes formed from multiple lipid components can laterally separate into coexisting liquid phases, or domains, with distinct compositions. This process, which may resemble raft formation in cell membranes, has been directly observed in giant unilamellar vesicles. Detailed theoretical frameworks link the elasticity of domains and their boundary properties to the shape adopted by membranes and the formation of particular domain patterns, but it has been difficult to experimentally probe and validate these theories. Here we show that high-resolution fluorescence imaging using two dyes preferentially labelling different fluid phases directly provides a correlation between domain composition and local membrane curvature. Using freely suspended membranes of giant unilamellar vesicles, we are able to optically resolve curvature and line tension interactions of circular, stripe and ring domains. We observe long-range domain ordering in the form of locally parallel stripes and hexagonal arrays of circular domains, curvature-dependent domain sorting, and membrane fission into separate vesicles at domain boundaries. By analysing our observations using available membrane theory, we are able to provide experimental estimates of boundary tension between fluid bilayer domains.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baumgart</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Applied and Engineering Physics, Cornell University, Ithaca, New York 14853, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hess</LastName><ForeName>Samuel T</ForeName><Initials>ST</Initials></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>Watt W</ForeName><Initials>WW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005456">Fluorescent Dyes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008051">Lipid Bilayers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008081">Liposomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010713">Phosphatidylcholines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010714">Phosphatidylethanolamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>3026-45-7</RegistryNumber><NameOfSubstance UI="C007510">1,2-dipalmitoyl-3-phosphatidylethanolamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EDS2L3ODLV</RegistryNumber><NameOfSubstance UI="C017251">1,2-oleoylphosphatidylcholine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005456" MajorTopicYN="N">Fluorescent Dyes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008051" MajorTopicYN="N">Lipid Bilayers</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008081" MajorTopicYN="N">Liposomes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008856" MajorTopicYN="N">Microscopy, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008956" MajorTopicYN="N">Models, Chemical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010713" MajorTopicYN="N">Phosphatidylcholines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010714" MajorTopicYN="N">Phosphatidylethanolamines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017785" MajorTopicYN="N">Photons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14574408</ArticleId><ArticleId IdType="doi">10.1038/nature02013</ArticleId><ArticleId IdType="pii">nature02013</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14581618</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>23</Issue><PubDate><Year>2003</Year><Month>Nov</Month><Day>11</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Inflammation is detrimental for neurogenesis in adult brain.</ArticleTitle><Pagination><StartPage>13632</StartPage><EndPage>13637</EndPage><MedlinePgn>13632-7</MedlinePgn></Pagination><Abstract><AbstractText>New hippocampal neurons are continuously generated in the adult brain. Here, we demonstrate that lipopolysaccharide-induced inflammation, which gives rise to microglia activation in the area where the new neurons are born, strongly impairs basal hippocampal neurogenesis in rats. The increased neurogenesis triggered by a brain insult is also attenuated if it is associated with microglia activation caused by tissue damage or lipopolysaccharide infusion. The impaired neurogenesis in inflammation is restored by systemic administration of minocycline, which inhibits microglia activation. Our data raise the possibility that suppression of hippocampal neurogenesis by activated microglia contributes to cognitive dysfunction in aging, dementia, epilepsy, and other conditions leading to brain inflammation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ekdahl</LastName><ForeName>Christine T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenesis and Cell Therapy, Section of Restorative Neurology, Wallenberg Neuroscience Center, Biomedical Center A-11, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claasen</LastName><ForeName>Jan-Hendrik</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Bonde</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kokaia</LastName><ForeName>Zaal</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Lindvall</LastName><ForeName>Olle</ForeName><Initials>O</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000963">Antimetabolites</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>FYY3R43WGO</RegistryNumber><NameOfSubstance UI="D008911">Minocycline</NameOfSubstance></Chemical><Chemical><RegistryNumber>G34N38R2N1</RegistryNumber><NameOfSubstance UI="D001973">Bromodeoxyuridine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000963" MajorTopicYN="N">Antimetabolites</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001973" MajorTopicYN="N">Bromodeoxyuridine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="Y">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008911" MajorTopicYN="N">Minocycline</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>5</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14581618</ArticleId><ArticleId IdType="pmc">PMC263865</ArticleId><ArticleId IdType="doi">10.1073/pnas.2234031100</ArticleId><ArticleId IdType="pii">2234031100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cameron, H. A. &amp; McKay, R. D. (2001) J. Comp. Neurol. 435, 406-417.</Citation><ArticleIdList><ArticleId IdType="pubmed">11406822</ArticleId></ArticleIdList></Reference><Reference><Citation>van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D. &amp; Gage, F. H. (2002) Nature 415, 1030-1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9284568</ArticleId><ArticleId IdType="pubmed">11875571</ArticleId></ArticleIdList></Reference><Reference><Citation>Shors, T. J., Miesegaes, G., Beylin, A., Zhao, M., Rydel, T. &amp; Gould, E. (2001) Nature 410, 372-376.</Citation><ArticleIdList><ArticleId IdType="pubmed">11268214</ArticleId></ArticleIdList></Reference><Reference><Citation>Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., Belzung, C. &amp; Hen, R. (2003) Science 301, 805-809.</Citation><ArticleIdList><ArticleId IdType="pubmed">12907793</ArticleId></ArticleIdList></Reference><Reference><Citation>Zitnik, G. &amp; Martin, G. M. (2002) J. Neurosci. Res. 70, 258-263.</Citation><ArticleIdList><ArticleId IdType="pubmed">12391584</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs, B. L. (2002) Brain Behav. Immun. 16, 602-609.</Citation><ArticleIdList><ArticleId IdType="pubmed">12401475</ArticleId></ArticleIdList></Reference><Reference><Citation>Haughey, N. J., Nath, A., Chan, S. L., Borchard, A. C., Rao, M. S. &amp; Mattson, M. P. (2002) J. Neurochem. 83, 1509-1524.</Citation><ArticleIdList><ArticleId IdType="pubmed">12472904</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson, P. T., Soma, L. A. &amp; Lavi, E. (2002) Ann. Med. 34, 491-500.</Citation><ArticleIdList><ArticleId IdType="pubmed">12553488</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, B. &amp; Hong, J. S. (2003) J. Pharmacol. Exp. Ther. 304, 1-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12490568</ArticleId></ArticleIdList></Reference><Reference><Citation>Pocock, J. M. &amp; Liddle, A. C. (2001) Prog. Brain Res. 132, 555-565.</Citation><ArticleIdList><ArticleId IdType="pubmed">11545020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanisch, U. K. (2002) Glia 40, 140-155.</Citation><ArticleIdList><ArticleId IdType="pubmed">12379902</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebicke-Haerter, P. J. (2001) Microsc. Res. Tech. 54, 47-58.</Citation><ArticleIdList><ArticleId IdType="pubmed">11526957</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoll, G., Jander, S. &amp; Schroeter, M. (1998) Prog. Neurobiol. 56, 149-171.</Citation><ArticleIdList><ArticleId IdType="pubmed">9760699</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson, P. B., Perry, V. H. &amp; Gordon, S. (1991) Neuroscience 42, 201-214.</Citation><ArticleIdList><ArticleId IdType="pubmed">1713656</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling, E. A., Ng, Y. K., Wu, C. H. &amp; Kaur, C. (2001) Prog. Brain Res. 132, 61-79.</Citation><ArticleIdList><ArticleId IdType="pubmed">11545023</ArticleId></ArticleIdList></Reference><Reference><Citation>Parent, J. M., Yu, T. W., Leibowitz, R. T., Geschwind, D. H., Sloviter, R. S. &amp; Lowenstein, D. H. (1997) J. Neurosci. 17, 3727-3738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573703</ArticleId><ArticleId IdType="pubmed">9133393</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, J., Solway, K., Messing, R. O. &amp; Sharp, F. R. (1998) J. Neurosci. 18, 7768-7778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793017</ArticleId><ArticleId IdType="pubmed">9742147</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengzon, J., Kokaia, Z., Elmer, E., Nanobashvili, A., Kokaia, M. &amp; Lindvall, O. (1997) Proc. Natl. Acad. Sci. USA 94, 10432-10437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23380</ArticleId><ArticleId IdType="pubmed">9294228</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvidsson, A., Kokaia, Z. &amp; Lindvall, O. (2001) Eur. J. Neurosci. 14, 10-18.</Citation><ArticleIdList><ArticleId IdType="pubmed">11488944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekdahl, C. T., Mohapel, P., Elmer, E. &amp; Lindvall, O. (2001) Eur. J. Neurosci. 14, 937-945.</Citation><ArticleIdList><ArticleId IdType="pubmed">11595032</ArticleId></ArticleIdList></Reference><Reference><Citation>Paxinos, G. &amp; Watson, C. (1997) The Rat Brain in Stereotaxic Coordinates (Academic, San Diego).</Citation></Reference><Reference><Citation>Ekdahl, C. T., Mohapel, P., Weber, E., Bahr, B., Blomgren, K. &amp; Lindvall, O. (2002) Eur. J. Neurosci. 16, 1463-1471.</Citation><ArticleIdList><ArticleId IdType="pubmed">12405959</ArticleId></ArticleIdList></Reference><Reference><Citation>Brundula, V., Rewcastle, N. B., Metz, L. M., Bernard, C. C. &amp; Yong, V. W. (2002) Brain 125, 1297-1308.</Citation><ArticleIdList><ArticleId IdType="pubmed">12023318</ArticleId></ArticleIdList></Reference><Reference><Citation>Selden, J. R., Dolbeare, F., Clair, J. H., Nichols, W. W., Miller, J. E., Kleemeyer, K. M., Hyland, R. J. &amp; DeLuca, J. G. (1993) Cytometry 14, 154-167.</Citation><ArticleIdList><ArticleId IdType="pubmed">8440149</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonchev, A. B., Yamashima, T., Zhao, L., Okano, H. J. &amp; Okano, H. (2003) Mol. Cell. Neurosci. 23, 292-301.</Citation><ArticleIdList><ArticleId IdType="pubmed">12812760</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagita, Y., Kitagawa, K., Sasaki, T., Miyata, T., Okano, H., Hori, M. &amp; Matsumoto, M. (2002) J. Neurosci. Res. 69, 750-756.</Citation><ArticleIdList><ArticleId IdType="pubmed">12205668</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai, M., Sato, K., Omori, N., Nagano, I., Manabe, Y., Shoji, M. &amp; Abe, K. (2002) J. Cereb. Blood Flow Metab. 22, 411-419.</Citation><ArticleIdList><ArticleId IdType="pubmed">11919512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, W. G., Mohney, R. P., Wilson, B., Jeohn, G. H., Liu, B. &amp; Hong, J. S. (2000) J. Neurosci. 20, 6309-6316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772569</ArticleId><ArticleId IdType="pubmed">10934283</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikka, T., Fiebich, B. L., Goldsteins, G., Keinanen, R. &amp; Koistinaho, J. (2001) J. Neurosci. 21, 2580-2588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762519</ArticleId><ArticleId IdType="pubmed">11306611</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallieres, L., Campbell, I. L., Gage, F. H. &amp; Sawchenko, P. E. (2002) J. Neurosci. 22, 486-492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758670</ArticleId><ArticleId IdType="pubmed">11784794</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuse, O., Iseki, E. &amp; Kosaka, K. (2003) Neuropathology 23, 9-15.</Citation><ArticleIdList><ArticleId IdType="pubmed">12722921</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry, V. H., Newman, T. A. &amp; Cunningham, C. (2003) Nat. Rev. Neurosci. 4, 103-112.</Citation><ArticleIdList><ArticleId IdType="pubmed">12563281</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer, P. L., Schulzer, M. &amp; McGeer, E. G. (1996) Neurology 47, 425-432.</Citation><ArticleIdList><ArticleId IdType="pubmed">8757015</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje, M. L., Mizumatsu, S., Fike, J. R. &amp; Palmer, T. D. (2002) Nat. Med. 8, 955-962.</Citation><ArticleIdList><ArticleId IdType="pubmed">12161748</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, M., Momma, S., Delfani, K., Carl&#xe9;n, M., Cassidy, R. M., Johansson, C. B., Brismar, H., Shupliakov, O., Fris&#xe9;n, J. &amp; Janson, A. (2003) Proc. Natl. Acad. Sci. USA, 100, 7925-7930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC164689</ArticleId><ArticleId IdType="pubmed">12792021</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z. &amp; Lindvall, O. (2002) Nat. Med. 9, 963-970.</Citation><ArticleIdList><ArticleId IdType="pubmed">12161747</ArticleId></ArticleIdList></Reference><Reference><Citation>Nencini, P., Sarti, C., Innocenti, R., Pracucci, G. &amp; Inzitari, D. (2003) Cerebrovasc. Dis. 15, 215-221.</Citation><ArticleIdList><ArticleId IdType="pubmed">12646783</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit, W. J., Walter, S. A. &amp; Pennell, N. A. (1999) Prog. Neurobiol. 57, 563-581.</Citation><ArticleIdList><ArticleId IdType="pubmed">10221782</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz, M. (2003) J. Cereb. Blood Flow Metab. 23, 385-394.</Citation><ArticleIdList><ArticleId IdType="pubmed">12679714</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14586007</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>30</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>29</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase.</ArticleTitle><Pagination><StartPage>9796</StartPage><EndPage>9804</EndPage><MedlinePgn>9796-804</MedlinePgn></Pagination><Abstract><AbstractText>Long-term treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) reduces the risk for Alzheimer's disease (AD). To determine the mechanisms by which inflammation affects AD and how NSAIDs protect against it, we stimulated neuroblastoma cells stably transfected with amyloid precursor protein (APP) with proinflammatory cytokines, which increased the secretion of amyloid-beta and APP ectodomain. Addition of ibuprofen, indomethacin, peroxisome proliferator-activated receptor-gamma (PPARgamma) agonists, or cotransfection with PPARgamma cDNA reversed this effect. The inhibitory action of ibuprofen and indomethacin was suppressed by PPARgamma antagonists. Finally, we observed that the mRNA levels, expression, and enzymatic activity of beta-secretase were increased by immunostimulation and normalized by NSAIDs. In conclusion, proinflammatory cytokines activate beta-secretase, and NSAIDs inhibit this effect through PPARgamma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sastre</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Bonn, 53127 Bonn, Germany. Magdalena.Sastre@ukb.uni-bonn.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dewachter</LastName><ForeName>Ilse</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Landreth</LastName><ForeName>Gary E</ForeName><Initials>GE</Initials></Author><Author ValidYN="Y"><LastName>Willson</LastName><ForeName>Timothy M</ForeName><Initials>TM</Initials></Author><Author ValidYN="Y"><LastName>Klockgether</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>van Leuven</LastName><ForeName>Fred</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Heneka</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D045162">Thiazolidinediones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>WK2XYI10QM</RegistryNumber><NameOfSubstance UI="D007052">Ibuprofen</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4OV71U42S</RegistryNumber><NameOfSubstance UI="D000077205">Pioglitazone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007052" MajorTopicYN="N">Ibuprofen</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009447" MajorTopicYN="N">Neuroblastoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077205" MajorTopicYN="N">Pioglitazone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="Y">agonists</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045162" MajorTopicYN="N">Thiazolidinediones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="Y">agonists</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>4</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14586007</ArticleId><ArticleId IdType="pmc">PMC6740896</ArticleId><ArticleId IdType="pii">23/30/9796</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-30-09796.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ ( 2003) Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289: 2819&#x2013;2826.</Citation><ArticleIdList><ArticleId IdType="pubmed">12783912</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, et al. ( 2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21: 383&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3887148</ArticleId><ArticleId IdType="pubmed">10858586</ArticleId></ArticleIdList></Reference><Reference><Citation>Alafuzoff I, Overmyer M, Helisalmi S, Soininen H ( 2000) Lower counts of astroglia and activated microglia in patients with Alzheimer's disease with regular use of non-steroidal anti-inflammatory drugs. J Alzheimers Dis 2: 37&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">12214109</ArticleId></ArticleIdList></Reference><Reference><Citation>Amara FM, Junaid A, Clough RR, Liang B ( 1999) TGF-beta(1), regulation of alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization. Brain Res Mol Brain Res 71: 42&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">10407185</ArticleId></ArticleIdList></Reference><Reference><Citation>Avramovich Y, Amit T, Youdim MB ( 2002) Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein. J Biol Chem 277: 31466&#x2013;31473.</Citation><ArticleIdList><ArticleId IdType="pubmed">12070143</ArticleId></ArticleIdList></Reference><Reference><Citation>Barger SW, Harmon AD ( 1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388: 878&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pubmed">9278049</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B ( 1999) TNF&#x3b1; plus IFN&#x3b3; induce the production of Alzheimer &#x3b2;-amyloid peptides and decrease the secretion of APPs. FASEB J 13: 63&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">9872930</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasko I, Veerhuis R, Stampfer-Kountchev M, Saurwein-Teissl M, Eikelenboom P, Grubeck-Loebenstein B ( 2000) Costimulatory effects of interferongamma and interleukin-1&#x3b2; or tumor necrosis factor alpha on the synthesis of A&#x3b2;1&#x2013;40 and A&#x3b2;1&#x2013;42 by human astrocytes. Neurobiol Dis 7: 682&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pubmed">11114266</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasko I, Apochal A, Boeck G, Hartmann T, Grubeck-Loebenstein B, Ransmayr G ( 2001) Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells. Neurobiol Dis 8: 1094&#x2013;1101.</Citation><ArticleIdList><ArticleId IdType="pubmed">11741404</ArticleId></ArticleIdList></Reference><Reference><Citation>Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE ( 2000) Inflammatory mechanisms in Alzheimer's disease: inhibition of &#x3b2;-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR&#x3b3; agonists. J Neurosci 20: 558&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772401</ArticleId><ArticleId IdType="pubmed">10632585</ArticleId></ArticleIdList></Reference><Reference><Citation>Combs CK, Bates P, Karlo JC, Landreth GE ( 2001) Regulation of beta-amyloid stimulated pro-inflammatory responses by peroxisome proliferator-activated receptor alpha. Neurochem Int 39: 449&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pubmed">11578780</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewachter I, Reverse D, Caluwaerts N, Ris L, Kuiperi C, Van den Haute C, Spittaels K, Umans L, Serneels L, Thiry E, Moechars D, Mercken M, Godaux E, Van Leuven F ( 2002) Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci 22: 3445&#x2013;3453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758348</ArticleId><ArticleId IdType="pubmed">11978821</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C ( 1993) Microglia and cytokines in neurological disease, with special reference to AIDs and Alzheimer's disease. Glia 7: 75&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">8423065</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukumoto H, Cheung BS, Hyman BT, Irizarry MC ( 2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59: 1381&#x2013;1389.</Citation><ArticleIdList><ArticleId IdType="pubmed">12223024</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White III CL, Araoz C ( 1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86: 7611&#x2013;7615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC298116</ArticleId><ArticleId IdType="pubmed">2529544</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartlage-Rubsamen M, Zeitschel U, Apelt J, Gartner U, Franke H, Stahl T, Gunther A, Schliebs R, Penkowa M, Bigl V, Rossner S ( 2003) Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent. Glia 4: 169&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">12509807</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Feinstein DL, Galea E, Gleichmann M, W&#xfc;llner U, Klockgether T ( 1999) Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase. J Neuroimmunol 100: 156&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">10695726</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Klockgether T, Feinstein DL ( 2000) Peroxisome proliferator-activated receptor &#x3b3; agonists reduce inducible nitric oxide synthase expression in cerebellar granule neurons in vivo J Neurosci 20: 6862&#x2013;6867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772804</ArticleId><ArticleId IdType="pubmed">10995830</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Landreth GE, Feinstein DL ( 2001) Role for peroxisome-activated receptor-&#x3b3; in Alzheimer's disease. Ann Neurol 49: 276.</Citation><ArticleIdList><ArticleId IdType="pubmed">11220752</ArticleId></ArticleIdList></Reference><Reference><Citation>Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G ( 2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann Neurol 51: 783&#x2013;786.</Citation><ArticleIdList><ArticleId IdType="pubmed">12112088</ArticleId></ArticleIdList></Reference><Reference><Citation>in t' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM, Stricker BH ( 2001) Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345: 1515&#x2013;1521.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794217</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C, Ting AT, Seed B ( 1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">9422509</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST ( 1995) APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nat Genet 10: 486&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">7670501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunsman GW, Rohrig TP ( 1993) Tissue distribution of ibuprofen in a fatal overdose. Am J Forensic Med Pathol 14: 48&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">8493969</ArticleId></ArticleIdList></Reference><Reference><Citation>Landreth GE, Heneka MT ( 2001) Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease. Neurobiol Aging 22: 937&#x2013;944.</Citation><ArticleIdList><ArticleId IdType="pubmed">11755002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA ( 1997) Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272: 3406&#x2013;3410.</Citation><ArticleIdList><ArticleId IdType="pubmed">9013583</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Hsiao Ashe K, Frautschy SA, Cole GM ( 2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20: 5709&#x2013;5714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772529</ArticleId><ArticleId IdType="pubmed">10908610</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim GP, Yang F, Chu T, Gahtan E, Ubeda O, Beech W, Overmier JB, Hsiao Ashe K, Frautschy SA, Cole GM ( 2001) Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice. Neurobiol Aging 22: 983&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pubmed">11755007</ArticleId></ArticleIdList></Reference><Reference><Citation>McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, Mcllroy SP, Passmore AP ( 2001) Association between polymorphism in regulatory region of gene encoding TNF&#x3b1; and risk of Alzheimer disease and vascular dementia: a case-control study. Lancet 357: 436&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">11273064</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG ( 1993) Microglia in degenerative neurological disease. Glia 7: 84&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">8423066</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer PL, Schulzer M, McGeer EG ( 1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47: 425&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pubmed">8757015</ArticleId></ArticleIdList></Reference><Reference><Citation>Murao K, Ohyama T, Imachi H, Ishida T, Cao WM, Namihira H, Sato M, Wong NC, Takahara J ( 2000) TNF-alpha stimulation of MCP-1 expression is mediated by the Akt/PKB signal transduction pathway in vascular endothelial cells. Biochem Biophys Res Commun 276: 791&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pubmed">11027549</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy GJ, Holder JC ( 2000) PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci 21: 469&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">11121836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoll JA, Mrak RE, Graham DI, Steward J, Wilcock G, MacGowan S, Esiri MM, Murray LS, Dewar D, Love S, Moss T, Griffin WS ( 2000) Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 47: 365&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833599</ArticleId><ArticleId IdType="pubmed">10716257</ArticleId></ArticleIdList></Reference><Reference><Citation>Papassotiropoulos A, Bagli M, Jessen F, Bayer TA, Maier W, Rao ML, Heun R ( 1999) Genetic variation of the inflammatory cytokine IL-6 delays the initial onset, and reduces the risk for sporadic Alzheimer's disease. Ann Neurol 45: 666&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pubmed">10319892</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlmutter LS, Barron E, Chui HC ( 1990) Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci Lett 119: 32&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">2097581</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry RT, Collins JS, Wiener H, Acton R, Go RCP ( 2001) The role of TNF and its receptors in Alzheimer's disease. Neurobiol Aging 22: 873&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pubmed">11754994</ArticleId></ArticleIdList></Reference><Reference><Citation>Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J ( 1995) Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45: 51&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">7824134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricote M, Huang JT, Welch JS, Glass CK ( 1999) The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte/macrophage function. J Leukoc Biol 66: 733&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">10577502</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P, Kogan F ( 1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43: 1609&#x2013;1611.</Citation><ArticleIdList><ArticleId IdType="pubmed">8351023</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JT, Leiter LM, McPhee J, Cahill CM, Zhan SS, Potter H, Nilsson LN ( 1999) Translation of the alzheimer amyloid precursor protein mRNA is upregulated by interleukin-1 through 5&#x2032;-untranslated region sequences. J Biol Chem 274: 6421&#x2013;6431.</Citation><ArticleIdList><ArticleId IdType="pubmed">10037734</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastre M, Turner RS, Levy E ( 1998) X11 interaction with &#x3b2;-amyloid precursor protein modulates its cellular stabilization and reduces amyloid &#x3b2;-protein secretion. J Biol Chem 273: 22351&#x2013;22357.</Citation><ArticleIdList><ArticleId IdType="pubmed">9712855</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastre M, Steiner H, Fuchs K, Capell A, Multhaup G, Condron MM, Teplow DB, Haass C ( 2001) Presenilin-dependent &#x3b3;-secretase processing of &#x3b2;-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep 2: 835&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1084035</ArticleId><ArticleId IdType="pubmed">11520861</ArticleId></ArticleIdList></Reference><Reference><Citation>Skovronsky DM, Lee VM, Pratico D ( 2001) Amyloid precursor protein and amyloid beta peptide in human platelets. Role of cyclooxygenase and protein kinase C. J Biol Chem 276: 17036&#x2013;17043.</Citation><ArticleIdList><ArticleId IdType="pubmed">11278299</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart WF, Kawas C, Corrada M, Metter EJ ( 1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48: 626&#x2013;632.</Citation><ArticleIdList><ArticleId IdType="pubmed">9065537</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun A, Koelsch G, Tang J, Bing G ( 2002) Localization of beta-secretase Memapsin 2 in the brain of Alzheimer's patients and normal aged controls. Exp Neurol 175: 10&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">12009756</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y, Hayashi I, Tominari Y, Rikimaru K, Morohashi Y, Kan T, Natsugari H, Fukuyama T, Tomita T, Iwatsubo T ( 2003) Sulindac sulfide is a non-competitive &#x3b3;-secretase inhibitor that preferentially reduces A&#x3b2;42 generation. J Biol Chem 278: 18664&#x2013;18670.</Citation><ArticleIdList><ArticleId IdType="pubmed">12637581</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamagno E, Bardini P, Obbili A, Vitali A, Borghi R, Zaccheo D, Pronzato MA, Danni O, Smith MA, Perry G, Tabaton M ( 2003) Oxidative stress increases expression andactivity of BACE in NT2 neurons. Neurol Dis 10: 279&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">12270690</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan J, Town T, Paris D, Mori T, Suo Z, Crawford F, Mattson MP, Flavell RA, Mullan M ( 1999) Microglial activation resulting from CD40&#x2013;CD40L interaction after beta-amyloid stimulation. Science 286: 2352&#x2013;2355.</Citation><ArticleIdList><ArticleId IdType="pubmed">10600748</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter J, Kaether C, Steiner H, Haass C ( 2001) The cell biology of Alzheimer's disease: uncovering the secret of secretases. Curr Opin Neurobiol 11: 585&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">11595492</ArticleId></ArticleIdList></Reference><Reference><Citation>Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH ( 2001) A subset of NSAIDs lower amyloidogenic A&#x3b2;42 independently of cyclooxygenase activity. Nature 414: 212&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11700559</ArticleId></ArticleIdList></Reference><Reference><Citation>Weggen S, Eriksen JL, Sagi SA, Pietrzik CU, Golde TE, Koo EH ( 2003) A&#x3b2;42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain. J Biol Chem 278: 30748&#x2013;30754.</Citation><ArticleIdList><ArticleId IdType="pubmed">12777371</ArticleId></ArticleIdList></Reference><Reference><Citation>Willson TM ( 2003) Chemical genomics of the orphan nuclear receptors. Ernst Schering Res Found Workshop 42: 29&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">12664534</ArticleId></ArticleIdList></Reference><Reference><Citation>Willson TM, Brown PJ, Sternbach DD, Henke BR ( 2000) The PPARs: from orphan receptors to drug discovery. J Med Chem 43: 527&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">10691680</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, Beach T, Sue L, Wong P, Price D, Li R, Shen Y ( 2003) Elevated &#x3b2;-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9: 3&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12514700</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14586010</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>30</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>29</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Discrete gene loci regulate neurodegeneration, lymphocyte infiltration, and major histocompatibility complex class II expression in the CNS.</ArticleTitle><Pagination><StartPage>9817</StartPage><EndPage>9823</EndPage><MedlinePgn>9817-23</MedlinePgn></Pagination><Abstract><AbstractText>Neurodegeneration and inflammation are fundamental aspects of many neurological diseases. A genome-wide scan of the response to ventral root avulsion (VRA) in a rat F2 cross discloses specific gene regions that regulate these processes. Two gene loci displayed linkage to neurodegeneration and T cell infiltration, respectively, and a single locus displayed extreme linkage to VRA-induced major histocompatibility complex class II expression on microglia. The demonstration that polymorphic genes in different loci control neurodegeneration and CNS inflammation has implications for various experimental rodent nervous system paradigms and potentially for genetically regulated susceptibility to a variety of human CNS diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lidman</LastName><ForeName>Olle</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institute, Karolinska Hospital, S-17176, Stockholm, Sweden. Olle.Lidman@cmm.ki.se</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swanberg</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Horvath</LastName><ForeName>Linn</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Broman</LastName><ForeName>Karl W</ForeName><Initials>KW</Initials></Author><Author ValidYN="Y"><LastName>Olsson</LastName><ForeName>Tomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Piehl</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000949">Histocompatibility Antigens Class II</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019771" MajorTopicYN="N">Axotomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003433" MajorTopicYN="N">Crosses, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008040" MajorTopicYN="Y">Genetic Linkage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000949" MajorTopicYN="N">Histocompatibility Antigens Class II</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011843" MajorTopicYN="N">Radiculopathy</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012183" MajorTopicYN="N">Retrograde Degeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>4</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14586010</ArticleId><ArticleId IdType="pmc">PMC6740878</ArticleId><ArticleId IdType="pii">23/30/9817</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-30-09817.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aloisi F, Ria F, Adorini L ( 2000) Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today 21: 141&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">10689302</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgart M, Moos V, Schuhbauer D, Muller B ( 1998) Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective/suppressive effects. Proc Natl Acad Sci USA 95: 6936&#x2013;6940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22692</ArticleId><ArticleId IdType="pubmed">9618517</ArticleId></ArticleIdList></Reference><Reference><Citation>Becanovic K, Wallstrom E, Kornek B, Glaser A, Broman KW, Dahlman I, Olofsson P, Holmdahl R, Luthman H, Lassmann H, Olsson T ( 2003) New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Immunol 170: 1062&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pubmed">12517974</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergsteinsdottir K, Yang HT, Pettersson U, Holmdahl R ( 2000) Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis. J Immunol 164: 1564&#x2013;1568.</Citation><ArticleIdList><ArticleId IdType="pubmed">10640775</ArticleId></ArticleIdList></Reference><Reference><Citation>Broman KW, Wu H, Sen S, Churchill GA ( 2003) R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889&#x2013;890.</Citation><ArticleIdList><ArticleId IdType="pubmed">12724300</ArticleId></ArticleIdList></Reference><Reference><Citation>Churchill GA, Doerge RW ( 1994) Empirical threshold values for quantitative trait mapping. Genetics 138: 963&#x2013;971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1206241</ArticleId><ArticleId IdType="pubmed">7851788</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland DW, Rothstein JD ( 2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2: 806&#x2013;819.</Citation><ArticleIdList><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Darvasi A, Soller M ( 1995) Advanced intercross lines, an experimental population for fine genetic mapping. Genetics 141: 1199&#x2013;1207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1206841</ArticleId><ArticleId IdType="pubmed">8582624</ArticleId></ArticleIdList></Reference><Reference><Citation>DeStefano AL, Golbe LI, Mark MH, Lazzarini AM, Maher NE, Saint-Hilaire M, Feldman RG, Guttman M, Watts RL, Suchowersky O, Lafontaine AL, Labelle N, Lew MF, Waters CH, Growdon JH, Singer C, Currie LJ, Wooten GF, Vieregge P, Pramstaller PP, et al. ( 2001) Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology 57: 1124&#x2013;1126.</Citation><ArticleIdList><ArticleId IdType="pubmed">11571351</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt JI, Tajti J, Appel SH ( 1993) Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol 50: 30&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">8093428</ArticleId></ArticleIdList></Reference><Reference><Citation>Flugel A, Berkowicz T, Ritter T, Labeur M, Jenne DE, Li Z, Ellwart JW, Willem M, Lassmann H, Wekerle H ( 2001) Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14: 547&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pubmed">11371357</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuya T, Salstrom JL, McCall-Vining S, Cannon GW, Joe B, Remmers EF, Griffiths MM, Wilder RL ( 2000) Genetic dissection of a rat model for rheumatoid arthritis: significant gender influences on autosomal modifier loci. Hum Mol Genet 9: 2241&#x2013;2250.</Citation><ArticleIdList><ArticleId IdType="pubmed">11001927</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerard C, Rollins BJ ( 2001) Chemokines and disease. Nat Immunol 2: 108&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">11175802</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Scarano F, Baltuch G ( 1999) Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22: 219&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">10202538</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths MM, Encinas JA, Remmers EF, Kuchroo VK, Wilder RL ( 1999) Mapping autoimmunity genes. Curr Opin Immunol 11: 689&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">10631556</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillery RW, Herrup K ( 1997) Quantification without pontification: choosing a method for counting objects in sectioned tissues. J Comp Neurol 386: 2&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9303520</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, Svenningsson A, Linda H, van Der Meide PH, Cullheim S, Olsson T, Piehl F ( 2000) Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 20: 5283&#x2013;5291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772346</ArticleId><ArticleId IdType="pubmed">10884312</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickey WF, Hsu BL, Kimura H ( 1991) T-lymphocyte entry into the central nervous system. J Neurosci Res 28: 254&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">2033653</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks AA, Petursson H, Jonsson T, Stefansson H, Johannsdottir HS, Sainz J, Frigge ML, Kong A, Gulcher JR, Stefansson K, Sveinbjornsdottir S ( 2002) A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol 52: 549&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">12402251</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Fink D, Mata M ( 2002) Microarray analysis suggests the involvement of proteasomes, lysosomes, and matrix metalloproteinases in the response of motor neurons to root avulsion. Eur J Neurosci 16: 1409&#x2013;1416.</Citation><ArticleIdList><ArticleId IdType="pubmed">12405953</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D, Han Y, Rani MR, Glabinski A, Trebst C, Sorensen T, Tani M, Wang J, Chien P, O'Bryan S, Bielecki B, Zhou ZL, Majumder S, Ransohoff RM ( 2000) Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev 177: 52&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">11138785</ArticleId></ArticleIdList></Reference><Reference><Citation>Itagaki S, McGeer PL, Akiyama H ( 1988) Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue. Neurosci Lett 91: 259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">2972943</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata T, Akiyama H, Yamada T, McGeer PL ( 1992) Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 140: 691&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>Kil K, Zang YC, Yang D, Markowski J, Fuoco GS, Vendetti GC, Rivera VM, Zhang JZ ( 1999) T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. J Neuroimmunol 98: 201&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">10430053</ArticleId></ArticleIdList></Reference><Reference><Citation>Koliatsos VE, Price WL, Pardo CA, Price DL ( 1994) Ventral root avulsion: an experimental model of death of adult motor neurons. J Comp Neurol 342: 35&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">8207127</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreutzberg GW, Graeber MB, Streit WJ ( 1989) Neuron-glial relationship during regeneration of motorneurons. Metab Brain Dis 4: 81&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">2649780</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A ( 1991) Simplified mammalian DNA isolation procedure. Nucleic Acids Res 19: 4293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC328579</ArticleId><ArticleId IdType="pubmed">1870982</ArticleId></ArticleIdList></Reference><Reference><Citation>Lander ES, Botstein D ( 1989) Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121: 185&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1203601</ArticleId><ArticleId IdType="pubmed">2563713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lander ES, Green P, Abrahamson J, Barlow A, Daly MJ, Lincoln SE, Newburg L ( 1987) MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics 1: 174&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">3692487</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AR ( 1971) The axon reaction: a review of the principal features of perikaryal responses to axon injury. Int Rev Neurobiol 14: 49&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">4948651</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou AK, Clark RS, Henshall DC, Yin XM, Chen J ( 2003) To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog Neurobiol 69: 103&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">12684068</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg C, Lidman O, Holmdahl R, Olsson T, Piehl F ( 2001) Neurodegeneration and glial activation patterns after mechanical nerve injury are differentially regulated by non-MHC genes in congenic inbred rat strains. J Comp Neurol 431: 75&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">11169991</ArticleId></ArticleIdList></Reference><Reference><Citation>Maehlen J, Olsson T, Zachau A, Klareskog L, Kristensson K ( 1989) Local enhancement of major histocompatibility complex (MHC) class I and II expression and cell infiltration in experimental allergic encephalomyelitis around axotomized motor neurons. J Neuroimmunol 23: 125&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">2786005</ArticleId></ArticleIdList></Reference><Reference><Citation>Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP ( 1994) Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology 44: 1872&#x2013;1877.</Citation><ArticleIdList><ArticleId IdType="pubmed">7936240</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer PL, Itagaki S, Boyes BE, McGeer EG ( 1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38: 1285&#x2013;1291.</Citation><ArticleIdList><ArticleId IdType="pubmed">3399080</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntire JJ, Umetsu SE, Akbari O, Potter M, Kuchroo VK, Barsh GS, Freeman GJ, Umetsu DT, DeKruyff RH ( 2001) Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol 2: 1109&#x2013;1116.</Citation><ArticleIdList><ArticleId IdType="pubmed">11725301</ArticleId></ArticleIdList></Reference><Reference><Citation>Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen I, Schwartz M ( 1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5: 49&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">9883839</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers A, Wavrant De-Vrieze F, Holmans P, Hamshere M, Crook R, Compton D, Marshall H, Meyer D, Shears S, Booth J, Ramic D, Knowles H, Morris JC, Williams N, Norton N, Abraham R, Kehoe P, Williams H, Rudrasingham V, Rice F, Giles P, Tunstall N, Jones L, Lovestone S, Williams J, Owen MJ, Hardy J, Goate A ( 2002) Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 114: 235&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">11857588</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers AJ, Goate AM ( 2001) The genetics of late-onset Alzheimer's disease. Curr Opin Neurol 14: 433&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">11470958</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann H, Medana IM, Bauer J, Lassmann H ( 2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 25: 313&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pubmed">12086750</ArticleId></ArticleIdList></Reference><Reference><Citation>Nissl F ( 1892) &#xdc;ber die Veranderungen der Ganlienzellen am Facialiskern des Kaninchens nach Ausreissung der Nerven. Allg Z Psychiatr 48: 197&#x2013;198.</Citation></Reference><Reference><Citation>Nussbaum RL, Ellis CE ( 2003) Alzheimer's disease and Parkinson's disease. N Engl J Med 348: 1356&#x2013;1364.</Citation><ArticleIdList><ArticleId IdType="pubmed">12672864</ArticleId></ArticleIdList></Reference><Reference><Citation>Olofsson P, Holmberg J, Tordsson J, Lu S, Akerstrom B, Holmdahl R ( 2003) Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 33: 25&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">12461526</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson T, Kristensson K, Ljungdahl A, Maehlen J, Holmdahl R, Klareskog L ( 1989) Gamma-interferon-like immunoreactivity in axotomized rat motor neurons. J Neurosci 9: 3870&#x2013;3875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6569937</ArticleId><ArticleId IdType="pubmed">2511280</ArticleId></ArticleIdList></Reference><Reference><Citation>Petitto JM, Huang Z, Lo J, Streit WJ ( 2003) IL-2 gene knockout affects T lymphocyte trafficking and the microglial response to regenerating facial motor neurons. J Neuroimmunol 134: 95&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">12507776</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettmann B, Henderson CE ( 1998) Neuronal cell death. Neuron 20: 633&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pubmed">9581757</ArticleId></ArticleIdList></Reference><Reference><Citation>Piehl F, Lundberg C, Khademi M, Bucht A, Dahlman I, Lorentzen J, Olsson T ( 1999) Non-MHC gene regulation of nerve root injury-induced spinal cord inflammation and neuron death. J Neuroimmunol 101: 87&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">10580817</ArticleId></ArticleIdList></Reference><Reference><Citation>Proudfoot AE ( 2002) Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2: 106&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097668</ArticleId><ArticleId IdType="pubmed">11910892</ArticleId></ArticleIdList></Reference><Reference><Citation>Raivich G, Jones L, Kloss C, Werner A, H N, Kreutzberg G ( 1998) Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J Neurosci 18: 5804&#x2013;5816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793073</ArticleId><ArticleId IdType="pubmed">9671668</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland LP, Shneider NA ( 2001) Amyotrophic lateral sclerosis. N Engl J Med 344: 1688&#x2013;1700.</Citation><ArticleIdList><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt HP, Emser W, Heimes C ( 1984) Familial occurrence of amyotrophic lateral sclerosis, parkinsonism, and dementia. Ann Neurol 16: 642&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">6524873</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen Jr FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Slotterbeck B, et al. ( 2001) Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA 286: 2239&#x2013;2244.</Citation><ArticleIdList><ArticleId IdType="pubmed">11710888</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman L, Rosenbaum JT, Sriram S, McDevitt HO ( 1981) In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis. Proc Natl Acad Sci USA 78: 7111&#x2013;7114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC349205</ArticleId><ArticleId IdType="pubmed">6947275</ArticleId></ArticleIdList></Reference><Reference><Citation>Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD ( 1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90: 8098&#x2013;8102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC47295</ArticleId><ArticleId IdType="pubmed">8367470</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanzi RE, Bertram L ( 2001) New frontiers in Alzheimer's disease genetics. Neuron 32: 181&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">11683989</ArticleId></ArticleIdList></Reference><Reference><Citation>Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, Kato M, Oda T, Tsuchiya K, Kosaka K ( 2002) Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J Neuroimmunol 124: 83&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">11958825</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapp B, Peterson J, Ransohoff R, Rudick R, M&#xf8;rk S, B&#xf8; L ( 1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338: 278&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pubmed">9445407</ArticleId></ArticleIdList></Reference><Reference><Citation>Vila M, Przedborski S ( 2003) Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci 4: 365&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">12728264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wekerle H, Linnington C, Lassmann H, Meyermann R ( 1986) Cellular immune reactivity within the CNS. Trends Neurosci 9: 271&#x2013;277.</Citation></Reference><Reference><Citation>Wyss-Coray T, Mucke L ( 2002) Inflammation in neurodegenerative disease: a double-edged sword. Neuron 35: 419&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pubmed">12165466</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong M, Guo SW ( 1997) Fine-scale mapping of quantitative trait loci using historical recombinations. Genetics 145: 1201&#x2013;1218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1207887</ArticleId><ArticleId IdType="pubmed">9093869</ArticleId></ArticleIdList></Reference><Reference><Citation>Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N ( 1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356: 63&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">1538783</ArticleId></ArticleIdList></Reference><Reference><Citation>Youssef S, Stuve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, Zamvil SS ( 2002) The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420: 78&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">12422218</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1459317</PMID><DateCompleted><Year>1993</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0338-1684</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>4</Issue><PubDate><Year>1992</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Diabete &amp; metabolisme</Title><ISOAbbreviation>Diabete Metab</ISOAbbreviation></Journal><ArticleTitle>Influence of obesity and hypertriglyceridaemia on the low HDL2-cholesterol level and on its relationship with prevalence of atherosclerosis in type 2 diabetes.</ArticleTitle><Pagination><StartPage>289</StartPage><EndPage>297</EndPage><MedlinePgn>289-97</MedlinePgn></Pagination><Abstract><AbstractText>High density lipoprotein subfraction 2 (HDL1)-cholesterol level is usually decreased in Type 2 (non-insulin-dependent) diabetes. A study was carried out in 251 Type 2 diabetic patients (106 males [M], 145 females [F]) and in 120 non diabetic controls in order to determine the influence of hypertriglyceridaemia and obesity on the HDL2-cholesterol level and to analyse the relationship between HDL2-cholesterol level and atherosclerosis (coronary heart disease, peripheral atherosclerosis or cerebral vascular disease), in Type 2 diabetes. Influence of hypertriglyceridaemia and obesity on HDL2-cholesterol level was studied by comparing the mean values of HDL2-cholesterol between diabetics and controls, after controlling for hypertriglyceridaemia and obesity, and by a multiple linear regression test. A stepwise logistic regression was performed to analyse the association between the prevalence of atherosclerosis and several variables: age, duration of diabetes, hypertension, cigarette smoking, body mass index, mean glycaemia, total cholesterol, triglyceride, HDL-cholesterol, HDL2-cholesterol and HDL3-cholesterol levels. In both men and women, when both of the factors (hypertriglyceridaemia and obesity) were present of when only one was, HDL2-cholesterol level was significantly lower in the diabetic population, compared with controls. But when obesity and hypertriglyceridaemia were absent, HDL2-cholesterol level, in the diabetic population, was not significantly different from controls (M: 17.9 +/- 13.3 vs 20.5 +/- 13.8 mg/dl: NS; F: 30.1 +/- 21.5 vs 27.6 +/- 14.2 mg/dl: NS).(ABSTRACT TRUNCATED AT 250 WORDS)</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Verges</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service d'Endocrinologie et Maladies m&#xe9;taboliques, CHU Dijon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brun</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Vaillant</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Quantin</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Brunet-Lecomte</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Farnier</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gambert</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Diabete Metab</MedlineTA><NlmUniqueID>7604157</NlmUniqueID><ISSNLinking>0338-1684</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008076">Cholesterol, HDL</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001161" MajorTopicYN="N">Arteriosclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008076" MajorTopicYN="N">Cholesterol, HDL</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015228" MajorTopicYN="N">Hypertriglyceridemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="Y">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1459317</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14593171</PMID><DateCompleted><Year>2003</Year><Month>12</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><Issue>5646</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>31</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>alpha-Synuclein locus triplication causes Parkinson's disease.</ArticleTitle><Pagination><StartPage>841</StartPage><MedlinePgn>841</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singleton</LastName><ForeName>A B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892, USA. singleta@mail.nih.gov</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farrer</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Singleton</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hague</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kachergus</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hulihan</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Peuralinna</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Dutra</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Nussbaum</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Lincoln</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Crawley</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hanson</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Maraganore</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Adler</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Cookson</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Muenter</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Baptista</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Blancato</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Gwinn-Hardy</LastName><ForeName>K</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497604">SNCA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051843">Synucleins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005091" MajorTopicYN="N">Exons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018628" MajorTopicYN="Y">Gene Dosage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008040" MajorTopicYN="N">Genetic Linkage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017404" MajorTopicYN="N">In Situ Hybridization, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051843" MajorTopicYN="N">Synucleins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>1</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>1</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14593171</ArticleId><ArticleId IdType="doi">10.1126/science.1090278</ArticleId><ArticleId IdType="pii">302/5646/841</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14593181</PMID><DateCompleted><Year>2003</Year><Month>12</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><Issue>5646</Issue><PubDate><Year>2003</Year><Month>Oct</Month><Day>31</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.</ArticleTitle><Pagination><StartPage>871</StartPage><EndPage>874</EndPage><MedlinePgn>871-4</MedlinePgn></Pagination><Abstract><AbstractText>The mechanisms involved in prion neurotoxicity are unclear, and therapies preventing accumulation of PrPSc, the disease-associated form of prion protein (PrP), do not significantly prolong survival in mice with central nervous system prion infection. We found that depleting endogenous neuronal PrPc in mice with established neuroinvasive prion infection reversed early spongiform change and prevented neuronal loss and progression to clinical disease. This occurred despite the accumulation of extraneuronal PrPSc to levels seen in terminally ill wild-type animals. Thus, the propagation of nonneuronal PrPSc is not pathogenic, but arresting the continued conversion of PrPc to PrPSc within neurons during scrapie infection prevents prion neurotoxicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mallucci</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medical Research Council Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dickinson</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Linehan</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Kl&#xf6;hn</LastName><ForeName>Peter-Christian</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>Brandner</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Collinge</LastName><ForeName>John</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_U123160654</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_U132692719</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018621">PrPC Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018620">PrPSc Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Science. 2003 Oct 31;302(5646):763-5. doi: 10.1126/science.302.5646.763a.</RefSource><PMID Version="1">14593140</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001923" MajorTopicYN="N">Brain Chemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018621" MajorTopicYN="N">PrPC Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018620" MajorTopicYN="N">PrPSc Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011995" MajorTopicYN="N">Recombination, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012608" MajorTopicYN="N">Scrapie</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019076" MajorTopicYN="N">Transgenes</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>1</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>1</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14593181</ArticleId><ArticleId IdType="doi">10.1126/science.1090187</ArticleId><ArticleId IdType="pii">302/5646/871</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14594945</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-9258</ISSN><JournalIssue CitedMedium="Print"><Volume>279</Volume><Issue>7</Issue><PubDate><Year>2004</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.</ArticleTitle><Pagination><StartPage>5915</StartPage><EndPage>5923</EndPage><MedlinePgn>5915-23</MedlinePgn></Pagination><Abstract><AbstractText>The MARK protein kinases were originally identified by their ability to phosphorylate a serine motif in the microtubule-binding domain of tau that is critical for microtubule binding. Here, we report the cloning and expression of a novel human paralog, MARK4, which shares 75% overall homology with MARK1-3 and is predominantly expressed in brain. Homology is most pronounced in the catalytic domain (90%), and MARK4 readily phosphorylates tau and the related microtubule-associated protein 2 (MAP2) and MAP4. In contrast to the three paralogs that all exhibit uniform cytoplasmic localization, MARK4 colocalizes with the centrosome and with microtubules in cultured cells. Overexpression of MARK4 causes thinning out of the microtubule network, concomitant with a reorganization of microtubules into bundles. In line with these findings, we show that a tandem affinity-purified MARK4 protein complex contains alpha-, beta-, and gamma-tubulin. In differentiated neuroblastoma cells, MARK4 is localized prominently at the tips of neurite-like processes. We suggest that although the four MARK/PAR-1 kinases might play multiple cellular roles in concert with different targets, MARK4 is likely to be directly involved in microtubule organization in neuronal cells and may contribute to the pathological phosphorylation of tau in Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trinczek</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicinal Chemistry, University of Kansas, Malott Hall, Lawrence, Kansas 66045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brajenovic</LastName><ForeName>Miro</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ebneth</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Drewes</LastName><ForeName>Gerard</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>AF465413</AccessionNumber><AccessionNumber>AY057448</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018076">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008164">Luminescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-22-9</RegistryNumber><NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>452VLY9402</RegistryNumber><NameOfSubstance UI="D012694">Serine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="C483047">MARK4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020816" MajorTopicYN="N">Amino Acid Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015152" MajorTopicYN="N">Blotting, Northern</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016466" MajorTopicYN="N">CHO Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020134" MajorTopicYN="N">Catalytic Domain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018385" MajorTopicYN="N">Centrosome</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003360" MajorTopicYN="N">Cosmids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049452" MajorTopicYN="N">Green Fluorescent Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008164" MajorTopicYN="N">Luminescent Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008870" MajorTopicYN="N">Microtubules</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009447" MajorTopicYN="N">Neuroblastoma</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011233" MajorTopicYN="N">Precipitin Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012694" MajorTopicYN="N">Serine</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14594945</ArticleId><ArticleId IdType="doi">10.1074/jbc.M304528200</ArticleId><ArticleId IdType="pii">S0021-9258(20)74931-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14596589</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2010</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0006-2960</ISSN><JournalIssue CitedMedium="Print"><Volume>42</Volume><Issue>44</Issue><PubDate><Year>2003</Year><Month>Nov</Month><Day>11</Day></PubDate></JournalIssue><Title>Biochemistry</Title><ISOAbbreviation>Biochemistry</ISOAbbreviation></Journal><ArticleTitle>Self-assembly of Abeta(1-42) into globular neurotoxins.</ArticleTitle><Pagination><StartPage>12749</StartPage><EndPage>12760</EndPage><MedlinePgn>12749-60</MedlinePgn></Pagination><Abstract><AbstractText>Amyloid beta 1-42 (Abeta(1-42)) is a self-associating peptide that becomes neurotoxic upon aggregation. Toxicity originally was attributed to the presence of large, readily formed Abeta fibrils, but a variety of other toxic species are now known. The current study shows that Abeta(1-42) can self-assemble into small, stable globular assemblies free of fibrils and protofibrils. Absence of large molecules was verified by atomic force microscopy (AFM) and nondenaturing gel electrophoresis. Denaturing electrophoresis revealed that the globular assemblies comprised oligomers ranging from trimers to 24mers. Oligomers prepared at 4 degrees C stayed fibril-free for days and remained so when shifted to 37 degrees C, although the spectrum of sizes shifted toward larger oligomers at the higher temperature. The soluble, globular Abeta(1-42) oligomers were toxic to PC12 cells, impairing reduction of MTT and interfering with ERK and Rac signal transduction. Occasionally, oligomers were neither toxic nor recognized by toxicity-neutralizing antibodies, suggesting that oligomers could assume alternative conformations. Tests for oligomerization-blocking activity were carried out by dot-blot immunoassays and showed that neuroprotective extracts of Ginkgo biloba could inhibit oligomer formation at very low doses. The observed neurotoxicity, structure, and stability of synthetic Abeta(1-42) globular assemblies support the hypothesis that Abeta(1-42) oligomers play a role in triggering nerve cell dysfunction and death in Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chromy</LastName><ForeName>Brett A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Biodefense Division, Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, 7000 East Avenue, L-446, Livermore, California 94551, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nowak</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Mary P</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Viola</LastName><ForeName>Kirsten L</ForeName><Initials>KL</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Lei</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Velasco</LastName><ForeName>Pauline T</ForeName><Initials>PT</Initials></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Bryan W</ForeName><Initials>BW</Initials></Author><Author ValidYN="Y"><LastName>Fernandez</LastName><ForeName>Sara J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Lacor</LastName><ForeName>Pascale N</ForeName><Initials>PN</Initials></Author><Author ValidYN="Y"><LastName>Horowitz</LastName><ForeName>Peleg</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Finch</LastName><ForeName>Caleb E</ForeName><Initials>CE</Initials></Author><Author ValidYN="Y"><LastName>Krafft</LastName><ForeName>Grant A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>William L</ForeName><Initials>WL</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01-AG15501</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01-AG18877</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochemistry</MedlineTA><NlmUniqueID>0370623</NlmUniqueID><ISSNLinking>0006-2960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009498">Neurotoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C075222">amyloid beta-protein (1-42)</NameOfSubstance></Chemical><Chemical><RegistryNumber>298-83-9</RegistryNumber><NameOfSubstance UI="D009580">Nitroblue Tetrazolium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001831" MajorTopicYN="N">Body Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004058" MajorTopicYN="N">Diffusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020441" MajorTopicYN="N">Ginkgo biloba</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009498" MajorTopicYN="N">Neurotoxins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009580" MajorTopicYN="N">Nitroblue Tetrazolium</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016716" MajorTopicYN="N">PC12 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14596589</ArticleId><ArticleId IdType="doi">10.1021/bi030029q</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14615545</PMID><DateCompleted><Year>2003</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><Issue>5651</Issue><PubDate><Year>2003</Year><Month>Dec</Month><Day>05</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Inflammatory blockade restores adult hippocampal neurogenesis.</ArticleTitle><Pagination><StartPage>1760</StartPage><EndPage>1765</EndPage><MedlinePgn>1760-5</MedlinePgn></Pagination><Abstract><AbstractText>Cranial radiation therapy causes a progressive decline in cognitive function that is linked to impaired neurogenesis. Chronic inflammation accompanies radiation injury, suggesting that inflammatory processes may contribute to neural stem cell dysfunction. Here, we show that neuroinflammation alone inhibits neurogenesis and that inflammatory blockade with indomethacin, a common nonsteroidal anti-inflammatory drug, restores neurogenesis after endotoxin-induced inflammation and augments neurogenesis after cranial irradiation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Monje</LastName><ForeName>Michelle L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Stanford University, Department of Neurosurgery, MSLS P309, Mail Code 5487, 1201 Welch Road, Stanford, CA 94305-5487, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toda</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Palmer</LastName><ForeName>Theo D</ForeName><Initials>TD</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F30 NS04696701</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH20016-05</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017077">Culture Media, Conditioned</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494200">Il6st protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494201">Il6st protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019947">Receptors, Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>133483-10-0</RegistryNumber><NameOfSubstance UI="D050822">Cytokine Receptor gp130</NameOfSubstance></Chemical><Chemical><RegistryNumber>XXE1CET956</RegistryNumber><NameOfSubstance UI="D007213">Indomethacin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Science. 2003 Dec 5;302(5651):1689-90. doi: 10.1126/science.1092864.</RefSource><PMID Version="1">14657479</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018920" MajorTopicYN="N">Coculture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017077" MajorTopicYN="N">Culture Media, Conditioned</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050822" MajorTopicYN="N">Cytokine Receptor gp130</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018891" MajorTopicYN="N">Dentate Gyrus</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005720" MajorTopicYN="N">Gamma Rays</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020287" MajorTopicYN="N">In Situ Nick-End Labeling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007213" MajorTopicYN="N">Indomethacin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008940" MajorTopicYN="N">Mitotic Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019947" MajorTopicYN="N">Receptors, Interleukin-6</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14615545</ArticleId><ArticleId IdType="doi">10.1126/science.1088417</ArticleId><ArticleId IdType="pii">1088417</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14617772</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>24</Issue><PubDate><Year>2003</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>In vivo reduction of amyloid-beta by a mutant copper transporter.</ArticleTitle><Pagination><StartPage>14193</StartPage><EndPage>14198</EndPage><MedlinePgn>14193-8</MedlinePgn></Pagination><Abstract><AbstractText>Cu ions have been suggested to enhance the assembly and pathogenic potential of the Alzheimer's disease amyloid-beta (Abeta) peptide. To explore this relationship in vivo, toxic-milk (txJ) mice with a mutant ATPase7b transporter favoring elevated Cu levels were analyzed in combination with the transgenic (Tg) CRND8 amyloid precursor protein mice exhibiting robust Abeta deposition. Unexpectedly, TgCRND8 mice homozygous for the recessive txJ mutation examined at 6 months of age exhibited a reduced number of amyloid plaques and diminished plasma Abeta levels. In addition, homozygosity for txJ increased survival of young TgCRND8 mice and lowered endogenous CNS Abeta at times before detectable increases in Cu in the CNS. These data suggest that the beneficial effect of the txJ mutation on CNS Abeta burden may proceed by a previously undescribed mechanism, likely involving increased clearance of peripheral pools of Abeta peptide.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Phinney</LastName><ForeName>Amie L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Center for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada M5S 3H2.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drisaldi</LastName><ForeName>Bettina</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Stephen D</ForeName><Initials>SD</Initials></Author><Author ValidYN="Y"><LastName>Lugowski</LastName><ForeName>Stan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Coronado</LastName><ForeName>Veronica</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Horne</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jing</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sekoulidis</LastName><ForeName>Joannis</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Coomaraswamy</LastName><ForeName>Janaky</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Chishti</LastName><ForeName>M Azhar</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Diane W</ForeName><Initials>DW</Initials></Author><Author ValidYN="Y"><LastName>Mathews</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>Nixon</LastName><ForeName>Ralph A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Carlson</LastName><ForeName>George A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>St George-Hyslop</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Westaway</LastName><ForeName>David</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D027682">Cation Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>789U1901C5</RegistryNumber><NameOfSubstance UI="D003300">Copper</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D000251">Adenosine Triphosphatases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 7.2.2.8</RegistryNumber><NameOfSubstance UI="D000073840">Copper-Transporting ATPases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000251" MajorTopicYN="N">Adenosine Triphosphatases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D027682" MajorTopicYN="N">Cation Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003300" MajorTopicYN="N">Copper</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073840" MajorTopicYN="N">Copper-Transporting ATPases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008809" MajorTopicYN="N">Mice, Inbred C3H</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008817" MajorTopicYN="N">Mice, Mutant Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>5</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14617772</ArticleId><ArticleId IdType="pmc">PMC283568</ArticleId><ArticleId IdType="doi">10.1073/pnas.2332851100</ArticleId><ArticleId IdType="pii">2332851100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Braak, E., Griffing, K., Arai, K., Bohl, J., Bratzke, H. &amp; Braak, H. (1999) Eur. Arch. Psychiatry Clin. Neurosci. 249, Suppl. 3, 14&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">10654095</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, W. L. (2002) Neurochem. Int. 41, 345&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">12176077</ArticleId></ArticleIdList></Reference><Reference><Citation>Glabe, C. (2001) J. Mol. Neurosci. 17, 137&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">11816787</ArticleId></ArticleIdList></Reference><Reference><Citation>Plantin, L. O., Lying-Tunell, U. &amp; Kristensson, K. (1987) Biol. Trace Elem. Res. 13, 69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">24254666</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwood, C. S., Huang, X., Moir, R. D., Tanzi, R. E. &amp; Bush, A. I. (1999) Met. Ions Biol. Syst. 36, 309&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">10093929</ArticleId></ArticleIdList></Reference><Reference><Citation>Bush, A. I. (2000) Curr. Opin. Chem. Biol. 4, 184&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">10742195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehmann, W. D., Markesbery, W. R., Alauddin, M., Hossain, T. I. &amp; Brubaker, E. H. (1986) Neurotoxicology 7, 195&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">3714121</ArticleId></ArticleIdList></Reference><Reference><Citation>Samudralwar, D. L., Diprete, C. C., Ni, B. F., Ehmann, W. D. &amp; Markesbery, W. R. (1995) J. Neurol. Sci. 130, 139&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">8586977</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson, C. M., Markesbery, W. R., Ehmann, W. D., Mao, Y. X. &amp; Vance, D. E. (1988) Neurotoxicology 9, 1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">3393299</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornett, C. R., Markesbery, W. R. &amp; Ehmann, W. D. (1998) Neurotoxicology 19, 339&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">9621340</ArticleId></ArticleIdList></Reference><Reference><Citation>Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C., L. &amp; Beyreuther, K. (1996) Science 271, 1406&#x2013;1409.</Citation><ArticleIdList><ArticleId IdType="pubmed">8596911</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnham, K. J., McKinstry, W. J., Multhaup, G., Galatis, D., Morton, C. J., Curtain, C. C., Williamson, N. W., White, A. R., Hinds, M. G., Norton, R. S., et al. (2003) J. Biol. Chem. 278, 17401&#x2013;17407.</Citation><ArticleIdList><ArticleId IdType="pubmed">12611883</ArticleId></ArticleIdList></Reference><Reference><Citation>Bush, A. I., Multhaup, G., Moir, R. D., Williamson, T. G., Small, D. H., Rumble, B., Pollwein, P., Beyreuther, K. &amp; Masters, C. L. (1993) J. Biol. Chem. 268, 16109&#x2013;16112.</Citation><ArticleIdList><ArticleId IdType="pubmed">8344894</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M., Romano, D. M., Hartshorn, M. A., Tanzi, R. E. &amp; Bush, A. I. (1998) J. Biol. Chem. 273, 12817&#x2013;12826.</Citation><ArticleIdList><ArticleId IdType="pubmed">9582309</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, D. S., McLaurin, J., Qin, K., Westaway, D. &amp; Fraser, P. E. (2000) Eur. J. Biochem. 267, 6692&#x2013;6698.</Citation><ArticleIdList><ArticleId IdType="pubmed">11054124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bush, A. I., Pettingell, W. H., Jr., de Paradis, M., Tanzi, R. E. &amp; Wasco, W. (1994) J. Biol. Chem. 269, 26618&#x2013;26621.</Citation><ArticleIdList><ArticleId IdType="pubmed">7929392</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, X., Atwood, C. S., Moir, R. D., Hartshorn, M. A., Vonsattel, J. P., Tanzi, R. E. &amp; Bush, A. I. (1997) J. Biol. Chem. 272, 26464&#x2013;26470.</Citation><ArticleIdList><ArticleId IdType="pubmed">9334223</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E. &amp; Bush, A. I. (2000) J. Neurochem. 75, 1219&#x2013;1233.</Citation><ArticleIdList><ArticleId IdType="pubmed">10936205</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherny, R. A., Legg, J. T., McLean, C. A., Fairlie, D. P., Huang, X., Atwood, C. S., Beyreuther, K., Tanzi, R. E., Masters, C. L. &amp; Bush, A. I. (1999) J. Biol. Chem. 274, 23223&#x2013;23228.</Citation><ArticleIdList><ArticleId IdType="pubmed">10438495</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchardt, T., Camakaris, J., Cappai, R., Masters, C. L., Beyreuther, K. &amp; Multhaup, G. (1999) Biochem. J. 344, Part 2, 461&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1220664</ArticleId><ArticleId IdType="pubmed">10567229</ArticleId></ArticleIdList></Reference><Reference><Citation>Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) Nature 408, 979&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pubmed">11140685</ArticleId></ArticleIdList></Reference><Reference><Citation>Chishti, M. A., Yang, D. S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) J. Biol. Chem. 276, 21562&#x2013;21570.</Citation><ArticleIdList><ArticleId IdType="pubmed">11279122</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox, D. W. &amp; Roberts, E. A. (1998) in Sleisenger and Fordtran's Gastrointestinal and Liver Disease, eds. Feldman, M., Schlarschmidt, B. F. &amp; Sleisenger, M. H. (Saunders, Philadelphia), pp. 1104&#x2013;1111.</Citation></Reference><Reference><Citation>Hung, I. H., Suzuki, M., Yamaguchi, Y., Yuan, D. S., Klausner, R. D. &amp; Gitlin, J. D. (1997) J. Biol. Chem. 272, 21461&#x2013;21466.</Citation><ArticleIdList><ArticleId IdType="pubmed">9261163</ArticleId></ArticleIdList></Reference><Reference><Citation>Forbes, J. R. &amp; Cox, D. W. (2000) Hum. Mol. Genet. 9, 1927&#x2013;1935.</Citation><ArticleIdList><ArticleId IdType="pubmed">10942420</ArticleId></ArticleIdList></Reference><Reference><Citation>Voskoboinik, I., Greenough, M., La Fontaine, S., Mercer, J. F. &amp; Camakaris, J. (2001) Biochem. Biophys. Res. Commun. 281, 966&#x2013;970.</Citation><ArticleIdList><ArticleId IdType="pubmed">11237756</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisner, B., Hartard, C. &amp; Dieu, C. (1987) J. Neurol. Sci. 79, 229&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">3612170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodama, H., Okabe, I., Yanagisawa, M., Nomiyama, H., Nomiyama, K., Nose, O. &amp; Kamoshita, S. (1988) Pediatr. Neurol. 4, 35&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">3233107</ArticleId></ArticleIdList></Reference><Reference><Citation>Theophilos, M. B., Cox, D. W. &amp; Mercer, J. F. (1996) Hum. Mol. Genet. 5, 1619&#x2013;1624.</Citation><ArticleIdList><ArticleId IdType="pubmed">8894697</ArticleId></ArticleIdList></Reference><Reference><Citation>La Fontaine, S., Theophilos, M. B., Firth, S. D., Gould, R., Parton, R. G. &amp; Mercer, J. F. (2001) Hum. Mol. Genet. 10, 361&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">11157799</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronado, V., Nanji, M. &amp; Cox, D. W. (2001) Mamm. Genome 12, 793&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pubmed">11668395</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronson, R. T., Sweet, H. O. &amp; Davisson, M. T. (1995) Mouse Genome 93, 152&#x2013;154.</Citation></Reference><Reference><Citation>Scott, M., Foster, D., Mirenda, C., Serban, D., Coufal, F., W&#xe4;lchli, M., Torchia, M., Groth, D., Carlson, G., DeArmond, S. J., et al. (1989) Cell 59, 847&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pubmed">2574076</ArticleId></ArticleIdList></Reference><Reference><Citation>Citron, M., Westaway, D., Xia, W., Carlson, G. A., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) Nat. Med. 3, 67&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">8986743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugowski, S., Smith, D. C. &amp; Van Loon, J. C. (1990) Clin. Mater. 6, 91&#x2013;104.</Citation></Reference><Reference><Citation>Lugowski, S. J., Smith, D. C., McHugh, A. D. &amp; Van Loon, J. C. (1991) J. Biomed. Mater. Res. 25, 1443&#x2013;1458.</Citation><ArticleIdList><ArticleId IdType="pubmed">1794994</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindquist, R. R. (1969) Arch. Pathol. 87, 370&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">5766764</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouton, P. R. (2000) The Stereologer Handbook (Systems Planning and Analysis, Alexandria, VA).</Citation></Reference><Reference><Citation>Paxinos, G. &amp; Frankin, K. B. J. (2001) The Mouse Brain in Stereotaxic Coordinates (Academic, San Diego).</Citation></Reference><Reference><Citation>Rozmahel, R., Huang, J., Chen, F., Liang, Y., Nguyen, V., Ikeda, M., Levesque, G., Yu, G., Nishimura, M., Mathews, P., et al. (2002) Neurobiol. Aging 23, 187&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">11804702</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage, M. J., Trusko, S. P., Howland, D. S., Pinsker, L. R., Mistretta, S., Reaume, A. G., Greenberg, B. D., Siman, R. &amp; Scott, R. W. (1998) J. Neurosci. 18, 1743&#x2013;1752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792617</ArticleId><ArticleId IdType="pubmed">9464999</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathews, P. M., Jiang, Y., Schmidt, S. D., Grbovic, O. M., Mercken, M. &amp; Nixon, R. A. (2002) J. Biol. Chem. 277, 36415&#x2013;36424.</Citation><ArticleIdList><ArticleId IdType="pubmed">12087104</ArticleId></ArticleIdList></Reference><Reference><Citation>Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., White, A. R., Beyreuther, K., Masters, C. L., Bush, A. I. &amp; Li, Q. X. (2002) J. Biol. Chem. 277, 44670&#x2013;44676.</Citation><ArticleIdList><ArticleId IdType="pubmed">12215434</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch, H. (1983) J. Hered. 74, 141&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">6863890</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell, J. M. &amp; Mercer, J. F. (1994) J. Comp. Pathol. 110, 37&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">8040371</ArticleId></ArticleIdList></Reference><Reference><Citation>Biempica, L., Rauch, H., Quintana, N. &amp; Sternlieb, I. (1988) Lab. Invest. 59, 500&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pubmed">2845190</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao, K. K., Borchelt, D. R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., Xu, S., Eckman, C., Younkin, S., Price, D., et al. (1995) Neuron 15, 1203&#x2013;1218.</Citation><ArticleIdList><ArticleId IdType="pubmed">7576662</ArticleId></ArticleIdList></Reference><Reference><Citation>Bush, A. I. (2002) Neurobiol. Aging 23, 1031&#x2013;1038.</Citation><ArticleIdList><ArticleId IdType="pubmed">12470799</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer, T., Sch&#xe4;fer, S., Simons, A., Kemmling, A., Kamer, T., Eckert, A., Sch&#xfc;ssel, K., Eikenberg, O., Sturchler-Pierrat, C., Abramowski, D., et al. (2003) Proc. Natl. Acad. Sci. USA 100, 14187&#x2013;14192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC283567</ArticleId><ArticleId IdType="pubmed">14617773</ArticleId></ArticleIdList></Reference><Reference><Citation>Moechars, D., Dewachter, I., Lorent, K., Reverse, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V., Checler, F., et al. (1999) J. Biol. Chem. 274, 6483&#x2013;6492.</Citation><ArticleIdList><ArticleId IdType="pubmed">10037741</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson, G. A., Borchelt, D. R., Dake, A., Turner, S., Danielson, V., Coffin, J. D., Eckman, C., Meiners, J., Nilsen, S. P., Younkin, S. G. &amp; Hsiao, K. K. (1997) Hum. Mol. Genet. 6, 1951&#x2013;1959.</Citation><ArticleIdList><ArticleId IdType="pubmed">9302276</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutsenko, S., Petrukhin, K., Cooper, M. J., Gilliam, C. T. &amp; Kaplan, J. H. (1997) J. Biol. Chem. 272, 18939&#x2013;18944.</Citation><ArticleIdList><ArticleId IdType="pubmed">9228074</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J. Y., Cole, T. B., Palmiter, R. D., Suh, S. W. &amp; Koh, J. Y. (2002) Proc. Natl. Acad. Sci. USA 99, 7705&#x2013;7710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC124328</ArticleId><ArticleId IdType="pubmed">12032347</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J. C., Paul, S. M. &amp; Holtzman, D. M. (2001) Proc. Natl. Acad. Sci. USA 98, 8850&#x2013;8855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC37524</ArticleId><ArticleId IdType="pubmed">11438712</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos, R. B., Bales, K. R., Parsadanian, M., O'Dell, M. A., Foss, E. M., Paul, S. M. &amp; Holtzman, D. M. (2002) J. Neurochem. 81, 229&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">12064470</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y., et al. (2001) Neuron 30, 665&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">11430801</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14617773</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>24</Issue><PubDate><Year>2003</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice.</ArticleTitle><Pagination><StartPage>14187</StartPage><EndPage>14192</EndPage><MedlinePgn>14187-92</MedlinePgn></Pagination><Abstract><AbstractText>The Cu-binding beta-amyloid precursor protein (APP), and the amyloid Abeta peptide have been proposed to play a role in physiological metal regulation. There is accumulating evidence of an unbalanced Cu homeostasis with a causative or diagnostic link to Alzheimer's disease. Whereas elevated Cu levels are observed in APP knockout mice, APP overexpression results in reduced Cu in transgenic mouse brain. Moreover, Cu induces a decrease in Abeta levels in APP-transfected cells in vitro. To investigate the influence of bioavailable Cu, transgenic APP23 mice received an oral treatment with Cu-supplemented sucrose-sweetened drinking water (1). Chronic APP overexpression per se reduced superoxide dismutase 1 activity in transgenic mouse brain, which could be restored to normal levels after Cu treatment (2). A significant increase of brain Cu indicated its bioavailability on Cu treatment in APP23 mice, whereas Cu levels remained unaffected in littermate controls (3). Cu treatment lowered endogenous CNS Abeta before a detectable reduction of amyloid plaques. Thus, APP23 mice reveal APP-induced alterations linked to Cu homeostasis, which can be reversed by addition of dietary Cu.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bayer</LastName><ForeName>Thomas A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Division of Neurobiology, University of the Saarland Medical Center, D-66421 Homburg, Germany. thomas.bayer@uniklinik-saarland.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xe4;fer</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Simons</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kemmling</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kamer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Tepest</LastName><ForeName>Ralf</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Eckert</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Sch&#xfc;ssel</LastName><ForeName>Katrin</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Eikenberg</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Sturchler-Pierrat</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Abramowski</LastName><ForeName>Dorothee</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Staufenbiel</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Multhaup</LastName><ForeName>Gerd</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007527">Isoenzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>789U1901C5</RegistryNumber><NameOfSubstance UI="D003300">Copper</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003300" MajorTopicYN="N">Copper</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004795" MajorTopicYN="N">Enzyme Stability</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008959" MajorTopicYN="N">Models, Neurological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016874" MajorTopicYN="N">Neurofibrillary Tangles</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>5</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14617773</ArticleId><ArticleId IdType="pmc">PMC283567</ArticleId><ArticleId IdType="doi">10.1073/pnas.2332818100</ArticleId><ArticleId IdType="pii">2332818100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Selkoe, D. J. (2001) Physiol. Rev. 81, 741&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pubmed">11274343</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A., St. George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M. &amp; Neve, R. L. (1987) Science 235, 880&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">2949367</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K. &amp; Muller-Hill, B. (1987) Nature 325, 733&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">2881207</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodart, J. C., Mathis, C. &amp; Ungerer, A. (2000) Rev. Neurosci. 11, 75&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">10718147</ArticleId></ArticleIdList></Reference><Reference><Citation>Hesse, L., Beher, D., Masters, C. L. &amp; Multhaup, G. (1994) FEBS Lett. 349, 109&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">7913895</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E. &amp; Bush, A. I. (2000) J. Neurochem. 75, 1219&#x2013;1233.</Citation><ArticleIdList><ArticleId IdType="pubmed">10936205</ArticleId></ArticleIdList></Reference><Reference><Citation>Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L. &amp; Beyreuther, K. (1996) Science 271, 1406&#x2013;1409.</Citation><ArticleIdList><ArticleId IdType="pubmed">8596911</ArticleId></ArticleIdList></Reference><Reference><Citation>Simons, A., Ruppert, T., Schmidt, C., Schlicksupp, A., Pipkorn, R., Reed, J., Masters, C. L., White, A. R., Cappai, R., Beyreuther, K., et al. (2002) Biochemistry 41, 9310&#x2013;9320.</Citation><ArticleIdList><ArticleId IdType="pubmed">12135352</ArticleId></ArticleIdList></Reference><Reference><Citation>White, A. R., Multhaup, G., Galatis, D., McKinstry, W. J., Parker, M. W., Pipkorn, R., Beyreuther, K., Masters, C. L. &amp; Cappai, R. (2002) J. Neurosci. 22, 365&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758658</ArticleId><ArticleId IdType="pubmed">11784781</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnham, K. J., McKinstry, W. J., Multhaup, G., Galatis, D., Morton, C. J., Curtain, C. C., Williamson, N. W., White, A. R., Hinds, M. G., Norton, R. S., et al. (2003) J. Biol. Chem., in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">12611883</ArticleId></ArticleIdList></Reference><Reference><Citation>White, A. R., Bush, A. I., Beyreuther, K., Masters, C. L. &amp; Cappai, R. (1999) J. Neurochem. 72, 2092&#x2013;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">10217289</ArticleId></ArticleIdList></Reference><Reference><Citation>Multhaup, G., Ruppert, T., Schlicksupp, A., Hesse, L., Bill, E., Pipkorn, R., Masters, C. L. &amp; Beyreuther, K. (1998) Biochemistry 37, 7224&#x2013;7230.</Citation><ArticleIdList><ArticleId IdType="pubmed">9585534</ArticleId></ArticleIdList></Reference><Reference><Citation>Multhaup, G. &amp; Masters, C. L. (1999) Met. Ions Biol. Syst. 36, 365&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">10093930</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M., Romano, D. M., Hartshorn, M. A., Tanzi, R. E. &amp; Bush, A. I. (1998) J. Biol. Chem. 273, 12817&#x2013;12826.</Citation><ArticleIdList><ArticleId IdType="pubmed">9582309</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., et al. (1999) J. Biol. Chem. 274, 37111&#x2013;37116.</Citation><ArticleIdList><ArticleId IdType="pubmed">10601271</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., et al. (1999) Biochemistry 38, 7609&#x2013;7616.</Citation><ArticleIdList><ArticleId IdType="pubmed">10386999</ArticleId></ArticleIdList></Reference><Reference><Citation>White, A. R., Zheng, H., Galatis, D., Maher, F., Hesse, L., Multhaup, G., Beyreuther, K., Masters, C. L. &amp; Cappai, R. (1998) J. Neurosci. 18, 6207&#x2013;6217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793217</ArticleId><ArticleId IdType="pubmed">9698314</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. &amp; Cole, G. (1996) Science 274, 99&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">8810256</ArticleId></ArticleIdList></Reference><Reference><Citation>Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., White, A. R., Beyreuther, K., Masters, C. L., Bush, A. I. &amp; Li, Q. X. (2002) J. Biol. Chem. 277, 44670&#x2013;44676.</Citation><ArticleIdList><ArticleId IdType="pubmed">12215434</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchardt, T., Camakaris, J., Cappai, R., Masters, C. L., Beyreuther, K. &amp; Multhaup, G. (1999) Biochem. J. 344, 461&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1220664</ArticleId><ArticleId IdType="pubmed">10567229</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchardt, T., Schmidt, C., Camarkis, J., Cappai, R., Masters, C. L., Beyreuther, K. &amp; Multhaup, G. (2000) Cell. Mol. Biol. (Noisy-le-grand) 46, 785&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pubmed">10875440</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheuermann, S., Hambsch, B., Hesse, L., Stumm, J., Schmidt, C., Beher, D., Bayer, T. A., Beyreuther, K. &amp; Multhaup, G. (2001) J. Biol. Chem. 276, 33923&#x2013;33929.</Citation><ArticleIdList><ArticleId IdType="pubmed">11438549</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K. H., Mistl, C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P. A., et al. (1997) Proc. Natl. Acad. Sci. USA 94, 13287&#x2013;13292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC24301</ArticleId><ArticleId IdType="pubmed">9371838</ArticleId></ArticleIdList></Reference><Reference><Citation>Nebot, C., Moutet, M., Huet, P., Xu, J. Z., Yadan, J. C. &amp; Chaudiere, J. (1993) Anal. Biochem. 214, 442&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pubmed">8109732</ArticleId></ArticleIdList></Reference><Reference><Citation>Phinney, A. L., Drisaldi, B., Lugowski, S., Schmidt, S. D., Coronado, V., Liang, Y., Horne, P., Yang, J., Sekoulidis, J., Coomaraswamy, J., et al. (2003) Proc. Natl. Acad. Sci. USA 100, 14193&#x2013;14198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC283568</ArticleId><ArticleId IdType="pubmed">14617772</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, P. C., Waggoner, D., Subramaniam, J. R., Tessarollo, L., Bartnikas, T. B., Culotta, V. C., Price, D. L., Rothstein, J. &amp; Gitlin, J. D. (2000) Proc. Natl. Acad. Sci. USA 97, 2886&#x2013;2891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16025</ArticleId><ArticleId IdType="pubmed">10694572</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields, M., Ferretti, R. J., Smith, J. C., Jr., &amp; Reiser, S. (1983) J. Nutr. 113, 1335&#x2013;1345.</Citation><ArticleIdList><ArticleId IdType="pubmed">6345733</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson, G. A., Borchelt, D. R., Dake, A., Turner, S., Danielson, V., Coffin, J. D., Eckman, C., Meiners, J., Nilsen, S. P., Younkin, S. G. &amp; Hsiao, K. K. (1997) Hum. Mol. Genet. 6, 1951&#x2013;1959.</Citation><ArticleIdList><ArticleId IdType="pubmed">9302276</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao, K. K., Borchelt, D. R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., Xu, S., Eckman, C., Younkin, S., Price, D., et al. (1995) Neuron 15, 1203&#x2013;1218.</Citation><ArticleIdList><ArticleId IdType="pubmed">7576662</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K. &amp; Carlson, G. A. (1999) Nat. Neurosci. 2, 157&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">10195200</ArticleId></ArticleIdList></Reference><Reference><Citation>White, A. R., Reyes, R., Mercer, J. F., Camakaris, J., Zheng, H., Bush, A. I., Multhaup, G., Beyreuther, K., Masters, C. L. &amp; Cappai, R. (1999) Brain Res. 842, 439&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pubmed">10526140</ArticleId></ArticleIdList></Reference><Reference><Citation>Huffman, D. L. &amp; O'Halloran, T. V. (2001) Annu. Rev. Biochem. 70, 677&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pubmed">11395420</ArticleId></ArticleIdList></Reference><Reference><Citation>Rae, T. D., Torres, A. S., Pufahl, R. A. &amp; O'Halloran, T. V. (2001) J. Biol. Chem. 276, 5166&#x2013;5176.</Citation><ArticleIdList><ArticleId IdType="pubmed">11018045</ArticleId></ArticleIdList></Reference><Reference><Citation>McLoughlin, D. M., Standen, C. L., Lau, K. F., Ackerley, S., Bartnikas, T. P., Gitlin, J. D. &amp; Miller, C. C. (2001) J. Biol. Chem. 276, 9303&#x2013;9307.</Citation><ArticleIdList><ArticleId IdType="pubmed">11115513</ArticleId></ArticleIdList></Reference><Reference><Citation>Culotta, V. C., Klomp, L. W., Strain, J., Casareno, R. L., Krems, B. &amp; Gitlin, J. D. (1997) J. Biol. Chem. 272, 23469&#x2013;23472.</Citation><ArticleIdList><ArticleId IdType="pubmed">9295278</ArticleId></ArticleIdList></Reference><Reference><Citation>Casareno, R. L., Waggoner, D. &amp; Gitlin, J. D. (1998) J. Biol. Chem. 273, 23625&#x2013;23628.</Citation><ArticleIdList><ArticleId IdType="pubmed">9726962</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y., et al. (2001) Neuron 30, 665&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">11430801</ArticleId></ArticleIdList></Reference><Reference><Citation>Bush, A. I. (2002) Neurobiol. Aging 23, 1031&#x2013;1038.</Citation><ArticleIdList><ArticleId IdType="pubmed">12470799</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugawara, N., Sugawara, C. &amp; Katakura, M. (1991) Res. Commun. Chem. Pathol. Pharmacol. 72, 97&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">2052751</ArticleId></ArticleIdList></Reference><Reference><Citation>Rae, T. D., Schmidt, P. J., Pufahl, R. A., Culotta, V. C. &amp; O'Halloran, T. V. (1999) Science 284, 805&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">10221913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei, J. P., Srinivasan, C., Han, H., Valentine, J. S. &amp; Gralla, E. B. (2001) J. Biol. Chem. 276, 44798&#x2013;44803.</Citation><ArticleIdList><ArticleId IdType="pubmed">11581253</ArticleId></ArticleIdList></Reference><Reference><Citation>De Freitas, J. M., Liba, A., Meneghini, R., Valentine, J. S. &amp; Gralla, E. B. (2000) J. Biol. Chem. 275, 11645&#x2013;11649.</Citation><ArticleIdList><ArticleId IdType="pubmed">10766782</ArticleId></ArticleIdList></Reference><Reference><Citation>Torsdottir, G., Kristinsson, J., Hreidarsson, S., Snaedal, J. &amp; Johannesson, T. (2001) Pharmacol. Toxicol. (Copenhagen) 89, 320&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">11903959</ArticleId></ArticleIdList></Reference><Reference><Citation>Squitti, R., Lupoi, D., Pasqualetti, P., Dal Forno, G., Vernieri, F., Chiovenda, P., Rossi, L., Cortesi, M., Cassetta, E. &amp; Rossini, P. M. (2002) Neurology 59, 1153&#x2013;1161.</Citation><ArticleIdList><ArticleId IdType="pubmed">12391342</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartnikas, T. B. &amp; Gitlin, J. D. (2003) J. Biol. Chem. 278, 33602&#x2013;33608.</Citation><ArticleIdList><ArticleId IdType="pubmed">12815046</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14622574</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Nov</Month><Day>13</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor.</ArticleTitle><Pagination><StartPage>685</StartPage><EndPage>694</EndPage><MedlinePgn>685-94</MedlinePgn></Pagination><Abstract><AbstractText>Many neurodegenerative diseases, including tauopathies, Parkinson's disease, amyotrophic lateral sclerosis, and the polyglutamine diseases, are characterized by intracellular aggregation of pathogenic proteins. It is difficult to study modifiers of this process in intact cells in a high-throughput and quantitative manner, although this could facilitate molecular insights into disease pathogenesis. Here we introduce a high-throughput assay to measure intracellular polyglutamine protein aggregation using fluorescence resonance energy transfer (FRET). We screened over 2800 biologically active small molecules for inhibitory activity and have characterized one lead compound in detail. Y-27632, an inhibitor of the Rho-associated kinase p160ROCK, diminished polyglutamine protein aggregation (EC(50) congruent with 5 microM) and reduced neurodegeneration in a Drosophila model of polyglutamine disease. This establishes a novel high-throughput approach to study protein misfolding and aggregation associated with neurodegenerative diseases and implicates a signaling pathway of previously unrecognized importance in polyglutamine protein processing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pollitt</LastName><ForeName>Sonia K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pallos</LastName><ForeName>Judit</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Jieya</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Urvee A</ForeName><Initials>UA</Initials></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Aye Aye K</ForeName><Initials>AA</Initials></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Leslie Michels</ForeName><Initials>LM</Initials></Author><Author ValidYN="Y"><LastName>Marsh</LastName><ForeName>J Lawrence</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Diamond</LastName><ForeName>Marc I</ForeName><Initials>MI</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1R21NS045350</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>BM3355</GrantID><Acronym>BM</Acronym><Agency>FDA HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS045283</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000577">Amides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086055">HTT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071058">Huntingtin Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011725">Pyridines</NameOfSubstance></Chemical><Chemical><RegistryNumber>138381-45-0</RegistryNumber><NameOfSubstance UI="C108830">Y 27632</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D054460">rho-Associated Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000577" MajorTopicYN="N">Amides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001681" MajorTopicYN="N">Biological Assay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019556" MajorTopicYN="N">COS Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D031541" MajorTopicYN="N">Fluorescence Resonance Energy Transfer</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071058" MajorTopicYN="N">Huntingtin Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017956" MajorTopicYN="N">Photoreceptor Cells, Invertebrate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019680" MajorTopicYN="N">Trinucleotide Repeat Expansion</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054460" MajorTopicYN="N">rho-Associated Kinases</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14622574</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00697-4</ArticleId><ArticleId IdType="pii">S0896627303006974</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14622586</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Nov</Month><Day>13</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline.</ArticleTitle><Pagination><StartPage>835</StartPage><EndPage>845</EndPage><MedlinePgn>835-45</MedlinePgn></Pagination><Abstract><AbstractText>Activation of the cAMP/protein kinase A (PKA) pathway has been proposed as a mechanism for improving age-related cognitive deficits based on studies of hippocampal function. However, normal aging also afflicts prefrontal cortical cognitive functioning. Here, we report that agents that increase PKA activity impair rather than improve prefrontal cortical function in aged rats and monkeys with prefrontal cortical deficits. Conversely, PKA inhibition ameliorates prefrontal cortical cognitive deficits. Western blot and immunohistochemical analyses of rat brain further indicate that the cAMP/PKA pathway becomes disinhibited in the prefrontal cortex with advancing age. These data demonstrate that PKA inhibition, rather than activation, is the appropriate strategy for restoring prefrontal cortical cognitive abilities in the elderly.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramos</LastName><ForeName>Brian P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birnbaum</LastName><ForeName>Shari G</ForeName><Initials>SG</Initials></Author><Author ValidYN="Y"><LastName>Lindenmayer</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Newton</LastName><ForeName>Samuel S</ForeName><Initials>SS</Initials></Author><Author ValidYN="Y"><LastName>Duman</LastName><ForeName>Ronald S</ForeName><Initials>RS</Initials></Author><Author ValidYN="Y"><LastName>Arnsten</LastName><ForeName>Amy F T</ForeName><Initials>AF</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG06036</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH45481</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017362">Cyclic AMP Response Element-Binding Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018697">Nootropic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010726">Phosphodiesterase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013873">Thionucleotides</NameOfSubstance></Chemical><Chemical><RegistryNumber>23645-17-2</RegistryNumber><NameOfSubstance UI="C016957">adenosine-3',5'-cyclic phosphorothioate</NameOfSubstance></Chemical><Chemical><RegistryNumber>E0399OZS9N</RegistryNumber><NameOfSubstance UI="D000242">Cyclic AMP</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.11</RegistryNumber><NameOfSubstance UI="D017868">Cyclic AMP-Dependent Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.4.17</RegistryNumber><NameOfSubstance UI="D015105">3',5'-Cyclic-AMP Phosphodiesterases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.4.17</RegistryNumber><NameOfSubstance UI="D054703">Cyclic Nucleotide Phosphodiesterases, Type 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>K676NL63N7</RegistryNumber><NameOfSubstance UI="D020889">Rolipram</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neuron. 2003 Nov 13;40(4):669-70. doi: 10.1016/s0896-6273(03)00715-3.</RefSource><PMID Version="1">14622572</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015105" MajorTopicYN="N">3',5'-Cyclic-AMP Phosphodiesterases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000242" MajorTopicYN="N">Cyclic AMP</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017362" MajorTopicYN="N">Cyclic AMP Response Element-Binding Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017868" MajorTopicYN="N">Cyclic AMP-Dependent Protein Kinases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054703" MajorTopicYN="N">Cyclic Nucleotide Phosphodiesterases, Type 4</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008253" MajorTopicYN="N">Macaca mulatta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018697" MajorTopicYN="N">Nootropic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010726" MajorTopicYN="N">Phosphodiesterase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017397" MajorTopicYN="N">Prefrontal Cortex</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020889" MajorTopicYN="N">Rolipram</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013873" MajorTopicYN="N">Thionucleotides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14622586</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00694-9</ArticleId><ArticleId IdType="pii">S0896627303006949</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14627648</PMID><DateCompleted><Year>2003</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>33</Issue><PubDate><Year>2003</Year><Month>Nov</Month><Day>19</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.</ArticleTitle><Pagination><StartPage>10633</StartPage><EndPage>10644</EndPage><MedlinePgn>10633-44</MedlinePgn></Pagination><Abstract><AbstractText>Cdk5/p35 has been implicated in cytoskeletal protein phosphorylation in normal brain and in many human neurodegenerative disorders. Yet, mouse models of cdk5/p35 hyperactivity have not yielded corresponding changes in cytoskeletal protein phosphorylation. To elucidate the relationship between p35, cdk5, and the neuronal cytoskeleton, we deleted the p35 gene in mice having a pure C57BL/6 background. We found that p35 deficiency leads to a 38% reduction of cdk5 activity in adult brain. In addition, loss of p35 causes an anterograde redistribution of cdk5 toward peripheral neuronal processes. The unusual presence of nonphosphorylated neurofilament (NF) in aberrant axon fascicles and the relocation of tau and MAP2B from cell bodies and proximal neuronal processes to more distal sites of the neuropil in p35-/- mouse brain implicate p35 in neuronal trafficking, particularly in dynein-driven retrograde transport. In many axons of normal brain, cdk5 fails to colocalize with phosphorylated cytoskeletal protein epitopes. This observation, together with an unexpected increase of NF, tau, and MAP2B phosphoepitopes accompanying the decreased cdk5 activity in p35-/- mice, supports the idea that cdk5 does not phosphorylate cytoskeletal proteins directly. Rather, in structures where cdk5 does colocalize with phosphorylated cytoskeletal protein epitopes, it may function as a negative regulator of other proline-directed kinases that directly phosphorylate the proteins. Evidence for increased glycogen synthase kinase 3beta (GSK3beta) activity in p35-/- mice suggests that GSK3beta may be one such kinase regulated by cdk5. Our studies illustrate that p35 regulates the subcellular distribution of cdk5 and cytoskeletal proteins in neurons and that cdk5 has a hierarchical role in regulating the phosphorylation and function of cytoskeletal proteins.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hallows</LastName><ForeName>Janice L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>The Nathan Shock Center of Excellence in the Basic Biology of Aging and Department of Pathology, University of Washington, Seattle, Washington 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ken</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>DePinho</LastName><ForeName>Ronald A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>Inez</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG012721</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG000057</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG00057</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG12721</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003598">Cytoskeletal Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C089495">neuronal Cdk5 activator (p25-p35)</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051360">Cyclin-Dependent Kinase 5</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C000605506">GSK3B protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000071679">Glycogen Synthase Kinase 3 beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C000605507">Gsk3b protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.22</RegistryNumber><NameOfSubstance UI="C495906">Cdk5 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.22</RegistryNumber><NameOfSubstance UI="D018844">Cyclin-Dependent Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.26</RegistryNumber><NameOfSubstance UI="D038362">Glycogen Synthase Kinase 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051360" MajorTopicYN="N">Cyclin-Dependent Kinase 5</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018844" MajorTopicYN="N">Cyclin-Dependent Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003598" MajorTopicYN="N">Cytoskeletal Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038362" MajorTopicYN="N">Glycogen Synthase Kinase 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071679" MajorTopicYN="N">Glycogen Synthase Kinase 3 beta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008817" MajorTopicYN="N">Mice, Mutant Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>5</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14627648</ArticleId><ArticleId IdType="pmc">PMC6740918</ArticleId><ArticleId IdType="pii">23/33/10633</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-33-10633.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahlijanian MK, Barrezueta NX, Williams RD, Jakowski A, Kowsz KP, Mc-Carthy S, Coskran T, Carlo A, Seymour PA, Burkhardt JE, Nelson RB, McNeish JD ( 2000) Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci USA 97: 2910-2915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16029</ArticleId><ArticleId IdType="pubmed">10706614</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderton BH, Betts J, Blackstock WP, Brion JP, Chapman S, Connell J, Dayanandan R, Gallo JM, Gibb G, Hanger DP, Hutton M, Kardalinou E, Leroy K, Lovestone S, Mack T, Reynolds CH, Van Slegtenhorst M ( 2001) Sites of phosphorylation in tau and factors affecting their regulation. Biochem Soc Symp 67: 73-80.</Citation><ArticleIdList><ArticleId IdType="pubmed">11447841</ArticleId></ArticleIdList></Reference><Reference><Citation>Baas PW ( 1999) Microtubules and neuronal polarity: lessons from mitosis. Neuron 22: 23-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">10027286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj NP, Al-Sarraj ST, Anderson V, Kibble M, Leigh N, Miller CC ( 1998) Cyclin-dependent kinase-5 is associated with lipofuscin in motor neurones in amyotrophic lateral sclerosis. Neurosci Lett 245: 45-48.</Citation><ArticleIdList><ArticleId IdType="pubmed">9596352</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj NP, al-Sarraj ST, Leigh PN, Anderson V, Miller CC ( 1999) Cyclin dependent kinase-5 (CDK-5) phosphorylates neurofilament heavy (NF-H) chain to generate epitopes for antibodies that label neurofilament accumulations in amyotrophic lateral sclerosis (ALS) and is present in affected motor neurones in ALS. Prog Neuropsychopharmacol Biol Psychiatry 23: 833-850.</Citation><ArticleIdList><ArticleId IdType="pubmed">10509378</ArticleId></ArticleIdList></Reference><Reference><Citation>Berling B, Wille H, Roll B, Mandelkow EM, Garner C, Mandelkow E ( 1994) Phosphorylation of microtubule-associated proteins MAP2a, b and MAP2c at Ser136 by proline-directed kinases in vivo and in vitro. Eur J Cell Biol 64: 120-130.</Citation><ArticleIdList><ArticleId IdType="pubmed">7525290</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian F, Nath R, Sobocinski G, Booher RN, Lipinski WJ, Callahan MJ, Pack A, Wang KK, Walker LC ( 2002) Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. J Comp Neurol 446: 257-266.</Citation><ArticleIdList><ArticleId IdType="pubmed">11932941</ArticleId></ArticleIdList></Reference><Reference><Citation>Billingsley ML, Kincaid RL ( 1997) Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 323: 577-591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1218358</ArticleId><ArticleId IdType="pubmed">9169588</ArticleId></ArticleIdList></Reference><Reference><Citation>Binder LI, Frankfurter A, Rebhun LI ( 1986) Differential localization of MAP-2 and tau in mammalian neurons in situ. Ann NY Acad Sci 466: 145-166.</Citation><ArticleIdList><ArticleId IdType="pubmed">3089105</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghi R, Giliberto L, Assini A, Delacourte A, Perry G, Smith MA, Strocchi P, Zaccheo D, Tabaton M ( 2002) Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy. Neurology 58: 589-592.</Citation><ArticleIdList><ArticleId IdType="pubmed">11865137</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak E, Braak H, Mandelkow EM ( 1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87: 554-567.</Citation><ArticleIdList><ArticleId IdType="pubmed">7522386</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion JP, Couck AM ( 1995) Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. Am J Pathol 147: 1465-1476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1869502</ArticleId><ArticleId IdType="pubmed">7485409</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownlees J, Yates A, Bajaj NP, Davis D, Anderton BH, Leigh PN, Shaw CE, Miller CC ( 2000) Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J Cell Sci 113: 401-407.</Citation><ArticleIdList><ArticleId IdType="pubmed">10639328</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu B, Li J, Davies P, Vincent I ( 2002) Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J Neurosci 22: 6515-6525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758154</ArticleId><ArticleId IdType="pubmed">12151531</ArticleId></ArticleIdList></Reference><Reference><Citation>Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR ( 2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33: 95-130.</Citation><ArticleIdList><ArticleId IdType="pubmed">10967355</ArticleId></ArticleIdList></Reference><Reference><Citation>Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH ( 1997) Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18: 29-42.</Citation><ArticleIdList><ArticleId IdType="pubmed">9010203</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Jones Y, Ellisman MH, Goldstein LS, Karin M ( 2003) JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of Microtubule-associated proteins. Dev Cell 4: 521-533.</Citation><ArticleIdList><ArticleId IdType="pubmed">12689591</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng K, Li Z, Fu WY, Wang JH, Fu AK, Ip NY ( 2002) Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35. J Biol Chem 277: 31988-31993.</Citation><ArticleIdList><ArticleId IdType="pubmed">12084709</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen P, Frame S ( 2001) The renaissance of GSK3. Nat Rev Mol Cell Biol 2: 769-776.</Citation><ArticleIdList><ArticleId IdType="pubmed">11584304</ArticleId></ArticleIdList></Reference><Reference><Citation>Giasson BI, Mushynski WE ( 1997) Study of proline-directed protein kinases involved in phosphorylation of the heavy neurofilament subunit. J Neurosci 17: 9466-9472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573415</ArticleId><ArticleId IdType="pubmed">9391002</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein ME, Sternberger LA, Sternberger NH ( 1983) Microheterogeneity (&#x201c;neurotypy&#x201d;) of neurofilament proteins. Proc Natl Acad Sci USA 80: 3101-3105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC393982</ArticleId><ArticleId IdType="pubmed">6574474</ArticleId></ArticleIdList></Reference><Reference><Citation>Graeser R, Gannon J, Poon RY, Dubois T, Aitken A, Hunt T ( 2002) Regulation of the CDK-related protein kinase PCTAIRE-1 and its possible role in neurite outgrowth in Neuro-2A cells. J Cell Sci 115: 3479-3490.</Citation><ArticleIdList><ArticleId IdType="pubmed">12154078</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant P, Sharma P, Pant HC ( 2001) Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism. Eur J Biochem 268: 1534-1546.</Citation><ArticleIdList><ArticleId IdType="pubmed">11248670</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirokawa N ( 1998) Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 279: 519-526.</Citation><ArticleIdList><ArticleId IdType="pubmed">9438838</ArticleId></ArticleIdList></Reference><Reference><Citation>Honjyo Y, Kawamoto Y, Nakano S, Akiguchi L ( 2001) P39 immunoreactivity in glial cytoplasmic inclusions in brains with multiple system atrophy. Acta Neuropathol (Berl) 101: 190-194.</Citation><ArticleIdList><ArticleId IdType="pubmed">11307616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioffe E, Liu Y, Bhaumik M, Poirier F, Factor SM, Stanley P ( 1995) WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras. Proc Natl Acad Sci USA 92: 7357-7361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC41338</ArticleId><ArticleId IdType="pubmed">7638196</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro K, Kobayashi S, Omori A, Takamatsu M, Yonekura S, Anzai K, Imahori K, Uchida T ( 1994) Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain. FEBS Lett 342: 203-208.</Citation><ArticleIdList><ArticleId IdType="pubmed">8143878</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerjaschki D, Noronha-Blob L, Sacktor B, Farquhar MG ( 1984) Microdomains of distinctive glycoprotein composition in the kidney proximal tubule brush border. J Cell Biol 98: 1505-1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2113241</ArticleId><ArticleId IdType="pubmed">6371023</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerokoski P, Suuronen T, Salminen A, Soininen H, Pirttila T ( 2002) Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation. Biochem Biophys Res Commun 298: 693-698.</Citation><ArticleIdList><ArticleId IdType="pubmed">12419309</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH ( 2001) p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21: 6758-6771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763073</ArticleId><ArticleId IdType="pubmed">11517264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon YT, Tsai LH, Crandall JE ( 1999) Callosal axon guidance defects in p35(-/-) mice. J Comp Neurol 415: 218-229.</Citation><ArticleIdList><ArticleId IdType="pubmed">10545161</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KY, Clark AW, Rosales JL, Chapman K, Fung T, Johnston RN ( 1999) Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci Res 34: 21-29.</Citation><ArticleIdList><ArticleId IdType="pubmed">10413323</ArticleId></ArticleIdList></Reference><Reference><Citation>Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH ( 1994) A brain-specific activator of cyclin-dependent kinase 5. Nature 371: 423-426.</Citation><ArticleIdList><ArticleId IdType="pubmed">8090222</ArticleId></ArticleIdList></Reference><Reference><Citation>Li BS, Zhang L, Takahashi S, Ma W, Jaffe H, Kulkarni AB, Pant HC ( 2002) Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J 21: 324-333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125822</ArticleId><ArticleId IdType="pubmed">11823425</ArticleId></ArticleIdList></Reference><Reference><Citation>Litersky JM, Johnson GV ( 1992) Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J Biol Chem 267: 1563-1568.</Citation><ArticleIdList><ArticleId IdType="pubmed">1730702</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WK, Williams RT, Hall FL, Dickson DW, Yen SH ( 1995) Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. Am J Pathol 146: 228-238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1870752</ArticleId><ArticleId IdType="pubmed">7856730</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushita M, Tomizawa K, Lu YF, Moriwaki A, Tokuda M, Itano T, Wang JH, Hatase O, Matsui H ( 1996) Distinct cellular compartment of cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activator protein (p35nck5a) in the developing rat cerebellum. Brain Res 734: 319-322.</Citation><ArticleIdList><ArticleId IdType="pubmed">8896840</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel G, Mercken M, Murayama M, Noguchi K, Ishiguro K, Imahori K, Takashima A ( 1998) Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells. Biochim Biophys Acta 1380: 177-182.</Citation><ArticleIdList><ArticleId IdType="pubmed">9565682</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller CC, Ackerley S, Brownlees J, Grierson AJ, Jacobsen NJ, Thornhill P ( 2002) Axonal transport of neurofilaments in normal and disease states. Cell Mol Life Sci 59: 323-330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11146161</ArticleId><ArticleId IdType="pubmed">11924605</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullen RJ, Buck CR, Smith AM ( 1992) NeuN, a neuronal specific nuclear protein in vertebrates. Development 116: 201-211.</Citation><ArticleIdList><ArticleId IdType="pubmed">1483388</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura S, Kawamoto Y, Nakano S, Akiguchi I, Kimura J ( 1997a) p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease. Acta Neuropathol (Berl) 94: 153-157.</Citation><ArticleIdList><ArticleId IdType="pubmed">9255390</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura S, Kawamoto Y, Nakano S, Ikemoto A, Akiguchi I, Kimura J ( 1997b) Cyclin-dependent kinase 5 in Lewy body-like inclusions in anterior horn cells of a patient with sporadic amyotrophic lateral sclerosis. Neurology 48: 267-270.</Citation><ArticleIdList><ArticleId IdType="pubmed">9008532</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura S, Kawamaoto Y, Nakano S, Akiguchi I, Kimura J ( 1998) Cyclin-dependent kinase 5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy. J Neuropathol Exp Neurol 57: 690-698.</Citation><ArticleIdList><ArticleId IdType="pubmed">9690673</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen MD, Lariviere RC, Julien JP ( 2001) Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30: 135-147.</Citation><ArticleIdList><ArticleId IdType="pubmed">11343650</ArticleId></ArticleIdList></Reference><Reference><Citation>Niethammer M, Smith DS, Ayala R, Peng J, Ko J, Lee MS, Morabito M, Tsai LH ( 2000) NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 28: 697-711.</Citation><ArticleIdList><ArticleId IdType="pubmed">11163260</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolic M, Dudek H, Kwon YT, Ramos YF, Tsai LH ( 1996) The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev 10: 816-825.</Citation><ArticleIdList><ArticleId IdType="pubmed">8846918</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble W, Olm V, Takata K, Casey E, Mary O, Meyerson J, Gaynor K, LaFrancois J, Wang L, Kondo T, Davies P, Burns M, Veeranna, Nixon R, Dickson D, Matsuoka Y, Ahlijanian M, Lau LF, Duff K ( 2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38: 555-565.</Citation><ArticleIdList><ArticleId IdType="pubmed">12765608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB ( 1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 93: 11173-11178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC38303</ArticleId><ArticleId IdType="pubmed">8855328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohshima T, Gilmore EC, Longenecker G, Jacobowitz DM, Brady RO, Herrup K, Kulkarni AB ( 1999) Migration defects of cdk5(-/-) neurons in the developing cerebellum is cell autonomous. J Neurosci 19: 6017-6026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6783065</ArticleId><ArticleId IdType="pubmed">10407039</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohshima T, Ogawa M, Veeranna, Hirasawa M, Longenecker G, Ishiguro K, Pant HC, Brady RO, Kulkarni AB, Mikoshiba K ( 2001) Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain. Proc Natl Acad Sci USA 98: 2764-2769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC30213</ArticleId><ArticleId IdType="pubmed">11226314</ArticleId></ArticleIdList></Reference><Reference><Citation>Paglini G, Pigino G, Kunda P, Morfini G, Maccioni R, Quiroga S, Ferreira A, Caceres A ( 1998) Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth. J Neurosci 18: 9858-9869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793278</ArticleId><ArticleId IdType="pubmed">9822744</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH ( 1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402: 615-622.</Citation><ArticleIdList><ArticleId IdType="pubmed">10604467</ArticleId></ArticleIdList></Reference><Reference><Citation>Patzke H, Maddineni U, Ayala R, Morabito M, Volker J, Dikkes P, Ahlijanian MK, Tsai LH ( 2003) Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene. J Neurosci 23: 2769-2778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742110</ArticleId><ArticleId IdType="pubmed">12684463</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei JJ, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B, Cowburn RF ( 1998) Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res 797: 267-277.</Citation><ArticleIdList><ArticleId IdType="pubmed">9666145</ArticleId></ArticleIdList></Reference><Reference><Citation>Philpott A, Tsai L, Kirschner MW ( 1999) Neuronal differentiation and patterning in Xenopus: the role of cdk5 and a novel activator xp35.2. Dev Biol 207: 119-132.</Citation><ArticleIdList><ArticleId IdType="pubmed">10049569</ArticleId></ArticleIdList></Reference><Reference><Citation>Pigino G, Paglini G, Ulloa L, Avila J, Caceres A ( 1997) Analysis of the expression, distribution and function of cyclin dependent kinase 5 (cdk5) in developing cerebellar macroneurons. J Cell Sci 110: 257-270.</Citation><ArticleIdList><ArticleId IdType="pubmed">9044056</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratner N, Bloom GS, Brady ST ( 1998) A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein. J Neurosci 18: 7717-7726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793030</ArticleId><ArticleId IdType="pubmed">9742142</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez C, Diaz-Nido J, Avila J ( 2000) Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog Neurobiol 61: 133-168.</Citation><ArticleIdList><ArticleId IdType="pubmed">10704996</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato S, Tatebayashi Y, Akagi T, Chui DH, Murayama M, Miyasaka T, Planel E, Tanemura K, Sun X, Hashikawa T, Yoshioka K, Ishiguro K, Takashima A ( 2002) Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells. J Biol Chem 277: 42060-42065.</Citation><ArticleIdList><ArticleId IdType="pubmed">12191990</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P, Sharma M, Amin ND, Albers RW, Pant HC ( 1999) Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Proc Natl Acad Sci USA 96: 11156-11160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18003</ArticleId><ArticleId IdType="pubmed">10500146</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P, Veeranna, Sharma M, Amin ND, Sihag RK, Grant P, Ahn N, Kulkarni AB, Pant HC ( 2002) Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J Biol Chem 277: 528-534.</Citation><ArticleIdList><ArticleId IdType="pubmed">11684694</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea TB, Beermann ML ( 1993) Evidence that the monoclonal antibodies SMI-31 and SMI-34 recognize different phosphorylation-dependent epitopes of the murine high molecular mass neurofilament subunit. J Neuroimmunol 44: 117-121.</Citation><ArticleIdList><ArticleId IdType="pubmed">7684397</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea TB, Flanagan LA ( 2001) Kinesin, dynein and neurofilament transport. Trends Neurosci 24: 644-648.</Citation><ArticleIdList><ArticleId IdType="pubmed">11672808</ArticleId></ArticleIdList></Reference><Reference><Citation>Shetty KT, Kaech S, Link WT, Jaffe H, Flores CM, Wray S, Pant HC, Beushausen S ( 1995) Molecular characterization of a neuronal-specific protein that stimulates the activity of Cdk5. J Neurochem 64: 1988-1995.</Citation><ArticleIdList><ArticleId IdType="pubmed">7536802</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DS, Tsai LH ( 2002) Cdk5 behind the wheel: a role in trafficking and transport? Trends Cell Biol 12: 28-36.</Citation><ArticleIdList><ArticleId IdType="pubmed">11854007</ArticleId></ArticleIdList></Reference><Reference><Citation>Su JH, Cummings BJ, Cotman CW ( 1994) Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. NeuroReport 5: 2358-2362.</Citation><ArticleIdList><ArticleId IdType="pubmed">7533559</ArticleId></ArticleIdList></Reference><Reference><Citation>Takada K, Becker LE, Chan F ( 1988) Aberrant dendritic development in the human agyric cortex: a quantitative and qualitative Golgi study of two cases. Clin Neuropathol 7: 111-119.</Citation><ArticleIdList><ArticleId IdType="pubmed">3203480</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi M, Iseki E, Kosaka K ( 2000a) Cdk5 and munc-18/p67 co-localization in early stage neurofibrillary tangles-bearing neurons in Alzheimer type dementia brains. J Neurol Sci 172: 63-69.</Citation><ArticleIdList><ArticleId IdType="pubmed">10620662</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi M, Iseki E, Kosaka K ( 2000b) Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease. Brain Res 862: 253-256.</Citation><ArticleIdList><ArticleId IdType="pubmed">10799694</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashima A, Murayama M, Yasutake K, Takahashi H, Yokoyama M, Ishiguro K ( 2001) Involvement of cyclin dependent kinase 5 activator p25 on tau phosphorylation in mouse brain. Neurosci Lett 306: 37-40.</Citation><ArticleIdList><ArticleId IdType="pubmed">11403952</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D, Yeung J, Lee KY, Matsushita M, Matsui H, Tomizawa K, Hatase O, Wang JH ( 1995) An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J Biol Chem 270: 26897-26903.</Citation><ArticleIdList><ArticleId IdType="pubmed">7592934</ArticleId></ArticleIdList></Reference><Reference><Citation>Terada M, Yasuda H, Kogawa S, Maeda K, Haneda M, Hidaka H, Kashiwagi A, Kikkawa R ( 1998) Expression and activity of cyclin-dependent kinase 5/p35 in adult rat peripheral nervous system. J Neurochem 71: 2600-2606.</Citation><ArticleIdList><ArticleId IdType="pubmed">9832161</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas KR, Capecchi MR ( 1987) Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51: 503-512.</Citation><ArticleIdList><ArticleId IdType="pubmed">2822260</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai LH, Takahashi T, Caviness JR VS, Harlow E ( 1993) Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119: 1029-1040.</Citation><ArticleIdList><ArticleId IdType="pubmed">8306873</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai LH, Delalle I, Caviness Jr VS, Chae T, Harlow E ( 1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371: 419-423.</Citation><ArticleIdList><ArticleId IdType="pubmed">8090221</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Haute C, Spittaels K, Van Dorpe J, Lasrado R, Vandezande K, Laenen I, Geerts H, Van Leuven F ( 2001) Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice. Neurobiol Dis 8: 32-44.</Citation><ArticleIdList><ArticleId IdType="pubmed">11162238</ArticleId></ArticleIdList></Reference><Reference><Citation>Veeranna, Grant P, Pant HC ( 1997) Expression of p67 (Munc-18), Cdk5, P-NFH and syntaxin during development of the rat cerebellum. Dev Neurosci 19: 172-183.</Citation><ArticleIdList><ArticleId IdType="pubmed">9097032</ArticleId></ArticleIdList></Reference><Reference><Citation>Veeranna, Amin ND, Ahn NG, Jaffe H, Winters CA, Grant P, Pant HC ( 1998) Mitogen-activated protein kinases (Erk1, 2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J Neurosci 18: 4008-4021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792805</ArticleId><ArticleId IdType="pubmed">9592082</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent I, Rosado M, Kim E, Davies P ( 1994) Increased production of paired helical filament epitopes in a cell culture system reduces the turnover of tau. J Neurochem 62: 715-723.</Citation><ArticleIdList><ArticleId IdType="pubmed">7507514</ArticleId></ArticleIdList></Reference><Reference><Citation>Watcharasit P, Bijur GN, Zmijewski JW, Song L, Zmijewska A, Chen X, Johnson GV, Jope RS ( 2002) Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage. Proc Natl Acad Sci USA 99: 7951-7955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC123001</ArticleId><ArticleId IdType="pubmed">12048243</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi H, Ishiguro K, Uchida T, Takashima A, Lemere CA, Imahori K ( 1996) Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol (Berl) 92: 232-241.</Citation><ArticleIdList><ArticleId IdType="pubmed">8870824</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Lee HG, Raina AK, Perry G, Smith MA ( 2002) The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals 11: 270-281.</Citation><ArticleIdList><ArticleId IdType="pubmed">12566928</ArticleId></ArticleIdList></Reference><Reference><Citation>Zukerberg LR, Patrick GN, Nikolic M, Humbert S, Wu CL, Lanier LM, Gertler FB, Vidal M, Van Etten RA, Tsai LH ( 2000) Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 26: 633-646.</Citation><ArticleIdList><ArticleId IdType="pubmed">10896159</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14631045</PMID><DateCompleted><Year>2003</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><Issue>5649</Issue><PubDate><Year>2003</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Diverse psychotomimetics act through a common signaling pathway.</ArticleTitle><Pagination><StartPage>1412</StartPage><EndPage>1415</EndPage><MedlinePgn>1412-5</MedlinePgn></Pagination><Abstract><AbstractText>Three distinct classes of drugs: dopaminergic agonists (such as D-amphetamine), serotonergic agonists (such as LSD), and glutamatergic antagonists (such as PCP) all induce psychotomimetic states in experimental animals that closely resemble schizophrenia symptoms in humans. Here we implicate a common signaling pathway in mediating these effects. In this pathway, dopamine- and an adenosine 3',5'-monophosphate (cAMP)-regulated phospho-protein of 32 kilodaltons (DARPP-32) is phosphorylated or dephosphorylated at three sites, in a pattern predicted to cause a synergistic inhibition of protein phosphatase-1 and concomitant regulation of its downstream effector proteins glycogen synthesis kinase-3 (GSK-3), cAMP response element-binding protein (CREB), and c-Fos. In mice with a genetic deletion of DARPP-32 or with point mutations in phosphorylation sites of DARPP-32, the effects of D-amphetamine, LSD, and PCP on two behavioral parameters-sensorimotor gating and repetitive movements-were strongly attenuated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Svenningsson</LastName><ForeName>Per</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzavara</LastName><ForeName>Eleni T</ForeName><Initials>ET</Initials></Author><Author ValidYN="Y"><LastName>Carruthers</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Rachleff</LastName><ForeName>Ilan</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Wattler</LastName><ForeName>Sigrid</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Nehls</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>McKinzie</LastName><ForeName>David L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Fienberg</LastName><ForeName>Allen A</ForeName><Initials>AA</Initials></Author><Author ValidYN="Y"><LastName>Nomikos</LastName><ForeName>George G</ForeName><Initials>GG</Initials></Author><Author ValidYN="Y"><LastName>Greengard</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DA10044</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH40899</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002491">Central Nervous System Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017362">Cyclic AMP Response Element-Binding Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051937">Dopamine and cAMP-Regulated Phosphoprotein 32</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017447">Receptors, Dopamine D1</NameOfSubstance></Chemical><Chemical><RegistryNumber>8NA5SWF92O</RegistryNumber><NameOfSubstance UI="D008238">Lysergic Acid Diethylamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>9P21XSP91P</RegistryNumber><NameOfSubstance UI="D015632">1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000071679">Glycogen Synthase Kinase 3 beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.26</RegistryNumber><NameOfSubstance UI="D038362">Glycogen Synthase Kinase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.16</RegistryNumber><NameOfSubstance UI="D010749">Phosphoprotein Phosphatases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.16</RegistryNumber><NameOfSubstance UI="D054645">Protein Phosphatase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>J1DOI7UV76</RegistryNumber><NameOfSubstance UI="D010622">Phencyclidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>TZ47U051FI</RegistryNumber><NameOfSubstance UI="D003913">Dextroamphetamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber><NameOfSubstance UI="D004298">Dopamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Science. 2004 Jul 9;305(5681):180; author reply 180. doi: 10.1126/science.1096072.</RefSource><PMID Version="1">15247457</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015632" MajorTopicYN="N">1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002491" MajorTopicYN="N">Central Nervous System Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003342" MajorTopicYN="N">Corpus Striatum</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017362" MajorTopicYN="N">Cyclic AMP Response Element-Binding Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003913" MajorTopicYN="N">Dextroamphetamine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051937" MajorTopicYN="N">Dopamine and cAMP-Regulated Phosphoprotein 32</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005625" MajorTopicYN="N">Frontal Lobe</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016762" MajorTopicYN="N">Genes, fos</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038362" MajorTopicYN="N">Glycogen Synthase Kinase 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071679" MajorTopicYN="N">Glycogen Synthase Kinase 3 beta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008238" MajorTopicYN="N">Lysergic Acid Diethylamide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010622" MajorTopicYN="N">Phencyclidine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010749" MajorTopicYN="N">Phosphoprotein Phosphatases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054645" MajorTopicYN="N">Protein Phosphatase 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017447" MajorTopicYN="N">Receptors, Dopamine D1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013216" MajorTopicYN="N">Reflex, Startle</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14631045</ArticleId><ArticleId IdType="doi">10.1126/science.1089681</ArticleId><ArticleId IdType="pii">302/5649/1412</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14634645</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1078-8956</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>12</Issue><PubDate><Year>2003</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Local gene knockdown in the brain using viral-mediated RNA interference.</ArticleTitle><Pagination><StartPage>1539</StartPage><EndPage>1544</EndPage><MedlinePgn>1539-44</MedlinePgn></Pagination><Abstract><AbstractText>Conditional mutant techniques that allow spatial and temporal control over gene expression can be used to create mice with restricted genetic modifications. These mice serve as powerful disease models in which gene function in adult tissues can be specifically dissected. Current strategies for conditional genetic manipulation are inefficient, however, and often lack sufficient spatial control. Here we use viral-mediated RNA interference (RNAi) to generate a specific knockdown of Th, the gene encoding the dopamine synthesis enzyme tyrosine hydroxylase, within midbrain neurons of adult mice. This localized gene knockdown resulted in behavioral changes, including a motor performance deficit and reduced response to a psychostimulant. These results underscore the potential of using viral-mediated RNAi for the rapid production and testing of new genetic disease models. Similar strategies may be used in other model species, and may ultimately find applications in human gene therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hommel</LastName><ForeName>Jonathan D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75390-9070, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sears</LastName><ForeName>Robert M</ForeName><Initials>RM</Initials></Author><Author ValidYN="Y"><LastName>Georgescu</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Simmons</LastName><ForeName>Diana L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>DiLeone</LastName><ForeName>Ralph J</ForeName><Initials>RJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.16.2</RegistryNumber><NameOfSubstance UI="D014446">Tyrosine 3-Monooxygenase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000229" MajorTopicYN="N">Dependovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018390" MajorTopicYN="N">Gene Targeting</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="Y">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014446" MajorTopicYN="N">Tyrosine 3-Monooxygenase</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14634645</ArticleId><ArticleId IdType="doi">10.1038/nm964</ArticleId><ArticleId IdType="pii">nm964</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14655926</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0161-8105</ISSN><JournalIssue CitedMedium="Print"><Volume>26</Volume><Issue>7</Issue><PubDate><Year>2003</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Sleep</Title><ISOAbbreviation>Sleep</ISOAbbreviation></Journal><ArticleTitle>A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.</ArticleTitle><Pagination><StartPage>893</StartPage><EndPage>901</EndPage><MedlinePgn>893-901</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine the safety and efficacy of 2 dose formulations of melatonin for the treatment of insomnia in patients with Alzheimer's disease.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A multicenter, randomized, placebo-controlled clinical trial of 2 dose formulations of oral melatonin coordinated by the National Institute of Aging-funded Alzheimer's Disease Cooperative Study. Subjects with Alzheimer's disease and nighttime sleep disturbance were randomly assigned to 1 of 3 treatment groups: placebo, 2.5-mg slow-release melatonin, or 10-mg melatonin.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Private homes and long-term care facilities.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">157 individuals were recruited by 36 Alzheimer's disease research centers. Subjects with a diagnosis of Alzheimer's disease were eligible if they averaged less than 7 hours of sleep per night (as documented by wrist actigraphy) and had 2 or more episodes per week of nighttime awakenings reported by the caregiver.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Nocturnal total sleep time, sleep efficiency, wake-time after sleep onset, and day-night sleep ratio during 2- to 3-week baseline and 2-month treatment periods. Sleep was defined by an automated algorithmic analysis of wrist actigraph data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">No statistically significant differences in objective sleep measures were seen between baseline and treatment periods for the any of the 3 groups. Nonsignificant trends for increased nocturnal total sleep time and decreased wake after sleep onset were observed in the melatonin groups relative to placebo. Trends for a greater percentage of subjects having more than a 30-minute increase in nocturnal total sleep time in the 10-mg melatonin group and for a decline in the day-night sleep ratio in the 2.5-mg sustained-release melatonin group, compared to placebo, were also seen. On subjective measures, caregiver ratings of sleep quality showed improvement in the 2.5-mg sustained-release melatonin group relative to placebo. There were no significant differences in the number or seriousness of adverse events between the placebo and melatonin groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on actigraphy as an objective measure of sleep time, melatonin is not an effective soporific agent in people with Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singer</LastName><ForeName>Clifford</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Oregon Health &amp; Science University, Portland, USA. singerc@ohsu.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tractenberg</LastName><ForeName>Rochelle E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><LastName>Kaye</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Schafer</LastName><ForeName>Kim</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Gamst</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Grundman</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Ronald</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Thal</LastName><ForeName>Leon J</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><CollectiveName>Alzheimer's Disease Cooperative Study</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 AG010483</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG010483</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG 10483</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sleep</MedlineTA><NlmUniqueID>7809084</NlmUniqueID><ISSNLinking>0161-8105</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003692">Delayed-Action Preparations</NameOfSubstance></Chemical><Chemical><RegistryNumber>JL5DK93RCL</RegistryNumber><NameOfSubstance UI="D008550">Melatonin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002940" MajorTopicYN="N">Circadian Rhythm</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003692" MajorTopicYN="N">Delayed-Action Preparations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008550" MajorTopicYN="N">Melatonin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017286" MajorTopicYN="N">Polysomnography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012893" MajorTopicYN="N">Sleep Wake Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Disclosure Statement</b>. No significant financial interest/other relationship to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>5</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14655926</ArticleId><ArticleId IdType="mid">NIHMS683803</ArticleId><ArticleId IdType="pmc">PMC4418658</ArticleId><ArticleId IdType="doi">10.1093/sleep/26.7.893</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Swearer J, Drachman D, O&#x2019;Donnell B, Mitchell A. Troublesome and disruptive behaviors in dementia. J Am Geriatr Soc. 1988;36:784&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">3411060</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack CP, Perlick D. Sleep problems and institutionalization of the elderly. J Geriatri Psychiatry Neurol. 1991;4:204&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">1789908</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz PN, Vitaliano PP, Vitiello MV, et al. Sleep, EEG and mental function changes in senile dementia of the Alzheimer&#x2019;s type. Neurobiol Aging. 1982;3:299&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">7170052</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitiello MV, Prinz PN. Alzheimer&#x2019;s disease: sleep and sleep/wake patterns. Clin Geriatr Med. 1989;5:289&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">2665912</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitiello MV, Prinz PN, Williams DE, Frommlet MS, Ries RK. Sleep disturbances in patients with mild-stage Alzheimer&#x2019;s disease. J Gerontol: Med Sci. 1990;45:M131&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2365965</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitiello MV, Poceta JS, Prinz PN. Sleep in Alzheimer&#x2019;s disease and other dementing disorders. Can J Psychol. 1991;45:221&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">1873758</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaron-Peretz J, Masiah A, Pillar T, Epstein R, Tzischinsky O, Lavie P. Sleep-wake cycle in multi-infarct dementia and dementia of the Alzheimer&#x2019;s type. Neurology. 1991;41(10):1616&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1922804</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitiello MV, Bliwise DL, Prinz PN. Sleep in Alzheimer&#x2019;s disease and the sundowning syndrome. Neurology. 1992;42(Suppl 6):83&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">1630644</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliwise D. Sleep in normal aging and dementia. Sleep. 1993;16(1):40&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">8456235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancoli-Israel S, Klauber MR, Gillin JC, Campbell SS, Hofstetter CR. Sleep in non-institutionalized Alzheimer&#x2019;s disease patients. Aging Clin Exp Res. 1994;6:451&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7748919</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliwise DL, Hughes M, McMahon PM, Kutner N. Observed sleep/wakefulness and severity of dementia in an Alzheimer&#x2019;s disease special care unit. J Gerontol: Biol Med Sci. 1995;50(6):M303&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7583801</ArticleId></ArticleIdList></Reference><Reference><Citation>Moe KE, Vitiello MV, Larsen LH, Prinz PN. Sleep/wake patterns in Alzheimer&#x2019;s disease: Relationships with cognition and function. J Sleep Res. 1995;4:15&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">10607136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancoli-Israel S, Klauber MR, Jones DW, et al. Variations in circadian rhythms of activity, sleep and light exposure related to dementia in nursing-home patients. Sleep. 1997;20(1):24&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9130329</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollak CP, Stokes PE. Circadian rest-activity rhythms in demented and nondemented older community residents and their caregivers. J Am Geriatr Soc. 1997;45(4):446&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">9100713</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliwise DL. Sleep and circadian rhythm disorders in aging and dementia. In: Turek FW, Zee PC, editors. Regulation of Sleep and Circadian Rhythms. New York: Marcel Decker Inc; 1999. pp. 487&#x2013;525.</Citation></Reference><Reference><Citation>Zee PC, Grujic ZM. Neurological disorders associated with disturbed sleep and circadian rhythms. In: Turek FW, Zee PC, editors. Regulation of Sleep and Circadian Rhythms. New York: Marcel Decker Inc; 1999. pp. 557&#x2013;96.</Citation></Reference><Reference><Citation>McCurry SM, Logsdon RG, Teri L, et al. Characteristics of sleep disturbance in community-dwelling Alzheimer&#x2019;s disease patients. J Geriatr Psychiatry Neurol. 1999;12(2):53&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10483925</ArticleId></ArticleIdList></Reference><Reference><Citation>Werth E, Savaskan E, Knoblauch V, et al. Decline in long-term circadian rest-activity cycle organization in a patient with dementia. J Geriatr Psychiatry Neurol. 2002;15:55&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11936245</ArticleId></ArticleIdList></Reference><Reference><Citation>Yesavage JA, Taylor JL, Kraemer H, et al. Sleep/wake cycle disturbance in Alzheimer&#x2019;s disease: how much is due to an inherent trait? Int Psychogeriatr. 2002;14:73&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">12094910</ArticleId></ArticleIdList></Reference><Reference><Citation>Caselli JR, Reiman EM, Hentz JG, Osborne D, Alexander GE, Boeve BF. A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes. Sleep. 2002;25(4):447&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">12071547</ArticleId></ArticleIdList></Reference><Reference><Citation>Brzezinski A. Melatonin in humans. N Engl J Med. 1997;336:186&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">8988899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sack RL. Melatonin. Sci Med. 1998;5(5):8&#x2013;17.</Citation></Reference><Reference><Citation>Sack RL, Hughes RJ, Edgar DM, Lewy AJ. Sleep-promoting effects of melatonin: At what dose, in whom, under what conditions, and by what mechanisms? Sleep. 1997;20:908&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">9415954</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer C, Wild, Sack R, Lewy A. High dose melatonin is well tolerated by the elderly. Sleep Res. 1994c;23:86.</Citation></Reference><Reference><Citation>Singer C, MacArthur A, Hughes R, Sack R, Lewy A. High dose melatonn and sleep in the elderly. Sleep Res. 1995;24A:151.</Citation></Reference><Reference><Citation>Zhdnova IV, Wurtman RJ. Efficacy of melatonin as a sleep-promoting agent. J Biol Rhythms. 1997;12(6):644&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">9406040</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson WB. Efficacy of melatonin as a hypnotic agent. J Biol Rhythms. 1997;12(6):651&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9406041</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughs RJ, Sack RL, Lewy AJ. The role of melatonin and circadian phase in age-related sleep maintenance insomnia: assessment in a clinical trial of melatonin replacement. Sleep. 1998;21:52&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">9485533</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson D, Rogers NL, van den Heuvel CJ, Kennaway DJ, Lushington K. Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs. J Biol Rhythms. 1998;13(6):532&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9850013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisapel N. The use of melatonin for the treatment of insomnia. Biol Signals Recept. 1999;8(1&#x2013;2):84&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10085468</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone BM, Turner C, Mills SL, Nicholson AN. Hypnotic activity of melatonin. Sleep. 2000;23(5):663&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10947034</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti JM, Cardinali DP. A critical assessment of the melatonin effect on sleep in humans. Biol Signals Recept. 2000;9(6):328&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">11025339</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade C, Srihari BS, Reddy KP, Chandramma L. Melatonin in medically ill patients with insomnia: a double blind, placebo-controlled study. J Clin Psychiatry. 2001;62(1):41&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11235927</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer C, McArthur A, Hughes R, Sack R, Lewy A. Physiologic melatonin administration and sleep in the elderly. Sleep Res. 1995;24A:152.</Citation></Reference><Reference><Citation>Singer C, MacArthur A, Hughes R, Sack R, Lewy A. High dose melatonin and sleep in the elderly. Sleep Res. 1995;24A:151.</Citation></Reference><Reference><Citation>Singer C, Moffit M, Colling E, et al. Low dose melatonin administration and nocturnal activity levels in patients with Alzheimer&#x2019;s disease. Sleep Res. 1997;26:752.</Citation></Reference><Reference><Citation>Sack RL, Stevenson J, Lewy AJ. Entrainment of a previously free-running blind human with melatonin. Sleep Res. 1990;19:404.</Citation></Reference><Reference><Citation>Lewy AJ, Ahmed S, Jackson JML, Sack RL. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int. 1992;9:380&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">1394610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidan R, Geoffriau M, Brun J, et al. Melatonin is able to influence its secretion in humans: description of a phase-response curve. Neuroendocrinology. 1994;60:105&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">8090277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapierre O, Dumont M. Melatonin treatment of a non-24-hour sleep-wake cycle in a blind retarded child. Biol Psychiatry. 1995;38:119&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">7578644</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewy AJ, Sack RL. Melatonin as a chronobiotic: treatment of circadian desychrony in night workers and the blind. J Biol Rhythms. 1997;12(6):595&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pubmed">9406035</ArticleId></ArticleIdList></Reference><Reference><Citation>Czeisler CA. Evidence for melatonin as a circadian phase-shifting agent. J Biol Rhythms. 1997;12:618&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">9406037</ArticleId></ArticleIdList></Reference><Reference><Citation>Sack RL, Brandes RW, Kendall AR, Lewy AJ. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med. 2000;343:1070&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11027741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lockley SW, Skene DJ, James K, Thapan K, Wright J, Arendt J. Melatonin administration can entrain the free-running circadian system in blind subjects. J Endocrinol. 2000;164:R1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10607943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lockley SW, Skene DJ, Arendt J. Changes in sleep in relation to circadian phase in the blind. In: Touitou Y, editor. Biological Clocks: Mechanisms and Applications. Amsterdam: Elsevier; 1998. pp. 247&#x2013;52.</Citation></Reference><Reference><Citation>McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer&#x2019;s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services task Force on Alzheimer&#x2019;s Disease. Neurology. 1984;34:939&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">6610841</ArticleId></ArticleIdList></Reference><Reference><Citation>Yesavage JA, Friedman L, Ancoli-Israel S, et al. Development of diagnostic criteria for defining sleep disturbance in Alzheimer&#x2019;s disease. J Geriatr Psychiatry Neurol. 2003 in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">12967054</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">7991117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancoli-Israel S, Clopton P, Klauber MR, et al. Use of wrist activity for monitoring sleep/wake in demented nursing-home patients. Sleep. 1997;20(1):24&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2762477</ArticleId><ArticleId IdType="pubmed">9130330</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeh A, Hauri PJ, Kripke DF, Lavie P. The role of actigraphy in the evaluation of sleep disorders. Sleep. 1995;18:288&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">7618029</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeh A, Acebo C. The role of actigraphy in sleep medicine. Sleep Med Rev. 2002;6:113&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">12531147</ArticleId></ArticleIdList></Reference><Reference><Citation>Yesavage JA, Friedman L, Kraemer HC, et al. A follow-up study of actigraphic measures in home-residing Alzheimer disease patients. J Geriatr Psychiatry Neurol. 1998;11:7&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">9686746</ArticleId></ArticleIdList></Reference><Reference><Citation>Colling E, Wright M, Lahr S, Schmedlen L, DeJongh L, Singer C. A comparison of wrist actigraphy with polysomnography as an instrument of sleep detection in elderly persons. Sleep. 2000;23:A378.</Citation></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR. &#x201c;Mini-Mental State&#x201d;: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1974;12:189&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer&#x2019;s disease. Am J Psychiatry. 1984;141:1356&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">6496779</ArticleId></ArticleIdList></Reference><Reference><Citation>Galasko D, Bennet D, Sano M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Disease and Associated Disorders. 1997;11:S33&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9236950</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M. A rating scale for depression. J Neurol, Neurosurg Psychiatry. 1960;23:56&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC495331</ArticleId><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer C, Tractenberg R, Kaye J, et al. ADCS clinical trial of melatonin for the sleep disturbance of Alzheimer&#x2019;s disease: case report of an unusual sleep/wake cycle and response to melatonin. Am J Geriatr Psychiatry. 2002;2(Suppl 1):92.</Citation></Reference><Reference><Citation>Lewy AJ, Cutker NL, Sack RL. The endogenous melatonin profile as a marker for circadian phase position. J Biol Rhythms. 1999;14(3):227&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">10452335</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Ping Shi J, Leclair OU. Melatonin for treatment of age-related insomnia. J Clin Endocrinol Metab. 2001;86(10):4727&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">11600532</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewy AJ, Emens JS, Sack RL, Hasler BP, Bernert RA. Low, but not high doses of melatonin entrained a free-running blind person with a long circadian period. Chronobiol Int. 2002;19(3):649&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">12069043</ArticleId></ArticleIdList></Reference><Reference><Citation>Serfaty M, Kennell-Webb S, Warner J, Blizard, Raven P. Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry. 2002;17:1120&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12461760</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariot PN, Ryan M, Porteinsson AP, Loy R, Schneider LS. Pharmocologic therapy for behavioral symptoms of Alzheimer&#x2019;s disease. Clin Geriatr Med. 2001;17:359&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">11375140</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14657444</PMID><DateCompleted><Year>2003</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue CitedMedium="Internet"><Volume>349</Volume><Issue>23</Issue><PubDate><Year>2003</Year><Month>Dec</Month><Day>04</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>Transient memory impairment and hallucinations associated with tolterodine use.</ArticleTitle><Pagination><StartPage>2274</StartPage><EndPage>2275</EndPage><MedlinePgn>2274-5</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsao</LastName><ForeName>Jack W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Heilman</LastName><ForeName>Kenneth M</ForeName><Initials>KM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001559">Benzhydryl Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003408">Cresols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018727">Muscarinic Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>33RU150WUN</RegistryNumber><NameOfSubstance UI="D010665">Phenylpropanolamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>5T619TQR3R</RegistryNumber><NameOfSubstance UI="D000068737">Tolterodine Tartrate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001559" MajorTopicYN="N">Benzhydryl Compounds</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003408" MajorTopicYN="N">Cresols</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006212" MajorTopicYN="N">Hallucinations</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018727" MajorTopicYN="N">Muscarinic Antagonists</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010665" MajorTopicYN="Y">Phenylpropanolamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068737" MajorTopicYN="N">Tolterodine Tartrate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014549" MajorTopicYN="N">Urinary Incontinence</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14657444</ArticleId><ArticleId IdType="doi">10.1056/NEJM200312043492325</ArticleId><ArticleId IdType="pii">349/23/2274</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14657499</PMID><DateCompleted><Year>2003</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><Issue>5651</Issue><PubDate><Year>2003</Year><Month>Dec</Month><Day>05</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein.</ArticleTitle><Pagination><StartPage>1769</StartPage><EndPage>1772</EndPage><MedlinePgn>1769-72</MedlinePgn></Pagination><Abstract><AbstractText>Genome-wide screens were performed in yeast to identify genes that enhance the toxicity of a mutant huntingtin fragment or of alpha-synuclein. Of 4850 haploid mutants containing deletions of nonessential genes, 52 were identified that were sensitive to a mutant huntingtin fragment, 86 that were sensitive to alpha-synuclein, and only one mutant that was sensitive to both. Genes that enhanced toxicity of the mutant huntingtin fragment clustered in the functionally related cellular processes of response to stress, protein folding, and ubiquitin-dependent protein catabolism, whereas genes that modified alpha-synuclein toxicity clustered in the processes of lipid metabolism and vesicle-mediated transport. Genes with human orthologs were overrepresented in our screens, suggesting that we may have discovered conserved and nonoverlapping sets of cell-autonomous genes and pathways that are relevant to Huntington's disease and Parkinson's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Willingham</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Washington, Seattle, WA 98195-7280, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Outeiro</LastName><ForeName>Tiago Fleming</ForeName><Initials>TF</Initials></Author><Author ValidYN="Y"><LastName>DeVit</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Lindquist</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials></Author><Author ValidYN="Y"><LastName>Muchowski</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086055">HTT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071058">Huntingtin Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497604">SNCA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051843">Synucleins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001692" MajorTopicYN="N">Biological Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017353" MajorTopicYN="N">Gene Deletion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005800" MajorTopicYN="N">Genes, Fungal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071058" MajorTopicYN="N">Huntingtin Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015538" MajorTopicYN="N">Nitrosation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009997" MajorTopicYN="N">Osmotic Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051843" MajorTopicYN="N">Synucleins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014170" MajorTopicYN="N">Transformation, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14657499</ArticleId><ArticleId IdType="doi">10.1126/science.1090389</ArticleId><ArticleId IdType="pii">302/5651/1769</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14657500</PMID><DateCompleted><Year>2003</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><Issue>5651</Issue><PubDate><Year>2003</Year><Month>Dec</Month><Day>05</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Yeast cells provide insight into alpha-synuclein biology and pathobiology.</ArticleTitle><Pagination><StartPage>1772</StartPage><EndPage>1775</EndPage><MedlinePgn>1772-5</MedlinePgn></Pagination><Abstract><AbstractText>Alpha-synuclein is implicated in several neurodegenerative disorders, such as Parkinson's disease and multiple system atrophy, yet its functions remain obscure. When expressed in yeast, alpha-synuclein associated with the plasma membrane in a highly selective manner, before forming cytoplasmic inclusions through a concentration-dependent, nucleated process. Alpha-synuclein inhibited phospholipase D, induced lipid droplet accumulation, and affected vesicle trafficking. This readily manipulable system provides an opportunity to dissect the molecular pathways underlying normal alpha-synuclein biology and the pathogenic consequences of its misfolding.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Outeiro</LastName><ForeName>Tiago Fleming</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindquist</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NS044829-01</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C092350">FM 4-64</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005456">Fluorescent Dyes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011726">Pyridinium Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000644">Quaternary Ammonium Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051843">Synucleins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.4.4</RegistryNumber><NameOfSubstance UI="D010739">Phospholipase D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004705" MajorTopicYN="N">Endocytosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005456" MajorTopicYN="N">Fluorescent Dyes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007425" MajorTopicYN="N">Intracellular Membranes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010739" MajorTopicYN="N">Phospholipase D</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017354" MajorTopicYN="N">Point Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011726" MajorTopicYN="N">Pyridinium Compounds</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000644" MajorTopicYN="N">Quaternary Ammonium Compounds</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051843" MajorTopicYN="N">Synucleins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014617" MajorTopicYN="N">Vacuoles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2007</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14657500</ArticleId><ArticleId IdType="mid">NIHMS15899</ArticleId><ArticleId IdType="pmc">PMC1780172</ArticleId><ArticleId IdType="doi">10.1126/science.1090439</ArticleId><ArticleId IdType="pii">302/5651/1772</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lucking CB, Brice A. Cell Mol Life Sci. 2000;57:1894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11146993</ArticleId><ArticleId IdType="pubmed">11215516</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasser T. J Neurol. 2001;248:833.</Citation><ArticleIdList><ArticleId IdType="pubmed">11697518</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitada T, et al. Nature. 1998;392:605.</Citation><ArticleIdList><ArticleId IdType="pubmed">9560156</ArticleId></ArticleIdList></Reference><Reference><Citation>Leroy E, et al. Nature. 1998;395:451.</Citation><ArticleIdList><ArticleId IdType="pubmed">9774100</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT., Jr Cell. 2002;111:209.</Citation><ArticleIdList><ArticleId IdType="pubmed">12408865</ArticleId></ArticleIdList></Reference><Reference><Citation>Muchowski PJ. Neuron. 2002;35:9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12123602</ArticleId></ArticleIdList></Reference><Reference><Citation>Materials and methods, additional data, and other supporting materials concerning data not shown are available on Science Online.</Citation></Reference><Reference><Citation>McLean PJ, Kawamata H, Hyman BT. Neuroscience. 2001;104:901.</Citation><ArticleIdList><ArticleId IdType="pubmed">11440819</ArticleId></ArticleIdList></Reference><Reference><Citation>T. F. Outeiro, S. Lindquist, data not shown.</Citation></Reference><Reference><Citation>Jo E, McLaurin J, Yip CM, St George-Hyslop P, Fraser PE. J Biol Chem. 2000;275:34328.</Citation><ArticleIdList><ArticleId IdType="pubmed">10915790</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeropoulos MH, et al. Science. 1997;276:2045.</Citation><ArticleIdList><ArticleId IdType="pubmed">9197268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger R, et al. Nature Genet. 1998;18:106.</Citation><ArticleIdList><ArticleId IdType="pubmed">9462735</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo E, Fuller N, Rand RP, St George-Hyslop P, Fraser PE. J Mol Biol. 2002;315:799.</Citation><ArticleIdList><ArticleId IdType="pubmed">11812148</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussell R, Jr, Eliezer D. J Mol Biol. 2003;329:763.</Citation><ArticleIdList><ArticleId IdType="pubmed">12787676</ArticleId></ArticleIdList></Reference><Reference><Citation>Berke SJ, Paulson HL. Curr Opin Genet Dev. 2003;13:253.</Citation><ArticleIdList><ArticleId IdType="pubmed">12787787</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Hardy J, Fischbeck KH. Science. 2002;296:1991.</Citation><ArticleIdList><ArticleId IdType="pubmed">12065827</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway KA, et al. Proc Natl Acad Sci USA. 2000;97:571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC15371</ArticleId><ArticleId IdType="pubmed">10639120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hershko A, Ciechanover A, Varshavsky A. Nature Med. 2000;6:1073.</Citation><ArticleIdList><ArticleId IdType="pubmed">11017125</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA. J Neurosci. 2001;21:9549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763041</ArticleId><ArticleId IdType="pubmed">11739566</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampathu DM, Giasson BI, Pawlyk AC, Trojanowski JQ, Lee VM. Am J Pathol. 2003;163:91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868149</ArticleId><ArticleId IdType="pubmed">12819014</ArticleId></ArticleIdList></Reference><Reference><Citation>Bence NF, Sampat RM, Kopito RR. Science. 2001;292:1552.</Citation><ArticleIdList><ArticleId IdType="pubmed">11375494</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy DD, Rueter SM, Trojanowski JQ, Lee VM. J Neurosci. 2000;20:3214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6773130</ArticleId><ArticleId IdType="pubmed">10777786</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole NB, et al. J Biol Chem. 2002;277:6344.</Citation><ArticleIdList><ArticleId IdType="pubmed">11744721</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenco JM, Rawlingson A, Daniels B, Morris AJ. Biochemistry. 1998;37:4901.</Citation><ArticleIdList><ArticleId IdType="pubmed">9538008</ArticleId></ArticleIdList></Reference><Reference><Citation>Bankaitis VA, Aitken JR, Cleves AE, Dowhan W. Nature. 1990;347:561.</Citation><ArticleIdList><ArticleId IdType="pubmed">2215682</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudge SA, Pettitt TR, Zhou C, Wakelam MJ, Engebrecht JA. Genetics. 2001;158:1431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1461740</ArticleId><ArticleId IdType="pubmed">11514437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreenivas A, Patton-Vogt JL, Bruno V, Griac P, Henry SA. J Biol Chem. 1998;273:16635.</Citation><ArticleIdList><ArticleId IdType="pubmed">9642212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon R, et al. Proc Natl Acad Sci USA. 2001;98:9110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC55381</ArticleId><ArticleId IdType="pubmed">11481478</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon R, et al. Neuron. 2003;37:583.</Citation><ArticleIdList><ArticleId IdType="pubmed">12597857</ArticleId></ArticleIdList></Reference><Reference><Citation>Willingham S, Outeiro TF, DeVit MJ, Lindquist SL, Muchowski PJ. Science. 2003;302:1769.</Citation><ArticleIdList><ArticleId IdType="pubmed">14657499</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson TM, Dawson VL. J Clin Invest. 2003;111:145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151882</ArticleId><ArticleId IdType="pubmed">12531866</ArticleId></ArticleIdList></Reference><Reference><Citation>Singleton AB, et al. Science. 2003;302:841.</Citation><ArticleIdList><ArticleId IdType="pubmed">14593171</ArticleId></ArticleIdList></Reference><Reference><Citation>This work was funded by NIH/National Institute of Neurological Disorders and Stroke (grant NS044829-01). T.F.O. was partially supported by Programa Prax-is XXI, Fundacao para a Ciencia e Tecnologia, Portugal. We thank P. Lansbury, R. Esposito, J. Engebrecht, H. Chang, and S. Henry for plasmids and strains and members of the Lindquist laboratory for critical reading of this manuscript.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14676042</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-9942</ISSN><JournalIssue CitedMedium="Print"><Volume>60</Volume><Issue>12</Issue><PubDate><Year>2003</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Archives of neurology</Title><ISOAbbreviation>Arch Neurol</ISOAbbreviation></Journal><ArticleTitle>Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.</ArticleTitle><Pagination><StartPage>1685</StartPage><EndPage>1691</EndPage><MedlinePgn>1685-91</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Alzheimer disease (AD) may be caused by the toxic accumulation of beta-amyloid (Abeta).</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To test this theory, we developed a clinical intervention using clioquinol, a metal-protein-attenuating compound (MPAC) that inhibits zinc and copper ions from binding to Abeta, thereby promoting Abeta dissolution and diminishing its toxic properties.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A pilot phase 2 clinical trial in patients with moderately severe Alzheimer disease.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-six subjects were randomized. The effect of treatment was significant in the more severely affected group (baseline cognitive subscale score of the Alzheimer's Disease Assessment Scale, &gt;/=25), due to a substantial worsening of scores in those taking placebo compared with minimal deterioration for the clioquinol group. Plasma Abeta42 levels declined in the clioquinol group and increased in the placebo group. Plasma zinc levels rose in the clioquinol-treated group. The drug was well tolerated.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Subject to the usual caveats inherent in studies with small sample size, this pilot phase 2 study supports further investigation of this novel treatment strategy using a metal-protein-attenuating compound.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ritchie</LastName><ForeName>Craig W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Departments of Pathology, The University of Melbourne, The Mental Health Research Institute of Victoria, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bush</LastName><ForeName>Ashley I</ForeName><Initials>AI</Initials></Author><Author ValidYN="Y"><LastName>Mackinnon</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Macfarlane</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Mastwyk</LastName><ForeName>Maree</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>MacGregor</LastName><ForeName>Lachlan</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Kiers</LastName><ForeName>Lyn</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Cherny</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qiao-Xin</ForeName><Initials>QX</Initials></Author><Author ValidYN="Y"><LastName>Tammer</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Carrington</LastName><ForeName>Darryl</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Mavros</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Volitakis</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Xilinas</LastName><ForeName>Michel</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ames</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Beyreuther</LastName><ForeName>Konrad</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Tanzi</LastName><ForeName>Rudolph E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><LastName>Masters</LastName><ForeName>Colin L</ForeName><Initials>CL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Neurol</MedlineTA><NlmUniqueID>0372436</NlmUniqueID><ISSNLinking>0003-9942</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002614">Chelating Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C078592">amyloid beta-protein (1-40)</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C075222">amyloid beta-protein (1-42)</NameOfSubstance></Chemical><Chemical><RegistryNumber>789U1901C5</RegistryNumber><NameOfSubstance UI="D003300">Copper</NameOfSubstance></Chemical><Chemical><RegistryNumber>7BHQ856EJ5</RegistryNumber><NameOfSubstance UI="D007464">Clioquinol</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance UI="D015032">Zinc</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Arch Neurol. 2004 May;61(5):776</RefSource></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Arch Neurol. 2003 Dec;60(12):1678-9. doi: 10.1001/archneur.60.12.1678.</RefSource><PMID Version="1">14676040</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002614" MajorTopicYN="N">Chelating Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007464" MajorTopicYN="N">Clioquinol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003300" MajorTopicYN="N">Copper</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>8</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14676042</ArticleId><ArticleId IdType="doi">10.1001/archneur.60.12.1685</ArticleId><ArticleId IdType="pii">60/12/1685</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14677633</PMID><DateCompleted><Year>2004</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1474-9718</ISSN><JournalIssue CitedMedium="Print"><Volume>2</Volume><Issue>6</Issue><PubDate><Year>2003</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Aging cell</Title><ISOAbbreviation>Aging Cell</ISOAbbreviation></Journal><ArticleTitle>Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of alzheimer's disease.</ArticleTitle><Pagination><StartPage>305</StartPage><EndPage>318</EndPage><MedlinePgn>305-18</MedlinePgn></Pagination><Abstract><AbstractText>Anterograde transport of herpes simplex virus (HSV) from its site of synthesis in the neuronal cell body out the neuronal process to the mucosal membrane is crucial for transmission of the virus from one person to another, yet the molecular mechanism is not known. By injecting GFP-labeled HSV into the giant axon of the squid, we reconstitute fast anterograde transport of human HSV and use this as an assay to uncover the underlying molecular mechanism. HSV travels by fast axonal transport at velocities four-fold faster (0.9 microm/sec average, 1.2 microm/sec maximal) than that of mitochondria moving in the same axon (0.2 microm/sec) and ten-fold faster than negatively charged beads (0.08 microm/sec). Transport of HSV utilizes cellular transport mechanisms because it appears to be driven from inside cellular membranes as revealed by negative stain electron microscopy and by the association of TGN46, a component of the cellular secretory pathway, with GFP-labeled viral particles. Finally, we show that amyloid precursor protein (APP), a putative receptor for the microtubule motor, kinesin, is a major component of viral particles, at least as abundant as any viral encoded protein, while another putative motor receptor, JIP 1/2, is not detected. Conventional kinesin is also associated with viral particles. This work links fast anterograde transport of the common pathogen, HSV, with the neurodegenerative Alzheimer's disease. This novel connection should prompt new ideas for treatment and prevention strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Satpute-Krishnan</LastName><ForeName>Prasanna</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeGiorgis</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Bearer</LastName><ForeName>Elaine L</ForeName><Initials>EL</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM047368</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GMS 47562</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Cell</MedlineTA><NlmUniqueID>101130839</NlmUniqueID><ISSNLinking>1474-9718</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008164">Luminescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-22-9</RegistryNumber><NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.4</RegistryNumber><NameOfSubstance UI="D016547">Kinesins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Aging Cell.2010 Jun;9(3):454</RefSource></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Aging Cell. 2004 Apr;3(2):79-80. doi: 10.1111/j.1474-9728.2004.00088.x.</RefSource><PMID Version="1">15038823</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001370" MajorTopicYN="N">Axonal Transport</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049832" MajorTopicYN="N">Decapodiformes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049452" MajorTopicYN="N">Green Fluorescent Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016547" MajorTopicYN="N">Kinesins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008164" MajorTopicYN="N">Luminescent Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018139" MajorTopicYN="N">Simplexvirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>8</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14677633</ArticleId><ArticleId IdType="mid">NIHMS452058</ArticleId><ArticleId IdType="pmc">PMC3622731</ArticleId><ArticleId IdType="doi">10.1046/j.1474-9728.2003.00069.x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adams RJ, Bray D. Rapid transport of foreign particles microinjected into crab axons. Nature. 1983;303:718&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">6190095</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen RD, Metuzals J, Tasaki I, Brady ST, Gilbert SP. Fast axonal transport in squid giant axon. Science. 1982;218:1127&#x2013;1129.</Citation><ArticleIdList><ArticleId IdType="pubmed">6183744</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer TA, Wirths O, Majtenyi K, Hartmann T, Multhaup G, Beyreuther K, Czech C. Key factors in Alzheimer&#x2019;s disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol. 2001;11:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8098450</ArticleId><ArticleId IdType="pubmed">11145195</ArticleId></ArticleIdList></Reference><Reference><Citation>Bearer EL, Breakefield XO, Schuback D, Reese TS, LaVail JH. Retrograde axonal transport of herpes simplex virus: evidence for a single mechanism and a role for tegument. Proc Natl Acad Sci USA. 2000;97:8146&#x2013;8150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16684</ArticleId><ArticleId IdType="pubmed">10884436</ArticleId></ArticleIdList></Reference><Reference><Citation>Bearer EL, DeGiorgis JA, Bodner RA, Kao AW, Reese TS. Evidence for myosin motors on organelles in squid axoplasm. Proc Natl Acad Sci USA. 1993;90:11252&#x2013;11256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC47960</ArticleId><ArticleId IdType="pubmed">8248236</ArticleId></ArticleIdList></Reference><Reference><Citation>Bearer EL, DeGiorgis JA, Jaffe H, Medeiros NA, Reese TS. An axoplasmic myosin with a calmodulin-like light chain. Proc Natl Acad Sci USA. 1996a;93:6064&#x2013;6068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC39189</ArticleId><ArticleId IdType="pubmed">8650220</ArticleId></ArticleIdList></Reference><Reference><Citation>Bearer EL, DeGiorgis JA, Medeiros NA, Reese TS. Actin-based motility of isolated axoplasmic organelles. Cell Motil Cytoskel. 1996b;33:106&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4507568</ArticleId><ArticleId IdType="pubmed">8635200</ArticleId></ArticleIdList></Reference><Reference><Citation>Bearer EL, Reese TS. Association of actin filaments with axonal microtubule tracts. J Neurocytol. 1999;28:85&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4643673</ArticleId><ArticleId IdType="pubmed">10590510</ArticleId></ArticleIdList></Reference><Reference><Citation>Beher D, Wrigley JD, Owens AP, Shearman MS. Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity. J Neurochem. 2002;82:563&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pubmed">12153480</ArticleId></ArticleIdList></Reference><Reference><Citation>Beushausen S, Kladakis A, Jaffe H. Kinesin light chains: identification and characterization of a family of proteins from the optic lobe of the squid Loligo pealii. DNA Cell Biol. 1993;12:901&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">8274223</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyreuther K, Bush AI, Dyrks T, Hilbich C, Konig G, Monning U, Multhaup G, Prior R, Rumble B, Schubert W, et al. Mechanisms of amyloid deposition in Alzheimer&#x2019;s disease. Ann NY Acad Sci. 1991;640:129&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">1776729</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowman AB, Kamal A, Ritchings BW, Philp AV, McGrail M, Gindhart JG, Goldstein LS. Kinesin-dependent axonal transport is mediated by the sunday driver (SYD) protein. Cell. 2000;103:583&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pubmed">11106729</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgos JS, Ramirez C, Sastre I, Bullido MJ, Valdivieso F, Selkoe DJ. Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system. J Virol. 2002;76:12394&#x2013;12398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136918</ArticleId><ArticleId IdType="pubmed">12414984</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrd DT, Kawasaki M, Walcoff M, Hisamoto N, Matsumoto K, Jin Y. UNC-16, a JNK-signaling scaffold protein, regulates vesicle transport in C. elegans. Neuron. 2001;32:787&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">11738026</ArticleId></ArticleIdList></Reference><Reference><Citation>Campadelli G, Brandimarti R, Di Lazzaro C, Ward PL, Roizman B, Torrisi MR. Fragmentation and dispersal of Golgi proteins and redistribution of glycoproteins and glycolipids processed through the Golgi apparatus after infection with herpes simplex virus 1. Proc Natl Acad Sci USA. 1993;90:2798&#x2013;2802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC46183</ArticleId><ArticleId IdType="pubmed">8385343</ArticleId></ArticleIdList></Reference><Reference><Citation>Caplan MJ. Ion pump sorting in polarized renal epithelial cells. Kidney Int. 2001;60:427&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">11473621</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporaso GL, Takei K, Gandy SE, Matteoli M, Mundigl O, Greengard P, De Camilli P. Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer beta/A4 amyloid precursor protein. J Neurosci. 1994;14:3122&#x2013;3138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6577440</ArticleId><ArticleId IdType="pubmed">8182461</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen DL. Squid p196, a new member of the myosin-V class of motor proteins, is associated with motile axoplasmic organelles. Brain Res. 2001;890:233&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">11164789</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper B, Craessaerts K, Dewachter I, Moechars D, Greenberg B, Van Leuven F, Van den Berghe H, Wall JS, Brown JC. Basolateral secretion of amyloid precursor protein in Madin-Darby canine kidney cells is disturbed by alterations of intracellular pH and by introducing a mutation associated with familial Alzheimer&#x2019;s disease. J Biol Chem. 1995;270:4058&#x2013;4065.</Citation><ArticleIdList><ArticleId IdType="pubmed">7876155</ArticleId></ArticleIdList></Reference><Reference><Citation>DeGiorgis JA, Reese TS, Bearer EL. Association of a nonmuscle myosin II with axoplasmic organelles. Mol Biol Cell. 2002;13:1046&#x2013;1057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC99618</ArticleId><ArticleId IdType="pubmed">11907281</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson CB, Itzhaki RF. Herpes simplex virus type 1 and Alzheimer&#x2019;s disease. Neurobiol Aging. 1999;20:457&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">10604441</ArticleId></ArticleIdList></Reference><Reference><Citation>Dohner K, Wolfstein A, Prank U, Echeverri C, Dujardin D, Vallee R, Sodeik B. Function of dynein and dynactin in herpes simplex virus capsid transport. Mol Biol Cell. 2002;13:2795&#x2013;2809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC117943</ArticleId><ArticleId IdType="pubmed">12181347</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyrks T, Weidemann A, Multhaup G, Salbaum JM, Lemaire HG, Kang J, Muller-Hill B, Masters CL, Beyreuther K. Identification, trans-membrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer&#x2019;s disease. EMBO J. 1988;7:949&#x2013;957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC454420</ArticleId><ArticleId IdType="pubmed">2900137</ArticleId></ArticleIdList></Reference><Reference><Citation>Enquist LW, Tomishima MJ, Gross S, Smith GA. Directional spread of an alpha-herpesvirus in the nervous system. Vet Microbiol. 2002;86:5&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">11888685</ArticleId></ArticleIdList></Reference><Reference><Citation>Evin G, Weidemann A. Biogenesis and metabolism of Alzheimer&#x2019;s disease Abeta amyloid peptides. Peptides. 2002;23:1285&#x2013;1297.</Citation><ArticleIdList><ArticleId IdType="pubmed">12128085</ArticleId></ArticleIdList></Reference><Reference><Citation>Galbraith JA, Reese TS, Schlief ML, Gallant PE. Slow transport of unpolymerized tubulin and polymerized neurofilament in the squid giant axon. Proc Natl Acad Sci USA. 1999;96:11589&#x2013;11594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18078</ArticleId><ArticleId IdType="pubmed">10500221</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett. 1993;160:139&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">8247344</ArticleId></ArticleIdList></Reference><Reference><Citation>Gindhart JG, Jr, Goldstein LS. Tetratrico peptide repeats are present in the kinesin light chain. Trends Biochem Sci. 1996;21:52&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">8851660</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein L. Kinesin molecular motors: transport pathways, receptors, and human disease. Proc Natl Acad Sci USA. 2001;98:6999&#x2013;7003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC34613</ArticleId><ArticleId IdType="pubmed">11416178</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein DJ, Weller SK. Factor (s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant. Virology. 1988;166:41&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">2842955</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein LS, Yang Z. Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu Rev Neurosci. 2000;23:39&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">10845058</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant WB, Campbell A, Itzhaki RF, Savory J. The significance of environmental factors in the etiology of Alzheimer&#x2019;s disease. J Alzheimers Dis. 2002;4:179&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">12226537</ArticleId></ArticleIdList></Reference><Reference><Citation>Granzow H, Klupp BG, Fuchs Veits W, Osterrieder J, Mettenleiter NTC. Egress of alphaherpes viruses: comparative ultrastructural study. J Virol. 2001;75:3675&#x2013;3684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114859</ArticleId><ArticleId IdType="pubmed">11264357</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawardena S, Goldstein LS. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron. 2001;32(3):389&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">11709151</ArticleId></ArticleIdList></Reference><Reference><Citation>Haarr L, Skulstad S. The herpes simplex virus type 1 particle: structure and molecular functions. Apmis. 1994;102:321&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pubmed">8024735</ArticleId></ArticleIdList></Reference><Reference><Citation>Heine JW, Honess RW, Cassai E, Roizman B. Proteins specified by herpes simplex virus. XII The virion polypeptides of type 1 strains. J Virol. 1974;14:640&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC355559</ArticleId><ArticleId IdType="pubmed">4369085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemling N, Roytta M, Rinne J, Pollanen P, Broberg E, Tapio V, Vahlberg T, Hukkanen V. Herpesviruses in brains in Alzheimer&#x2019;s and Parkinson&#x2019;s diseases. Ann Neurol. 2003;54:267&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">12891684</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland DJ, Miranda-Saksena M, Boadle RA, Armati P, Cunningham AL. Anterograde transport of herpes simplex virus proteins in axons of peripheral human fetal neurons: an immunoelectron microscopy study. J Virol. 1999;73:8503&#x2013;8511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112870</ArticleId><ArticleId IdType="pubmed">10482603</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer&#x2019;s disease. Proc Natl Acad Sci USA. 2000;97:2892&#x2013;2897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16026</ArticleId><ArticleId IdType="pubmed">10694577</ArticleId></ArticleIdList></Reference><Reference><Citation>Huemer HP, Menzel HJ, Potratz D, Brake B, Falke D, Utermann G, Dierich MP. Herpes simplex virus binds to human serum lipoprotein. Intervirology. 1988;29:68&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">2842273</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki RF, Dobson CB. Alzheimer&#x2019;s disease and herpes. CMAJ. 2002;167:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC116625</ArticleId><ArticleId IdType="pubmed">12137067</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer&#x2019;s disease. Lancet. 1997;349:241&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">9014911</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF. Latent herpes simplex virus type 1 in normal and Alzheimer&#x2019;s disease brains. J Med Virol. 1991;33:224&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">1649907</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen HL, Norrild B. Temporal morphogenesis of herpes simplex virus type 1-infected and brefeldin A-treated human fibroblasts. Mol Med. 2002;8:210&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2039982</ArticleId><ArticleId IdType="pubmed">12149570</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson DC, Spear PG. Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. J Virol. 1982;43:1102&#x2013;1112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC256222</ArticleId><ArticleId IdType="pubmed">6292453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaether C, Skehel P, Dotti CG. Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. Mol Biol Cell. 2000;11:1213&#x2013;1224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC14842</ArticleId><ArticleId IdType="pubmed">10749925</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature. 2001;414:643&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">11740561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal A, Goldstein LS. Principles of cargo attachment to cytoplasmic motor proteins. Curr Opin Cell Biol. 2002;14:63&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">11792546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal A, Stokin GB, Yang Z, Xia CH, Goldstein LS. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron. 2000;28:449&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pubmed">11144355</ArticleId></ArticleIdList></Reference><Reference><Citation>Klopfenstein DR, Tomishige M, Stuurman N, Vale RD. Role of phosphatidylinositol (4,5) bisphosphate organization in membrane transport by the Unc104 kinesin motor. Cell. 2002;109:347&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2851634</ArticleId><ArticleId IdType="pubmed">12015984</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga J, Chatterjee S, Whitley RJ, Jensen HL, Norrild B. Studies on herpes simplex virus type 1 glycoproteins using monoclonal antibodies. Virology. 1986;151:385&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pubmed">3010559</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, Tanzi RE, Hyman BT, Strickland DK. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell. 1995;82:331&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">7543026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensson K, Lycke E, Roytta M, Svennerholm B, Vahlne A. Neuritic transport of herpes simplex virus in rat sensory neurons in vitro. Effects of substances interacting with microtubular function and axonal flow [nocodazole, taxol and erythro-9&#x2013;3-(2-hydroxynonyl) adenine] J Gen Virol. 1986;67:2023&#x2013;2028.</Citation><ArticleIdList><ArticleId IdType="pubmed">2427647</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuznetsov SA, Langford GM, Weiss DG. Actin-dependent organelle movement in squid axoplasm. Nature. 1992;356:722&#x2013;725.</Citation><ArticleIdList><ArticleId IdType="pubmed">1570018</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford GM, Kuznetsov SA, Johnson D, Cohen DL, Weiss DG. Movement of axoplasmic organelles on actin filaments assembled on acrosomal processes: evidence for a barbed-end-directed organelle motor. J Cell Sci. 1994;107:2291&#x2013;2298.</Citation><ArticleIdList><ArticleId IdType="pubmed">7527056</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasek RJ, Brady ST. Attachment of transported vesicles to microtubules in axoplasm is facilitated by AMP-PNP. Nature. 1985;316:645&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pubmed">4033761</ArticleId></ArticleIdList></Reference><Reference><Citation>van Leeuwen H, Elliott G, O&#x2019;Hare P. Evidence of a role for nonmuscle myosin II in herpes simplex virus type 1 egress. J Virol. 2002;76:3471&#x2013;3481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136054</ArticleId><ArticleId IdType="pubmed">11884571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo AC, Thinakaran G, Slunt HH, Sisodia SS. Metabolism of the amyloid precursor-like protein 2 in MDCK cells. Polarized trafficking occurs independent of the chondroitin sulfate glycosaminoglycan chain. J Biol Chem. 1995;270:12641&#x2013;12645.</Citation><ArticleIdList><ArticleId IdType="pubmed">7759513</ArticleId></ArticleIdList></Reference><Reference><Citation>Lycke E, Kristensson K, Svennerholm B, Vahlne A, Ziegler R. Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture. J Gen Virol. 1984;65:55&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">6319574</ArticleId></ArticleIdList></Reference><Reference><Citation>Martenson C, Stone K, Reedy M, Sheetz M, Whealy ME, Robbins AK, Tufaro F, Enquist LW. Fast axonal transport is required for growth cone advance. Nature. 1993;366:66&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">7694151</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda S, Yasukawa T, Homma Y, Ito Y, Niikura T, Hiraki T, Hirai S, Ohno S, Kita Y, Kawasumi M, et al. c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer&#x2019;s amyloid precursor protein with JNK. J Neurosci. 2001;21:6597&#x2013;6607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763068</ArticleId><ArticleId IdType="pubmed">11517249</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan TN, Johnson DC. Cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions. J Virol. 2001;75:1928&#x2013;1940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC115139</ArticleId><ArticleId IdType="pubmed">11160692</ArticleId></ArticleIdList></Reference><Reference><Citation>Mettenleiter TC. Herpesvirus assembly and egress. J Virol. 2002;76:1537&#x2013;1547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC135924</ArticleId><ArticleId IdType="pubmed">11799148</ArticleId></ArticleIdList></Reference><Reference><Citation>Miki H, Setou M, Kaneshiro K, Hirokawa N. All kinesin superfamily protein, KIF, genes in mouse and human. Proc Natl Acad Sci USA. 2001;98:7004&#x2013;7011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC34614</ArticleId><ArticleId IdType="pubmed">11416179</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda-Saksena M, Armati P, Boadle RA, Holland DJ, Cunningham AL. Anterograde transport of herpes simplex virus type 1 in cultured, dissociated human and rat dorsal root ganglion neurons. J Virol. 2000;74:1827&#x2013;1839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC111661</ArticleId><ArticleId IdType="pubmed">10644356</ArticleId></ArticleIdList></Reference><Reference><Citation>Molyneaux BJ, Langford GM. Characterization of antibodies to the head and tail domains of squid brain myosin V. Biol Bull. 1997;193:222&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">9390390</ArticleId></ArticleIdList></Reference><Reference><Citation>Molyneaux BJ, Mulcahey MK, Stafford P, Langford GM. Sequence and phylogenetic analysis of squid myosin-V: a vesicle motor in nerve cells. Cell Motil Cytoskel. 2000;46:108&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">10891856</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris RL, Hollenbeck PJ. The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. J Cell Sci. 1993;104:917&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pubmed">8314882</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakajima K, Takei Y, Tanaka Y, Nakagawa T, Nakata T, Noda Y, Setou M, Hirokawa N, Wall JS, Brown JC. Molecular motor KIF1C is not essential for mouse survival and motor-dependent retrograde Golgi apparatus-to-endoplasmic reticulum transport. Mol Cell Biol. 2002;22:866&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC133549</ArticleId><ArticleId IdType="pubmed">11784862</ArticleId></ArticleIdList></Reference><Reference><Citation>Neve RL, McPhie DL, Chen Y. Alzheimer&#x2019;s disease: a dysfunction of the amyloid precursor protein (1) Brain Res. 2000;886:54&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">11119687</ArticleId></ArticleIdList></Reference><Reference><Citation>Newcomb WW, Trus BL, Booy FP, Steven AC, Wall JS, Brown JC. Structure of the herpes simplex virus capsid. Molecular composition of the pentons and the triplexes. J Mol Biol. 1993;232:499&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">8393939</ArticleId></ArticleIdList></Reference><Reference><Citation>Niclas J, Navone F, Hom-Booher N, Vale RD. Cloning and localization of a conventional kinesin motor expressed exclusively in neurons. Neuron. 1994;12:1059&#x2013;1072.</Citation><ArticleIdList><ArticleId IdType="pubmed">7514426</ArticleId></ArticleIdList></Reference><Reference><Citation>Pant HC, Shecket G, Gainer H, Lasek RJ. Neurofilament protein is phosphorylated in the squid giant axon. J Cell Biol. 1978;78:R23&#x2013;R27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2110134</ArticleId><ArticleId IdType="pubmed">690167</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrzik CU, Busse T, Merriam DE, Weggen S, Koo EH. The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. EMBO J. 2002;21:5691&#x2013;5700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC131065</ArticleId><ArticleId IdType="pubmed">12411487</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott AR, Lucocq JM, James J, Lister JM, Ponnambalam S. Distinct compartmentalization of TGN46 and beta 1,4-galactosyltransferase in HeLa cells. Eur J Cell Biol. 1997;72:238&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">9084986</ArticleId></ArticleIdList></Reference><Reference><Citation>Price DL, Sisodia SS, Gandy SE. Amyloid beta amyloidosis in Alzheimer&#x2019;s disease. Curr Opin Neurol. 1995;8:268&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">7582041</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyles RB. The association of herpes simplex virus and Alzheimer&#x2019;s disease: a potential synthesis of genetic and environmental factors. Herpes. 2001;8:64&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">11867022</ArticleId></ArticleIdList></Reference><Reference><Citation>Roghi C, Allan VJ, Wall JS, Brown JC. Dynamic association of cytoplasmic dynein heavy chain 1a with the Golgi apparatus and intermediate compartment. J Cell Sci. 1999;112:4673&#x2013;4685.</Citation><ArticleIdList><ArticleId IdType="pubmed">10574715</ArticleId></ArticleIdList></Reference><Reference><Citation>Roizman B, Knipe DM. Herpes simplex viruses and their replication. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott, Williams &amp; Wilkins; 2001. pp. 2399&#x2013;2459.</Citation></Reference><Reference><Citation>Scaduto RC, Jr, Grotyohann LW. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J. 1999;76:469&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1302536</ArticleId><ArticleId IdType="pubmed">9876159</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnapp BJ, Reese TS, Bechtold R. Kinesin is bound with high affinity to squid axon organelles that move to the plus-end of microtubules. J Cell Biol. 1992;119:389&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2289649</ArticleId><ArticleId IdType="pubmed">1400582</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnapp BJ, Vale RD, Sheetz MP, Reese TS. Single microtubules from squid axoplasm support bidirectional movement of organelles. Cell. 1985;40:455&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pubmed">2578325</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroer TA, Brady ST, Kelly RB. Fast axonal transport of foreign synaptic vesicles in squid axoplasm. J Cell Biol. 1985;101:568&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2113654</ArticleId><ArticleId IdType="pubmed">3848436</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ. Alzheimer&#x2019;s disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pubmed">11274343</ArticleId></ArticleIdList></Reference><Reference><Citation>Signor D, Scholey J. Microtubule-based transport along axons, dendrites and axonemes. Essays Biochem. 2000;35:89&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">12471892</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisodia SS, Price DL. Role of the beta-amyloid protein in Alzheimer&#x2019;s disease. Faseb J. 1995;9:366&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">7896005</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GA, Gross SP, Enquist LW. Herpesviruses use bidirectional fast-axonal transport to spread in sensory neurons. Proc Natl Acad Sci USA. 2001;98:3466&#x2013;3470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC30676</ArticleId><ArticleId IdType="pubmed">11248101</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodeik B, Ebersold MW, Helenius A. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J Cell Biol. 1997;136:1007&#x2013;1021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2132479</ArticleId><ArticleId IdType="pubmed">9060466</ArticleId></ArticleIdList></Reference><Reference><Citation>Stannard LM, Fuller AO, Spear PG, Newcomb WW, Trus BL, Booy FP, Steven AC, Wall JS, Brown JC. Herpes simplex virus glycoproteins associated with different morphological entities projecting from the virion envelope. J Gen Virol. 1987;68:715&#x2013;725.</Citation><ArticleIdList><ArticleId IdType="pubmed">3029300</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabb JS, Molyneaux BJ, Cohen DL, Kuznetsov SA, Langford GM. Transport of ER vesicles on actin filaments in neurons by myosin V. J Cell Sci. 1998;111:3221&#x2013;3234.</Citation><ArticleIdList><ArticleId IdType="pubmed">9763516</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarr PE, Roncarati R, Pelicci G, Pelicci PG, D&#x2019;Adamio L. Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc. J Biol Chem. 2002;277:16798&#x2013;16804.</Citation><ArticleIdList><ArticleId IdType="pubmed">11877420</ArticleId></ArticleIdList></Reference><Reference><Citation>Taru H, Kirino Y, Suzuki T. Differential roles of JIP scaffold proteins in the modulation of amyloid precursor protein metabolism. J Biol Chem. 2002;277:27567&#x2013;27574.</Citation><ArticleIdList><ArticleId IdType="pubmed">12023290</ArticleId></ArticleIdList></Reference><Reference><Citation>Terada S, Hirokawa N. Moving on to the cargo problem of microtubule-dependent motors in neurons. Curr Opin Neurobiol. 2000;10:566&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pubmed">11084318</ArticleId></ArticleIdList></Reference><Reference><Citation>Terasaki M, Schmidek A, Galbraith JA, Gallant PE, Reese TS. Transport of cytoskeletal elements in the squid giant axon. Proc Natl Acad Sci USA. 1995;92:11500&#x2013;11503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC40429</ArticleId><ArticleId IdType="pubmed">8524791</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomishima MJ, Enquist LW. A conserved alpha-herpesvirus protein necessary for axonal localization of viral membrane proteins. J Cell Biol. 2001;154:741&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2196449</ArticleId><ArticleId IdType="pubmed">11502759</ArticleId></ArticleIdList></Reference><Reference><Citation>Topp KS, Meade LB, LaVail JH. Microtubule polarity in the peripheral processes of trigeminal ganglion cells: relevance for the retrograde transport of herpes simplex virus. J Neurosci. 1994;14:318&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6576856</ArticleId><ArticleId IdType="pubmed">8283239</ArticleId></ArticleIdList></Reference><Reference><Citation>Vale RD, Reese TS, Sheetz MP. Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility. Cell. 1985a;42:39&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2851632</ArticleId><ArticleId IdType="pubmed">3926325</ArticleId></ArticleIdList></Reference><Reference><Citation>Vale RD, Schnapp BJ, Reese TS, Sheetz MP. Movement of organelles along filaments dissociated from the axoplasm of the squid giant axon. Cell. 1985b;40:449&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">2578324</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhey KJ, Meyer D, Deehan R, Blenis J, Schnapp BJ, Rapoport TA, Margolis B. Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J Cell Biol. 2001;152:959&#x2013;970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2198804</ArticleId><ArticleId IdType="pubmed">11238452</ArticleId></ArticleIdList></Reference><Reference><Citation>Whealy ME, Robbins AK, Tufaro F, Enquist LW. A cellular function is required for pseudorabies virus envelope glycoprotein processing and virus egress. J Virol. 1992;66:3803&#x2013;3810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC241166</ArticleId><ArticleId IdType="pubmed">1316483</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitley RJ. Herpes simplex viruses. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott, Williams &amp; Wilkins; 2001. pp. 2461&#x2013;2506.</Citation></Reference><Reference><Citation>Willard M. Rapid directional translocations in virus replication. J Virol. 2002;76:5220&#x2013;5232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136128</ArticleId><ArticleId IdType="pubmed">11967336</ArticleId></ArticleIdList></Reference><Reference><Citation>Wollert T, Weiss DG, Gerdes HH, Kuznetsov SA, Wall JS, Brown JC. Activation of myosin V-based motility and F-actin-dependent network formation of endoplasmic reticulum during mitosis. J Cell Biol. 2002;159:571&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2173107</ArticleId><ArticleId IdType="pubmed">12438410</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, Schillinger J, Sternberg M, Johnson R, Lee F, Nahmias A, Markowitz L. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988&#x2013;94. J Infect Dis. 2002;185:1019&#x2013;1024.</Citation><ArticleIdList><ArticleId IdType="pubmed">11930310</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng P, Eastman J, Vande Pol S, Pimplikar SW. PAT1, a microtubule-interacting protein, recognizes the basolateral sorting signal of amyloid precursor protein. Proc Natl Acad Sci USA. 1998;95:14745&#x2013;14750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC24520</ArticleId><ArticleId IdType="pubmed">9843960</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14687544</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>6</Issue><PubDate><Year>2003</Year><Month>Dec</Month><Day>18</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death.</ArticleTitle><Pagination><StartPage>1087</StartPage><EndPage>1093</EndPage><MedlinePgn>1087-93</MedlinePgn></Pagination><Abstract><AbstractText>Converging evidence suggests that the accumulation of cerebral amyloid beta-protein (Abeta) in Alzheimer's disease (AD) reflects an imbalance between the production and degradation of this self-aggregating peptide. Upregulation of proteases that degrade Abeta thus represents a novel therapeutic approach to lowering steady-state Abeta levels, but the consequences of sustained upregulation in vivo have not been studied. Here we show that transgenic overexpression of insulin-degrading enzyme (IDE) or neprilysin (NEP) in neurons significantly reduces brain Abeta levels, retards or completely prevents amyloid plaque formation and its associated cytopathology, and rescues the premature lethality present in amyloid precursor protein (APP) transgenic mice. Our findings demonstrate that chronic upregulation of Abeta-degrading proteases represents an efficacious therapeutic approach to combating Alzheimer-type pathology in vivo.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leissring</LastName><ForeName>Malcolm A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farris</LastName><ForeName>Wesley</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Alice Y</ForeName><Initials>AY</Initials></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Dominic M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xining</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Frosch</LastName><ForeName>Matthew P</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Selkoe</LastName><ForeName>Dennis J</ForeName><Initials>DJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG12749</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.11</RegistryNumber><NameOfSubstance UI="D015260">Neprilysin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.56</RegistryNumber><NameOfSubstance UI="D007339">Insulysin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007339" MajorTopicYN="N">Insulysin</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015260" MajorTopicYN="N">Neprilysin</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14687544</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00787-6</ArticleId><ArticleId IdType="pii">S0896627303007876</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14687548</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>6</Issue><PubDate><Year>2003</Year><Month>Dec</Month><Day>18</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain.</ArticleTitle><Pagination><StartPage>1133</StartPage><EndPage>1145</EndPage><MedlinePgn>1133-45</MedlinePgn></Pagination><Abstract><AbstractText>TGF-beta1 is a key regulator of diverse biological processes in many tissues and cell types, but its exact function in the developing and adult mammalian CNS is still unknown. We report that lack of TGF-beta1 expression in neonatal Tgfb1(-/-) mice results in a widespread increase in degenerating neurons accompanied by reduced expression of synaptophysin and laminin and a prominent microgliosis. Lack of TGF-beta1 also strongly reduces survival of primary neurons cultured from Tgfb1(-/-) mice. TGF-beta1 deficiency in adult Tgfb1(-/+) mice results in increased neuronal susceptibility to excitotoxic injury, whereas astroglial overexpression of TGF-beta1 protects adult mice against neurodegeneration in acute, excitotoxic and chronic injury paradigms. This study reveals a nonredundant function for TGF-beta1 in maintaining neuronal integrity and survival of CNS neurons and in regulating microglial activation. Because individual TGF-beta1 expression levels in the brain vary considerably between humans, this finding could have important implications for susceptibility to neurodegeneration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brionne</LastName><ForeName>Thomas C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tesseur</LastName><ForeName>Ina</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Masliah</LastName><ForeName>Eliezer</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Wyss-Coray</LastName><ForeName>Tony</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG15871</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG18440</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG5131</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS40994</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508961">Tgfb1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053773">Transforming Growth Factor beta1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005911" MajorTopicYN="N">Gliosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053773" MajorTopicYN="N">Transforming Growth Factor beta1</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14687548</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00766-9</ArticleId><ArticleId IdType="pii">S0896627303007669</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14697205</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0092-8674</ISSN><JournalIssue CitedMedium="Print"><Volume>115</Volume><Issue>7</Issue><PubDate><Year>2003</Year><Month>Dec</Month><Day>26</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>A neuronal isoform of the aplysia CPEB has prion-like properties.</ArticleTitle><Pagination><StartPage>879</StartPage><EndPage>891</EndPage><MedlinePgn>879-91</MedlinePgn></Pagination><Abstract><AbstractText>Prion proteins have the unusual capacity to fold into two functionally distinct conformations, one of which is self-perpetuating. When yeast prion proteins switch state, they produce heritable phenotypes. We report prion-like properties in a neuronal member of the CPEB family (cytoplasmic polyadenylation element binding protein), which regulates mRNA translation. Compared to other CPEB family members, the neuronal protein has an N-terminal extension that shares characteristics of yeast prion-determinants: a high glutamine content and predicted conformational flexibility. When fused to a reporter protein in yeast, this region confers upon it the epigenetic changes in state that characterize yeast prions. Full-length CPEB undergoes similar changes, but surprisingly it is the dominant, self-perpetuating prion-like form that has the greatest capacity to stimulate translation of CPEB-regulated mRNA. We hypothesize that conversion of CPEB to a prion-like state in stimulated synapses helps to maintain long-term synaptic changes associated with memory storage.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Kausik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Neurobiology and Behavior, College of Physicians and Surgeons of Columbia University, New York State Psychiatric Institute, 722 West 168th Street, New York, NY 10032, USA. ks560@columbia.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindquist</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kandel</LastName><ForeName>Eric R</ForeName><Initials>ER</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C490388">Cpeb1 protein, Xenopus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011328">Prions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029867">Xenopus Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039221">mRNA Cleavage and Polyadenylation Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0RH81L854J</RegistryNumber><NameOfSubstance UI="D005973">Glutamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2003 Dec 26;115(7):767-8. doi: 10.1016/s0092-8674(03)01022-5.</RefSource><PMID Version="1">14697195</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001048" MajorTopicYN="N">Aplysia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005973" MajorTopicYN="N">Glutamine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008568" MajorTopicYN="N">Memory</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009473" MajorTopicYN="N">Neuronal Plasticity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011328" MajorTopicYN="N">Prions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029867" MajorTopicYN="N">Xenopus Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039221" MajorTopicYN="N">mRNA Cleavage and Polyadenylation Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14697205</ArticleId><ArticleId IdType="doi">10.1016/s0092-8674(03)01020-1</ArticleId><ArticleId IdType="pii">S0092867403010201</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14697204</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0092-8674</ISSN><JournalIssue CitedMedium="Print"><Volume>115</Volume><Issue>7</Issue><PubDate><Year>2003</Year><Month>Dec</Month><Day>26</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>A key role for TRPM7 channels in anoxic neuronal death.</ArticleTitle><Pagination><StartPage>863</StartPage><EndPage>877</EndPage><MedlinePgn>863-77</MedlinePgn></Pagination><Abstract><AbstractText>Excitotoxicity in brain ischemia triggers neuronal death and neurological disability, and yet these are not prevented by antiexcitotoxic therapy (AET) in humans. Here, we show that in neurons subjected to prolonged oxygen glucose deprivation (OGD), AET unmasks a dominant death mechanism perpetuated by a Ca2+-permeable nonselective cation conductance (IOGD). IOGD was activated by reactive oxygen/nitrogen species (ROS), and permitted neuronal Ca2+ overload and further ROS production despite AET. IOGD currents corresponded to those evoked in HEK-293 cells expressing the nonselective cation conductance TRPM7. In cortical neurons, blocking IOGD or suppressing TRPM7 expression blocked TRPM7 currents, anoxic 45Ca2+ uptake, ROS production, and anoxic death. TRPM7 suppression eliminated the need for AET to rescue anoxic neurons and permitted the survival of neurons previously destined to die from prolonged anoxia. Thus, excitotoxicity is a subset of a greater overall anoxic cell death mechanism, in which TRPM7 channels play a key role.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aarts</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Toronto Western Hospital Research Institute, 11-416 MC-PAV, 399 Bathurst Street, Toronto, Ontario M5T-2S8 Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iihara</LastName><ForeName>Koji</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wen-Li</ForeName><Initials>WL</Initials></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Zhi-Gang</ForeName><Initials>ZG</Initials></Author><Author ValidYN="Y"><LastName>Arundine</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Cerwinski</LastName><ForeName>Waldy</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>MacDonald</LastName><ForeName>John F</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Tymianski</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NS 39060</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002412">Cations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007473">Ion Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009498">Neurotoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050053">TRPM Cation Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>27YG812J1I</RegistryNumber><NameOfSubstance UI="D016718">Arachidonic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>E1UOL152H7</RegistryNumber><NameOfSubstance UI="D007501">Iron</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.-</RegistryNumber><NameOfSubstance UI="D011494">Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="C421903">Trpm7 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C486583">TRPM7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2003 Dec 26;115(7):768-70. doi: 10.1016/s0092-8674(03)01019-5.</RefSource><PMID Version="1">14697196</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016718" MajorTopicYN="N">Arachidonic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020013" MajorTopicYN="N">Calcium Signaling</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002412" MajorTopicYN="N">Cations</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020925" MajorTopicYN="N">Hypoxia-Ischemia, Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015640" MajorTopicYN="N">Ion Channel Gating</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007473" MajorTopicYN="N">Ion Channels</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007501" MajorTopicYN="N">Iron</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="Y">Membrane Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009498" MajorTopicYN="N">Neurotoxins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011494" MajorTopicYN="N">Protein Kinases</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050053" MajorTopicYN="N">TRPM Cation Channels</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14697204</ArticleId><ArticleId IdType="doi">10.1016/s0092-8674(03)01017-1</ArticleId><ArticleId IdType="pii">S0092867403010171</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14697206</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0092-8674</ISSN><JournalIssue CitedMedium="Print"><Volume>115</Volume><Issue>7</Issue><PubDate><Year>2003</Year><Month>Dec</Month><Day>26</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in aplysia.</ArticleTitle><Pagination><StartPage>893</StartPage><EndPage>904</EndPage><MedlinePgn>893-904</MedlinePgn></Pagination><Abstract><AbstractText>Synapse-specific facilitation requires rapamycin-dependent local protein synthesis at the activated synapse. In Aplysia, rapamycin-dependent local protein synthesis serves two functions: (1) it provides a component of the mark at the activated synapse and thereby confers synapse specificity and (2) it stabilizes the synaptic growth associated with long-term facilitation. Here we report that a neuron-specific isoform of cytoplasmic polyadenylation element binding protein (CPEB) regulates this synaptic protein synthesis in an activity-dependent manner. Aplysia CPEB protein is upregulated locally at activated synapses, and it is needed not for the initiation but for the stable maintenance of long-term facilitation. We suggest that Aplysia CPEB is one of the stabilizing components of the synaptic mark.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Kausik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Neurobiology and Behavior, College of Physicians and Surgeons of Columbia University, New York State Psychiatric Institute, 722 West 168th Street, New York, NY 10032, USA. ks560@columbia.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giustetto</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Etkin</LastName><ForeName>Amit</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Ruby</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Janisiewicz</LastName><ForeName>Agnieszka M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Miniaci</LastName><ForeName>Maria Conchetta</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Joung-Hun</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Huixiang</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Kandel</LastName><ForeName>Eric R</ForeName><Initials>ER</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000199">Actins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C490388">Cpeb1 protein, Xenopus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018076">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029867">Xenopus Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039221">mRNA Cleavage and Polyadenylation Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>24937-83-5</RegistryNumber><NameOfSubstance UI="D011061">Poly A</NameOfSubstance></Chemical><Chemical><RegistryNumber>333DO1RDJY</RegistryNumber><NameOfSubstance UI="D012701">Serotonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.11</RegistryNumber><NameOfSubstance UI="D017868">Cyclic AMP-Dependent Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.2.1.-</RegistryNumber><NameOfSubstance UI="D022021">Tacrolimus Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2003 Dec 26;115(7):767-8. doi: 10.1016/s0092-8674(03)01022-5.</RefSource><PMID Version="1">14697195</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000199" MajorTopicYN="N">Actins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001048" MajorTopicYN="N">Aplysia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017868" MajorTopicYN="N">Cyclic AMP-Dependent Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017774" MajorTopicYN="N">Long-Term Potentiation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011061" MajorTopicYN="N">Poly A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020871" MajorTopicYN="N">RNA Stability</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012689" MajorTopicYN="N">Sequence Homology, Nucleic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012701" MajorTopicYN="N">Serotonin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022021" MajorTopicYN="N">Tacrolimus Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029867" MajorTopicYN="N">Xenopus Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039221" MajorTopicYN="N">mRNA Cleavage and Polyadenylation Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14697206</ArticleId><ArticleId IdType="doi">10.1016/s0092-8674(03)01021-3</ArticleId><ArticleId IdType="pii">S0092867403010213</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14698294</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-2836</ISSN><JournalIssue CitedMedium="Print"><Volume>335</Volume><Issue>4</Issue><PubDate><Year>2004</Year><Month>Jan</Month><Day>23</Day></PubDate></JournalIssue><Title>Journal of molecular biology</Title><ISOAbbreviation>J Mol Biol</ISOAbbreviation></Journal><ArticleTitle>Effect of different anti-Abeta antibodies on Abeta fibrillogenesis as assessed by atomic force microscopy.</ArticleTitle><Pagination><StartPage>997</StartPage><EndPage>1006</EndPage><MedlinePgn>997-1006</MedlinePgn></Pagination><Abstract><AbstractText>Extensive data suggest that the conversion of the amyloid-beta (Abeta) peptide from soluble to insoluble forms is a key factor in the pathogenesis of Alzheimer's disease (AD). In recent years, atomic force microscopy (AFM) has provided useful insights into the physicochemical processes involving Abeta morphology, and it can now be used to explore factors that either inhibit or promote fibrillogenesis. We used ex situ AFM to explore the impact of anti-Abeta antibodies directed against different domains of Abeta on fibril formation. For the AFM studies, two monoclonal antibodies (m3D6 and m266.2) were incubated in solution with Abeta(1-42) with a molar ratio of 1:10 (antibody to Abeta) over several days. Fibril formation was analyzed quantitatively by determining the number of fibrils per microm(2) and by aggregate size analysis. m3D6, which is directed against an N-terminal domain of Abeta (amino acid residues 1-5) slowed down fibril formation. However, m266.2, which is directed against the central domain of Abeta (amino acid residues 13-28) appeared to completely prevent the formation of fibrils over the course of the experiment. Inhibition of fibril formation by both antibodies was also confirmed by thioflavin-T (ThT) fluorescence experiments carried out with Abeta(1-40) incubated for five days. However, unlike AFM results, ThT did not differentiate between the samples incubated with m3D6 versus m266.2. These results indicate that AFM can be not only reliably used to study the effect of different molecules on Abeta aggregation, but that it can provide additional information such as the role of epitope specificity of antibodies as potential inhibitors of fibril formation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Legleiter</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Carnegie Mellon University, 4400 Fifth Avenue, Pittsburgh, PA 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czilli</LastName><ForeName>Dan L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Gitter</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>DeMattos</LastName><ForeName>Ronald B</ForeName><Initials>RB</Initials></Author><Author ValidYN="Y"><LastName>Holtzman</LastName><ForeName>David M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Kowalewski</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG05681</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG20222</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Mol Biol</MedlineTA><NlmUniqueID>2985088R</NlmUniqueID><ISSNLinking>0022-2836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000906">Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052160">Benzothiazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013844">Thiazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C075222">amyloid beta-protein (1-42)</NameOfSubstance></Chemical><Chemical><RegistryNumber>2390-54-7</RegistryNumber><NameOfSubstance UI="C009462">thioflavin T</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052160" MajorTopicYN="N">Benzothiazoles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005453" MajorTopicYN="N">Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018625" MajorTopicYN="Y">Microscopy, Atomic Force</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016874" MajorTopicYN="N">Neurofibrillary Tangles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020836" MajorTopicYN="N">Protein Structure, Quaternary</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013844" MajorTopicYN="N">Thiazoles</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14698294</ArticleId><ArticleId IdType="doi">10.1016/j.jmb.2003.11.019</ArticleId><ArticleId IdType="pii">S0022283603014116</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14699153</PMID><DateCompleted><Year>2004</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-9258</ISSN><JournalIssue CitedMedium="Print"><Volume>279</Volume><Issue>11</Issue><PubDate><Year>2004</Year><Month>Mar</Month><Day>12</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1.</ArticleTitle><Pagination><StartPage>10542</StartPage><EndPage>10550</EndPage><MedlinePgn>10542-50</MedlinePgn></Pagination><Abstract><AbstractText>Site-specific proteolysis of the amyloid-beta precursor protein (APP) by BACE 1 and gamma-secretase, a central event in Alzheimer disease, releases a large secreted extracellular fragment (called APP(S)), peptides of 40-43 residues derived from extracellular and transmembrane sequences (Abeta), and a short intracellular fragment (APP intracellular domain) that may function as a transcriptional activator in a complex with the adaptor protein Fe65 and the nuclear protein Tip60. APP is closely related to APP-like protein (APLP) 1 and APLP2, but only APP is known to be cleaved by BACE 1 and to be involved in Alzheimer disease. We now demonstrate that similar to APP, APLP1 and APLP2 are also cleaved by BACE 1 but not by ADAM 9, another APP protease, and also transactivate nuclear Tip60 in a complex with Fe65. Paradoxically, although BACE 1 cleavage appears to be specific for APP and APLPs, their cleavage sequences exhibit no homology, and a short sequence (7 amino acids) from APP that when placed close to the membrane converts a membrane protein that is normally not cleaved by BACE 1 into a BACE 1 substrate. Our data demonstrate that APLPs and APP are processed similarly to act via the same nuclear target, suggesting that BACE 1 cleavage regulates a common function of APP and APLPs in neurons.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qiming</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Center for Basic Neuroscience, Department of Molecular Genetics and Howard Hughes Medical Institute, The University of Texas Southwestern Medical Center, Dallas, Texas 75390-9111, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xfc;dhof</LastName><ForeName>Thomas C</ForeName><Initials>TC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01-MH69585-01</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>12</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C091042">APBB1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C489697">APLP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C084104">APLP2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C486243">Apbb1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C492952">Aplp2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019483">Disintegrins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.-</RegistryNumber><NameOfSubstance UI="D000123">Acetyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.48</RegistryNumber><NameOfSubstance UI="D051548">Histone Acetyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.48</RegistryNumber><NameOfSubstance UI="C098489">KAT5 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.48</RegistryNumber><NameOfSubstance UI="D000074443">Lysine Acetyltransferase 5</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.-</RegistryNumber><NameOfSubstance UI="D051722">ADAM Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.-</RegistryNumber><NameOfSubstance UI="C098339">ADAM9 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.-</RegistryNumber><NameOfSubstance UI="C498316">Adam9 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.-</RegistryNumber><NameOfSubstance UI="D008666">Metalloendopeptidases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051722" MajorTopicYN="N">ADAM Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000123" MajorTopicYN="N">Acetyltransferases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019556" MajorTopicYN="N">COS Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019483" MajorTopicYN="N">Disintegrins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004591" MajorTopicYN="N">Electrophoresis, Polyacrylamide Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051548" MajorTopicYN="N">Histone Acetyltransferases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015151" MajorTopicYN="N">Immunoblotting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074443" MajorTopicYN="N">Lysine Acetyltransferase 5</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008666" MajorTopicYN="N">Metalloendopeptidases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008957" MajorTopicYN="N">Models, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015533" MajorTopicYN="N">Transcriptional Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>5</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14699153</ArticleId><ArticleId IdType="doi">10.1074/jbc.M310001200</ArticleId><ArticleId IdType="pii">S0021-9258(17)47713-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14715132</PMID><DateCompleted><Year>2005</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>41</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Jan</Month><Day>08</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease.</ArticleTitle><Pagination><StartPage>27</StartPage><EndPage>33</EndPage><MedlinePgn>27-33</MedlinePgn></Pagination><Abstract><AbstractText>beta-site APP cleaving enzyme 1 (BACE1) is the beta-secretase enzyme required for generating pathogenic beta-amyloid (Abeta) peptides in Alzheimer's disease (AD). BACE1 knockout mice lack Abeta and are phenotypically normal, suggesting that therapeutic inhibition of BACE1 may be free of mechanism-based side effects. However, direct evidence that BACE1 inhibition would improve cognition is lacking. Here we show that BACE1 null mice engineered to overexpress human APP (BACE1(-/-).Tg2576(+)) are rescued from Abeta-dependent hippocampal memory deficits. Moreover, impaired hippocampal cholinergic regulation of neuronal excitability found in the Tg2576 AD model is ameliorated in BACE1(-/-).Tg2576(+) bigenic mice. The behavioral and electrophysiological rescue of deficits in BACE1(-/-).Tg2576(+) mice is correlated with a dramatic reduction of cerebral Abeta40 and Abeta42 levels and occurs before amyloid deposition in Tg2576 mice. Our gene-based approach demonstrates that lower Abeta levels are beneficial for AD-associated memory impairments, validating BACE1 as a therapeutic target for AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ohno</LastName><ForeName>Masuo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. ohno@northwestern.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sametsky</LastName><ForeName>Evgeny A</ForeName><Initials>EA</Initials></Author><Author ValidYN="Y"><LastName>Younkin</LastName><ForeName>Linda H</ForeName><Initials>LH</Initials></Author><Author ValidYN="Y"><LastName>Oakley</LastName><ForeName>Holly</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Younkin</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials></Author><Author ValidYN="Y"><LastName>Citron</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Vassar</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Disterhoft</LastName><ForeName>John F</ForeName><Initials>JF</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH067251</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AG08796</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002799" MajorTopicYN="Y">Cholinergic Fibers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>9</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14715132</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00810-9</ArticleId><ArticleId IdType="pii">S0896627303008109</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14715666</PMID><DateCompleted><Year>2004</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-9258</ISSN><JournalIssue CitedMedium="Print"><Volume>279</Volume><Issue>12</Issue><PubDate><Year>2004</Year><Month>Mar</Month><Day>19</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Modulation of amyloid precursor protein cleavage by cellular sphingolipids.</ArticleTitle><Pagination><StartPage>11984</StartPage><EndPage>11991</EndPage><MedlinePgn>11984-91</MedlinePgn></Pagination><Abstract><AbstractText>Lipid rafts and their component, cholesterol, modulate the processing of beta-amyloid precursor protein (APP). However, the role of sphingolipids, another major component of lipid rafts, in APP processing remains undetermined. Here we report the effect of sphingolipid deficiency on APP processing in Chinese hamster ovary cells treated with a specific inhibitor of serine palmitoyltransferase, which catalyzes the first step of sphingolipid biosynthesis, and in a mutant LY-B strain defective in the LCB1 subunit of serine palmitoyltransferase. We found that in sphingolipid-deficient cells, the secretion of soluble APPalpha (sAPPalpha) and the generation of C-terminal fragment cleaved at alpha-site dramatically increased, whereas beta-cleavage activity remained unchanged, and the epsilon-cleavage activity decreased without alteration of the total APP level. The secretion of amyloid beta-protein 42 increased in sphingolipid-deficient cells, whereas that of amyloid beta-protein 40 did not. All of these alterations were restored in sphingolipid-deficient cells by adding exogenous sphingosine and in LY-B cells by transfection with cLCB1. Sphingolipid deficiency increased MAPK/ERK activity and a specific inhibitor of MAPK kinase, PD98059, restored sAPPalpha level, indicating that sphingolipid deficiency enhances sAPPalpha secretion via activation of MAPK/ERK pathway. These results suggest that not only the cellular level of cholesterol but also that of sphingolipids may be involved in the pathological process of Alzheimer's disease by modulating APP cleavage.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sawamura</LastName><ForeName>Naoya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Dementia Research, National Institute for Longevity Sciences, 36-3 Gengo, Morioka, Obu, Aichi 474-8522, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Mihee</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Wenxin</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Kun</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Hanada</LastName><ForeName>Kentaro</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Toshiharu</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Jian-Sheng</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Yanagisawa</LastName><ForeName>Katsuhiko</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Michikawa</LastName><ForeName>Makoto</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013107">Sphingolipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016466" MajorTopicYN="N">CHO Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006868" MajorTopicYN="N">Hydrolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013107" MajorTopicYN="N">Sphingolipids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>5</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14715666</ArticleId><ArticleId IdType="doi">10.1074/jbc.M309832200</ArticleId><ArticleId IdType="pii">S0021-9258(19)64417-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14718715</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Jan</Month><Day>13</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Alpha-synuclein haplotypes implicated in risk of Parkinson's disease.</ArticleTitle><Pagination><StartPage>128</StartPage><EndPage>131</EndPage><MedlinePgn>128-31</MedlinePgn></Pagination><Abstract><AbstractText>The authors examined four- and six-loci haplotype constructs (from five single nucleotide polymorphisms and three microsatellite regions) of the alpha-synuclein gene in patients with Parkinson's disease (PD) and controls in an ethnic Chinese population. Logistic regression analysis demonstrated an association of NACP-Rep1 (p = 0.002) and L478 (p &lt; 0.0001) with risk of PD after correction for the effects of age, sex, and the other polymorphic loci. Specific four-loci and six-loci haplotypes were significantly associated with an increased or decreased risk of PD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>E K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Department of Neurology, Singapore General Hospital, Singapore. gnrtek@sgh.com.sg</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chai</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Teo</LastName><ForeName>Y Y</ForeName><Initials>YY</Initials></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Chandran</LastName><ForeName>V R</ForeName><Initials>VR</Initials></Author><Author ValidYN="Y"><LastName>Teoh</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Yih</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Pavanni</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Puvan</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Y L</ForeName><Initials>YL</Initials></Author><Author ValidYN="Y"><LastName>Yap</LastName><ForeName>E</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497604">SNCA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051843">Synucleins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="Y">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018895" MajorTopicYN="N">Microsatellite Repeats</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009010" MajorTopicYN="N">Monte Carlo Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012846" MajorTopicYN="N" Type="Geographic">Singapore</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051843" MajorTopicYN="N">Synucleins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14718715</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000101721.25345.dc</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14720212</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3042</ISSN><JournalIssue CitedMedium="Print"><Volume>88</Volume><Issue>3</Issue><PubDate><Year>2004</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of neurochemistry</Title><ISOAbbreviation>J Neurochem</ISOAbbreviation></Journal><ArticleTitle>A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes.</ArticleTitle><Pagination><StartPage>623</StartPage><EndPage>634</EndPage><MedlinePgn>623-34</MedlinePgn></Pagination><Abstract><AbstractText>Apolipoprotein E (apoE) is an important protein involved in lipoprotein clearance and cholesterol redistribution. ApoE is abundantly expressed in astrocytes in the brain and is closely linked to the pathogenesis of Alzheimer's disease (AD). We report here that small molecule ligands that activate either liver X receptors (LXR) or retinoid X receptor (RXR) lead to a dramatic increase in apoE mRNA and protein expression as well as secretion of apoE in a human astrocytoma cell line (CCF-STTG1 cells). Examination of primary mouse astrocytes also revealed significant induction of apoE mRNA, and protein expression and secretion following incubation with LXR/RXR agonists. Moreover, treatment of mice with a specific synthetic LXR agonist T0901317 resulted in up-regulation of apoE mRNA and protein in both hippocampus and cerebral cortex, indicating that apoE expression in brain can be up-regulated by LXR agonists in vivo. Along with a dramatic induction of ABCA1 cholesterol transporter expression, these ligands effectively mediate cholesterol efflux in both CCF-STTG1 cells and mouse astrocytes in the presence or absence of apolipoprotein AI (apoAI). Our studies provide strong evidence that small molecule LXR/RXR agonists can effectively mediate apoE synthesis and secretion as well as cholesterol homeostasis in astrocytes. LXR/RXR agonists may have significant impact on the pathogenesis of multiple neurological diseases, including AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Lilly Research Laboratories, Eli Lilly &amp; Company, Indianapolis, Indiana 46285, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Suizhen</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Beyer</LastName><ForeName>Thomas P</ForeName><Initials>TP</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Youyan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xin</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Bales</LastName><ForeName>Kelly R</ForeName><Initials>KR</Initials></Author><Author ValidYN="Y"><LastName>DeMattos</LastName><ForeName>Ronald B</ForeName><Initials>RB</Initials></Author><Author ValidYN="Y"><LastName>May</LastName><ForeName>Patrick C</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shuyu Dan</ForeName><Initials>SD</Initials></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xian-Cheng</ForeName><Initials>XC</Initials></Author><Author ValidYN="Y"><LastName>Eacho</LastName><ForeName>Patrick I</ForeName><Initials>PI</Initials></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Guoqing</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Steven M</ForeName><Initials>SM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurochem</MedlineTA><NlmUniqueID>2985190R</NlmUniqueID><ISSNLinking>0022-3042</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000924">Anticholesteremic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006845">Hydrocarbons, Fluorinated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071518">Liver X Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057093">Orphan Nuclear Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018168">Receptors, Retinoic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047488">Retinoid X Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C423915">T0901317</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000924" MajorTopicYN="N">Anticholesteremic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019281" MajorTopicYN="N">Dimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006845" MajorTopicYN="N">Hydrocarbons, Fluorinated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071518" MajorTopicYN="N">Liver X Receptors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057093" MajorTopicYN="N">Orphan Nuclear Receptors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018168" MajorTopicYN="N">Receptors, Retinoic Acid</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047488" MajorTopicYN="N">Retinoid X Receptors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14720212</ArticleId><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02183.x</ArticleId><ArticleId IdType="pii">2183</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14730301</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1061-4036</ISSN><JournalIssue CitedMedium="Print"><Volume>36</Volume><Issue>2</Issue><PubDate><Year>2004</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Nature genetics</Title><ISOAbbreviation>Nat Genet</ISOAbbreviation></Journal><ArticleTitle>Comparing genomic expression patterns across species identifies shared transcriptional profile in aging.</ArticleTitle><Pagination><StartPage>197</StartPage><EndPage>204</EndPage><MedlinePgn>197-204</MedlinePgn></Pagination><Abstract><AbstractText>We developed a method for systematically comparing gene expression patterns across organisms using genome-wide comparative analysis of DNA microarray experiments. We identified analogous gene expression programs comprising shared patterns of regulation across orthologous genes. Biological features of these patterns could be identified as highly conserved subpatterns that correspond to Gene Ontology categories. Here, we demonstrate these methods by analyzing a specific biological process, aging, and show that similar analysis can be applied to a range of biological processes. We found that two highly diverged animals, the nematode Caenorhabditis elegans and the fruit fly Drosophila melanogaster, implement a shared adult-onset expression program of genes involved in mitochondrial metabolism, DNA repair, catabolism, peptidolysis and cellular transport. Most of these changes were implemented early in adulthood. Using this approach to search databases of gene expression data, we found conserved transcriptional signatures in larval development, embryogenesis, gametogenesis and mRNA degradation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCarroll</LastName><ForeName>Steven A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Program in Neuroscience, University of California, San Francisco, California 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Coleen T</ForeName><Initials>CT</Initials></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Sige</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Pletcher</LastName><ForeName>Scott D</ForeName><Initials>SD</Initials></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Chen-Shan</ForeName><Initials>CS</Initials></Author><Author ValidYN="Y"><LastName>Jan</LastName><ForeName>Yuh Nung</ForeName><Initials>YN</Initials></Author><Author ValidYN="Y"><LastName>Kenyon</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Bargmann</LastName><ForeName>Cornelia I</ForeName><Initials>CI</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hao</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Genet</MedlineTA><NlmUniqueID>9216904</NlmUniqueID><ISSNLinking>1061-4036</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017173" MajorTopicYN="N">Caenorhabditis elegans</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030541" MajorTopicYN="N">Databases, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="Y">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14730301</ArticleId><ArticleId IdType="doi">10.1038/ng1291</ArticleId><ArticleId IdType="pii">ng1291</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14730359</PMID><DateCompleted><Year>2004</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1078-8956</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2004</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease.</ArticleTitle><Pagination><StartPage>148</StartPage><EndPage>154</EndPage><MedlinePgn>148-54</MedlinePgn></Pagination><Abstract><AbstractText>Inhibition of polyglutamine-induced protein aggregation could provide treatment options for polyglutamine diseases such as Huntington disease. Here we showed through in vitro screening studies that various disaccharides can inhibit polyglutamine-mediated protein aggregation. We also found that various disaccharides reduced polyglutamine aggregates and increased survival in a cellular model of Huntington disease. Oral administration of trehalose, the most effective of these disaccharides, decreased polyglutamine aggregates in cerebrum and liver, improved motor dysfunction and extended lifespan in a transgenic mouse model of Huntington disease. We suggest that these beneficial effects are the result of trehalose binding to expanded polyglutamines and stabilizing the partially unfolded polyglutamine-containing protein. Lack of toxicity and high solubility, coupled with efficacy upon oral administration, make trehalose promising as a therapeutic drug or lead compound for the treatment of polyglutamine diseases. The saccharide-polyglutamine interaction identified here thus provides a new therapeutic strategy for polyglutamine diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Motomasa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory for Structural Neuropathology, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako City, Saitama 351-0198, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machida</LastName><ForeName>Yoko</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Niu</LastName><ForeName>Sanyong</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>Tetsurou</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Jana</LastName><ForeName>Nihar R</ForeName><Initials>NR</Initials></Author><Author ValidYN="Y"><LastName>Doi</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Kurosawa</LastName><ForeName>Masaru</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Nekooki</LastName><ForeName>Munenori</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Nukina</LastName><ForeName>Nobuyuki</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086055">HTT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C506812">Htt protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071058">Huntingtin Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009211">Myoglobin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>B8WCK70T7I</RegistryNumber><NameOfSubstance UI="D014199">Trehalose</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Med. 2004 Feb;10(2):123-4. doi: 10.1038/nm0204-123.</RefSource><PMID Version="1">14760414</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071058" MajorTopicYN="N">Huntingtin Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009211" MajorTopicYN="N">Myoglobin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014199" MajorTopicYN="N">Trehalose</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>4</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14730359</ArticleId><ArticleId IdType="doi">10.1038/nm985</ArticleId><ArticleId IdType="pii">nm985</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14732624</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-9942</ISSN><JournalIssue CitedMedium="Print"><Volume>61</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Archives of neurology</Title><ISOAbbreviation>Arch Neurol</ISOAbbreviation></Journal><ArticleTitle>Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.</ArticleTitle><Pagination><StartPage>82</StartPage><EndPage>88</EndPage><MedlinePgn>82-8</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Antioxidants may protect the aging brain against oxidative damage associated with pathological changes of Alzheimer disease (AD).</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine the relationship between antioxidant supplement use and risk of AD.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Cross-sectional and prospective study of dementia. Elderly (65 years or older) county residents were assessed in 1995 to 1997 for prevalent dementia and AD, and again in 1998 to 2000 for incident illness. Supplement use was ascertained at the first contact.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Cache County, Utah.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Among 4740 respondents (93%) with data sufficient to determine cognitive status at the initial assessment, we identified 200 prevalent cases of AD. Among 3227 survivors at risk, we identified 104 incident AD cases at follow-up.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURE" NlmCategory="METHODS">Diagnosis of AD by means of multistage assessment procedures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Analyses of prevalent and incident AD yielded similar results. Use of vitamin E and C (ascorbic acid) supplements in combination was associated with reduced AD prevalence (adjusted odds ratio, 0.22; 95% confidence interval, 0.05-0.60) and incidence (adjusted hazard ratio, 0.36; 95% confidence interval, 0.09-0.99). A trend toward lower AD risk was also evident in users of vitamin E and multivitamins containing vitamin C, but we saw no evidence of a protective effect with use of vitamin E or vitamin C supplements alone, with multivitamins alone, or with vitamin B-complex supplements.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Use of vitamin E and vitamin C supplements in combination is associated with reduced prevalence and incidence of AD. Antioxidant supplements merit further study as agents for the primary prevention of AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zandi</LastName><ForeName>Peter P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Mental Health, Bloomberg School of Public Health, The Johns Hopkins University, Hampton House Room 857, 624 N Broadway, Baltimore, MD 21205, USA. pzandi@jhsph.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anthony</LastName><ForeName>James C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Khachaturian</LastName><ForeName>Ara S</ForeName><Initials>AS</Initials></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Stephanie V</ForeName><Initials>SV</Initials></Author><Author ValidYN="Y"><LastName>Gustafson</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Tschanz</LastName><ForeName>JoAnn T</ForeName><Initials>JT</Initials></Author><Author ValidYN="Y"><LastName>Norton</LastName><ForeName>Maria C</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Welsh-Bohmer</LastName><ForeName>Kathleen A</ForeName><Initials>KA</Initials></Author><Author ValidYN="Y"><LastName>Breitner</LastName><ForeName>John C S</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><CollectiveName>Cache County Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K05 DA015799</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG 11380</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 MH 14592</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Neurol</MedlineTA><NlmUniqueID>0372436</NlmUniqueID><ISSNLinking>0003-9942</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-18-4</RegistryNumber><NameOfSubstance UI="D014810">Vitamin E</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014810" MajorTopicYN="N">Vitamin E</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>21</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>21</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14732624</ArticleId><ArticleId IdType="doi">10.1001/archneur.61.1.82</ArticleId><ArticleId IdType="pii">61/1/82</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14732699</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>101</Volume><Issue>4</Issue><PubDate><Year>2004</Year><Month>Jan</Month><Day>27</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein.</ArticleTitle><Pagination><StartPage>1075</StartPage><EndPage>1080</EndPage><MedlinePgn>1075-80</MedlinePgn></Pagination><Abstract><AbstractText>Amyloid-beta peptide (Abeta) is central to the pathogenesis of Alzheimer's disease, and the low-density lipoprotein receptor-related protein (LRP) has been shown to alter Abeta metabolism in vitro. Here, we show that overexpression of a functional LRP minireceptor in the brain of PDAPP mice results in age-dependent increase of soluble brain Abeta, with no changes in Abeta plaque burden. Importantly, soluble brain Abeta was found to be primarily in the form of monomers/dimers and to be highly correlated with deficits in spatial learning and memory. These results provide in vivo evidence that LRP may contribute to memory deficits typical of Alzheimer's disease by modulating the pool of small soluble forms of Abeta.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zerbinatti</LastName><ForeName>Celina V</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Departments of Pediatrics, Washington University School of Medicine, St Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wozniak</LastName><ForeName>David F</ForeName><Initials>DF</Initials></Author><Author ValidYN="Y"><LastName>Cirrito</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Cam</LastName><ForeName>Judy A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Osaka</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Bales</LastName><ForeName>Kelly R</ForeName><Initials>KR</Initials></Author><Author ValidYN="Y"><LastName>Zhuo</LastName><ForeName>Min</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Steven M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Holtzman</LastName><ForeName>David M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Bu</LastName><ForeName>Guojun</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NS41872</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG05681</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG011355</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005681</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F32 NS041872</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG11355</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026502">LDL-Receptor Related Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026502" MajorTopicYN="N">LDL-Receptor Related Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008809" MajorTopicYN="N">Mice, Inbred C3H</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>21</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>21</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>7</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14732699</ArticleId><ArticleId IdType="pmc">PMC327153</ArticleId><ArticleId IdType="doi">10.1073/pnas.0305803101</ArticleId><ArticleId IdType="pii">0305803101</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardy, J. &amp; Selkoe, D. J. (2002) Science 297, 353&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy, J. A. &amp; Higgins, G. A. (1992) Science 256, 184&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">1566067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lendon, C. L., Talbot, C. J., Craddock, N. J., Han, S. W., Wragg, M., Morris, J. C. &amp; Goate, A. M. (1997) Neurosci. Lett. 222, 187&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">9148246</ArticleId></ArticleIdList></Reference><Reference><Citation>Wavrant-DeVrieze, F., Lambert, J. C., Stas, L., Crook, R., Cottel, D., Pasquier, F., Frigard, B., Lambrechts, M., Thiry, E., Amouyel, P., et al. (1999) Hum. Genet. 104, 432&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">10394937</ArticleId></ArticleIdList></Reference><Reference><Citation>Narita, M., Holtzman, D. M., Schwartz, A. L. &amp; Bu, G. (1997) J. Neurochem. 69, 1904&#x2013;1911.</Citation><ArticleIdList><ArticleId IdType="pubmed">9349534</ArticleId></ArticleIdList></Reference><Reference><Citation>Du, Y., Bales, K. R., Dodel, R. C., Liu, X., Glinn, M. A., Horn, J. W., Little, S. P. &amp; Paul, S. M. (1998) J. Neurochem. 70, 1182&#x2013;1188.</Citation><ArticleIdList><ArticleId IdType="pubmed">9489740</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu, Z., Strickland, D. K., Hyman, B. T. &amp; Rebeck, G. W. (1999) J. Neurochem. 73, 1393&#x2013;1398.</Citation><ArticleIdList><ArticleId IdType="pubmed">10501182</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Uden, E., Sagara, Y., Van Uden, J., Orlando, R., Mallory, M., Rockenstein, E. &amp; Masliah, E. (2000) J. Biol. Chem. 275, 30525&#x2013;30530.</Citation><ArticleIdList><ArticleId IdType="pubmed">10899157</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, D. E., Pietrzik, C. U., Baum, L., Chevallier, N., Merriam, D. E., Kounnas, M. Z., Wagner, S. L., Troncoso, J. C., Kawas, C. H., Katzman, R. &amp; Koo, E. H. (2000) J. Clin. Invest. 106, 1159&#x2013;1166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC301422</ArticleId><ArticleId IdType="pubmed">11067868</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J. &amp; Zlokovic, B. V. (2000) J. Clin. Invest. 106, 1489&#x2013;1499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC387254</ArticleId><ArticleId IdType="pubmed">11120756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulery, P. G., Beers, J., Mikhailenko, I., Tanzi, R. E., Rebeck, G. W., Hyman, B. T. &amp; Strickland, D. K. (2000) J. Biol. Chem. 275, 7410&#x2013;7415.</Citation><ArticleIdList><ArticleId IdType="pubmed">10702315</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrzik, C. U., Busse, T., Merriam, D. E., Weggen, S. &amp; Koo, E. H. (2002) EMBO J. 21, 5691&#x2013;5700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC131065</ArticleId><ArticleId IdType="pubmed">12411487</ArticleId></ArticleIdList></Reference><Reference><Citation>Herz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H. &amp; Stanley, K. K. (1988) EMBO J. 7, 4119&#x2013;4127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC455121</ArticleId><ArticleId IdType="pubmed">3266596</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Uden, E., Kang, D. E., Koo, E. H. &amp; Masliah, E. (2000) Microsc. Res. Tech. 50, 268&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">10936878</ArticleId></ArticleIdList></Reference><Reference><Citation>Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) Nature 373, 523&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">7845465</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt, D. R., Davis, J., Fischer, M., Lee, M. K., Slunt, H. H., Ratovitsky, T., Regard, J., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., et al. (1996) Genet. Anal. 13, 159&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">9117892</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos, R. B., Bales, K. R., Parsadanian, M., O'Dell, M. A., Foss, E. M., Paul, S. M. &amp; Holtzman, D. M. (2002) J. Neurochem. 81, 229&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">12064470</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose, K., Goldberg, M. P. &amp; Choi, D. W. (1993) in Methods in Toxicology: In Vitro Biological Methods, eds. Tyson, C. A. &amp; Frazier, J. M. (Academic, San Diego), pp. 46&#x2013;60.</Citation></Reference><Reference><Citation>Bu, G., Morton, P. A. &amp; Schwartz, A. L. (1992) J. Biol. Chem. 267, 15595&#x2013;15602.</Citation><ArticleIdList><ArticleId IdType="pubmed">1322401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko, K. W., McLeod, R. S., Avramoglu, R. K., Nimpf, J., FitzGerald, D. J., Vukmirica, J. &amp; Yao, Z. (1998) J. Biol. Chem. 273, 27779&#x2013;27785.</Citation><ArticleIdList><ArticleId IdType="pubmed">9774386</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos, R. B., O'dell, M. A., Parsadanian, M., Taylor, J. W., Harmony, J. A., Bales, K. R., Paul, S. M., Aronow, B. J. &amp; Holtzman, D. M. (2002) Proc. Natl. Acad. Sci. USA 99, 10843&#x2013;10848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125060</ArticleId><ArticleId IdType="pubmed">12145324</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho, N., Liauw, J. A., Blaeser, F., Wei, F., Hanissian, S., Muglia, L. M., Wozniak, D. F., Nardi, A., Arvin, K. L., Holtzman, D. M., et al. (2000) J. Neurosci. 20, 6459&#x2013;6472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772951</ArticleId><ArticleId IdType="pubmed">10964952</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, G., Chen, K. S., Knox, J., Inglis, J., Bernard, A., Martin, S. J., Justice, A., McConlogue, L., Games, D., Freedman, S. B., et al. (2000) Nature 408, 975&#x2013;979.</Citation><ArticleIdList><ArticleId IdType="pubmed">11140684</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermoeller-McCormick, L. M., Li, Y., Osaka, H., FitzGerald, D. J., Schwartz, A. L. &amp; Bu, G. (2001) J. Cell Sci. 114, 899&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">11181173</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A. &amp; LaDu, M. J. (2002) J. Biol. Chem. 277, 32046&#x2013;32053.</Citation><ArticleIdList><ArticleId IdType="pubmed">12058030</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J. &amp; Selkoe, D. J. (2002) Nature 416, 535&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">11932745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argraves, W. S., Tanzi, R. E., Hyman, B. T. &amp; Strickland, D. K. (1995) Cell 82, 331&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">7543026</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebeck, G. W., Moir, R. D., Mui, S., Strickland, D. K., Tanzi, R. E. &amp; Hyman, B. T. (2001) Brain Res. Mol. Brain Res. 87, 238&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">11245926</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita, A., Whelan, C. M., Smith, C. J., Mikhailenko, I., Rebeck, G. W., Strickland, D. K. &amp; Hyman, B. T. (2001) J. Neurosci. 21, 8354&#x2013;8361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762817</ArticleId><ArticleId IdType="pubmed">11606623</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo, E. H. &amp; Squazzo, S. L. (1994) J. Biol. Chem. 269, 17386&#x2013;17389.</Citation><ArticleIdList><ArticleId IdType="pubmed">8021238</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe, D. J. (1998) Trends Cell Biol. 8, 447&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pubmed">9854312</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto, J. J. &amp; Tanzi, R. E. (2002) J. Mol. Neurosci. 19, 37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">12212791</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Uden, E., Mallory, M., Veinbergs, I., Alford, M., Rockenstein, E. &amp; Masliah, E. (2002) J. Neurosci. 22, 9298&#x2013;9304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758061</ArticleId><ArticleId IdType="pubmed">12417655</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Beyreuther, K., Bush, A. I. &amp; Masters, C. L. (1999) Ann. Neurol. 46, 860&#x2013;866.</Citation><ArticleIdList><ArticleId IdType="pubmed">10589538</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, W. L., Krafft, G. A. &amp; Finch, C. E. (2001) Trends Neurosci. 24, 219&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">11250006</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe, D. J. (2002) Science 298, 789&#x2013;791.</Citation><ArticleIdList><ArticleId IdType="pubmed">12399581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lue, L. F., Kuo, Y. M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E. &amp; Rogers, J. (1999) Am. J. Pathol. 155, 853&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866907</ArticleId><ArticleId IdType="pubmed">10487842</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K. &amp; McConlogue, L. (2000) J. Neurosci. 20, 4050&#x2013;4058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772621</ArticleId><ArticleId IdType="pubmed">10818140</ArticleId></ArticleIdList></Reference><Reference><Citation>Koistinaho, M., Kettunen, M. I., Goldsteins, G., Keinanen, R., Salminen, A., Ort, M., Bures, J., Liu, D., Kauppinen, R. A., Higgins, L. S., et al. (2001) Proc. Natl. Acad. Sci. USA 98, 14675&#x2013;14680.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W. &amp; Glabe, C. G. (2003) Science 300, 486&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pubmed">12702875</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A. &amp; Klein, W. L. (2003) Proc. Natl. Acad. Sci. USA 100, 10417&#x2013;10422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC193576</ArticleId><ArticleId IdType="pubmed">12925731</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodart, J. C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) Nat. Neurosci. 5, 452&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pubmed">11941374</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Groen, T., Liu, L., Ikonen, S. &amp; Kadish, I. (2003) Neuroscience 119, 1185&#x2013;1197.</Citation><ArticleIdList><ArticleId IdType="pubmed">12831872</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14734594</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>291</Volume><Issue>3</Issue><PubDate><Year>2004</Year><Month>Jan</Month><Day>21</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>317</StartPage><EndPage>324</EndPage><MedlinePgn>317-24</MedlinePgn></Pagination><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Memantine is a low- to moderate-affinity, uncompetitive N-methyl-D-aspartate receptor antagonist. Controlled trials have demonstrated the safety and efficacy of memantine monotherapy for patients with moderate to severe Alzheimer disease (AD) but no controlled trials of memantine in patients receiving a cholinesterase inhibitor have been performed.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the efficacy and safety of memantine vs placebo in patients with moderate to severe AD already receiving stable treatment with donepezil.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="METHODS">A randomized, double-blind, placebo-controlled clinical trial of 404 patients with moderate to severe AD and Mini-Mental State Examination scores of 5 to 14, who received stable doses of donepezil, conducted at 37 US sites between June 11, 2001, and June 3, 2002. A total of 322 patients (80%) completed the trial.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Participants were randomized to receive memantine (starting dose 5 mg/d, increased to 20 mg/d, n = 203) or placebo (n = 201) for 24 weeks.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Change from baseline on the Severe Impairment Battery (SIB), a measure of cognition, and on a modified 19-item AD Cooperative Study-Activities of Daily Living Inventory (ADCS-ADL19). Secondary outcomes included a Clinician's Interview-Based Impression of Change Plus Caregiver Input (CIBIC-Plus), the Neuropsychiatric Inventory, and the Behavioral Rating Scale for Geriatric Patients (BGP Care Dependency Subscale).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The change in total mean (SE) scores favored memantine vs placebo treatment for SIB (possible score range, 0-100), 0.9 (0.67) vs -2.5 (0.69), respectively (P&lt;.001); ADCS-ADL19 (possible score range, 0-54), -2.0 (0.50) vs -3.4 (0.51), respectively (P =.03); and the CIBIC-Plus (possible score range, 1-7), 4.41 (0.074) vs 4.66 (0.075), respectively (P =.03). All other secondary measures showed significant benefits of memantine treatment. Treatment discontinuations because of adverse events for memantine vs placebo were 15 (7.4%) vs 25 (12.4%), respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients with moderate to severe AD receiving stable doses of donepezil, memantine resulted in significantly better outcomes than placebo on measures of cognition, activities of daily living, global outcome, and behavior and was well tolerated. These results, together with previous studies, suggest that memantine represents a new approach for the treatment of patients with moderate to severe AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tariot</LastName><ForeName>Pierre N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Rochester Medical Center, Monroe Community Hospital, Rochester, NY 14620, USA. pierre_tariot@urmc.rochester.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farlow</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Grossberg</LastName><ForeName>George T</ForeName><Initials>GT</Initials></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>Stephen M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>McDonald</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Gergel</LastName><ForeName>Ivan</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><CollectiveName>Memantine Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U19 AG010483</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002800">Cholinesterase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015259">Dopamine Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018691">Excitatory Amino Acid Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007189">Indans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018697">Nootropic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010880">Piperidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>8SSC91326P</RegistryNumber><NameOfSubstance UI="D000077265">Donepezil</NameOfSubstance></Chemical><Chemical><RegistryNumber>W8O17SJF3T</RegistryNumber><NameOfSubstance UI="D008559">Memantine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2004 Apr 14;291(14):1695; author reply 1695. doi: 10.1001/jama.291.14.1695-a.</RefSource><PMID Version="1">15082684</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Evid Based Ment Health. 2004 Aug;7(3):76. doi: 10.1136/ebmh.7.3.76.</RefSource><PMID Version="1">15273220</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>ACP J Club. 2004 Sep-Oct;141(2):38.</RefSource><PMID Version="1">15341458</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002800" MajorTopicYN="N">Cholinesterase Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077265" MajorTopicYN="N">Donepezil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015259" MajorTopicYN="N">Dopamine Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018691" MajorTopicYN="N">Excitatory Amino Acid Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007189" MajorTopicYN="N">Indans</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008559" MajorTopicYN="N">Memantine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018697" MajorTopicYN="N">Nootropic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010880" MajorTopicYN="N">Piperidines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14734594</ArticleId><ArticleId IdType="doi">10.1001/jama.291.3.317</ArticleId><ArticleId IdType="pii">291/3/317</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14741101</PMID><DateCompleted><Year>2005</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>41</Volume><Issue>2</Issue><PubDate><Year>2004</Year><Month>Jan</Month><Day>22</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo.</ArticleTitle><Pagination><StartPage>193</StartPage><EndPage>202</EndPage><MedlinePgn>193-202</MedlinePgn></Pagination><Abstract><AbstractText>Apolipoprotein E (apoE) and clusterin can influence structure, toxicity, and accumulation of the amyloid-beta (Abeta) peptide in brain. Both molecules may also be involved in Abeta metabolism prior to its deposition. To assess this possibility, we compared PDAPP transgenic mice that develop age-dependent Abeta accumulation in the absence of apoE or clusterin as well as in the absence of both proteins. apoE(-/-) and clusterin(-/-) mice accumulated similar Abeta levels but much less fibrillar Abeta. In contrast, apoE(-/-)/clusterin(-/-) mice had both earlier onset and markedly increased Abeta and amyloid deposition. Both apoE(-/-) and apoE(-/-)/clusterin(-/-) mice had elevated CSF and brain interstitial fluid Abeta, as well as significant differences in the elimination half-life of interstitial fluid Abeta measured by in vivo microdialysis. These findings demonstrate additive effects of apoE and clusterin on influencing Abeta deposition and that apoE plays an important role in regulating extracellular CNS Abeta metabolism independent of Abeta synthesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>DeMattos</LastName><ForeName>Ronald B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Neuroscience Discovery Research, Lilly Research Laboratories, Indianapolis, IN 46285, USA. holtzman@neuro.wustl.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cirrito</LastName><ForeName>John R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Parsadanian</LastName><ForeName>Maia</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>May</LastName><ForeName>Patrick C</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>O'Dell</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Jennie W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Harmony</LastName><ForeName>Judith A K</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Aronow</LastName><ForeName>Bruce J</ForeName><Initials>BJ</Initials></Author><Author ValidYN="Y"><LastName>Bales</LastName><ForeName>Kelly R</ForeName><Initials>KR</Initials></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Steven M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Holtzman</LastName><ForeName>David M</ForeName><Initials>DM</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG05681</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG11355</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG13956</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495243">Clu protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051152">Clusterin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018832">Molecular Chaperones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001923" MajorTopicYN="N">Brain Chemistry</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051152" MajorTopicYN="N">Clusterin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005110" MajorTopicYN="N">Extracellular Space</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006207" MajorTopicYN="N">Half-Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006651" MajorTopicYN="N">Histocytochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017551" MajorTopicYN="N">Microdialysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018832" MajorTopicYN="N">Molecular Chaperones</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>9</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14741101</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00850-x</ArticleId><ArticleId IdType="pii">S089662730300850X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14745448</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1061-4036</ISSN><JournalIssue CitedMedium="Print"><Volume>36</Volume><Issue>2</Issue><PubDate><Year>2004</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Nature genetics</Title><ISOAbbreviation>Nat Genet</ISOAbbreviation></Journal><ArticleTitle>Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia.</ArticleTitle><Pagination><StartPage>131</StartPage><EndPage>137</EndPage><MedlinePgn>131-7</MedlinePgn></Pagination><Abstract><AbstractText>AKT-GSK3beta signaling is a target of lithium and as such has been implicated in the pathogenesis of mood disorders. Here, we provide evidence that this signaling pathway also has a role in schizophrenia. Specifically, we present convergent evidence for a decrease in AKT1 protein levels and levels of phosphorylation of GSK3beta at Ser9 in the peripheral lymphocytes and brains of individuals with schizophrenia; a significant association between schizophrenia and an AKT1 haplotype associated with lower AKT1 protein levels; and a greater sensitivity to the sensorimotor gating-disruptive effect of amphetamine, conferred by AKT1 deficiency. Our findings support the proposal that alterations in AKT1-GSK3beta signaling contribute to schizophrenia pathogenesis and identify AKT1 as a potential schizophrenia susceptibility gene. Consistent with this proposal, we also show that haloperidol induces a stepwise increase in regulatory phosphorylation of AKT1 in the brains of treated mice that could compensate for an impaired function of this signaling pathway in schizophrenia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Emamian</LastName><ForeName>Effat S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>The Rockefeller University, Laboratory of Human Neurogenetics, 1230 York Avenue, Box #313, New York, New York 10021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Birnbaum</LastName><ForeName>Morris J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Karayiorgou</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gogos</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Genet</MedlineTA><NlmUniqueID>9216904</NlmUniqueID><ISSNLinking>1061-4036</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>452VLY9402</RegistryNumber><NameOfSubstance UI="D012694">Serine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.-</RegistryNumber><NameOfSubstance UI="D010770">Phosphotransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C494918">AKT1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C000605506">GSK3B protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000071679">Glycogen Synthase Kinase 3 beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C000605507">Gsk3b protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.26</RegistryNumber><NameOfSubstance UI="D038362">Glycogen Synthase Kinase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>J6292F8L3D</RegistryNumber><NameOfSubstance UI="D006220">Haloperidol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Genet. 2004 Feb;36(2):115-6. doi: 10.1038/ng0204-115.</RefSource><PMID Version="1">14752519</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038362" MajorTopicYN="N">Glycogen Synthase Kinase 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071679" MajorTopicYN="N">Glycogen Synthase Kinase 3 beta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006220" MajorTopicYN="N">Haloperidol</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010770" MajorTopicYN="N">Phosphotransferases</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011518" MajorTopicYN="Y">Proto-Oncogene Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012694" MajorTopicYN="N">Serine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2004</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14745448</ArticleId><ArticleId IdType="doi">10.1038/ng1296</ArticleId><ArticleId IdType="pii">ng1296</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14747503</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>291</Volume><Issue>4</Issue><PubDate><Year>2004</Year><Month>Jan</Month><Day>28</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.</ArticleTitle><Pagination><StartPage>460</StartPage><EndPage>469</EndPage><MedlinePgn>460-9</MedlinePgn></Pagination><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Premutation expansions (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene are frequent in the general population, with estimated prevalences of 1 per 259 females and 1 per 813 males. Several articles have recently described the presence of late-onset neurological symptoms in male carriers of premutation (FMR1) alleles. The main clinical features described in this newly identified syndrome are cerebellar ataxia and intention tremor. Additional documented symptoms include short-term memory loss, executive functional deficits, cognitive decline, parkinsonism, peripheral neuropathy, lower-limb proximal muscle weakness, and autonomic dysfunction.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the penetrance of the fragile X-associated tremor/ataxia syndrome (FXTAS) among premutation carriers.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="METHODS">Family-based study of 192 individuals (premutation carriers and controls) whose families belong to the Northern or Southern California Fragile X Associations. Data were collected (March 2002-April 2003) through a survey and a standardized neurological examination, which was videotaped and subsequently scored in a blinded fashion.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Penetrance of intention tremor and ataxia among adult carriers (aged &gt; or =50 years) of premutation expansions of the FMR1 gene.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Data from the survey of 192 individuals demonstrated an age-related penetrance of the combination of reported intention tremor and gait ataxia in male carriers (17%, 38%, 47%, and 75% [lower-bound estimates] for participants aged 50-59, 60-69, 70-79, and &gt; or =80 years, respectively). The male carrier group had an age-adjusted 13-fold increased risk (95% confidence interval, 3.9-25.4; P =.003) of combined intention tremor and gait ataxia when compared with male controls. The clinical examination data from 93 individuals demonstrated that male carriers experienced more difficulties on each of 3 standardized neurological rating scales compared with controls (P&lt;.05). Female carrier scores were also higher than those of female controls (P&lt;.05) on 2 of the 3 neurological rating scales, but no participant was identified with probable or definite FXTAS.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The study demonstrates that older male carriers of premutation alleles of the FMR1 gene are at high risk of developing FXTAS. Since male premutation carriers are relatively common in the general population, older men with ataxia and intention tremor should be screened for the FMR1 mutation, especially if these signs are accompanied by parkinsonism, autonomic dysfunction, or cognitive decline, regardless of family history.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jacquemont</LastName><ForeName>S&#xe9;bastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MIND Institute, University of California Davis Medical Center, Sacramento, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagerman</LastName><ForeName>Randi J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Leehey</LastName><ForeName>Maureen A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Deborah A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Levine</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Brunberg</LastName><ForeName>James A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lin</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Jardini</LastName><ForeName>Tristan</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Gane</LastName><ForeName>Louise W</ForeName><Initials>LW</Initials></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Susan W</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Herman</LastName><ForeName>Kristin</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Grigsby</LastName><ForeName>James</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Greco</LastName><ForeName>Claudia M</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Berry-Kravis</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Tassone</LastName><ForeName>Flora</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Hagerman</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS044299</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HD 36071</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS 43532</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497683">FMR1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>139135-51-6</RegistryNumber><NameOfSubstance UI="D051860">Fragile X Mental Retardation Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2004 Jun 23;291(24):2945; author reply 2945-6. doi: 10.1001/jama.291.24.2945-a.</RefSource><PMID Version="1">15213204</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001259" MajorTopicYN="N">Ataxia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002140" MajorTopicYN="N" Type="Geographic">California</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="Y">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051860" MajorTopicYN="N">Fragile X Mental Retardation Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005600" MajorTopicYN="N">Fragile X Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005684" MajorTopicYN="N">Gait</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009460" MajorTopicYN="N">Neurologic Examination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="Y">RNA-Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014202" MajorTopicYN="N">Tremor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14747503</ArticleId><ArticleId IdType="doi">10.1001/jama.291.4.460</ArticleId><ArticleId IdType="pii">291/4/460</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14749517</PMID><DateCompleted><Year>2004</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>101</Volume><Issue>6</Issue><PubDate><Year>2004</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Microtransplantation of functional receptors and channels from the Alzheimer's brain to frog oocytes.</ArticleTitle><Pagination><StartPage>1760</StartPage><EndPage>1763</EndPage><MedlinePgn>1760-3</MedlinePgn></Pagination><Abstract><AbstractText>About a decade ago, cell membranes from the electric organ of Torpedo and from the rat brain were transplanted to frog oocytes, which thus acquired functional Torpedo and rat neurotransmitter receptors. Nevertheless, the great potential that this method has for studying human diseases has remained virtually untapped. Here, we show that cell membranes from the postmortem brains of humans that suffered Alzheimer's disease can be microtransplanted to the plasma membrane of Xenopus oocytes. We show also that these postmortem membranes carry neurotransmitter receptors and voltage-operated channels that are still functional, even after they have been kept frozen for many years. This method provides a new and powerful approach to study directly the functional characteristics and structure of receptors, channels, and other membrane proteins of the Alzheimer's brain. This knowledge may help in understanding the basis of Alzheimer's disease and also help in developing new treatments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miledi</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurobiology and Behavior, University of California, Irvine, CA 92697-4550, USA. rmiledi@uci.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Due&#xf1;as</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Martinez-Torres</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kawas</LastName><ForeName>C H</ForeName><Initials>CH</Initials></Author><Author ValidYN="Y"><LastName>Eusebi</LastName><ForeName>F</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007473">Ion Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007473" MajorTopicYN="N">Ion Channels</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009865" MajorTopicYN="N">Oocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011956" MajorTopicYN="N">Receptors, Cell Surface</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>4</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>8</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14749517</ArticleId><ArticleId IdType="pmc">PMC341849</ArticleId><ArticleId IdType="doi">10.1073/pnas.0308224100</ArticleId><ArticleId IdType="pii">0308224100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maccioni, R. B., Mu&#xf1;oz, J. P. &amp; Barbeito, L. (2001) Arch. Med. Res. 32, 367-381.</Citation><ArticleIdList><ArticleId IdType="pubmed">11578751</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt, T. (2001) Neuroscience 102, 723-765.</Citation><ArticleIdList><ArticleId IdType="pubmed">11182240</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe, D. J. (2001) Physiol. Rev. 81, 741-766.</Citation><ArticleIdList><ArticleId IdType="pubmed">11274343</ArticleId></ArticleIdList></Reference><Reference><Citation>Small, D. H., Mok, S. S. &amp; Bornstein, J. C. (2001) Nat. Rev. Neurosci. 2, 595-598.</Citation><ArticleIdList><ArticleId IdType="pubmed">11484003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagan, B. L., Hirakura, Y., Azimov, R., Azimova, R. &amp; Lin, M. C. (2002) Peptides 7, 1311-1315.</Citation><ArticleIdList><ArticleId IdType="pubmed">12128087</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe, D. J. (2002) Science 298, 789-791.</Citation><ArticleIdList><ArticleId IdType="pubmed">12399581</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies, P. &amp; Maloney, A. J. (1976) Lancet 2, 1403 (lett.).</Citation><ArticleIdList><ArticleId IdType="pubmed">63862</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu, D. C., Penney, J. B. &amp; Young, A. B. (1987) Neurosci. Lett. 82, 246-252.</Citation><ArticleIdList><ArticleId IdType="pubmed">2827074</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilles, K., Qu, M., Schleicher, A., Schroeter, M., Kraemer, M. &amp; Witte, O. W. (1995) Arzneim. Forsch. 45, 361-366.</Citation><ArticleIdList><ArticleId IdType="pubmed">7763327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomovic, M. D., Mizukami, K., Warde, D., Sheffield, R., Hamilton, R., Wenthold, R. J. &amp; Armstrong, D. M. (1999) Exp. Neurol. 160, 194-204.</Citation><ArticleIdList><ArticleId IdType="pubmed">10630204</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomovic, M. D., Nocera, R., Mizukami, K. &amp; Armstrong, D. M. (2000) Exp. Neurol. 166, 363-375.</Citation><ArticleIdList><ArticleId IdType="pubmed">11085901</ArticleId></ArticleIdList></Reference><Reference><Citation>Hynd, M. R., Scott, H. L. &amp; Dodd, P. R. (2001) J. Neurochem. 78, 175-182.</Citation><ArticleIdList><ArticleId IdType="pubmed">11432984</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze, C.-I., Bi, H., Kleinschmidt-DeMasters, B. K., Filley, C. M. &amp; Martin, L. J. (2001) J. Neurol. Sci. 182, 151-159.</Citation><ArticleIdList><ArticleId IdType="pubmed">11137521</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulugeta, E., Karlsson, E., Islam, A., Kalaria, R., Mangat, H., Winblad, B. &amp; Adem, A. (2003) Brain Res. 960, 259-262.</Citation><ArticleIdList><ArticleId IdType="pubmed">12505680</ArticleId></ArticleIdList></Reference><Reference><Citation>Miledi, R., Parker, I. &amp; Sumikawa, K. (1989) Fidia Research Foundation Neuroscience Award Lecture (Raven, New York), Vol. 3, pp. 57-90.</Citation></Reference><Reference><Citation>Gundersen, C. B., Miledi, R. &amp; Parker, I. (1984) Nature 308, 421-424.</Citation><ArticleIdList><ArticleId IdType="pubmed">6323990</ArticleId></ArticleIdList></Reference><Reference><Citation>Umbach, J. A. &amp; Gundersen, C. B. (1989) Mol. Pharmacol. 36, 582-588.</Citation><ArticleIdList><ArticleId IdType="pubmed">2572961</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma, E., Esposito, V., Mileo, A. M., Di Gennaro, G., Quarato, P., Giangaspero, F., Scoppetta, C., Onorati, P., Trettel, F., Miledi, R. &amp; Eusebi, F. (2002) Proc. Natl. Acad. Sci. USA 99, 15078-15083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC137546</ArticleId><ArticleId IdType="pubmed">12409614</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsal, J., Tigyi, G. &amp; Miledi, R. (1995) Proc. Natl. Acad. Sci. USA 92, 5224-5228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC41881</ArticleId><ArticleId IdType="pubmed">7761478</ArticleId></ArticleIdList></Reference><Reference><Citation>Miledi, R., Eusebi, F., Martinez-Torres, A., Palma, E. &amp; Trettel, F. (2002) Proc. Natl. Acad. Sci. USA. 99, 13238-13242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC130617</ArticleId><ArticleId IdType="pubmed">12237406</ArticleId></ArticleIdList></Reference><Reference><Citation>Miledi, R. (1982) Proc. R. Soc. London Ser. B 215, 491-497.</Citation><ArticleIdList><ArticleId IdType="pubmed">6127718</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusano, K., Miledi, R. &amp; Stinnakre, J. (1982) J. Physiol. 328, 143-170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1225651</ArticleId><ArticleId IdType="pubmed">7131311</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer, M., Koeppe, R. A., Frey, K. A., Foster, N. L. &amp; Kuhl, D. E. (1995) Arch. Neurol. 52, 314-317.</Citation><ArticleIdList><ArticleId IdType="pubmed">7872887</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizukami, K., Ikonomovic, M. D., Grayson, D. R., Rubin, R. T., Warde, D., Sheffield, R., Hamilton, R. L., Davies, P. &amp; Armstrong, D. M. (1997) Exp. Neurol. 147, 333-345.</Citation><ArticleIdList><ArticleId IdType="pubmed">9344558</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohyama, M., Senda, M., Ishiwata, K., Kitamura, S., Mishina, M., Ishii, K., Toyama, H., Oda, K. &amp; Katayama, Y. (1999) Ann. Nucl. Med. 13, 309-315.</Citation><ArticleIdList><ArticleId IdType="pubmed">10582800</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell, O., Atack, J. R., Dewar, D., McKernan, R. M. &amp; Sur, C. O. (2000) Neuroscience 98, 669-675.</Citation><ArticleIdList><ArticleId IdType="pubmed">10891610</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizukami, K., Ikonomovic, M. D., Grayson, D. R., Sheffield, R. &amp; Armstrong, D. M. (1998) Mol. Brain Res. 799, 148-155.</Citation><ArticleIdList><ArticleId IdType="pubmed">9666109</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizukami, K., Grayson, D. R., Ikonomovic, M. D., Sheffield, R. &amp; Armstrong, D. M. (1998) Mol. Brain Res. 56, 268-272.</Citation><ArticleIdList><ArticleId IdType="pubmed">9602147</ArticleId></ArticleIdList></Reference><Reference><Citation>Arispe, N., Pollard, H. B. &amp; Rojas, E. (1993) Proc. Natl. Acad. Sci. USA 90, 10573-10577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC47819</ArticleId><ArticleId IdType="pubmed">7504270</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, H., Bhatia, R. &amp; Lal, R. (2001) FASEB J. 15, 2433-2444.</Citation><ArticleIdList><ArticleId IdType="pubmed">11689468</ArticleId></ArticleIdList></Reference><Reference><Citation>Arispe, N., Pollard, H. B. &amp; Rojas, E. (1994) Mol. Cell. Biochem. 140, 119-125.</Citation><ArticleIdList><ArticleId IdType="pubmed">7898484</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragsdale, D. &amp; Miledi, R. (1991) Proc. Natl. Acad. Sci. USA 88, 1854-1858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC51124</ArticleId><ArticleId IdType="pubmed">1705710</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14752167</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>303</Volume><Issue>5663</Issue><PubDate><Year>2004</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Cross-linking cellular prion protein triggers neuronal apoptosis in vivo.</ArticleTitle><Pagination><StartPage>1514</StartPage><EndPage>1516</EndPage><MedlinePgn>1514-6</MedlinePgn></Pagination><Abstract><AbstractText>Neuronal death is a prominent, but poorly understood, pathological hallmark of prion disease. Notably, in the absence of the cellular prion protein (PrPC), the disease-associated isoform, PrPSc, appears not to be intrinsically neurotoxic, suggesting that PrPC itself may participate directly in the prion neurodegenerative cascade. Here, cross-linking PrPC in vivo with specific monoclonal antibodies was found to trigger rapid and extensive apoptosis in hippocampal and cerebellar neurons. These findings suggest that PrPC functions in the control of neuronal survival and provides a model to explore whether cross-linking of PrPC by oligomeric PrPSc can promote neuronal loss during prion infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Solforosi</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Criado</LastName><ForeName>Jose R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>McGavern</LastName><ForeName>Dorian B</ForeName><Initials>DB</Initials></Author><Author ValidYN="Y"><LastName>Wirz</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Alavez</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Sugama</LastName><ForeName>Shuei</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>DeGiorgio</LastName><ForeName>Lorraine A</ForeName><Initials>LA</Initials></Author><Author ValidYN="Y"><LastName>Volpe</LastName><ForeName>Bruce T</ForeName><Initials>BT</Initials></Author><Author ValidYN="Y"><LastName>Wiseman</LastName><ForeName>Erika</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Abalos</LastName><ForeName>Gil</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Masliah</LastName><ForeName>Eliezer</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Gilden</LastName><ForeName>Donald</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Oldstone</LastName><ForeName>Michael B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Conti</LastName><ForeName>Bruno</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Williamson</LastName><ForeName>R Anthony</ForeName><Initials>RA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG00080</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG04342</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI09484</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HL63817</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>01</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007140">Immunoglobulin Fab Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019006">Neural Cell Adhesion Molecules</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018621">PrPC Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003167" MajorTopicYN="N">Complement Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019281" MajorTopicYN="N">Dimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007140" MajorTopicYN="N">Immunoglobulin Fab Fragments</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020287" MajorTopicYN="N">In Situ Nick-End Labeling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019006" MajorTopicYN="N">Neural Cell Adhesion Molecules</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018621" MajorTopicYN="N">PrPC Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14752167</ArticleId><ArticleId IdType="doi">10.1126/science.1094273</ArticleId><ArticleId IdType="pii">1094273</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14760408</PMID><DateCompleted><Year>2004</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2010</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1078-8956</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2004</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer disease.</ArticleTitle><Pagination><StartPage>117</StartPage><EndPage>119</EndPage><MedlinePgn>117-8; author reply 118-9</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akiyama</LastName><ForeName>Haruhiko</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>McGeer</LastName><ForeName>Patrick L</ForeName><Initials>PL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000906">Antibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Nat Med. 2003 Apr;9(4):448-52. doi: 10.1038/nm840.</RefSource><PMID Version="1">12640446</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007167" MajorTopicYN="Y">Immunotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>2</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>4</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>2</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14760408</ArticleId><ArticleId IdType="doi">10.1038/nm0204-117</ArticleId><ArticleId IdType="pii">nm0204-117</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14766175</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>41</Volume><Issue>3</Issue><PubDate><Year>2004</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels.</ArticleTitle><Pagination><StartPage>351</StartPage><EndPage>365</EndPage><MedlinePgn>351-65</MedlinePgn></Pagination><Abstract><AbstractText>Nitric oxide (NO) and zinc (Zn2+) are implicated in the pathogenesis of cerebral ischemia and neurodegenerative diseases. However, their relationship and the molecular mechanism of their neurotoxic effects remain unclear. Here we show that addition of exogenous NO or NMDA (to increase endogenous NO) leads to peroxynitrite (ONOO-) formation and consequent Zn2+ release from intracellular stores in cerebrocortical neurons. Free Zn2+ in turn induces respiratory block, mitochondrial permeability transition (mPT), cytochrome c release, generation of reactive oxygen species (ROS), and p38 MAP kinase activation. This pathway leads to caspase-independent K+ efflux with cell volume loss and apoptotic-like death. Moreover, Zn2+ chelators, ROS scavengers, Bcl-xL, dominant-interfering p38, or K+ channel blockers all attenuate NO-induced K+ efflux, cell volume loss, and neuronal apoptosis. Thus, these data establish a new form of crosstalk between NO and Zn2+ apoptotic signal transduction pathways that may contribute to neurodegeneration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bossy-Wetzel</LastName><ForeName>Ella</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Neuroscience &amp; Aging, The Burnham Institute, La Jolla, CA 92037, USA. ebossy-wetzel@burnham.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talantova</LastName><ForeName>Maria V</ForeName><Initials>MV</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Wilson D</ForeName><Initials>WD</Initials></Author><Author ValidYN="Y"><LastName>Sch&#xf6;lzke</LastName><ForeName>Marion N</ForeName><Initials>MN</Initials></Author><Author ValidYN="Y"><LastName>Harrop</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mathews</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>G&#xf6;tz</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Jiahuai</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ellisman</LastName><ForeName>Mark H</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Perkins</LastName><ForeName>Guy A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Lipton</LastName><ForeName>Stuart A</ForeName><Initials>SA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 HD29587</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P41 RR04050</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EY05477</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EY09024</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS047456</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS14718</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS41207</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS44314</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017362">Cyclic AMP Response Element-Binding Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024642">Potassium Channels, Voltage-Gated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C059983">potassium channel protein I(sk)</NameOfSubstance></Chemical><Chemical><RegistryNumber>147336-22-9</RegistryNumber><NameOfSubstance UI="D049452">Green Fluorescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D048051">p38 Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance UI="D015032">Zinc</NameOfSubstance></Chemical><Chemical><RegistryNumber>K848JZ4886</RegistryNumber><NameOfSubstance UI="D003545">Cysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017362" MajorTopicYN="N">Cyclic AMP Response Element-Binding Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003545" MajorTopicYN="N">Cysteine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049452" MajorTopicYN="N">Green Fluorescent Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008564" MajorTopicYN="N">Membrane Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018408" MajorTopicYN="N">Patch-Clamp Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024642" MajorTopicYN="Y">Potassium Channels, Voltage-Gated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048051" MajorTopicYN="N">p38 Mitogen-Activated Protein Kinases</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2003</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>2</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>2</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14766175</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(04)00015-7</ArticleId><ArticleId IdType="pii">S0896627304000157</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14766981</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>101</Volume><Issue>7</Issue><PubDate><Year>2004</Year><Month>Feb</Month><Day>17</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation.</ArticleTitle><Pagination><StartPage>2140</StartPage><EndPage>2144</EndPage><MedlinePgn>2140-4</MedlinePgn></Pagination><Abstract><AbstractText>The neurotransmitter acetylcholine is considered essential for proper functioning of the hippocampus-dependent declarative memory system, and it represents a major neuropharmacological target for the treatment of memory deficits, such as those in Alzheimer's disease. During slow-wave sleep (SWS), however, declarative memory consolidation is particularly strong, while acetylcholine levels in the hippocampus drop to a minimum. Observations in rats led to the hypothesis that the low cholinergic tone during SWS is necessary for the replay of new memories in the hippocampus and their long-term storage in neocortical networks. However, this low tone should not affect nondeclarative memory systems. In this study, increasing central nervous cholinergic activation during SWS-rich sleep by posttrial infusion of 0.75 mg of the cholinesterase inhibitor physostigmine completely blocked SWS-related consolidation of declarative memories for word pairs in human subjects. The treatment did not interfere with consolidation of a nondeclarative mirror tracing task. Also, physostigmine did not alter memory consolidation during waking, when the endogenous central nervous cholinergic tone is maximal. These findings are in line with predictions that a low cholinergic tone during SWS is essential for declarative memory consolidation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gais</LastName><ForeName>Steffen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroendocrinology, University of L&#xfc;beck, Ratzeburger Allee 160, 23538 L&#xfc;beck, Germany. gais@kfg.mu-luebeck.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Born</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D018848">Controlled Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002800">Cholinesterase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>9U1VM840SP</RegistryNumber><NameOfSubstance UI="D010830">Physostigmine</NameOfSubstance></Chemical><Chemical><RegistryNumber>N9YNS0M02X</RegistryNumber><NameOfSubstance UI="D000109">Acetylcholine</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1795-6. doi: 10.1073/pnas.0400237101.</RefSource><PMID Version="1">14769926</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000109" MajorTopicYN="N">Acetylcholine</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002800" MajorTopicYN="N">Cholinesterase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008568" MajorTopicYN="N">Memory</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011939" MajorTopicYN="N">Mental Recall</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010830" MajorTopicYN="N">Physostigmine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012890" MajorTopicYN="N">Sleep</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014851" MajorTopicYN="N">Wakefulness</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>2</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>2</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>8</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14766981</ArticleId><ArticleId IdType="pmc">PMC357065</ArticleId><ArticleId IdType="doi">10.1073/pnas.0305404101</ArticleId><ArticleId IdType="pii">0305404101</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McGaugh, J. L. (2000) Science 287, 248-251.</Citation><ArticleIdList><ArticleId IdType="pubmed">10634773</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Ormer, E. B. (1933) Psychol. Bull. 30, 415-439.</Citation></Reference><Reference><Citation>Graves, E. A. (1936) J. Exp. Psychol. 19, 316-322.</Citation></Reference><Reference><Citation>Plihal, W. &amp; Born, J. (1997) J. Cognit. Neurosci. 9, 534-547.</Citation><ArticleIdList><ArticleId IdType="pubmed">23968216</ArticleId></ArticleIdList></Reference><Reference><Citation>Stickgold, R., Hobson, J. A., Fosse, R. &amp; Fosse, M. (2001) Science 294, 1052-1057.</Citation><ArticleIdList><ArticleId IdType="pubmed">11691983</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlides, C. &amp; Winson, J. (1989) J. Neurosci. 9, 2907-2918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6569689</ArticleId><ArticleId IdType="pubmed">2769370</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzsaki, G. (1996) Cereb. Cortex 6, 81-92.</Citation><ArticleIdList><ArticleId IdType="pubmed">8670641</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, A. K. &amp; Wilson, M. A. (2002) Neuron 36, 1183-1194.</Citation><ArticleIdList><ArticleId IdType="pubmed">12495631</ArticleId></ArticleIdList></Reference><Reference><Citation>Maquet, P. (2001) Science 294, 1048-1052.</Citation><ArticleIdList><ArticleId IdType="pubmed">11691982</ArticleId></ArticleIdList></Reference><Reference><Citation>Benington, J. H. &amp; Frank, M. G. (2003) Prog. Neurobiol. 69, 71-101.</Citation><ArticleIdList><ArticleId IdType="pubmed">12684067</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaggs, W. E. &amp; McNaughton, B. L. (1996) Science 271, 1870-1873.</Citation><ArticleIdList><ArticleId IdType="pubmed">8596957</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadasdy, Z., Hirase, H., Czurko, A., Csicsvari, J. &amp; Buzsaki, G. (1999) J. Neurosci. 19, 9497-9507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782894</ArticleId><ArticleId IdType="pubmed">10531452</ArticleId></ArticleIdList></Reference><Reference><Citation>Squire, L. R. (1998) C. R. Acad. Sci. Ser. III 321, 153-156.</Citation><ArticleIdList><ArticleId IdType="pubmed">9759333</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler, M. J., Sullivan, M. J. &amp; Ekstrand, B. R. (1973) Science 179, 302-304.</Citation><ArticleIdList><ArticleId IdType="pubmed">4345657</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer, S., Hallschmid, M., Elsner, A. L. &amp; Born, J. (2002) Proc. Natl. Acad. Sci. USA 99, 11987-11991.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC129381</ArticleId><ArticleId IdType="pubmed">12193650</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrosu, F., Portas, C., Mascia, M. S., Casu, M. A., Fa, M., Giagheddu, M., Imperato, A. &amp; Gessa, G. L. (1995) Brain Res. 671, 329-332.</Citation><ArticleIdList><ArticleId IdType="pubmed">7743225</ArticleId></ArticleIdList></Reference><Reference><Citation>Pace-Schott, E. F. &amp; Hobson, J. A. (2002) Nat. Rev. Neurosci. 3, 591-605.</Citation><ArticleIdList><ArticleId IdType="pubmed">12154361</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyle, J. T., Price, D. L. &amp; DeLong, M. R. (1983) Science 219, 1184-1190.</Citation><ArticleIdList><ArticleId IdType="pubmed">6338589</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitaram, N., Weingartner, H. &amp; Gillin, J. C. (1978) Science 201, 274-276.</Citation><ArticleIdList><ArticleId IdType="pubmed">351808</ArticleId></ArticleIdList></Reference><Reference><Citation>Iversen, S. D. (1998) C. R. Acad. Sci. Ser. III 321, 209-215.</Citation><ArticleIdList><ArticleId IdType="pubmed">9759343</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, K. L., Mohs, R. C., Tinklenberg, J. R., Pfefferbaum, A., Hollister, L. E. &amp; Kopell, B. S. (1978) Science 201, 272-274.</Citation><ArticleIdList><ArticleId IdType="pubmed">351807</ArticleId></ArticleIdList></Reference><Reference><Citation>Santucci, A. C., Kanof, P. D. &amp; Haroutunian, V. (1989) Psychopharmacology 99, 70-74.</Citation><ArticleIdList><ArticleId IdType="pubmed">2506606</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, C., Tenn, C. &amp; Annett, R. (1991) Can. J. Psychol. 45, 115-124.</Citation><ArticleIdList><ArticleId IdType="pubmed">1873751</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasselmo, M. E. &amp; Wyble, B. P. (1997) Behav. Brain Res. 89, 1-34.</Citation><ArticleIdList><ArticleId IdType="pubmed">9475612</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzsaki, G. (1989) Neuroscience 31, 551-570.</Citation><ArticleIdList><ArticleId IdType="pubmed">2687720</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasselmo, M. E. (1999) Trends Cognit. Sci. 3, 351-359.</Citation><ArticleIdList><ArticleId IdType="pubmed">10461198</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzsaki, G. (1986) Brain Res. 398, 242-252.</Citation><ArticleIdList><ArticleId IdType="pubmed">3026567</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasselmo, M. E., Schnell, E. &amp; Barkai, E. (1995) J. Neurosci. 15, 5249-5262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6577857</ArticleId><ArticleId IdType="pubmed">7623149</ArticleId></ArticleIdList></Reference><Reference><Citation>Aquilonius, S. M. &amp; Hartvig, P. (1986) Clin. Pharmacokinet. 11, 236-249.</Citation><ArticleIdList><ArticleId IdType="pubmed">3524957</ArticleId></ArticleIdList></Reference><Reference><Citation>Rechtschaffen, A. &amp; Kales, A. (1968) A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects (Brain Inf. Service, Univ. of California, Los Angeles).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Plihal, W. &amp; Born, J. (1999) Neuroreport 10, 2741-2747.</Citation><ArticleIdList><ArticleId IdType="pubmed">10511433</ArticleId></ArticleIdList></Reference><Reference><Citation>McGaugh, J. L. &amp; Roozendaal, B. (2002) Curr. Opin. Neurobiol. 12, 205-210.</Citation><ArticleIdList><ArticleId IdType="pubmed">12015238</ArticleId></ArticleIdList></Reference><Reference><Citation>McClelland, J. L., McNaughton, B. L. &amp; O'Reilly, R. C. (1995) Psychol. Rev. 102, 419-457.</Citation><ArticleIdList><ArticleId IdType="pubmed">7624455</ArticleId></ArticleIdList></Reference><Reference><Citation>Power, A. E., Vazdarjanova, A. &amp; McGaugh, J. L. (2003) Neurobiol. Learn. Mem. 80, 178-193.</Citation><ArticleIdList><ArticleId IdType="pubmed">14521862</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson, J. A., Stickgold, R. &amp; Pace-Schott, E. F. (1998) Neuroreport 9, R1-R14.</Citation><ArticleIdList><ArticleId IdType="pubmed">9512371</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitaram, N., Wyatt, R. J., Dawson, S. &amp; Gillin, J. C. (1976) Science 191, 1281-1283.</Citation><ArticleIdList><ArticleId IdType="pubmed">176724</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejnowski, T. J. &amp; Destexhe, A. (2000) Brain Res. 886, 208-223.</Citation><ArticleIdList><ArticleId IdType="pubmed">11119697</ArticleId></ArticleIdList></Reference><Reference><Citation>Gais, S., Molle, M., Helms, K. &amp; Born, J. (2002) J. Neurosci. 22, 6830-6834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758170</ArticleId><ArticleId IdType="pubmed">12151563</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, C. (2001) Sleep Med. Rev. 5, 491-506.</Citation><ArticleIdList><ArticleId IdType="pubmed">12531156</ArticleId></ArticleIdList></Reference><Reference><Citation>Peigneux, P., Laureys, S., Delbeuck, X. &amp; Maquet, P. (2001) Neuroreport 12, A111-A124.</Citation><ArticleIdList><ArticleId IdType="pubmed">11742260</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier-Koll, A., Bussmann, B., Schmidt, C. &amp; Neuschwander, D. (1999) Percept. Mot. Skills 88, 1141-1159.</Citation><ArticleIdList><ArticleId IdType="pubmed">10485095</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14769913</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>101</Volume><Issue>7</Issue><PubDate><Year>2004</Year><Month>Feb</Month><Day>17</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.</ArticleTitle><Pagination><StartPage>2173</StartPage><EndPage>2178</EndPage><MedlinePgn>2173-8</MedlinePgn></Pagination><Abstract><AbstractText>The pathogenesis of incipient Alzheimer's disease (AD) has been resistant to analysis because of the complexity of AD and the overlap of its early-stage markers with normal aging. Gene microarrays provide new tools for addressing complexity because they allow overviews of the simultaneous activity of multiple cellular pathways. However, microarray data interpretation is often hindered by low statistical power, high false positives or false negatives, and by uncertain relevance to functional endpoints. Here, we analyzed hippocampal gene expression of nine control and 22 AD subjects of varying severity on 31 separate microarrays. We then tested the correlation of each gene's expression with MiniMental Status Examination (MMSE) and neurofibrillary tangle (NFT) scores across all 31 subjects regardless of diagnosis. These well powered tests revealed a major transcriptional response comprising thousands of genes significantly correlated with AD markers. Several hundred of these genes were also correlated with AD markers across only control and incipient AD subjects (MMSE &gt; 20). Biological process categories associated with incipient AD-correlated genes were identified statistically (ease program) and revealed up-regulation of many transcription factor/signaling genes regulating proliferation and differentiation, including tumor suppressors, oligodendrocyte growth factors, and protein kinase A modulators. In addition, up-regulation of adhesion, apoptosis, lipid metabolism, and initial inflammation processes occurred, and down-regulation of protein folding/metabolism/transport and some energy metabolism and signaling pathways took place. These findings suggest a new model of AD pathogenesis in which a genomically orchestrated up-regulation of tumor suppressor-mediated differentiation and involution processes induces the spread of pathology along myelinated axons.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blalock</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Molecular and Biomedical Pharmacology, Spinal Cord and Brain Injury Research Center, and Sanders-Brown Research Center on Aging, University of Kentucky College of Medicine, Lexington, KY 40536, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geddes</LastName><ForeName>James W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Kuey Chu</ForeName><Initials>KC</Initials></Author><Author ValidYN="Y"><LastName>Porter</LastName><ForeName>Nada M</ForeName><Initials>NM</Initials></Author><Author ValidYN="Y"><LastName>Markesbery</LastName><ForeName>William R</ForeName><Initials>WR</Initials></Author><Author ValidYN="Y"><LastName>Landfield</LastName><ForeName>Philip W</ForeName><Initials>PW</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG010836</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005144</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG05144</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG10836</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.11</RegistryNumber><NameOfSubstance UI="D017868">Cyclic AMP-Dependent Protein Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020013" MajorTopicYN="N">Calcium Signaling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017868" MajorTopicYN="N">Cyclic AMP-Dependent Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="Y">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016147" MajorTopicYN="N">Genes, Tumor Suppressor</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="Y">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>2</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>2</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>8</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14769913</ArticleId><ArticleId IdType="pmc">PMC357071</ArticleId><ArticleId IdType="doi">10.1073/pnas.0308512100</ArticleId><ArticleId IdType="pii">0308512100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tanzi, R. E. &amp; Bertram, L. (2001) Neuron 32, 181-184.</Citation><ArticleIdList><ArticleId IdType="pubmed">11683989</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, W. L., Krafft, G. A. &amp; Finch, C. E. (2001) Trends Neurosci. 24, 219-224.</Citation><ArticleIdList><ArticleId IdType="pubmed">11250006</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy, J. &amp; Selkoe, D. J. (2002) Science 297, 353-356.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Price, D. L. &amp; Sisodia, S. S. (1998) Annu. Rev. Neurosci. 21, 479-505.</Citation><ArticleIdList><ArticleId IdType="pubmed">9530504</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K. &amp; McConlogue, L. (2000) J. Neurosci. 20, 4050-4058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772621</ArticleId><ArticleId IdType="pubmed">10818140</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullan, M. &amp; Crawford, F. (1994) Mol. Neurobiol. 9, 15-22.</Citation><ArticleIdList><ArticleId IdType="pubmed">7888092</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan, D. (2003) Neurochem. Res. 28, 1029-1034.</Citation><ArticleIdList><ArticleId IdType="pubmed">12737527</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble, W., Olm, V., Takata, K., Casey, E., Mary, O., Meyerson, J., Gaynor, K., LaFrancois, J., Wang, L., Kondo, T., et al. (2003) Neuron 38, 555-565.</Citation><ArticleIdList><ArticleId IdType="pubmed">12765608</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, G. V. &amp; Bailey, C. D. (2002) J. Alzheimer's Dis. 4, 375-398.</Citation><ArticleIdList><ArticleId IdType="pubmed">12446970</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze, C. I., Troncoso, J. C., Kawas, C., Mouton, P., Price, D. L. &amp; Martin, L. J. (1997) J. Neuropathol. Exp. Neurol. 56, 933-944.</Citation><ArticleIdList><ArticleId IdType="pubmed">9258263</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheff, S. W. &amp; Price, D. A. (2001) J. Alzheimer's Dis. 3, 495-505.</Citation><ArticleIdList><ArticleId IdType="pubmed">12214036</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah, E., Mallory, M., Hansen, L., DeTeresa, R., Alford, M. &amp; Terry, R. (1994) Neurosci. Lett. 174, 67-72.</Citation><ArticleIdList><ArticleId IdType="pubmed">7970158</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksenov, M. Y., Aksenova, M. V., Butterfield, D. A., Geddes, J. W. &amp; Markesbery, W. R. (2001) Neuroscience 103, 373-383.</Citation><ArticleIdList><ArticleId IdType="pubmed">11246152</ArticleId></ArticleIdList></Reference><Reference><Citation>Bickford, P. C., Gould, T., Briederick, L., Chadman, K., Pollock, A., Young, D., Shukitt-Hale, B. &amp; Joseph, J. (2000) Brain Res. 866, 211-217.</Citation><ArticleIdList><ArticleId IdType="pubmed">10825496</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson, G. E. (2002) Free Radical Biol. Med. 32, 1061-1070.</Citation><ArticleIdList><ArticleId IdType="pubmed">12031890</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemma, C., Mesches, M. H., Sepesi, B., Choo, K., Holmes, D. B. &amp; Bickford, P. C. (2002) J. Neurosci. 22, 6114-6120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6757915</ArticleId><ArticleId IdType="pubmed">12122072</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrak, R. E. &amp; Griffin, W. S. (2001) Neurobiol. Aging 22, 903-908.</Citation><ArticleIdList><ArticleId IdType="pubmed">11754997</ArticleId></ArticleIdList></Reference><Reference><Citation>Finch, C. E., Morgan, T., Rozovsky, I., Xie, Z., Weindruch, R. &amp; Prolla, T. (2002) in Microglia in the Degenerating and Regenerating CNS, ed. Streit, W. J. (Springer, New York).</Citation></Reference><Reference><Citation>Rogers, J., Webster, S., Lue, L. F., Brachova, L., Civin, W. H., Emmerling, M., Shivers, B., Walker, D. &amp; McGeer, P. (1996) Neurobiol. Aging 17, 681-686.</Citation><ArticleIdList><ArticleId IdType="pubmed">8892340</ArticleId></ArticleIdList></Reference><Reference><Citation>Nixon, R. A., Mathews, P. M. &amp; Cataldo, A. M. (2001) J. Alzheimer's Dis. 3, 97-107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12214078</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman, M. S., Lee, V. M. &amp; Trojanowski, J. Q. (2003) Trends Neurosci. 26, 407-410.</Citation><ArticleIdList><ArticleId IdType="pubmed">12900170</ArticleId></ArticleIdList></Reference><Reference><Citation>Disterhoft, J. F., Moyer, J. R., Jr., &amp; Thompson, L. T. (1994) Ann. N. Y. Acad. Sci. 747, 382-406.</Citation><ArticleIdList><ArticleId IdType="pubmed">7847686</ArticleId></ArticleIdList></Reference><Reference><Citation>Landfield, P. W., Thibault, O., Mazzanti, M. L., Porter, N. M. &amp; Kerr, D. S. (1992) J. Neurobiol. 23, 1247-1260.</Citation><ArticleIdList><ArticleId IdType="pubmed">1469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Nixon, R. A., Saito, K. I., Grynspan, F., Griffin, W. R., Katayama, S., Honda, T., Mohan, P. S., Shea, T. B. &amp; Beermann, M. (1994) Ann. N. Y. Acad. Sci. 747, 77-91.</Citation><ArticleIdList><ArticleId IdType="pubmed">7847693</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson, M. P., LaFerla, F. M., Chan, S. L., Leissring, M. A., Shepel, P. N. &amp; Geiger, J. D. (2000) Trends Neurosci. 23, 222-229.</Citation><ArticleIdList><ArticleId IdType="pubmed">10782128</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibault, O., Porter, N. M., Chen, K. C., Blalock, E. M., Kaminker, P. G., Clodfelter, G. V., Brewer, L. D. &amp; Landfield, P. W. (1998) Cell Calcium 24, 417-433.</Citation><ArticleIdList><ArticleId IdType="pubmed">10091010</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt, T., Holzer, M., Stobe, A., Gartner, U., Luth, H. J., Bruckner, M. K. &amp; Ueberham, U. (2000) Ann. N. Y. Acad. Sci. 920, 249-255.</Citation><ArticleIdList><ArticleId IdType="pubmed">11193159</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowser, R. &amp; Smith, M. A. (2002) J. Alzheimer's Dis. 4, 249-254.</Citation><ArticleIdList><ArticleId IdType="pubmed">12226545</ArticleId></ArticleIdList></Reference><Reference><Citation>Petanceska, S. S., DeRosa, S., Olm, V., Diaz, N., Sharma, A., Thomas-Bryant, T., Duff, K., Pappolla, M. &amp; Refolo, L. M. (2002) J. Mol. Neurosci. 19, 155-161.</Citation><ArticleIdList><ArticleId IdType="pubmed">12212773</ArticleId></ArticleIdList></Reference><Reference><Citation>Puglielli, L., Konopka, G., Pack-Chung, E., Ingano, L. A., Berezovska, O., Hyman, B. T., Chang, T. Y., Tanzi, R. E. &amp; Kovacs, D. M. (2001) Nat. Cell Biol. 3, 905-912.</Citation><ArticleIdList><ArticleId IdType="pubmed">11584272</ArticleId></ArticleIdList></Reference><Reference><Citation>Green, P. S. &amp; Simpkins, J. W. (2000) Ann. N.Y. Acad. Sci. 924, 93-98.</Citation><ArticleIdList><ArticleId IdType="pubmed">11193809</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffer, B. &amp; Olson, L. (1997) J. Neural Transm. 49, Suppl., 1-10.</Citation><ArticleIdList><ArticleId IdType="pubmed">9266409</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry, R. (1999) in Alzheimer's Disease, eds. Terry, R., Katzman, R., Bick, K. &amp; Sisodia, S. S. (Lippincott Williams &amp;Wilkins, Philadelphia), pp. 187-206.</Citation></Reference><Reference><Citation>Schmitt, F. A., Davis, D. G., Wekstein, D. R., Smith, C. D., Ashford, J. W. &amp; Markesbery, W. R. (2000) Neurology 55, 370-376.</Citation><ArticleIdList><ArticleId IdType="pubmed">10932270</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell, T. W., Mufson, E. J., Schneider, J. A., Cochran, E. J., Nissanov, J., Han, L. Y., Bienias, J. L., Lee, V. M., Trojanowski, J. Q., Bennett, D. A., et al. (2002) Ann. Neurol. 51, 182-189.</Citation><ArticleIdList><ArticleId IdType="pubmed">11835374</ArticleId></ArticleIdList></Reference><Reference><Citation>Schena, M., Heller, R. A., Theriault, T. P., Konrad, K., Lachenmeier, E. &amp; Davis, R. W. (1998) Trends Biotechnol 16, 301-306.</Citation><ArticleIdList><ArticleId IdType="pubmed">9675914</ArticleId></ArticleIdList></Reference><Reference><Citation>Barlow, C. &amp; Lockhart, D. J. (2002) Curr. Opin. Neurobiol. 12, 554-561.</Citation><ArticleIdList><ArticleId IdType="pubmed">12367635</ArticleId></ArticleIdList></Reference><Reference><Citation>Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G. &amp; Lukiw, W. J. (2002) J. Neurosci. Res. 70, 462-473.</Citation><ArticleIdList><ArticleId IdType="pubmed">12391607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsberg, S. D., Hemby, S. E., Lee, V. M., Eberwine, J. H. &amp; Trojanowski, J. Q. (2000) Ann. Neurol. 48, 77-87.</Citation><ArticleIdList><ArticleId IdType="pubmed">10894219</ArticleId></ArticleIdList></Reference><Reference><Citation>Loring, J. F., Wen, X., Lee, J. M., Seilhamer, J. &amp; Somogyi, R. (2001) DNA Cell Biol. 20, 683-695.</Citation><ArticleIdList><ArticleId IdType="pubmed">11788046</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinetti, G. M. (2001) J. Neurosci. Res. 65, 471-476.</Citation><ArticleIdList><ArticleId IdType="pubmed">11550214</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao, P. J., Zhu, M., Pyun, E. I., Brooks, A. I., Therianos, S., Meyers, V. E. &amp; Coleman, P. D. (2003) Neurobiol. Dis. 12, 97-109.</Citation><ArticleIdList><ArticleId IdType="pubmed">12667465</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickey, C. A., Loring, J. F., Montgomery, J., Gordon, M. N., Eastman, P. S. &amp; Morgan, D. (2003) J. Neurosci. 23, 5219-5226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6741153</ArticleId><ArticleId IdType="pubmed">12832546</ArticleId></ArticleIdList></Reference><Reference><Citation>Blalock, E. M., Chen, K. C., Sharrow, K., Herman, J. P., Porter, N. M., Foster, T. C. &amp; Landfield, P. W. (2003) J. Neurosci. 23, 3807-3819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742177</ArticleId><ArticleId IdType="pubmed">12736351</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, R. A., Galecki, A. &amp; Shmookler-Reis, R. J. (2001) J. Gerontol. A Biol. Sci. Med. Sci. 56, B52-B57.</Citation><ArticleIdList><ArticleId IdType="pubmed">11213267</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark, C. M., Sheppard, L., Fillenbaum, G. G., Galasko, D., Morris, J. C., Koss, E., Mohs, R. &amp; Heyman, A. (1999) Arch. Neurol. 56, 857-862.</Citation><ArticleIdList><ArticleId IdType="pubmed">10404988</ArticleId></ArticleIdList></Reference><Reference><Citation>Geddes, J. W., Tekirian, T. L., Soultanian, N. S., Ashford, J. W., Davis, D. G. &amp; Markesbery, W. R. (1997) Neurobiol. Aging 18, S99-S105.</Citation><ArticleIdList><ArticleId IdType="pubmed">9330997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman, B. T. (1997) Neurobiol. Aging 18, S27-S32.</Citation><ArticleIdList><ArticleId IdType="pubmed">9330982</ArticleId></ArticleIdList></Reference><Reference><Citation>Galasko, D., Hansen, L. A., Katzman, R., Wiederholt, W., Masliah, E., Terry, R., Hill, L. R., Lessin, P. &amp; Thal, L. J. (1994) Arch. Neurol. 51, 888-895.</Citation><ArticleIdList><ArticleId IdType="pubmed">8080388</ArticleId></ArticleIdList></Reference><Reference><Citation>Affymetrix (2001) Affymetrix Microarray Suite User's Guide (Affymetrix, Santa Clara, CA), Version 5.</Citation></Reference><Reference><Citation>Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) Nat. Genet. 25, 25-29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A. &amp; Levitt, P. (2000) Neuron 28, 53-67.</Citation><ArticleIdList><ArticleId IdType="pubmed">11086983</ArticleId></ArticleIdList></Reference><Reference><Citation>Prolla, T. A., Allison, D. B. &amp; Weindruch, R. (2001) J. Gerontol. A Biol. Sci. Med. Sci. 56, B327-B330.</Citation><ArticleIdList><ArticleId IdType="pubmed">11487590</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. &amp; Golani, I. (2001) Behav. Brain Res. 125, 279-284.</Citation><ArticleIdList><ArticleId IdType="pubmed">11682119</ArticleId></ArticleIdList></Reference><Reference><Citation>Stork, P. J. &amp; Schmitt, J. M. (2002) Trends Cell Biol. 12, 258-266.</Citation><ArticleIdList><ArticleId IdType="pubmed">12074885</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Monte, S. M., Sohn, Y. K. &amp; Wands, J. R. (1997) J. Neurol. Sci. 152, 73-83.</Citation><ArticleIdList><ArticleId IdType="pubmed">9395128</ArticleId></ArticleIdList></Reference><Reference><Citation>Slack, R. S., Skerjanc, I. S., Lach, B., Craig, J., Jardine, K. &amp; McBurney, M. W. (1995) J. Cell Biol. 129, 779-788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120451</ArticleId><ArticleId IdType="pubmed">7730411</ArticleId></ArticleIdList></Reference><Reference><Citation>Galderisi, U., Melone, M. A., Jori, F. P., Piegari, E., Di Bernardo, G., Cipollaro, M., Cascino, A., Peluso, G., Claudio, P. P. &amp; Giordano, A. (2001) Mol. Cell Neurosci. 17, 415-425.</Citation><ArticleIdList><ArticleId IdType="pubmed">11273639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipinski, M. M., Macleod, K. F., Williams, B. O., Mullaney, T. L., Crowley, D. &amp; Jacks, T. (2001) EMBO J. 20, 3402-3413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125524</ArticleId><ArticleId IdType="pubmed">11432828</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyajima, M., Nornes, H. O., Sato, K. &amp; Neuman, T. (1996) J. Neurosci. Res. 46, 108-113.</Citation><ArticleIdList><ArticleId IdType="pubmed">8892111</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kesteren, R. E., Syed, N. I., Munno, D. W., Bouwman, J., Feng, Z. P., Geraerts, W. P. &amp; Smit, A. B. (2001) J. Neurosci. 21, RC161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763132</ArticleId><ArticleId IdType="pubmed">11473132</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi, J. (2001) Trends Cell Biol. 11, S27-S31.</Citation><ArticleIdList><ArticleId IdType="pubmed">11684439</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell, E. M., Meiners, S., DiProspero, N. A. &amp; Geller, H. M. (1997) Cell Tissue Res. 290, 385-393.</Citation><ArticleIdList><ArticleId IdType="pubmed">9321702</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawcett, J. W. &amp; Asher, R. A. (1999) Brain Res. Bull. 49, 377-391.</Citation><ArticleIdList><ArticleId IdType="pubmed">10483914</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeon, R. J., Jurynec, M. J. &amp; Buck, C. R. (1999) J. Neurosci. 19, 10778-10788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6784959</ArticleId><ArticleId IdType="pubmed">10594061</ArticleId></ArticleIdList></Reference><Reference><Citation>Minamitani, T., Ariga, H. &amp; Matsumoto, K. (2002) Biol. Pharm. Bull. 25, 1472-1475.</Citation><ArticleIdList><ArticleId IdType="pubmed">12419962</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki, H. &amp; Fukushima, M. (1994) Anticancer Drugs 5, 131-138.</Citation><ArticleIdList><ArticleId IdType="pubmed">8049495</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, R. L., Gupta, S., Miele, A., Shiffman, D., Stein, J. L., Stein, G. S. &amp; van Wijnen, A. J. (2003) J. Biol. Chem. 278, 26589-26596.</Citation><ArticleIdList><ArticleId IdType="pubmed">12732645</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordin, S. &amp; Tan, X. (2001) Cell Signalling 13, 119-123.</Citation><ArticleIdList><ArticleId IdType="pubmed">11257456</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagarajan, R., Svaren, J., Le, N., Araki, T., Watson, M. &amp; Milbrandt, J. (2001) Neuron 30, 355-368.</Citation><ArticleIdList><ArticleId IdType="pubmed">11394999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei, Q., Miskimins, W. K. &amp; Miskimins, R. (2003) Mol. Cell. Biol. 23, 4035-4045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC156141</ArticleId><ArticleId IdType="pubmed">12773549</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, J. Z., Wu, Q., Smith, A., Grundke-Iqbal, I. &amp; Iqbal, K. (1998) FEBS Lett. 436, 28-34.</Citation><ArticleIdList><ArticleId IdType="pubmed">9771888</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard, C. M., Claudio, P. P., De Luca, A., Stiegler, P., Jori, F. P., Safdar, N. M., Caputi, M., Khalili, K. &amp; Giordano, A. (2000) Cancer Res. 60, 2737-2744.</Citation><ArticleIdList><ArticleId IdType="pubmed">10825149</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand, B. &amp; Raff, M. (2000) BioEssays 22, 64-71.</Citation><ArticleIdList><ArticleId IdType="pubmed">10649292</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh, L. Y., Denninger, A., Colvin, J. S., Vyas, A., Tole, S., Ornitz, D. M. &amp; Bansal, R. (2003) J. Neurosci. 23, 883-894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6741926</ArticleId><ArticleId IdType="pubmed">12574417</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagri, A., Cheng, H. J., Yaron, A., Pleasure, S. J. &amp; Tessier-Lavigne, M. (2003) Cell 113, 285-299.</Citation><ArticleIdList><ArticleId IdType="pubmed">12732138</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn, T. B., Brown, M. D., Wilcox, C. L., Raper, J. A. &amp; Bamburg, J. R. (1999) J. Neurosci. 19, 1965-1975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782563</ArticleId><ArticleId IdType="pubmed">10066250</ArticleId></ArticleIdList></Reference><Reference><Citation>Spassky, N., de Castro, F., Le Bras, B., Heydon, K., Queraud-LeSaux, F., Bloch-Gallego, E., Chedotal, A., Zalc, B. &amp; Thomas, J. L. (2002) J. Neurosci. 22, 5992-6004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6757938</ArticleId><ArticleId IdType="pubmed">12122061</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak, H. &amp; Braak, E. (1998) J. Neural Transm. Suppl. 53, 127-140.</Citation><ArticleIdList><ArticleId IdType="pubmed">9700651</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>